Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADIPOQ,Adiponectin,38013,-0.256845769094832,0.00601192910780865,-0.268629150146137,-0.245062388043527,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGRP,Agouti-related protein,40516,0.277335016029031,0.00464854415782014,0.268223869479703,0.286446162578358,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCN1,CCN family member 1,40280,0.379170730462278,0.00686319609096328,0.36571886612399,0.392622594800566,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CES1,Liver carboxylesterase 1,40352,0.299210447732315,0.00693187450411717,0.285623973704245,0.312796921760385,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F7,Coagulation factor VII,40376,0.111628915958302,0.00274008426578153,0.10625835079737,0.116999481119233,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FURIN,Furin,40411,0.133302634972849,0.00306123362093148,0.127302617075824,0.139302652869875,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GCG,Pro-glucagon,39980,0.48134569131889,0.0113566064756456,0.459086742626624,0.503604640011155,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GHR,Growth hormone receptor,37671,0.105644689382054,0.00262537938129956,0.100498945794707,0.110790432969401,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,37942,0.300417934532962,0.00678959734294015,0.287110323740799,0.313725545325124,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGSF9,Protein turtle homolog A,37990,0.287198976936375,0.0072606723079539,0.272968059212785,0.301429894659965,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INHBC,Inhibin beta C chain,40332,0.155338381266748,0.00390724959316804,0.147680172064138,0.162996590469357,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,37987,0.0812992895174639,0.00202422687389632,0.0773318048446271,0.0852667741903007,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LDLR,Low-density lipoprotein receptor,40356,0.428128327633359,0.00372232544715168,0.420832569756942,0.435424085509776,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LPL,Lipoprotein lipase,40359,-0.193252174995227,0.00414047128688127,-0.201367498717515,-0.18513685127294,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MFGE8,Lactadherin,40332,0.224119954936517,0.00364814836352382,0.21696958414401,0.231270325729024,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPY,Pro-neuropeptide Y,40489,0.353220487029553,0.00577400731088716,0.341903432700214,0.364537541358892,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,40332,0.118368067518546,0.00287196352397655,0.112739019011552,0.12399711602554,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRAP1,Proline-rich acidic protein 1,37998,0.157759207891033,0.00385072296184231,0.150211790885822,0.165306624896244,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RARRES2,Retinoic acid receptor responder protein 2,40424,0.180171895238126,0.00419779802639972,0.171944211106382,0.188399579369869,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,40489,0.130412142123804,0.00300088021858272,0.124530416895381,0.136293867352226,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40403,0.152201301205012,0.00386504257073115,0.144625817766379,0.159776784643645,1.1125369292536e-308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTH,Parathyroid hormone,37572,0.274260180741658,0.0072166514387348,0.260115543921738,0.288404817561579,6.49742034631955e-300
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL27,C-C motif chemokine 27,40359,0.207191292612454,0.00548397917163024,0.196442693436059,0.217939891788849,3.23902395242e-299
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRP1,Neuropilin-1,40424,-0.0968090288864834,0.00259845316917127,-0.101901997098059,-0.0917160606749077,2.1079622817767e-291
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPM,Carboxypeptidase M,40415,0.117386559233583,0.00316169287097161,0.111189641206478,0.123583477260687,1.75457403213827e-289
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL23,C-C motif chemokine 23,40422,0.139769019781581,0.00378305232562938,0.132354237223347,0.147183802339815,8.54827050965716e-287
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DSG2,Desmoglein-2,40332,-0.0918899673040926,0.00248744250412012,-0.0967653546121681,-0.0870145799960172,1.15773548597893e-286
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD4,T-cell surface glycoprotein CD4,40309,0.10335525132673,0.00281869380501687,0.0978306114688973,0.108879891184563,1.30190706732926e-282
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMPRSS15,Enteropeptidase,40305,0.309249043901519,0.00849865619874147,0.292591677751986,0.325906410051053,1.63835897367515e-278
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPR37,Prosaposin receptor GPR37,40042,0.223892606652742,0.00620672436936923,0.211727426888779,0.236057786416706,9.49169531491565e-274
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJB1,DnaJ homolog subfamily B member 1,40305,0.291651271372582,0.00811249441387568,0.275750782321386,0.307551760423779,3.6486988066021e-272
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC39A5,Zinc transporter ZIP5,40341,0.177668286019974,0.00495262619923953,0.167961138669464,0.187375433370483,4.51927235649737e-271
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMAD1,Mothers against decapentaplegic homolog 1,39980,0.266707877388673,0.00743384255763901,0.252137545975701,0.281278208801646,6.83908216752136e-271
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PROC,Vitamin K-dependent protein C,40372,0.0825971697323045,0.0023372370749874,0.0780161850653292,0.0871781543992798,1.94132520072586e-263
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APCS,Serum amyloid P-component,37882,0.116231000817896,0.00331070948163792,0.109742010233886,0.122719991401906,2.04353684648804e-258
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,40305,0.253011915292291,0.00733112324644982,0.238642913729249,0.267380916855332,9.88493187246105e-252
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,40305,0.333889809454052,0.00971854418432033,0.314841462852784,0.352938156055319,1.47375977422578e-249
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLTP,Phospholipid transfer protein,40461,-0.107967499795302,0.0031792348448575,-0.114198800091223,-0.101736199499382,3.63270448163316e-244
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD300LG,CMRF35-like molecule 9,40332,-0.118725320331552,0.00350205674988624,-0.125589351561329,-0.111861289101775,2.71134635196955e-243
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40330,0.323562522068957,0.0095824291528836,0.304780960929305,0.342344083208609,1.95497033346742e-241
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASGR1,Asialoglycoprotein receptor 1,40228,0.091544519478156,0.00272486521197039,0.0862037836626941,0.096885255293618,4.66583162794106e-239
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40042,0.169983464646985,0.00506010132328069,0.160065666053354,0.179901263240615,6.40337296705861e-239
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,40141,0.454470875157792,0.0137566297949915,0.427507880759609,0.481433869555976,1.90721637623421e-231
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40489,0.106619801295434,0.003230564889188,0.100287894112626,0.112951708478243,3.63531320228134e-231
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TTR,Transthyretin,37871,0.078299884447373,0.00236703164286638,0.0736605024273549,0.0829392664673912,9.51712333006213e-231
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL6,C-X-C motif chemokine 6,40516,0.238005506589342,0.00723465083887606,0.223825590945145,0.252185422233539,9.18474267140359e-230
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,40305,0.205438885330436,0.00627963204932129,0.193130806513766,0.217746964147106,3.17685721145257e-227
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFI,Complement factor I,38013,0.0610530925771649,0.00186393208502994,0.0573997856905062,0.0647063994638236,1.53020533969893e-226
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRIP2,Cysteine-rich protein 2,40228,0.10943613368872,0.00336396841796587,0.102842755589506,0.116029511787933,9.37116823098096e-225
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40042,0.25383847679784,0.00783331173461804,0.238485185797989,0.269191767797692,5.4109702412991e-223
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GUSB,Beta-glucuronidase,40419,0.176241138831877,0.00544689006234226,0.165565234309687,0.186917043354068,1.6220019125842e-222
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFH,Complement factor H,37301,0.068713482350925,0.0021435007225409,0.0645122209347448,0.0729147437671052,5.49224820830103e-217
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F9,Coagulation factor IX,40372,0.0532604570641952,0.0016757153786361,0.0499760549220685,0.056544859206322,5.34952466467845e-215
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40471,0.154538250559038,0.00486778202505886,0.144997397789923,0.164079103328153,1.45706476296074e-214
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINF1,Pigment epithelium-derived factor,37790,0.076553818553433,0.00240695614166562,0.0718361845157684,0.0812714525910976,4.8488367148381e-214
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MXRA8,Matrix remodeling-associated protein 8,37671,-0.0901798881797155,0.0028351747607704,-0.0957368307108255,-0.0846229456486055,5.30176992009278e-214
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPIND1,Heparin cofactor 2,37981,0.0808150431264457,0.00254241949971904,0.0758319009069964,0.085798185345895,6.57020270107018e-214
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,40443,0.0907741867802136,0.00287906434698695,0.0851312206601192,0.096417152900308,9.94608974838557e-212
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFPI,Tissue factor pathway inhibitor,40309,0.0914010396383629,0.00290491947102022,0.0857073974751633,0.0970946818015626,7.68270084184774e-211
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAMR1,Inactive serine protease PAMR1,40332,0.0817828509289368,0.00260756206899652,0.0766720292737036,0.08689367258417,1.47492821656349e-209
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGR3,Anterior gradient protein 3,39963,0.174160190674805,0.00555555437500467,0.163271304099796,0.185049077249814,3.19839404986062e-209
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTN3,Contactin-3,40332,0.102207952855457,0.00326441034034285,0.0958097085883854,0.108606197122529,7.25937015826088e-209
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PON3,Serum paraoxonase/lactonase 3,40422,-0.0799084546245804,0.00255854518715379,-0.0849232031914018,-0.074893706057759,6.65425655279062e-208
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFP,Properdin,38013,0.0634776759211559,0.00203526360952255,0.0594885592464917,0.0674667925958201,2.65985379856352e-206
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSTA1,Glutathione S-transferase A1,40333,0.240396991819135,0.00772808908232658,0.225249937217775,0.255544046420495,2.84318305236134e-206
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,40500,-0.339431092051754,0.0109626983070114,-0.360917980733496,-0.317944203370011,1.70570621376579e-204
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G10,Group 10 secretory phospholipase A2,40228,-0.172811939825233,0.00559145023968193,-0.183771182295009,-0.161852697355456,1.09678037332067e-203
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOS3,"Nitric oxide synthase, endothelial",39961,0.157863740572913,0.00510693651136764,0.147854145010633,0.167873336135194,1.18783631925176e-203
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1RN,Interleukin-1 receptor antagonist protein,40313,0.158916072011982,0.00514774780681026,0.148826486310634,0.16900565771333,2.87239375798318e-203
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA5,Plasma serine protease inhibitor,37835,0.0940392835868215,0.00306584400060555,0.0880302293456346,0.100048337828008,9.74926990738628e-200
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,40497,-0.181443810220998,0.00594181142174585,-0.193089760607619,-0.169797859834376,4.03412062055171e-199
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,39980,0.166704283648699,0.00547892936464334,0.155965582093998,0.1774429852034,1.47027307360292e-197
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBP5,Retinol-binding protein 5,40305,0.156280225740003,0.00517075295211219,0.146145549953863,0.166414901526143,3.77967785186969e-195
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSTA3,Glutathione S-transferase A3,39980,0.21226339989851,0.00708088886448787,0.198384857724113,0.226141942072906,5.52185249938441e-192
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SKAP1,Src kinase-associated phosphoprotein 1,40192,0.204708521503783,0.00686251773714708,0.191257986738975,0.218159056268592,3.01851293535038e-190
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACY1,Aminoacylase-1,40359,0.165976729152413,0.00557147001936069,0.155056647914466,0.17689681039036,8.1449149478899e-190
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLAT,Tissue-type plasminogen activator,40490,0.136217815088963,0.00459087543355331,0.127219699239198,0.145215930938727,2.13033037586287e-188
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UPB1,Beta-ureidopropionase,37990,0.252843286830384,0.00852892527516332,0.236126593291064,0.269559980369704,3.4852226577803e-187
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40228,0.204719831848348,0.00692467553654838,0.191147467796713,0.218292195899983,5.27782933740016e-187
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHBG,Sex hormone-binding globulin,37987,-0.149194993504944,0.00503722444605731,-0.159067953419216,-0.139322033590672,7.3940467003635e-187
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40160,0.126789680838886,0.00430631030160137,0.118349312647748,0.135230049030025,1.64046626726822e-185
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCHE,Cholinesterase,37748,0.0779244971614362,0.00264054003553848,0.0727490386917808,0.0830999556310916,1.86117410963432e-185
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLI1,Friend leukemia integration 1 transcription factor,39980,0.297985049239636,0.0101831530827482,0.27802606919745,0.317944029281823,2.81944109402643e-183
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,40536,-0.0947471627029709,0.00324369146432294,-0.101104797973044,-0.0883895274328979,8.3733650408835e-183
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGSF8,Immunoglobulin superfamily member 8,40359,0.0818393319610363,0.0028020571252837,0.0763472999954803,0.0873313639265924,1.01798914881108e-182
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF21,Fibroblast growth factor 21,40453,0.319944320872031,0.0109783197946231,0.29842681407457,0.341461827669493,5.57651951972722e-182
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERP44,Endoplasmic reticulum resident protein 44,40280,0.0698208619963907,0.00239922691609734,0.0651183772408399,0.0745233467519415,1.994389211825e-181
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA4,Kallistatin,37781,0.0652171697509554,0.00224014278196592,0.0608264898983021,0.0696078496036086,1.04544418797418e-180
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMBP,Protein AMBP,40470,0.0544527773054234,0.00187733593460399,0.0507731988735996,0.0581323557372472,2.49979068410409e-180
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHMP6,Charged multivesicular body protein 6,37990,0.151357974933057,0.00521154367037734,0.141143349339117,0.161572600526997,5.89277675257121e-180
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLA,Alpha-galactosidase A,37642,0.0982256434085583,0.00338437019182726,0.0915922778325768,0.10485900898454,1.38330405795426e-179
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BPIFB1,BPI fold-containing family B member 1,40261,-0.167223991165554,0.00577738494752467,-0.178547665662702,-0.155900316668406,1.52822553279933e-179
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNCA,Alpha-synuclein,37671,0.30790557006733,0.0106504559062743,0.287030676491032,0.328780463643627,2.9520848084439e-178
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,P4HB,Protein disulfide-isomerase,40266,0.104472754075351,0.0036241549828191,0.0973694103090251,0.111576097841676,3.87318282523409e-178
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,39887,0.0498965722250997,0.00173406696608991,0.0464978009715635,0.053295343478636,2.09266825390983e-177
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,40311,0.0510115096418339,0.00177831051123422,0.0475260210398148,0.054496998243853,1.80306565054784e-176
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHA1,Ephrin type-A receptor 1,40400,0.0917576504215831,0.00320239353107222,0.0854809591006815,0.0980343417424847,4.14552590932885e-176
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AFM,Afamin,38013,0.0496060333715249,0.00174542874383724,0.0461849930336039,0.0530270737094459,1.22888031956705e-172
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGFR2,Fibroblast growth factor receptor 2,40411,0.0568906481861861,0.00200665469941125,0.05295760497534,0.0608236913970321,1.49378292794073e-172
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KYNU,Kynureninase,40516,0.118395480921754,0.00418612558002698,0.110190674784901,0.126600287058607,8.84447842545156e-172
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LATS1,Serine/threonine-protein kinase LATS1,37598,0.223927907762211,0.00789796196273918,0.208447902315243,0.23940791320918,1.07729110822227e-171
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL16,C-C motif chemokine 16,40536,0.139448450784476,0.00496865463933095,0.129709887691388,0.149187013877565,3.00185458879736e-169
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM20A,Pseudokinase FAM20A,37990,0.0743595796527241,0.00265000353651656,0.0691655727211516,0.0795535865842966,1.89140872118008e-168
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAB2,Stabilin-2,37998,0.0731570770173162,0.002621202384494,0.0680195203437079,0.0782946336909244,1.01098466600654e-166
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL16,Pro-interleukin-16,40516,0.105220665153172,0.00379281919787149,0.0977867395253444,0.112654590781001,1.68618573778058e-165
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMAD2,Mothers against decapentaplegic homolog 2,37900,0.176038923489886,0.00636742853302192,0.163558763565163,0.188519083414609,1.10083721219124e-163
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNAPIN,SNARE-associated protein Snapin,37959,0.148582316177271,0.00538037767984792,0.138036775924769,0.159127856429773,2.3838414469293e-163
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUMB,Protein numb homolog,37598,0.215837235258526,0.00782542167749795,0.20049940877063,0.231175061746422,7.63823771800487e-163
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F10,Coagulation factor X,37987,0.0670364003262894,0.00243318117473409,0.0622673652238105,0.0718054354287682,1.2665605019027e-162
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39980,0.173933425927624,0.00633174487571764,0.161523205971218,0.186343645884031,2.94848150571676e-162
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,37920,0.214150615220144,0.00781030505699894,0.198842417308426,0.229458813131862,4.143414249945e-161
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,40044,0.143085703590964,0.00523917331861383,0.132816923886481,0.153354483295448,1.84003012922042e-160
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CREG1,Protein CREG1,40145,0.0924101683541608,0.0033887607403671,0.0857681973030413,0.0990521394052803,5.09799969076452e-160
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL17,C-X-C motif chemokine 17,40516,0.105953978229396,0.00389379630078317,0.0983221374798609,0.113585818978931,1.94080515084759e-159
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37901,0.357063077334929,0.0130932130758559,0.331400379706251,0.382725774963606,1.95921859031688e-159
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C9,Complement component C9,37987,-0.124508426393866,0.00456951043459028,-0.133464666845663,-0.115552185942069,3.35987578961956e-159
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDHR5,Cadherin-related family member 5,40359,0.0995461226159301,0.00366373007956422,0.0923652116599843,0.106727033571876,5.99116202610719e-159
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAT2,Linker for activation of T-cells family member 2,40305,0.311355273555686,0.0114870990132846,0.288840559489648,0.333869987621723,3.41158492344271e-158
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPY30,Protein dpy-30 homolog,40414,0.151447104620712,0.00559128006976885,0.140488195683965,0.162406013557459,5.21505982654008e-158
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLUL1,Clusterin-like protein 1,40338,-0.115924235147366,0.00428356874113621,-0.124320029879993,-0.107528440414739,1.00296560447659e-157
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F11R,Junctional adhesion molecule A,40332,0.143550897060872,0.00531581275900294,0.133131904053227,0.153969890068518,4.51664085974097e-157
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOMO1,Nodal modulator 1,40332,0.0600066333374711,0.00222710848804318,0.0556415007009065,0.0643717659740358,2.16974972313011e-156
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENO3,Beta-enolase,37628,0.144001126268423,0.00533598767191022,0.133542590431479,0.154459662105367,3.56851452913537e-156
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRP,Gastrin-releasing peptide,37628,0.13768341210924,0.00511664091840748,0.127654795909161,0.147712028309319,2.61223551640661e-155
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRSS8,Prostasin,40293,0.10185022066064,0.00379900343861395,0.0944041739209567,0.109296267400323,6.96574884894068e-155
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DTYMK,Thymidylate kinase,37990,0.174175307505433,0.00650356575517119,0.161428318625297,0.186922296385568,5.26813173186094e-154
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37990,0.182436387924994,0.00682075616377606,0.169067705843993,0.195805070005995,1.26044259479471e-153
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL18R1,Interleukin-18 receptor 1,40516,0.0815070574293592,0.00306505208615637,0.0754995553404927,0.0875145595182256,1.63294555292429e-152
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37562,0.170104026659207,0.00639498773604304,0.157569850696563,0.182638202621852,7.08731078489726e-152
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL22,C-C motif chemokine 22,40204,0.128323125976531,0.00484260218612641,0.118831625691723,0.137814626261339,2.04445871030317e-151
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNAP29,Synaptosomal-associated protein 29,40411,0.22680767894733,0.00858144996083334,0.209988037024097,0.243627320870564,1.06522522879462e-150
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SYAP1,Synapse-associated protein 1,37671,0.140514560162696,0.00531113919580568,0.130104727338917,0.150924392986475,2.42696019576882e-150
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCS1,Neuronal calcium sensor 1,40489,0.0708246748754961,0.00269134809761501,0.0655496326041707,0.0760997171468215,1.85675947614964e-149
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAA80,N-alpha-acetyltransferase 80,37572,0.293464674620429,0.0111730411098159,0.271565514045189,0.315363835195668,3.12439458180273e-148
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTSS1,Protein MTSS 1,37901,0.272580696412374,0.0104110051222629,0.252175126372738,0.292986266452009,2.04132217492732e-147
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EEF1D,Elongation factor 1-delta,37990,0.225405301594698,0.00861320862436508,0.208523412690942,0.242287190498453,2.62581715766929e-147
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RTN4R,Reticulon-4 receptor,40489,0.0833360198034952,0.00319090427770251,0.0770818474191983,0.0895901921877921,2.77930636207243e-147
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40305,0.101727695095203,0.00390747459575343,0.094069044887526,0.109386345302879,2.38224342391387e-146
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPTL2,Angiopoietin-related protein 2,40377,0.0976847268540735,0.00375464872267096,0.0903256153576384,0.105043838350509,3.54304021601593e-146
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ABL1,Tyrosine-protein kinase ABL1,40305,0.166194582526871,0.00639545506036069,0.153659490608564,0.178729674445178,7.85751807081648e-146
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37628,0.140193794194856,0.00538660655316654,0.12963604535065,0.150751543039063,1.15738147237547e-145
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,40203,0.216980072614885,0.008370476040598,0.200573939575313,0.233386205654457,4.07759651121001e-145
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CKB,Creatine kinase B-type,37998,-0.147383390483837,0.00570246356861799,-0.158560219078329,-0.136206561889346,8.12020218917369e-144
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL13,C-X-C motif chemokine 13,40471,0.15394114245075,0.00597593122783468,0.142228317244194,0.165653967657306,2.03043820012833e-143
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDHR2,Cadherin-related family member 2,40305,0.185590057938617,0.00723830239659876,0.171402985241284,0.199777130635951,4.23749068039314e-142
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYH9,Myosin-9,37998,0.270858901934168,0.0105749199610332,0.250132058810543,0.291585745057793,2.44015138621967e-141
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39980,0.148527602032191,0.00581074556335979,0.137138540728005,0.159916663336376,3.4005383847062e-141
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCLY,Selenocysteine lyase,40434,0.11459481164576,0.00449681710848219,0.105781050113135,0.123408573178385,1.88640987220196e-140
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40305,0.0737960010765506,0.00289870025754462,0.0681145485717631,0.079477453581338,3.68427623708106e-140
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,40490,0.0503504885355081,0.00197802483313159,0.0464735598625702,0.054227417208446,3.72136150192068e-140
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AP1G2,AP-1 complex subunit gamma-like 2,37900,0.190969671182953,0.00750597654684562,0.176257957151136,0.205681385214771,1.66658225587411e-139
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SELPLG,P-selectin glycoprotein ligand 1,40341,0.0662348500705621,0.00260869225769064,0.0611218132454885,0.0713478868956358,1.92921072912931e-139
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FYB1,FYN-binding protein 1,40311,0.218740721396461,0.00861758354520798,0.201850257647854,0.235631185145069,2.31555623892685e-139
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KDR,Vascular endothelial growth factor receptor 2,40411,0.0603421848948644,0.00238248401512317,0.055672516225223,0.0650118535645058,8.66238338225496e-139
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37628,0.20118703493202,0.00795825237839914,0.185588860270358,0.216785209593682,9.81637044454573e-138
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YES1,Tyrosine-protein kinase Yes,40305,0.269813031136044,0.0106946057846265,0.248851603798176,0.290774458473912,9.92871789986356e-138
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40411,0.0820418404420323,0.00325702765963499,0.0756580662291477,0.0884256146549169,2.50123962247141e-137
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MLN,Promotilin,40341,0.210710502995569,0.00837114422649177,0.194303060311645,0.227117945679493,3.98595055438986e-137
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HEG1,Protein HEG homolog 1,37671,0.0627467646019963,0.00248920493975736,0.0578679229200719,0.0676256062839207,5.54290568305864e-137
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CANT1,Soluble calcium-activated nucleotidase 1,40312,0.0480386058422169,0.00192003219367995,0.0442753427426042,0.0518018689418296,1.5649304471599e-135
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCN2,Ficolin-2,40291,0.0966997552492302,0.00387034414397041,0.0891138807270482,0.104285629771412,3.65557008068303e-135
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMP4,Metalloproteinase inhibitor 4,40332,-0.0955151155906982,0.0038372920850067,-0.103036208077311,-0.0879940231040851,3.40859918739026e-134
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PROS1,Vitamin K-dependent protein S,38013,0.058924104644847,0.00236571220736303,0.0542873087184154,0.0635609005712785,6.16664163539302e-134
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL4A1,Collagen alpha-1(IV) chain,40359,-0.0930197389087016,0.00374295731585235,-0.100355935247772,-0.085683542569631,8.670811015852e-134
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSD,Cathepsin D,39243,0.0935567238501613,0.00376512718253113,0.0861770745724002,0.100936373127922,1.45729673025713e-133
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOST,Sclerostin,40330,0.0905940454294092,0.00364965128858534,0.083440728903782,0.0977473619550365,1.76643167679956e-133
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YTHDF3,YTH domain-containing family protein 3,40044,0.197910465031016,0.00800223129783235,0.182226091687265,0.213594838374768,1.71206860133514e-132
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,40536,0.090961957896127,0.00369406770302464,0.0837215851981987,0.0982023305940553,1.88714533950381e-131
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPPC,C-type natriuretic peptide,40341,0.0996996731965741,0.00407151269743152,0.0917195083096083,0.10767983808354,5.14398339440715e-130
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLKB1,Plasma kallikrein,37721,0.0581027652491724,0.00237544799285906,0.0534468871831687,0.0627586433151762,2.82949244379048e-129
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA3F,Semaphorin-3F,40359,0.0596354011489166,0.00244429667527534,0.0548445796653769,0.0644262226324562,4.21100354140713e-129
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NHLRC3,NHL repeat-containing protein 3,37370,0.0736610089844485,0.00301325260059374,0.0677550338872848,0.0795669840816122,4.67255456492242e-129
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HGF,Hepatocyte growth factor,40516,0.0788148471387433,0.00323539383713505,0.0724734752179586,0.085156219059528,9.68419674091706e-129
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MVK,Mevalonate kinase,40044,0.176118335413488,0.00724195979693657,0.161924094211492,0.190312576615484,2.97585950613461e-128
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37671,0.111517350452579,0.00458226037646257,0.102536120114712,0.120498580790445,5.1397874614994e-128
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SORD,Sorbitol dehydrogenase,40417,0.153389444337293,0.00631745535870578,0.14100723183423,0.165771656840357,6.54272891455752e-128
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,37900,0.117095873346582,0.00482421518106084,0.107640411591703,0.126551335101461,2.06565254749447e-127
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATRN,"Attractin, Isoform 2",38013,0.0374442082351361,0.00154349135494399,0.0344189651794458,0.0404694512908263,2.66358775476022e-127
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTBS,Di-N-acetylchitobiase,37819,0.0620145618480246,0.00255646342482216,0.0570038935353732,0.0670252301606761,3.00946123048428e-127
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SORT1,Sortilin,40330,0.0829198545265356,0.00343252629259827,0.076192102993043,0.0896476060600282,1.20107050171896e-126
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,40403,0.0620753041158606,0.00257033252245059,0.0570374523718575,0.0671131558598638,1.36231156513003e-126
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXLNA,Alpha-taxilin,40228,0.203018953151543,0.00841680512686169,0.186522015102894,0.219515891200192,2.9030390539737e-126
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJA2,DnaJ homolog subfamily A member 2,40471,0.18673741749856,0.00775522918078699,0.171537168304217,0.201937666692902,7.10546554747266e-126
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TJAP1,Tight junction-associated protein 1,40411,0.187277009693795,0.00779598149572331,0.171996885962177,0.202557133425412,2.70293092530594e-125
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DKK1,Dickkopf-related protein 1,40471,0.135181316670893,0.00563675657282769,0.124133273788151,0.146229359553635,6.73436239021291e-125
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,37628,0.16399466017104,0.00683580752344088,0.150596477425096,0.177392842916984,1.6029278717508e-124
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SARG,Specifically androgen-regulated gene protein,37931,0.245678684820865,0.0102517274049935,0.225585299107078,0.265772070534652,2.54698401934429e-124
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINF2,Alpha-2-antiplasmin,37755,0.0306543776842893,0.00128096035182989,0.0281436953947027,0.0331650599738759,5.98852214734225e-124
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KHK,Ketohexokinase,37628,0.14567143861927,0.00609073569957915,0.133733596648095,0.157609280590445,8.71654072187442e-124
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40403,-0.0846816745547661,0.0035494809778279,-0.0916386572713088,-0.0777246918382234,1.22876285894411e-123
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HJV,Hemojuvelin,37959,0.103766562389585,0.0043551956147871,0.0952303789846021,0.112302745794568,6.0825966576068e-123
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40341,0.21399465624981,0.00900230945512151,0.196350129717772,0.231639182781849,9.16176149863735e-123
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40228,0.121797242025794,0.00512919566920663,0.111744018514149,0.131850465537439,1.69243159204253e-122
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUCB2,Nucleobindin-2,40447,0.0833024099135637,0.00351053607126391,0.0764217592138865,0.090183060613241,2.32062386364328e-122
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD2AP,CD2-associated protein,40359,0.143414917509205,0.00604792247891511,0.131560989450531,0.155268845567878,3.45280630770463e-122
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40305,0.101832670323412,0.00429445920468244,0.093415530282234,0.110249810364589,3.55109093113593e-122
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGRN,Agrin,40422,0.0742197251530686,0.00313766974213279,0.0680698924584883,0.0803695578476489,1.30052867107235e-121
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40305,0.216934366774248,0.00918138327705652,0.198938855551217,0.234929877997279,2.48422956476757e-121
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EHBP1,EH domain-binding protein 1,37990,0.166702307287279,0.00704866676949919,0.152886920419061,0.180517694155498,3.31769812710524e-121
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BECN1,Beclin-1,37628,0.136375261729654,0.00576592670207323,0.125074045393591,0.147676478065718,3.70861001277819e-121
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37922,0.187116615241356,0.00792009572184391,0.171593227626542,0.20264000285617,5.97292742592142e-121
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADH1B,All-trans-retinol dehydrogenase,37671,0.164692358202489,0.0069821115136199,0.151007419635794,0.178377296769184,1.56290734275925e-120
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37663,0.101333813422588,0.00429740587067,0.0929108979160744,0.109756728929101,1.8600833647888e-120
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,37671,0.184526778197385,0.00784904959423026,0.169142640992694,0.199910915402076,9.20464344201208e-120
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CES3,Carboxylesterase 3,40305,0.152008394486411,0.00648536423718438,0.139297080581529,0.164719708391292,1.83868991458764e-119
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37942,0.0890542048172077,0.00379925216693738,0.0816076705700104,0.096500739064405,3.96439992444679e-119
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCTN1,Dynactin subunit 1,40489,0.145458501303997,0.00621913721769842,0.133268992357308,0.157648010250686,5.40216685719383e-119
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LSP1,Lymphocyte-specific protein 1,40341,0.0883463007822139,0.00377975724257658,0.0809379765867638,0.095754624977664,7.96730120741716e-119
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PYY,Peptide YY,37562,0.210013870887336,0.00898355693555927,0.19240609929364,0.227621642481032,1.88203979939082e-118
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGT1,Glutathione hydrolase 1 proenzyme,40303,0.106763036682889,0.00458248538738877,0.0977813653236072,0.115744708042171,4.4346016111985e-118
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC1B,C-type lectin domain family 1 member B,40471,0.211177550775943,0.00911076986586944,0.193320441838839,0.229034659713048,6.19704517526994e-117
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TARBP2,RISC-loading complex subunit TARBP2,39961,0.172848673114847,0.00745750510762845,0.158231963103895,0.187465383125799,7.31869128228756e-117
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD63,CD63 antigen,40203,0.114257530879821,0.00493117936248614,0.104592419329348,0.123922642430294,8.06655324922955e-117
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EZR,Ezrin,40471,0.0517290595465616,0.00223955193278847,0.0473395377582962,0.056118581334827,3.80817134269525e-116
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAPK9,Mitogen-activated protein kinase 9,40341,0.0937989801471569,0.00406241172163978,0.0858366531727429,0.101761307121571,4.76666147729701e-116
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP20,Centrosomal protein 20,39980,0.160740354194893,0.00696677690745988,0.147085471456271,0.174395236933514,7.71416370131675e-116
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAXX,Protein PAXX,37671,0.0989747297287064,0.00428582516301178,0.0905745124092033,0.107374947048209,1.03394288239979e-115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40277,0.227081947491601,0.0098555535117085,0.207765062608652,0.246398832374549,1.43334131754276e-115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP4,"Fatty acid-binding protein, adipocyte",40536,0.106896201101057,0.00464507737447909,0.0977918494470782,0.116000552755036,2.51284727796393e-115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSO,Cathepsin O,40516,0.0654105541076768,0.00284762788056921,0.0598292034617612,0.0709919047535924,6.53193252144113e-115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AP3S2,AP-3 complex subunit sigma-2,37942,0.101228726307045,0.00440961608364426,0.0925858787831021,0.109871573830988,1.95810251360835e-114
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37901,0.0649063371436483,0.00283115450720596,0.0593572743095246,0.0704553999777719,3.91175111305622e-114
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HBEGF,Proheparin-binding EGF-like growth factor,40434,0.15675963487395,0.00685474436646497,0.143324335915679,0.170194933832221,6.36032808273541e-114
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37901,0.0583931645310185,0.00255000545242546,0.0533951538442646,0.0633911752177724,7.02765144334628e-114
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS9,Galectin-9,40350,0.0695311586083584,0.00304419694891238,0.0635645325884901,0.0754977846282266,1.21516124570862e-113
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IDUA,Alpha-L-iduronidase,40489,0.0976714111392662,0.00428139279234155,0.0892798812662767,0.106062941012256,2.15902675096015e-113
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CES2,Cocaine esterase,40305,0.115513504911404,0.00506385075089125,0.105588357439657,0.125438652383151,2.34496481301206e-113
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THOP1,Thimet oligopeptidase,40288,0.0645907239895391,0.00283653887975583,0.0590311077852177,0.0701503401938606,5.75818313677414e-113
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,39980,0.144387697965008,0.00634006765623546,0.131961165358787,0.15681423057123,5.85913486596865e-113
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37714,0.2406122858653,0.010565916552168,0.21990308942305,0.261321482307549,1.22550329957169e-112
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AXIN1,Axin-1,40341,0.20195125779384,0.00889584398731426,0.184515403578704,0.219387112008976,2.61525767961577e-112
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL17,C-C motif chemokine 17,40333,0.194343764352261,0.00857104192704181,0.177544522175259,0.211143006529263,4.77934001456808e-112
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A4,Protein S100-A4,40411,0.12377571795115,0.00546550450521701,0.113063329120925,0.134488106781375,8.62872730657159e-112
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37860,0.232314697624794,0.0102479399125022,0.21222873539629,0.252400659853299,1.11396766079784e-111
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRHBP,Corticotropin-releasing factor-binding protein,40357,0.0601183431119595,0.00265676856853739,0.0549110767176262,0.0653256095062928,1.30872389023792e-111
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP5,Fatty acid-binding protein 5,40432,0.148054039080919,0.00654730532392138,0.135221320646033,0.160886757515805,1.80143461606492e-111
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LBR,Delta(14)-sterol reductase LBR,40471,0.140270046116956,0.00620993027788475,0.128098582772302,0.152441509461611,3.0849272735554e-111
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,39980,0.106126918453335,0.00469720970414226,0.0969203874332158,0.115333449473453,3.08859417439998e-111
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,39980,0.149702636967027,0.00662738187043624,0.136712968500972,0.162692305433082,3.45424218482699e-111
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STC1,Stanniocalcin-1,40471,0.0883701637840698,0.0039212111725803,0.0806845898858124,0.0960557376823272,9.55037037482134e-111
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FETUB,Fetuin-B,40372,0.0719030227952013,0.00319947740701261,0.0656320470774565,0.078173998512946,3.88324607816948e-110
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,40341,0.0803277104649551,0.00357485282743471,0.073320998923183,0.0873344220067271,4.19100184657701e-110
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,37942,0.228027326737747,0.0101585841299603,0.208116501843025,0.24793815163247,1.38189651336089e-109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SELP,P-selectin,40403,0.122118910112029,0.00545932299687187,0.11141863703816,0.132819183185898,3.75204811566587e-109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37990,0.0614377717706448,0.00274813172220476,0.0560514335951235,0.0668241099461662,9.6571371522178e-109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAB2,Disabled homolog 2,40489,0.233085786749507,0.0104409685418369,0.212621488407507,0.253550085091507,9.7097423524873e-109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL18A1,Collagen alpha-1(XVIII) chain,40391,0.0489804854510946,0.00219530028191486,0.0446776968985415,0.0532832740036478,1.30663353035613e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,40341,0.223851893116497,0.0100392998054858,0.204174865497744,0.243528920735249,1.78916407914297e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTD,Biotinidase,38013,0.0436300332679906,0.00195555803686925,0.0397971395157269,0.0474629270202543,2.55437764584501e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39886,0.115641754149019,0.00519381648610911,0.105461873836245,0.125821634461793,4.0168665899597e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GH1,Somatotropin,40330,-0.369358201145343,0.0165959234157183,-0.401886211040151,-0.336830191250535,4.41404410409062e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,40411,0.0511094346240916,0.00229722454168099,0.0466068745223969,0.0556119947257864,5.10722435797456e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFB1,Transforming growth factor beta-1 proprotein,40502,0.0797921890538278,0.00359022755524592,0.0727553430455458,0.0868290350621098,8.31384600118757e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD6,T-cell differentiation antigen CD6,40502,0.111822329739757,0.00503431509024719,0.101955072162872,0.121689587316641,1.09622839884147e-107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPY,Pancreatic prohormone,40337,0.211671823040956,0.00955564328132995,0.19294276220955,0.230400883872363,4.19840660853304e-107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARF6,ADP-ribosylation factor 6,37901,0.220659057674135,0.00994898651639267,0.201159044102005,0.240159071246264,4.4985242866547e-107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MCAM,Cell surface glycoprotein MUC18,40403,-0.071304387372742,0.00322362737744514,-0.0776226970325344,-0.0649860777129495,8.2684552774884e-107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37959,0.200922788350999,0.00907359676585758,0.183138538689918,0.21870703801208,9.42342283667914e-107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPL,N-acetylneuraminate lyase,37990,0.090289296557997,0.00408383674997162,0.0822849765280527,0.0982936165879414,1.96236527395538e-106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT18,"Keratin, type I cytoskeletal 18",40305,0.160791420890196,0.00729214280304417,0.14649882099623,0.175084020784163,3.74735700844186e-106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37671,0.0443705197819061,0.00201265000006461,0.0404257257817795,0.0483153137820328,8.35407895466955e-106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP85,Centrosomal protein of 85 kDa,39980,0.131304168376367,0.00596992234969349,0.119603120570968,0.143005216181766,1.32974464306814e-105
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EGLN1,Egl nine homolog 1,40341,0.110509265159648,0.00502978246760491,0.100650891523142,0.120367638796153,2.01489452378642e-105
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLXNA4,Plexin-A4,40341,0.171616863166172,0.00782209007678779,0.156285566615668,0.186948159716676,3.90236890004477e-105
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLIN1,Perilipin-1,39961,0.0736516884928672,0.00335828298551729,0.0670694538412534,0.0802339231444811,5.11748846245703e-105
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,37990,0.13569145357897,0.00618054472600057,0.123577585916009,0.147805321241931,5.26314011723139e-105
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,37628,0.155719128444215,0.00709677558276193,0.141809448302002,0.169628808586429,7.66126896148344e-105
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTSS2,Protein MTSS 2,37900,0.20428086075116,0.00931611701258448,0.186021271406495,0.222540450095826,9.58142321554459e-105
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERBIN,Erbin,40305,0.212263978189813,0.00970041375373764,0.193251167232487,0.231276789147138,1.35613228832108e-104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATG16L1,Autophagy-related protein 16-1,37901,0.175260817901475,0.00801811233445423,0.159545317725945,0.190976318077005,4.18134914955469e-104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNIP1,TNFAIP3-interacting protein 1,37942,0.182774718834077,0.00839973041569226,0.16631124721932,0.199238190448833,3.30517047432221e-103
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FN1,Fibronectin,38013,0.0539992503508731,0.00248357778749449,0.0491314378873839,0.0588670628143623,4.63731404823095e-103
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OTUD7B,OTU domain-containing protein 7B,37959,0.130147097285483,0.00599078976254387,0.118405149350897,0.141889045220069,6.87972317949538e-103
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF4B,Eukaryotic translation initiation factor 4B,40228,0.121733585212779,0.00561384000042401,0.110730458811948,0.132736711613611,9.04622196010394e-103
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,40341,0.212897040665229,0.00982612155850955,0.19363784241055,0.232156238919908,1.2940912970419e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAMDC4,Apical endosomal glycoprotein,37900,0.11230665070363,0.0051766320709904,0.102160451844489,0.122452849562772,1.30421555398488e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R9B,Neurabin-2,40516,0.192726836952522,0.00889792392999288,0.175286906049736,0.210166767855308,1.43660793628452e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,40044,0.141796444346322,0.00654515646950081,0.1289679376661,0.154624951026544,1.44187143797153e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KAZN,Kazrin,37901,0.213291265118135,0.00983632453797822,0.194012069023698,0.232570461212572,1.638702214357e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YOD1,Ubiquitin thioesterase OTU1,37562,0.130673756246468,0.00602798668392913,0.118858902345967,0.142488610146969,2.0663058632471e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MME,Neprilysin,40305,0.166461731397314,0.00770636778853509,0.151357250531785,0.181566212262843,5.22255528640776e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40516,0.204596429032274,0.00947975027438989,0.18601611849447,0.223176739570078,7.31140500052522e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,40305,0.174405946591122,0.00808212710857545,0.158564977458315,0.19024691572393,8.17676818854879e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCR,Breakpoint cluster region protein,40341,0.185988869854535,0.00863073491256845,0.169072629425901,0.20290511028317,1.51139067581137e-101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL5,C-X-C motif chemokine 5,40309,0.23347992987853,0.0108889760034095,0.212137536911848,0.254822322845213,1.45090829300133e-100
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSIP1,PC4 and SFRS1-interacting protein,40341,0.12599527823137,0.00588111492056284,0.114468292987067,0.137522263475674,2.10587953869911e-100
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37562,0.150665044365036,0.00703297570263259,0.136880411987876,0.164449676742196,4.23388906788015e-100
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VEGFC,Vascular endothelial growth factor C,40411,0.113162050954924,0.00529572450991361,0.102782430915493,0.123541670994355,6.55356101126146e-100
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BACH1,Transcription regulator protein BACH1,40341,0.147068601331617,0.00688583699110711,0.133572360829047,0.160564841834187,8.25790239493811e-100
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDCD5,Programmed cell death protein 5,40471,0.118111281041678,0.00553247685803097,0.107267626399937,0.128954935683419,9.78976217893598e-100
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACE2,Angiotensin-converting enzyme 2,40042,0.0988442211822298,0.00463776407876617,0.0897542035878481,0.107934238776611,2.2454125093111e-99
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LEP,Leptin,40359,0.129188848769535,0.00606264889125223,0.11730605694268,0.141071640596389,2.28567528706343e-99
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRELD2,Protein disulfide isomerase CRELD2,40396,0.104622010921843,0.00491132508179945,0.0949958137615159,0.11424820808217,2.61214763882165e-99
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH2D1A,SH2 domain-containing protein 1A,40341,0.110706217044725,0.00520000841480524,0.100514200551707,0.120898233537743,3.42771127138303e-99
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDLIM7,PDZ and LIM domain protein 7,40422,0.251862790030826,0.0118528716264186,0.228631161643046,0.275094418418606,7.81571680269687e-99
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPB2,Carboxypeptidase B2,37981,0.0450453796371921,0.00211839060954061,0.0408933340424925,0.0491974252318916,1.00248076607062e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OGFR,Opioid growth factor receptor,40305,0.0665188615711924,0.00313223760214982,0.0603796758709788,0.0726580472714061,1.03025224412689e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNAP23,Synaptosomal-associated protein 23,40359,0.175091809629975,0.00825082041190345,0.158920201622644,0.191263417637305,1.41103832107564e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SRPK2,SRSF protein kinase 2,40341,0.166400434331901,0.00784337886387575,0.151027411758704,0.181773456905097,1.5943518842188e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,37628,0.207362417722515,0.00976059770630586,0.188231646218156,0.226493189226875,1.63786281953366e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AAMDC,Mth938 domain-containing protein,37628,0.108218458724228,0.00509534056049696,0.098231591225654,0.118205326222802,1.8584614891817e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PHACTR2,Phosphatase and actin regulator 2,37959,0.22897926856945,0.0108166446728627,0.20777864501064,0.250179892128261,7.09397535082757e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IKBKG,NF-kappa-B essential modulator,40341,0.183770004045915,0.00872332893628874,0.166672279330789,0.200867728761041,3.42984040627682e-97
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDGFC,Platelet-derived growth factor C,39980,0.0593634874655999,0.002819271603707,0.0538377151223342,0.0648892598088656,4.53186094399984e-97
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINH1,Serpin H1,37714,0.25751973279695,0.012222314319309,0.233563996731105,0.281475468862796,5.81620381434445e-97
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLB1,Beta-galactosidase,40228,0.0814026692417411,0.00387134841754457,0.0738148263433538,0.0889905121401285,7.88822668376993e-97
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TOP2B,DNA topoisomerase 2-beta,37598,0.157583797281143,0.00750337034925345,0.142877191396606,0.17229040316568,2.39776575728638e-96
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40305,0.087161211778863,0.00415808121577297,0.079011372595948,0.095311050961778,2.9459003434523e-96
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HCLS1,Hematopoietic lineage cell-specific protein,40516,0.111123329096168,0.00530838218116737,0.10071890002108,0.121527758171256,5.05579350517885e-96
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STK11,Serine/threonine-protein kinase STK11,40042,0.144683990240616,0.00692162507951537,0.131117605084766,0.158250375396466,1.02577034955193e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,40109,0.041093495124023,0.00196964772729799,0.0372329855785189,0.044954004669527,2.2782848382532e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSME1,Proteasome activator complex subunit 1,40216,0.0744547111968515,0.00357721737475038,0.0674433651423407,0.0814660572513622,6.14461622895287e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLSCR3,Phospholipid scramblase 3,37919,0.118399962432597,0.00568223503425516,0.107262781765457,0.129537143099737,6.2661398891016e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BID,BH3-interacting domain death agonist,40341,0.132281578930058,0.00635656104388334,0.119822719284046,0.144740438576069,6.42833015834229e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37959,0.166222339018613,0.00798178918802417,0.150578032210086,0.18186664582714,7.85529272226597e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLA2,Src-like-adapter 2,37959,0.203810561439268,0.00978811070980934,0.184625864448042,0.222995258430495,8.33654251838262e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCXR,L-xylulose reductase,40411,0.10315410398127,0.00496031565659866,0.0934318852943362,0.112876322668203,8.49810558780446e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ELN,Elastin,37990,0.0694226803722012,0.0033354717476298,0.0628851557468468,0.0759602049975557,9.88493685300279e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCK2,Cytoplasmic protein NCK2,40422,0.205922970423727,0.00991418096325545,0.186491175735747,0.225354765111708,1.4176462798796e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,39961,0.0989284541446915,0.00476705373766112,0.0895850288188757,0.108271879470507,2.22021842606106e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB11FIP3,Rab11 family-interacting protein 3,37990,0.210817389229402,0.0101571703003341,0.190909335440747,0.230725443018057,3.18320408020496e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40044,0.0863821874812091,0.00416774586218938,0.078213405591318,0.0945509693711003,3.71276978366335e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAT,Linker for activation of T-cells family member 1,40516,0.148580310246579,0.0071710015388718,0.13452514723039,0.162635473262767,3.91224976045712e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUGP1,SURP and G-patch domain-containing protein 1,37901,0.0780023710479387,0.00376001101649209,0.0706327494556142,0.0853719926402632,4.00190942531709e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPTL7,Angiopoietin-related protein 7,40489,0.0727824480487032,0.00351507644018778,0.0658928982259351,0.0796719978714712,5.19673382689247e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,37942,0.0724188344089909,0.00349436489948921,0.065569879205992,0.0792677896119898,6.02178547122117e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TANK,TRAF family member-associated NF-kappa-B activator,40044,0.137010409315818,0.00661881327568668,0.124037535295472,0.149983283336164,6.30504019947233e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39980,0.161771806657727,0.00781941109618432,0.146445760909205,0.177097852406248,8.07214813949298e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40411,0.187077288569317,0.00904645019175159,0.169346246193484,0.20480833094515,8.93512491613457e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40228,0.185772325432535,0.00898322792506895,0.1681651986994,0.20337945216567,9.17708847626706e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAT5B,Signal transducer and activator of transcription 5B,40305,0.270014128419693,0.0130614868331632,0.244413614226693,0.295614642612693,1.05035699092434e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL7,C-C motif chemokine 7,40341,0.119314313740457,0.00577593847290481,0.107993474333563,0.13063515314735,1.4242696695409e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPD52L2,Tumor protein D54,37671,0.211863930755469,0.0102458732685456,0.19178201914912,0.231945842361819,1.63977129621055e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL5,C-C motif chemokine 5,40403,0.196315265662715,0.00950795587394996,0.177679672149773,0.214950859175657,1.71181869709262e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DOK2,Docking protein 2,40359,0.236351647303394,0.0114615805766108,0.213886949373237,0.258816345233551,2.92780935324707e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,37900,0.223722874813003,0.010844391959565,0.202467866572255,0.24497788305375,4.0344045966148e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL10,C-X-C motif chemokine 10,40422,0.131960265283032,0.00640935740340334,0.119397924772361,0.144522605793702,5.57131231428634e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37990,0.150646659155813,0.00731299708721839,0.136313184864865,0.164980133446761,7.26408565318997e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40042,0.188432958225792,0.00915960600843559,0.170480130449258,0.206385786002326,8.29708868848176e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD5,T-cell surface glycoprotein CD5,40470,0.0651717688869583,0.00317495692748318,0.0589488533090913,0.0713946844648253,1.91358321160521e-92
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MINK1,Misshapen-like kinase 1,37942,0.180572328081364,0.00879428487860565,0.163335529719297,0.197809126443431,2.8000981854562e-92
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HEXIM1,Protein HEXIM1,40341,0.159037285427267,0.00775613211204153,0.143835266487665,0.174239304366868,3.04539297701297e-92
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VEGFA,Vascular endothelial growth factor A,40456,0.114316309301751,0.00557898043538752,0.103381507648391,0.125251110955111,3.96730927652429e-92
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ORM1,Alpha-1-acid glycoprotein 1,37950,0.0386307779650429,0.00188433713286634,0.0349374771846249,0.0423240787454609,5.28308274381832e-92
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,USO1,General vesicular transport factor p115,40305,0.175312210121466,0.00859973109876882,0.158456737167879,0.192167683075053,3.29384007384055e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,40332,0.0442067055918452,0.00217840284390456,0.0399370360177922,0.0484763751658981,2.06495333908759e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MASP1,Mannan-binding lectin serine protease 1,40192,0.0458205889976149,0.0022591267796825,0.0413927005094372,0.0502484774857926,2.61431800398021e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,37901,0.175306263443939,0.00863443524885366,0.158382770356186,0.192229756531692,2.70556402472564e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40305,0.085096879379407,0.00419772401342389,0.0768693403130962,0.0933244184457178,3.14620925865664e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINE1,Plasminogen activator inhibitor 1,40536,0.129906048066032,0.00641389739783313,0.117334809166279,0.142477286965785,4.35643983558765e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OXT,Oxytocin-neurophysin 1,40471,0.254417193302455,0.0125623157479079,0.229795054436556,0.279039332168355,4.52775158463564e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFX1,Transcriptional repressor NF-X1,37562,0.13082589278949,0.00645104293683067,0.118181848633302,0.143469936945678,4.63929280911834e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCN2,CCN family member 2,40358,0.110552972253504,0.00546947975109966,0.0998327919413486,0.121273152565659,1.01097005786329e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL13,C-C motif chemokine 13,40483,0.133710539395574,0.00662267841788089,0.120730089696528,0.146690989094621,1.5579446068447e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOXO1,Forkhead box protein O1,40341,0.162214904474539,0.00803513141002731,0.146466046910885,0.177963762038193,1.64418123847472e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUOM,Fucose mutarotase,37671,0.119766992210068,0.00592733544885978,0.108149414730303,0.131384569689833,1.93756075579421e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SELE,E-selectin,40536,0.0958081771428863,0.00474874680286213,0.0865006334092765,0.105115720876496,2.05008458426835e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37942,0.132291693516285,0.00655124807408467,0.119451247291079,0.145132139741491,2.33100295380066e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTDH,Protein LYRIC,37598,0.175498633859035,0.00869627794772591,0.158453929081492,0.192543338636578,3.21823163454526e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP43,Centrosomal protein 43,39934,0.132073929498639,0.00655455638927386,0.119226998975663,0.144920860021616,3.73534379736175e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRELD1,Protein disulfide isomerase CRELD1,37671,0.0720954142071995,0.00357538167036367,0.0650876661332867,0.0791031622811123,4.37366790683398e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCTN3,Tectonic-3,37990,0.055855791771536,0.00277246201129547,0.0504217662293969,0.0612898173136752,5.77072753330968e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37901,0.207934670843728,0.0103403838107311,0.187667518574695,0.228201823112761,1.23011834312806e-88
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CMIP,C-Maf-inducing protein,37900,0.156827235850764,0.00780209442216713,0.141535130783317,0.172119340918212,1.44822219173887e-88
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,37901,0.110227583803096,0.00548815534799207,0.0994707993210318,0.120984368285161,1.98081514226671e-88
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37990,0.122773370445985,0.00613244194591747,0.110753784231987,0.134792956659983,6.82146135834335e-88
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37959,0.146233623835468,0.00730973573351359,0.131906541797781,0.160560705873154,9.19460002772587e-88
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARSB,Arylsulfatase B,40305,0.104179893795236,0.00521542761158328,0.0939576556765326,0.114402131913939,1.08005763444758e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PON2,Serum paraoxonase/arylesterase 2,40042,0.065244254961702,0.00326676920117481,0.0588413873273994,0.0716471225960046,1.19863854385376e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIAE,Sialate O-acetylesterase,40374,0.0888643292241161,0.00445018513171312,0.0801419663659584,0.0975866920822738,1.21691750727364e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,37942,0.118399491304689,0.00592471642036826,0.106787047120767,0.13001193548861,1.39777667290058e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNMBP,Dynamin-binding protein,40228,0.116797240036504,0.00585253728297907,0.105326266961865,0.128268213111143,1.57295881079541e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGF,Placenta growth factor,40516,0.049708136800044,0.00249609538752898,0.0448157898404872,0.0546004837596008,3.43710126346683e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37900,0.13697603939073,0.00687211570349006,0.123506692611889,0.15044538616957,3.86221367087725e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RABEP1,Rab GTPase-binding effector protein 1,37671,0.149515379486255,0.00750220296913585,0.134811061666748,0.164219697305761,4.26816227973877e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40305,0.143490240571635,0.00722796013183322,0.129323438713241,0.157657042430028,1.19052620443425e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,39961,0.0504059746207351,0.00253999263504647,0.045427589056044,0.0553843601854261,1.44269762875745e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBPL,FK506-binding protein-like,37901,0.111253553313905,0.00560294633148664,0.100271778504191,0.122235328123619,1.67993974757485e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKT1S1,Proline-rich AKT1 substrate 1,39961,0.12715259817772,0.00641731131968987,0.114574667991128,0.139730528364312,2.62794513888336e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,40341,0.210283355276968,0.0106189177357366,0.189470276514924,0.231096434039011,3.08693056504947e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGA5,Integrin alpha-5,40332,0.0468271185989914,0.00236671878683865,0.0421883497767877,0.0514658874211952,4.2995790604569e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC27,Cell division cycle protein 27 homolog,39980,0.114301872769792,0.00578744535492853,0.102958479874132,0.125645265665452,9.04185618134712e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,QDPR,Dihydropteridine reductase,40290,0.0821384521185875,0.00416593718095615,0.0739732152439135,0.0903036889932616,1.64120504490995e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AP3B1,AP-3 complex subunit beta-1,37901,0.143225617873938,0.00725719180179353,0.129001521942422,0.157449713805453,1.7184920899971e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37901,0.192450169606185,0.00975201110507485,0.173336227840238,0.211564111372132,1.76104288459739e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNCG,Gamma-synuclein,40228,0.125301520975865,0.00636118293534728,0.112833602422584,0.137769439529145,2.38210275895648e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSZ,Cathepsin Z,40345,0.0581650463364764,0.00295356913262646,0.0523760508365285,0.0639540418364242,2.56352463066567e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MUC13,Mucin-13,39961,0.0939115502143865,0.00476985870058914,0.0845626271612318,0.103260473267541,2.96525319083938e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFRA1,GDNF family receptor alpha-1,40453,0.0520932893311528,0.00264762193462226,0.0469039503392932,0.0572826283230125,3.54548444666143e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,39980,0.120030715882808,0.00610008636886422,0.108074546599835,0.131986885165782,3.70025349956223e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,37942,0.17028891188656,0.00865370341363074,0.153327653195843,0.187250170577276,5.14441832856292e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40536,0.0534066208130054,0.00271977147072716,0.0480758687303802,0.0587373728956306,7.43115033025522e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,METAP2,Methionine aminopeptidase 2,40453,0.109876188776085,0.00559605349942637,0.0989079239172097,0.120844453634961,7.79085860876621e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIGYF2,GRB10-interacting GYF protein 2,37959,0.141659112176433,0.00720687626206414,0.127533634702787,0.155784589650079,7.82401978217116e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EREG,Proepiregulin,40192,0.149779578113982,0.00762870524092135,0.134827315841776,0.164731840386187,8.2299177985235e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAK4,Serine/threonine-protein kinase PAK 4,39961,0.113866767435613,0.00581139295793597,0.102476437238058,0.125257097633167,1.83372270041814e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40359,0.0518613719493135,0.00265184094657818,0.0466637636940203,0.0570589802046067,3.51485675275657e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40192,0.207106397426453,0.0106134437120887,0.186304047750759,0.227908747102147,8.21471255765175e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SRP14,Signal recognition particle 14 kDa protein,40305,0.109962643997427,0.00563780566667899,0.0989125448907362,0.121012743104118,9.61547120287231e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,37671,0.132235717537633,0.0067739476254079,0.118958780191834,0.145512654883433,1.08830105398479e-83
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH2,Cadherin-2,40359,0.0652942105673708,0.00335383337483924,0.0587206971526858,0.0718677239820557,1.89612002932698e-83
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJB6,DnaJ homolog subfamily B member 6,37557,0.156651883932781,0.00803635128181021,0.140900635420433,0.172403132445129,1.9074412406581e-83
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40414,0.107776627829877,0.00553955654017333,0.0969190970111377,0.118634158648617,2.39762497343394e-83
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCBP2,Poly(rC)-binding protein 2,37959,0.132547282664354,0.00682777270015227,0.119164848172055,0.145929717156652,8.03062918801775e-83
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAMBP,STAM-binding protein,40192,0.119165794617124,0.00614834029908574,0.107115047630916,0.131216541603332,1.01061146273955e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THPO,Thrombopoietin,40042,0.0703317819966207,0.00363083676889758,0.0632153419295814,0.0774482220636599,1.27399701584631e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",40042,0.168788446441641,0.00872627330233803,0.151684950769058,0.185891942114223,2.17095925275985e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ISM1,Isthmin-1,40341,0.0716986446841877,0.00370977223459386,0.0644274911043837,0.0789697982639917,2.79915468195971e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GOLM2,Protein GOLM2,40471,0.041238738859153,0.00213425241105575,0.0370556041334837,0.0454218735848223,3.00315137762398e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CST3,Cystatin-C,40372,0.0515654204761379,0.00266914712622517,0.0463338921087365,0.0567969488435392,3.23743111728502e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NIT2,Omega-amidase NIT2,37936,0.138920638361465,0.00718791557382491,0.124832323836768,0.153008952886162,4.09528692548171e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WASHC3,WASH complex subunit 3,37942,0.137708928157853,0.0071330278579267,0.123728193556316,0.151689662759389,6.0946730556496e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAG1,Dystroglycan,40422,0.0867158390544772,0.00450038280409102,0.0778950887584588,0.0955365893504956,8.3568385795775e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NSFL1C,NSFL1 cofactor p47,40471,0.122136267271044,0.00634134225931615,0.109707236442784,0.134565298099304,9.69884033471637e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD36,Platelet glycoprotein 4,37598,0.0814045299672702,0.00422349271014164,0.0731264842553926,0.0896825756791478,1.17869474375359e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHSG,Alpha-2-HS-glycoprotein,37987,0.0495892591810712,0.00257346342667698,0.0445452708647843,0.054633247497358,1.19813879595824e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PXN,Paxillin,39961,0.09468867644946,0.00491828206017346,0.08504884361152,0.1043285092874,1.20657106405104e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VAMP8,Vesicle-associated membrane protein 8,37598,0.162457958830747,0.00844133203917883,0.145912948033956,0.179002969627537,2.02010564224478e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SYTL4,Synaptotagmin-like protein 4,37990,0.133844290621842,0.00696425231672959,0.120194356081052,0.147494225162632,3.10353342056989e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40422,0.189252524201847,0.00986199538917893,0.169923013239057,0.208582035164638,3.66601546172759e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37901,0.0930401760929515,0.00484594571340242,0.0835421224946828,0.10253822969122,4.51793139145392e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYDGF,Myeloid-derived growth factor,37990,0.182900776617553,0.00954916152887282,0.164184420020962,0.201617133214144,1.05169069646308e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMAD5,Mothers against decapentaplegic homolog 5,40305,0.0375703177909022,0.00196400971351313,0.0337208587524165,0.041419776829388,1.16340884373938e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNST,Consortin,40359,0.196220073357832,0.0102608526241648,0.176108802214469,0.216331344501195,1.29820703297638e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ELOA,Elongin-A,40305,0.0926779927797286,0.00484937427623043,0.0831732191983169,0.10218276636114,1.63214538269493e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HAO1,Hydroxyacid oxidase 1,40489,0.237004496742739,0.0124040370081775,0.212692584206711,0.261316409278766,1.72741003205417e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDGFB,Platelet-derived growth factor subunit B,40422,0.155702899979888,0.00814923744983658,0.139730394578208,0.171675405381567,1.76209443826102e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOD,Apolipoprotein D,37345,-0.0810903739046885,0.00424063821216779,-0.0894020248005373,-0.0727787230088396,2.13096535106781e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,37714,0.0959338138590703,0.00501972614378543,0.0860951506172508,0.10577247710089,2.43266834637946e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNX15,Sorting nexin-15,37671,0.0985280686094579,0.00515814481197512,0.0884181047779867,0.108638032440929,2.94960154591859e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37901,0.161806281489942,0.00850510682880973,0.145136272105475,0.178476290874409,1.18258576034006e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLXNB3,Plexin-B3,40310,0.084373077735523,0.00444205222632039,0.075666655371935,0.0930795000991109,1.45496574187126e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEC31A,Protein transport protein Sec31A,37628,0.138569320626294,0.00728849035873361,0.124283879523177,0.152854761729412,1.56705792402732e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CMC1,COX assembly mitochondrial protein homolog,37990,0.16276454973817,0.00856340773597328,0.145980270575663,0.179548828900678,1.615097588064e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,40283,0.0582119443713477,0.00306589752157993,0.0522027852290511,0.0642211035136444,1.67088013889447e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VNN1,Pantetheinase,37987,0.130810432314465,0.0068865886983297,0.117312718465739,0.144308146163191,2.02014616660811e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GZMA,Granzyme A,40516,0.0634932440497421,0.00334983498906359,0.0569275674711774,0.0700589206283067,2.98664165536583e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37628,0.12667013050493,0.00667521654488861,0.113586706076949,0.139753554932912,3.04830391161164e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAG4,BAG family molecular chaperone regulator 4,37598,0.0878663553229442,0.00463266398632505,0.0787863339097471,0.0969463767361413,3.65317816899586e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,A1BG,Alpha-1B-glycoprotein,38013,0.0315241163309365,0.00166700197654963,0.0282567924568993,0.0347914402049738,9.57617626250471e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDT5,ADP-sugar pyrophosphatase,40332,0.0936523292587709,0.00496519376102424,0.0839205494871633,0.103384109030378,1.69413669914585e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SKAP2,Src kinase-associated phosphoprotein 2,40422,0.187323261978864,0.00993189296682238,0.167856751763893,0.206789772193836,1.70650861654134e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PARP1,Poly [ADP-ribose] polymerase 1,40341,0.0970591243482735,0.00515185318937398,0.0869614920971005,0.107156756599447,2.54713827581706e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGCC,Regulator of cell cycle RGCC,37959,0.134411402680622,0.00712906757466924,0.12043843023427,0.148384375126974,2.74918851090354e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COMMD1,COMM domain-containing protein 1,37628,0.110588292665782,0.00586577653138374,0.0990913706642702,0.122085214667294,2.95687487070905e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TAX1BP1,Tax1-binding protein 1,37942,0.115021351168192,0.00610490598448985,0.103055735438592,0.126986966897792,3.51499197056072e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CIRBP,Cold-inducible RNA-binding protein,37901,0.170686926352633,0.00906862679450654,0.1529124178354,0.188461434869866,5.03081602727347e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TALDO1,Transaldolase,37966,0.0799865053784857,0.00425002239770109,0.0716564614789915,0.0883165492779798,5.10981380438807e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VWA1,von Willebrand factor A domain-containing protein 1,40453,0.0750716012187774,0.00399469399347488,0.0672420009915667,0.0829012014459882,5.96442999301787e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,40042,0.164655524815089,0.00876640504374113,0.147473370929356,0.181837678700821,7.57746325711445e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40379,0.0531428441084253,0.00283062183349917,0.0475948253147669,0.0586908629020836,8.47195981116624e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AZI2,5-azacytidine-induced protein 2,37959,0.0985143955638919,0.00524532075101913,0.0882335668918944,0.108795224235889,1.04485332305653e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HYOU1,Hypoxia up-regulated protein 1,40536,0.0386335737192181,0.00206038029860389,0.0345952283339545,0.0426719191044817,1.28333437056366e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DLK1,Protein delta homolog 1,40536,0.0944592067743468,0.00504551553047813,0.0845699963346097,0.104348417214084,2.19876426025068e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYN,Tyrosine-protein kinase Lyn,40305,0.149313435638863,0.00797971326521331,0.133673197639045,0.164953673638681,2.70430415392264e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NT5E,5'-nucleotidase,40411,0.103035119453239,0.00550677198824385,0.0922418463562814,0.113828392550197,2.72052815836059e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGSF3,Immunoglobulin superfamily member 3,40305,0.0614270125907681,0.00328468067779188,0.0549890384622961,0.0678649867192402,3.28321525698979e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40333,0.10889280268241,0.00582645526609029,0.0974729503608726,0.120312655003947,4.05473471273819e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40516,0.0460288505397425,0.00246593924015003,0.0411956096290484,0.0508620914504366,6.10909700444367e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,37563,0.0878772692904931,0.0047034519046997,0.0786585035572817,0.0970960350237045,6.6931276775912e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MITD1,MIT domain-containing protein 1,40228,0.171450539206367,0.00919296443728206,0.153432328909294,0.189468749503439,8.41612233114688e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,37628,0.0555987047908616,0.00298226842732831,0.0497534586732981,0.0614439509084251,1.38465010302757e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAGK,N-acetyl-D-glucosamine kinase,37608,0.100452755386261,0.0053962570157895,0.0898760916353139,0.111029419137209,2.30561451091297e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBCC,Tubulin-specific chaperone C,40228,0.143747913071661,0.0077306755822371,0.128595788930476,0.158900037212846,2.32931118466392e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37671,0.103784871384139,0.00557870388460284,0.0928506117703172,0.11471913099796,2.81231950859376e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMN,Protein amnionless,40044,0.0843188339322715,0.00453744340133804,0.0754254448656489,0.093212222998894,2.94100374770955e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,40350,0.087335581488614,0.00470176099519509,0.0781201299380316,0.0965510330391964,3.27176025133282e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAS6,Growth arrest-specific protein 6,40429,-0.0453529579117584,0.00244742668006577,-0.0501499142046873,-0.0405560016188295,7.25300807487505e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD99L2,CD99 antigen-like protein 2,40332,0.0418975648667477,0.00226378241056378,0.0374605513420427,0.0463345783914527,1.11616826647721e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIT1,ARF GTPase-activating protein GIT1,37598,0.172525315852318,0.00931304445964329,0.154271748711417,0.190778882993219,1.18563285277942e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TDRKH,Tudor and KH domain-containing protein,39961,0.149703517958212,0.00809078919046663,0.133845571144897,0.165561464771526,1.27188617378454e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37959,0.115784122503517,0.00625343075858039,0.1035273982167,0.128040846790335,1.33658676439367e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1S,Complement C1s subcomponent,38013,0.0365335082224199,0.00197529339547763,0.0326619331672838,0.0404050832775561,1.90580452120331e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM5,Tripartite motif-containing protein 5,40341,0.149591220546943,0.00810436283548352,0.133706669389396,0.165475771704491,2.74571923856822e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40341,0.176074046562834,0.00956771456004436,0.157321326025147,0.194826767100521,7.45244814866389e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,37942,0.055851618558915,0.00303408506571133,0.0499048118301208,0.0617984252877092,9.29426490875282e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL11,Eotaxin,40516,0.065836786531278,0.00358382556349546,0.0588124884268269,0.0728610846357291,1.31253326595224e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH2B3,SH2B adapter protein 3,39980,0.170181301090529,0.00930093236531686,0.151951473654508,0.18841112852655,5.21289492565407e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASE4,Ribonuclease 4,37575,0.0476753908999037,0.0026049135814435,0.0425697602802744,0.0527810215195329,6.59620495619424e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40280,0.131695830570095,0.00720457981370829,0.117574854135227,0.145816807004963,6.93712849932328e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAT2,Signal transducer and activator of transcription 2,37598,0.133723879843234,0.00732213095398796,0.119372503173418,0.148075256513051,1.32308165985772e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MENT,Protein MENT,37671,-0.0377275900933956,0.00206663186561905,-0.041778188550009,-0.0336769916367823,1.49246146131835e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGAP45,Rho GTPase-activating protein 45,37671,0.14300511422797,0.00783758463174385,0.127643448349752,0.158366780106188,1.76909928129729e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS1,Galectin-1,40359,0.058415332998202,0.00320625109431741,0.0521310808533398,0.0646995851430641,2.02605234487031e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GORASP2,Golgi reassembly-stacking protein 2,37901,0.0813192400025122,0.00446318981810511,0.0725713879590262,0.0900670920459982,2.72137001311546e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C3,Complement C3,37360,0.0816578017940752,0.00448107189813809,0.0728749008737245,0.0904407027144259,2.81227246256246e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRKL,Crk-like protein,40374,0.184284731466012,0.010139572122731,0.164411170105459,0.204158292826565,4.47411275758135e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40341,0.124723989933691,0.00686390793351931,0.111270730383993,0.138177249483389,4.8062643416071e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COCH,Cochlin,37990,0.0807671086735787,0.00444188795991468,0.072061008272146,0.0894732090750115,5.18621717243741e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DTNB,Dystrobrevin beta,37878,0.0723356803698411,0.0039787942192481,0.0645372437001148,0.0801341170395673,5.53708755831907e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MPHOSPH8,M-phase phosphoprotein 8,40042,0.129237798633453,0.00711688961881884,0.115288694980568,0.143186902286338,6.11347394849292e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DGKA,Diacylglycerol kinase alpha,37598,0.0941226555855005,0.00517837174579129,0.0839730469637496,0.104272264207251,6.22271908494221e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40273,0.0466873217035998,0.00257355577759526,0.0416431523795131,0.0517314910276865,8.24004439027996e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37714,0.183845501490168,0.0101290997027824,0.163992466072714,0.203698536907621,9.68474143214109e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALDH1A1,Retinal dehydrogenase 1,40332,0.0911551440918586,0.00503019428013386,0.0812959633027962,0.101014324880921,1.16070761294723e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,40341,0.138229468713818,0.00763027660608398,0.123274126565893,0.153184810861742,1.28295436330305e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,37901,0.0917027169068797,0.00506163488900122,0.0817819125244373,0.101623521289322,1.69296977679385e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM13A,Protein FAM13A,37901,0.116100717561989,0.00641642107972449,0.103524532245729,0.128676902878249,2.54086284823319e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNLR1,Interferon lambda receptor 1,40341,0.0644286632045765,0.0035645445217072,0.0574421559420304,0.0714151704671227,2.66243683286414e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,40411,0.0544425812466479,0.00301552200280109,0.0485321581211578,0.0603530043721381,3.8208924226583e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37959,0.136343043574008,0.00755142614065,0.121542248338334,0.151143838809682,5.02909011990095e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40359,-0.168726514792952,0.00935405447963918,-0.187060461573044,-0.150392568012859,5.13099892387125e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,39980,0.108705638252948,0.00603933896853228,0.0968685338746244,0.120542742631271,1.05000889195346e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDHD2,Phospholipase DDHD2,37959,0.113503597922084,0.00630764720920852,0.101140609392035,0.125866586452132,1.4678417661189e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37959,0.184654910280101,0.0102674296391425,0.164530748187382,0.20477907237282,1.75287096288841e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OGA,Protein O-GlcNAcase,37901,0.120239532067028,0.00668946973353026,0.107128171389308,0.133350892744747,2.11057820613996e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39980,0.1338976256137,0.00746552008834181,0.11926520624055,0.14853004498685,3.25727622645844e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRAP,BRCA1-associated protein,37778,0.186956881471865,0.0104319675599261,0.16651022505441,0.20740353788932,5.44417287859354e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUS,RNA-binding protein FUS,39960,0.0672377208557269,0.00375773275337753,0.0598725646591069,0.0746028770523468,6.87492070874233e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMP3,Metalloproteinase inhibitor 3,40422,0.224559320992446,0.0125647426133284,0.199932425470322,0.249186216514569,9.48841009378463e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,37959,0.116456493780731,0.00651194631288849,0.103693079007469,0.129219908553992,1.03419134536118e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASAH2,Neutral ceramidase,40228,0.0894093942903843,0.00500391176434289,0.0796017272322722,0.0992170613484964,1.0427950447707e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS8,Galectin-8,40471,0.102781233179575,0.0057546167046101,0.0915021844385395,0.114060281920611,1.15621954679688e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STIP1,Stress-induced-phosphoprotein 1,40307,0.111356333332515,0.00623666895694449,0.0991324621769042,0.123580204488127,1.29546922962678e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLT4,Vascular endothelial growth factor receptor 3,40411,0.0565434652705928,0.00316822543989738,0.050333743408394,0.0627531871327917,1.47697207285128e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40228,0.132546352415621,0.00742682812343569,0.117989769293687,0.147102935537555,1.50599940419557e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL3,C-C motif chemokine 3,40341,0.104592543843502,0.0058635986057734,0.0930998905761864,0.116085197110818,1.75514012723421e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GOLGA3,Golgin subfamily A member 3,37959,0.133337224483861,0.00747000059427698,0.118696023319078,0.147978425648644,1.86971264674674e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FMNL1,Formin-like protein 1,39961,0.101761009499171,0.00570647295172406,0.0905763225137921,0.11294569648455,1.99218527174674e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASC3,Protein CASC3,37572,0.0697488535685519,0.00390876383963943,0.0620876764428586,0.0774100306942452,2.17156226166213e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,40305,0.196708462654148,0.0110355298708728,0.175078824107237,0.218338101201058,2.19649751402001e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37391,0.0595958369861185,0.00334061193021101,0.0530482376029049,0.0661434363693321,2.40873719109039e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IST1,IST1 homolog,37812,0.170231014325018,0.00954423249201977,0.151524318640659,0.188937710009377,2.42344980056021e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40411,0.123361927827563,0.00693084265764031,0.109777476218588,0.136946379436538,3.43009850503351e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40396,0.147942580714684,0.00831219609892154,0.131650676360797,0.16423448506857,3.47897184577419e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37901,0.25021539898902,0.0140493580647302,0.222678657182149,0.277752140795891,3.78785875759159e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMOX2,Heme oxygenase 2,39961,0.0772815588277051,0.0043436863000365,0.0687679336796336,0.0857951839757767,4.07414877860976e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39980,0.0754491637096497,0.0042409587354813,0.0671368845881063,0.083761442831193,4.14580914433158e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,37562,0.105230367496701,0.00591456174311424,0.0936378264801976,0.116822908513205,5.43415478122495e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GMPR2,GMP reductase 2,37671,0.114964425163032,0.00646516698693214,0.102292697868645,0.127636152457419,6.32753630552385e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,37598,0.15235272283014,0.00856869947501079,0.135558071859119,0.169147373801161,6.61723090423024e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",37642,0.144902019209281,0.00815038608206534,0.128927262488433,0.160876775930129,6.76216158475506e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB27B,Ras-related protein Rab-27B,37990,0.13883581532227,0.00781600413447047,0.123516447218708,0.154155183425833,8.45190750030226e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXNDC5,Thioredoxin domain-containing protein 5,40471,0.113266219777991,0.00638594760852841,0.100749762465275,0.125782677090707,1.01130656871185e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HS1BP3,HCLS1-binding protein 3,37628,0.151399806604265,0.00853373442767646,0.13467368712602,0.168125926082511,1.29466146520763e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OCLN,Occludin,37959,0.0737582409963963,0.00415871595363345,0.0656071577272747,0.0819093242655178,1.3622375885351e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40332,0.0771297406165895,0.0043615065326966,0.0685811878125041,0.0856782934206748,2.56208560122893e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17RB,Interleukin-17 receptor B,40126,-0.0900089354027929,0.00509295011362425,-0.0999911176254964,-0.0800267531800893,3.16186900710549e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBC1D23,TBC1 domain family member 23,40305,0.150572691346895,0.0085339457250215,0.133846157725853,0.167299224967937,5.16781833646309e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DBNL,Drebrin-like protein,40422,0.155062176112743,0.0087924441107721,0.13782898565563,0.172295366569857,5.88573723814722e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIA1,Nucleolysin TIA-1 isoform p40,39836,0.202594596568709,0.011487574403351,0.180078950738141,0.225110242399277,6.21389279252776e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NIT1,Deaminated glutathione amidase,37628,0.0835180010129267,0.00473496181981385,0.0742374758460915,0.0927985261797618,7.68587142544166e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RWDD1,RWD domain-containing protein 1,40471,0.107902489877106,0.00613817067975971,0.0958716753447767,0.119933304409435,1.57081232824744e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,40419,0.0533312690530897,0.00303565739948453,0.0473813805501,0.0592811575560794,1.897731229132e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC4A,C-type lectin domain family 4 member A,40341,-0.0576010602798583,0.0032802943203842,-0.0640304371478113,-0.0511716834119053,2.21596682212437e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R2,Protein phosphatase inhibitor 2,40359,0.132658155992091,0.00755830255634465,0.117843882981655,0.147472429002526,2.5581484354536e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ST13,Hsc70-interacting protein,37671,0.095467271097432,0.00543433831416106,0.0848159680016764,0.106118574193188,2.6089021166266e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1RL2,Interleukin-1 receptor-like 2,40044,0.0677608752824699,0.00386363323019009,0.0601881541512974,0.0753335964136425,3.30868844020494e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37900,0.0798009804277853,0.00454889268409622,0.0708851507669567,0.0887168100886139,3.85839033515196e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40305,0.149269945215399,0.00852064752990695,0.132569476056781,0.165970414374016,4.52031386670964e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,40340,0.0945231738503724,0.00540149024181449,0.083936252976416,0.105110094724329,6.26789624845404e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LEFTY2,Left-right determination factor 2,40453,0.0863052364152894,0.00495064674975026,0.0766019687857789,0.0960085040447999,1.9412707607541e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL18,Interleukin-18,40292,0.0787177263978,0.00451566618481083,0.0698670206755708,0.0875684321200293,2.00293344926799e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TWF2,Twinfilin-2,37998,0.137782251925102,0.00790384385093628,0.122290717977267,0.153273785872937,2.54322021993854e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OPHN1,Oligophrenin-1,37942,0.177565193501706,0.0101922020119241,0.157588477558334,0.197541909445077,3.07174757723734e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPART,Spartin,37671,0.128215233461281,0.00736059338475299,0.113788470427166,0.142641996495397,3.31886438052762e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39980,0.0874891827938362,0.00503780198242233,0.0776150909082884,0.097363274679384,6.33833375554785e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBXN1,UBX domain-containing protein 1,37671,0.114542728807062,0.00659179254908823,0.101622815410849,0.127462642203275,6.86303422665373e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICA1,Islet cell autoantigen 1,40044,0.131181646115878,0.00756126185343782,0.11636157288314,0.146001719348616,8.47732435622478e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GMPR,GMP reductase 1,40516,0.0843950123031222,0.00486524146057519,0.0748591390403948,0.0939308855658496,8.5064222872853e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37959,0.0783228408404313,0.00451831708838229,0.069466939347202,0.0871787423336606,1.355134301358e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL3,C-X-C motif chemokine 3,40350,0.153292417884935,0.00887096095744632,0.13590533440834,0.17067950136153,2.67129755854756e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37900,0.136000330030058,0.00786540747890612,0.120584131371402,0.151416528688714,2.86165270446142e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH3GLB2,Endophilin-B2,37942,0.110416672229919,0.00638827780921956,0.0978956477238488,0.12293769673599,3.18909498717802e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40359,0.138166933504294,0.00800669273223472,0.122473815749114,0.153860051259474,4.00234826866362e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GASK1A,Golgi-associated kinase 1A,37562,0.0713651979262653,0.004138477341813,0.0632537823363118,0.0794766135162188,6.57460107383135e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUB1,NEDD8 ultimate buster 1,40341,0.137006393286827,0.00795943626612283,0.121405898205227,0.152606888368428,8.36740901493602e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPB1,Carboxypeptidase B,40536,0.0923694757090341,0.00537155230862762,0.081841233184124,0.102897718233944,1.09850448652691e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEP1A,Meprin A subunit alpha,37901,0.11228452981159,0.00652942839607071,0.0994868501552918,0.125082209467889,1.41091051838264e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ESM1,Endothelial cell-specific molecule 1,40357,-0.0554754626248603,0.00322973231786067,-0.0618057379678672,-0.0491451872818534,1.55288372915577e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSPA1A,Heat shock 70 kDa protein 1A,40400,0.116561943344818,0.00679599408782578,0.10324179493268,0.129882091756957,2.35826287914355e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHMP1A,Charged multivesicular body protein 1a,40228,0.129777357196437,0.00757229369796504,0.114935661548426,0.144619052844449,2.98623055304362e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDLIM5,PDZ and LIM domain protein 5,37959,0.193638224613104,0.0112930039321099,0.171503936906168,0.215772512320039,3.2528655574662e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ESYT2,Extended synaptotagmin-2,37942,0.133429691848035,0.00778226675178516,0.118176449014536,0.148682934681534,3.33654457925728e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRAF2,TNF receptor-associated factor 2,40341,0.11619726078981,0.00678776357123039,0.102893244190199,0.129501277389422,4.13198547591992e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUSD1,Sushi domain-containing protein 1,40042,0.0803614848539153,0.00469576369564891,0.0711577880104435,0.0895651816973872,4.61309832212829e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40228,0.0937231686154725,0.00548550022968199,0.0829715881652958,0.104474749065649,7.27573342543202e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNPY4,Protein canopy homolog 4,40305,0.121650344394783,0.00712376706526951,0.107687760946855,0.135612927842712,8.4015563059527e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRSS2,Trypsin-2,40403,0.0816935639784939,0.00478450113255922,0.0723159417586778,0.0910711861983099,8.62806455308691e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37608,0.131249882112179,0.00768595424620794,0.116185411789611,0.146314352434747,1.10183474527436e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GTPBP2,GTP-binding protein 2,37572,0.1301930139797,0.00762448730711231,0.11524901885776,0.14513700910164,1.12433337566552e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,40044,0.0978188050922123,0.00574076978679021,0.0865668963101034,0.109070713874321,1.60927814457532e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAX,Protein max,39961,0.169507186847992,0.00995409112296353,0.149997168246984,0.189017205449001,1.9304611025778e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BPIFB2,BPI fold-containing family B member 2,37951,0.109907820732717,0.0064808321559781,0.0972053897070003,0.122610251758434,7.56988768791545e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DFFA,DNA fragmentation factor subunit alpha,40516,0.109681872379975,0.00647470628734919,0.0969914480567709,0.12237229670318,8.15935236270999e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPRY2,Protein sprouty homolog 2,40044,0.148852837535985,0.00878626778281146,0.131631752681674,0.166073922390295,8.26995906733412e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD22,B-cell receptor CD22,40516,0.0662098823528914,0.00390884565518161,0.0585485448687355,0.0738712198370474,8.37740080413712e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MOCS2,Molybdopterin synthase catalytic subunit,37671,0.108382664077604,0.00641990331564251,0.0957996535789451,0.120965674576264,2.79174299542873e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SDC4,Syndecan-4,40359,0.0728117625751665,0.00431726589206613,0.0643499214267169,0.0812736037236162,2.87321455336382e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TP53,Cellular tumor antigen p53,39980,0.0692879409646323,0.00411081827380248,0.0612307371479795,0.0773451447812852,3.51073480794934e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAVS,Mitochondrial antiviral-signaling protein,39980,0.14895180102133,0.00884908469393303,0.131607595021221,0.166296007021438,5.10639608574386e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RTBDN,Retbindin,40305,0.0468833054767841,0.00279004143162699,0.0414148242707952,0.052351786682773,8.00045699858905e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT5,"Keratin, type II cytoskeletal 5",39961,0.0782426441399969,0.00465884975185424,0.0691112986263626,0.0873739896536312,9.60609401055873e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX4,Syntaxin-4,40305,0.0955800228436537,0.00569372301202645,0.0844203257400819,0.106739719947226,1.05826565104083e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40305,0.0516750411682016,0.00308085343277542,0.0456365684399618,0.0577135138964414,1.33296483652865e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40305,0.0442645021759243,0.00263975331943171,0.0390905856698381,0.0494384186820104,1.43687754765871e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,40359,0.0564843567485966,0.00337080647010139,0.0498775760671979,0.0630911374299953,1.73040239957076e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGBP1,Immunoglobulin-binding protein 1,37959,0.0980152173250921,0.0058465394249369,0.0865560000522158,0.109474434597968,1.89118518500226e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39980,0.136778005749869,0.00817035382517147,0.120764112252533,0.152791899247205,2.32766349170274e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39853,0.141400327938438,0.00845057386752636,0.124837203158087,0.15796345271879,2.68955203416376e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,37900,0.0920285504747399,0.00550177480913262,0.08124507184884,0.10281202910064,3.53345532558133e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRADD,Death domain-containing protein CRADD,40192,0.122061682504951,0.00730309612931704,0.107747614091489,0.136375750918412,3.57777890062494e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA4D,Semaphorin-4D,40471,0.0474346923166846,0.00284652447429853,0.0418555043470595,0.0530138802863097,7.9271488775438e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLOD4,Glyoxalase domain-containing protein 4,40328,0.0577401549450515,0.00346724022882481,0.0509443640965549,0.0645359457935481,9.60172716596623e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GYS1,"Glycogen [starch] synthase, muscle",40042,0.147532588725432,0.00887730192782601,0.130133076946893,0.164932100503971,1.71365501337119e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DOK1,Docking protein 1,37942,0.21612429688491,0.0130134136021803,0.190618006224637,0.241630587545184,2.48382680616166e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,40332,0.0925525110280046,0.00557977040492731,0.0816161610343471,0.103488861021662,2.8279215729412e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YWHAQ,14-3-3 protein theta,37671,0.116891190287194,0.00704477128752075,0.103083438563654,0.130698942010735,3.27421003216293e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RILPL2,RILP-like protein 2,37990,0.153923628629454,0.00928472842193073,0.13572556092247,0.172121696336439,4.01066750142839e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD69,Early activation antigen CD69,40288,0.139006513413812,0.0083912920906247,0.122559580916187,0.155453445911436,4.03820148639677e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PALM2,Paralemmin-2,37942,0.0584835740842671,0.00352957240264057,0.0515656121750916,0.0654015359934426,4.63368508520843e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBM17,Splicing factor 45,37959,0.120615098343403,0.00728729216990046,0.106332005690398,0.134898190996408,6.2183026953389e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",40332,0.121949078958634,0.00738846183232762,0.107467693767272,0.136430464149996,1.07524031625019e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,40357,0.079180376990439,0.00480003406951271,0.0697723102141941,0.088588443766684,1.25377669890612e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40228,0.0708357845287565,0.00429502769005621,0.0624175302562463,0.0792540388012667,1.33508836744909e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37901,0.162473444713918,0.00984785404286634,0.1431716507899,0.181775238637936,1.48202839726061e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD74,HLA class II histocompatibility antigen gamma chain,40471,0.0546776774573576,0.0033175638600653,0.0481752522916296,0.0611801026230856,1.57507145366762e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37671,0.132190339765942,0.00802259886619006,0.11646604598821,0.147914633543675,2.13669399677333e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YJU2,Splicing factor YJU2,37900,0.0503680441216388,0.00305745755450841,0.0443754273148024,0.0563606609284753,2.20629589607868e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,37572,0.107287403268498,0.00651385004887617,0.0945202571727012,0.120054549364296,2.40195835650224e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OTUD6B,Deubiquitinase OTUD6B,37901,0.0925528430766113,0.0056205501439294,0.0815365647945097,0.103569121358713,2.46973297043262e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA11,Annexin A11,40312,0.105704655213148,0.00642518520886825,0.0931112922037666,0.11829801822253,2.57960499556892e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39976,0.12226225012694,0.00743179846314664,0.107695925139172,0.136828575114707,2.66018360325746e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",40422,0.173347594376862,0.0105425430311549,0.152684210035799,0.194010978717926,2.95913566316763e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40341,0.151147998365841,0.00919311958865357,0.13312948397208,0.169166512759602,3.03703812512948e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CETN3,Centrin-3,37901,0.120255655385567,0.00732904357734831,0.105890729973964,0.13462058079717,6.38898358764106e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,40341,0.163553684107292,0.00997621701689095,0.144000298754186,0.183107069460398,6.5112740410605e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37628,0.121548885655796,0.00741215314746754,0.107021065486759,0.136076705824832,7.65445351730511e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPI,Glucose-6-phosphate isomerase,37987,0.0732873371897814,0.00446975668450181,0.0645266140881579,0.082048060291405,7.66818287590066e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF19,Fibroblast growth factor 19,40422,0.119677887955738,0.00731112454607329,0.105348083845435,0.134007692066042,9.71145026000143e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIFBP,KIF-binding protein,40305,0.12853989126064,0.00785401533248325,0.113146021208973,0.143933761312307,1.03021204290178e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RFC4,Replication factor C subunit 4,37900,0.0321166384531203,0.00196205009312838,0.0282710202705887,0.035962256635652,1.20190839391449e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TP53I3,Quinone oxidoreductase PIG3,37419,0.0838042812552463,0.00512422328650965,0.0737608036136874,0.0938477588968052,1.59031292390646e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PENK,Proenkephalin-A,37671,0.0481271615161557,0.00294702245838795,0.0423509974977153,0.0539033255345961,2.2708210218095e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATXN3,Ataxin-3,37942,0.097114275973246,0.00595373845728963,0.0854449485969583,0.108783603349534,3.01507297360972e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDC,Nuclear migration protein nudC,40516,0.0983089162717928,0.00603450031411032,0.0864812956561366,0.110136536887449,3.4012393441032e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCGB3A2,Secretoglobin family 3A member 2,40396,-0.131746339051664,0.00809334083678354,-0.147609287091759,-0.115883391011568,4.21132680884394e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDCP1,CUB domain-containing protein 1,40228,0.0754080300885816,0.00463332731734726,0.066326708546581,0.0844893516305822,4.4870227874635e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,40305,0.0870576147448401,0.00535302132094871,0.0765656929557807,0.0975495365338996,5.40055092101085e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPA1,Carboxypeptidase A1,40536,0.0888005915458896,0.00546057732849054,0.0780978599820482,0.0995033231097311,5.41525734569159e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBKS,Ribokinase,39991,0.0770955405637496,0.0047414543482403,0.0678022900411986,0.0863887910863006,5.82766995339736e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DLG4,Disks large homolog 4,37942,0.108894052820067,0.00669571292887537,0.095770455479471,0.122017650160662,6.53303045736934e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IMPACT,Protein IMPACT,37942,0.0883709592728084,0.00543412511198279,0.0777200740533221,0.0990218444922946,6.64123227325907e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RASSF2,Ras association domain-containing protein 2,39980,0.0853182380322234,0.00525094155695969,0.0750263925805824,0.0956100834838643,7.03798176725934e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,37598,0.0893620870699031,0.00549900090153753,0.0785840453028895,0.100140128836917,8.26851132130318e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AP2B1,AP-2 complex subunit beta,37572,0.0759748376378786,0.0046756566527225,0.0668105505985425,0.0851391246772147,8.50254724699027e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDNF,Cerebral dopamine neurotrophic factor,40305,0.0501227028618047,0.00308995044630549,0.0440663999870459,0.0561790057365634,1.06027489674069e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PF4,Platelet factor 4,37934,0.150460304984805,0.00928710655617645,0.1322575761347,0.168663033834911,1.7683373952723e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX8,Syntaxin-8,40341,0.0754635602989984,0.00466288049880974,0.0663243145213314,0.0846028060766655,1.92123840955528e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPBP,Platelet basic protein,37934,0.12960097964782,0.00801069141071563,0.113900024482818,0.145301934812823,2.53074035846753e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39980,0.130456150452174,0.00807421533754587,0.114630688390584,0.146281612513764,3.01898598132773e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPARC,SPARC,40411,0.109067131048735,0.00675513400175131,0.0958270684053022,0.122307193692167,3.51221166973114e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM40,E3 ubiquitin ligase TRIM40,37572,0.111027154714531,0.00687432383945704,0.0975534799891956,0.124500829439867,4.05748600847869e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RRAS,Ras-related protein R-Ras,37572,0.201195300297645,0.0124642007879919,0.176765466753181,0.225625133842109,4.69176788104258e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATOX1,Copper transport protein ATOX1,40411,0.110266390258148,0.006844492317281,0.0968511853162775,0.123681595200019,6.19026186040714e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP2,Microtubule-associated protein 2,37942,0.0705535516078438,0.00438024049340415,0.0619682802407717,0.079138822974916,7.8518363416456e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PKD2,Polycystin-2,37562,0.0917482367999304,0.00569563750819439,0.0805847872838694,0.102911686315991,7.97244574793618e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37942,0.148660933182409,0.00923363093287535,0.130563016553973,0.166758849810844,8.81413885593471e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APPL2,DCC-interacting protein 13-beta,37671,0.171676248971596,0.0106631868104951,0.150776402823026,0.192576095120167,9.04401263449102e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLG,Plasminogen,37705,0.0344305592824189,0.00214091652557923,0.0302343628922836,0.0386267556725542,1.19411675784068e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40044,0.0838468543885461,0.0052226605452204,0.0736104397199141,0.094083269057178,1.53891089805181e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DYNLT1,Dynein light chain Tctex-type 1,37572,0.124361561026272,0.00774636081658284,0.109178693825769,0.139544428226774,1.88206254408371e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,37716,0.0648198462643123,0.00403899426558165,0.0569034175037722,0.0727362750248523,2.03125109057728e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UROD,Uroporphyrinogen decarboxylase,37671,0.107884766331871,0.00672326810420862,0.0947071608476226,0.12106237181612,2.10640660946197e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CACYBP,Calcyclin-binding protein,37642,0.157107053777491,0.00979265574857622,0.137913448510281,0.1763006590447,2.21889705587137e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD72,B-cell differentiation antigen CD72,37671,0.0649497838306894,0.00404911935998775,0.0570135098851134,0.0728860577762654,2.31603008571361e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F13B,Coagulation factor XIII B chain,37934,0.039543802011322,0.00246557370581781,0.0347112775479191,0.0443763264747249,2.33717642115729e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKG1,cGMP-dependent protein kinase 1,37671,0.191649623218795,0.0119621611214273,0.168203787420798,0.215095459016793,3.13353846638001e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JAM3,Junctional adhesion molecule C,37671,0.0774845434402312,0.00483888919186507,0.0680003206241757,0.0869687662562868,3.5798826737688e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39980,0.150922605614963,0.0094365114047278,0.132427043261697,0.16941816796823,4.05529494187189e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCARB2,Lysosome membrane protein 2,40011,0.0471379745330085,0.00294754532833213,0.0413607856894775,0.0529151633765395,4.12390186390564e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37628,0.039706248713383,0.00248266711729217,0.0348402211634903,0.0445722762632756,4.88672040590324e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37990,0.0943730792341953,0.00590188708522275,0.0828053805471587,0.105940777921232,4.96362948816754e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADD1,Alpha-adducin,37671,0.107235894071975,0.00670784549500682,0.0940885169017613,0.120383271242188,5.4129617573233e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDGFA,Platelet-derived growth factor subunit A,40536,0.109350304819538,0.00686098626472139,0.0959027717406836,0.122797837898391,9.38944709164748e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LPP,Lipoma-preferred partner,37562,0.102367822348901,0.00641768947184162,0.089789150984091,0.11494649371371,9.59368029953671e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRAP2,GRB2-related adapter protein 2,40359,0.192988159650004,0.0121135761657038,0.169245550365225,0.216730768934784,1.05043989768377e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,39980,0.0878940346368373,0.00552541518303116,0.0770642208780963,0.0987238483955784,1.57809317175843e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSNK2A1,Casein kinase II subunit alpha,37959,-0.0689119068723788,0.00432982104840188,-0.0773983561272465,-0.0604254576175111,1.60976950406953e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MIF,Macrophage migration inhibitory factor,40307,0.104607464167683,0.0065779107164314,0.0917147591634774,0.117500169171889,1.65563755104238e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STK24,Serine/threonine-protein kinase 24,39961,0.0937150599146787,0.00589336909195776,0.0821640564944415,0.105266063334916,1.72122937325508e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLMAP,Sarcolemmal membrane-associated protein,37901,0.12651258351007,0.00795279866666908,0.110925098123398,0.142100068896741,1.82594281917889e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40228,0.0832799541148872,0.00524472874706158,0.0730002857706465,0.0935596224591279,2.42731009268451e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBCB,Tubulin-folding cofactor B,40228,0.153224025307935,0.00965027822025711,0.134309479996231,0.172138570619639,2.47002802051642e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RILP,Rab-interacting lysosomal protein,40434,0.0913094987733632,0.00575339153766143,0.0800328513595468,0.10258614618718,2.7271170458757e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMSB10,Thymosin beta-10,40332,0.114952078928661,0.0072464711648413,0.100748995445572,0.12915516241175,3.08061177522913e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,37900,0.131466217432715,0.00828376977584504,0.115230028672059,0.147702406193371,3.28984047739461e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40489,0.0954519911100325,0.0060228313718534,0.0836472416211998,0.107256740598865,3.84891265234323e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,39980,0.115822915081574,0.00731026692624374,0.101494791906136,0.130151038257012,4.26263165846999e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMED8,Protein TMED8,37901,0.155396254867038,0.00980873219176928,0.136171139771171,0.174621369962906,5.07082553304926e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37900,0.0583885472352277,0.0036892732672859,0.0511575716313473,0.065619522839108,6.51707137000822e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,40359,0.102498548837431,0.00648725489837824,0.0897835292366101,0.115213568438253,8.26701956753834e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37628,0.147490070738836,0.00933727052991647,0.1291890205002,0.165791120977472,1.07701768983446e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJB14,DnaJ homolog subfamily B member 14,37901,0.096963527222506,0.00614122562680477,0.0849267249939686,0.109000329451043,1.17102372584372e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40305,0.081920774054296,0.00520075471223979,0.071727294818306,0.092114253290286,1.76093008575747e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOA2,Apolipoprotein A-II,37987,-0.0716590659875346,0.00454630948626528,-0.0805698325806146,-0.0627482993944547,1.76718572217654e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,40471,0.0991827794269415,0.00629712235145233,0.0868404196180949,0.111525139235788,1.77685849225243e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40471,-0.0680545250713011,0.00432160663645976,-0.0765248740787622,-0.05958417606384,1.86145217901951e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PARK7,Parkinson disease protein 7,40332,0.0804619122330646,0.0051107904043416,0.0704447630405551,0.0904790614255742,1.99659791542813e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37671,0.156082773875743,0.00992506662933132,0.136629643282254,0.175535904469233,3.16895259110796e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPC5,Glypican-5,40228,0.0840111601136419,0.00534698775565465,0.0735310641125588,0.094491256114725,3.28740260175993e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEXN,Nexilin,37987,0.102588328842859,0.00652532683359505,0.0897986882490126,0.115377969436705,3.3117602903531e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LACTB2,Endoribonuclease LACTB2,40359,0.0990488534233127,0.00630722460318492,0.0866866932010702,0.111411013645555,3.68374777844404e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP10,Caspase-10,39961,0.107469488615562,0.00684905232219523,0.0940453460640598,0.120893631167065,4.60913380126922e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37671,0.0948558102844301,0.00604187176329231,0.0830137416283772,0.106697878940483,4.76803272529859e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37714,0.0996724746912765,0.00635831053955056,0.0872101860337574,0.112134763348796,6.86440144439036e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM24,Transcription intermediary factor 1-alpha,37687,0.0963016757020974,0.006151514942449,0.0842447064148973,0.108358644989297,9.51319079439216e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37714,0.0738184222992746,0.0047184951171098,0.0645701718697394,0.0830666727288098,1.11553298283019e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,37959,0.127756094540932,0.0081691720723685,0.11174451727909,0.143767671802774,1.19335660951377e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNM3,Dynamin-3,37959,0.0819839338152673,0.00524318287157634,0.0717072953869777,0.092260572243557,1.24054246933656e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,40471,0.0703519224671738,0.00450638576003411,0.0615194063775069,0.0791844385568406,1.53091371704524e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EGF,Pro-epidermal growth factor,40324,0.153046778301062,0.00981204313613253,0.133815173754242,0.172278382847882,1.90910397163978e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39939,0.0860463088425454,0.00551614912309788,0.0752346565612735,0.0968579611238172,1.91952859008026e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GP1BB,Platelet glycoprotein Ib beta chain,37562,0.100926567955838,0.0064703708691213,0.0882446410523607,0.113608494859316,2.30224887252515e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDH9,Protocadherin-9,37901,0.0504162686855042,0.00323316627289464,0.0440792627906307,0.0567532745803777,2.41021784534002e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINE2,Glia-derived nexin,37990,0.0956483274166103,0.00613616063836184,0.0836214525654211,0.1076752022678,2.61702076836418e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERP29,Endoplasmic reticulum resident protein 29,37671,0.17648261032044,0.01132486466509,0.154285875576863,0.198679345064016,2.85641410929664e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40516,0.043214547219441,0.00277901773534668,0.0377676724581615,0.0486614219807205,3.92830548584144e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL10RB,Interleukin-10 receptor subunit beta,40422,0.0422905298204033,0.00271986470846519,0.0369595949918115,0.0476214646489951,4.04339504592193e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOXJ3,Forkhead box protein J3,37598,0.0649717439104532,0.00417874754293389,0.0567813987263027,0.0731620890946036,4.95548518499555e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJB2,DnaJ homolog subfamily B member 2,37671,0.0810061432243,0.00521173860180429,0.0707911355647636,0.0912211508838364,5.32787543821356e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD226,CD226 antigen,37598,0.0622829246577864,0.00400869435325891,0.054425883725399,0.0701399655901739,5.88139253705057e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD244,Natural killer cell receptor 2B4,40516,0.0394174670262962,0.00254373070779203,0.0344317548390238,0.0444031792135686,9.0531885185813e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NTRK3,NT-3 growth factor receptor,40471,-0.0323081437725081,0.00208526383586664,-0.0363952608908067,-0.0282210266542095,9.41236901176564e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SULT2A1,Bile salt sulfotransferase,40341,0.0787054538503389,0.0050870714102818,0.0687347938861866,0.0886761138144912,1.32572371160555e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC4G,C-type lectin domain family 4 member G,40341,0.0486633164070879,0.00314560221598327,0.0424979360637607,0.0548286967504151,1.35428243121457e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATXN2L,Ataxin-2-like protein,37959,0.0714260474318077,0.00461528076014969,0.0623800971419143,0.0804719977217011,1.45172216191362e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSS,Cathepsin S,37057,0.0364571703632111,0.00235579387102857,0.0318398143759951,0.0410745263504271,1.5753756608875e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRC59,Leucine-rich repeat-containing protein 59,37990,0.0694267598869981,0.00449193265724245,0.0606225718788029,0.0782309478951933,1.96858042396627e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINB1,Leukocyte elastase inhibitor,40287,0.130972567782716,0.00849347499683423,0.114325356788921,0.147619778776511,2.911531561631e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,37863,0.0638786129096746,0.00414910013787086,0.0557463766394477,0.0720108491799015,4.96245153964845e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSTB,Cystatin-B,40097,0.0615192144719264,0.00400050045747647,0.0536782335752726,0.0693601953685803,5.62212110809845e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,39961,0.110590935674753,0.00719397538573465,0.0964907439187131,0.124691127430793,6.12876293212867e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD274,Programmed cell death 1 ligand 1,40228,0.0510071564840926,0.00331945685812286,0.0445010210421718,0.0575132919260134,6.67450490156323e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CIAPIN1,Anamorsin,40411,0.0936035038527142,0.00609397909864546,0.0816593048193691,0.105547702886059,7.25204227361465e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUOX,"Sulfite oxidase, mitochondrial",37959,0.0906577872303013,0.00590053201274467,0.0790927444853218,0.102222829975281,7.93824832730947e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL12A_IL12B,Interleukin-12,40305,0.114736333029815,0.00748530028990602,0.1000651444616,0.129407521598031,1.18168597212614e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDT,D-dopachrome decarboxylase,37998,0.0599865162646261,0.00391399106526831,0.0523150937767002,0.067657938752552,1.41093428312879e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UMOD,Uromodulin,40502,-0.0793401142804937,0.00518045554876179,-0.0894938071560668,-0.0691864214049206,1.42283230488046e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MPI,Mannose-6-phosphate isomerase,40305,0.125249962786925,0.00819488408015164,0.109187989989828,0.141311935584023,2.31160683794662e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F2R,Proteinase-activated receptor 1,40396,0.0838293343524038,0.00548796435438735,0.0730729242178046,0.094585744487003,2.62775426909567e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CETN2,Centrin-2,39961,0.097970161438274,0.00641435729488803,0.0853980211402934,0.110542301736254,2.754473490287e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF4E,Eukaryotic translation initiation factor 4E,37598,0.133356651699543,0.0087253921477619,0.11625488308993,0.150458420309156,2.76087678410829e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDIA4,Protein disulfide-isomerase A4,37998,0.0882647726314074,0.00578247320692964,0.0769311251458253,0.0995984201169895,3.59731279690086e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP7,Caspase-7,37942,0.122133473949539,0.00800679703720353,0.10644015175662,0.137826796142457,4.2289375658351e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",37928,0.0593278055164857,0.00389168775047363,0.0517000975255574,0.066955513507414,4.84567110797334e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37959,0.116669259989245,0.00765942299083471,0.101656790927209,0.131681729051281,5.84630861802941e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOF,Apolipoprotein F,37987,-0.0351029527886425,0.00230872085571833,-0.0396280456658504,-0.0305778599114346,8.83554188759709e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1R2,Interleukin-1 receptor type 2,40330,0.0283307076789373,0.00186503530798589,0.024675238475285,0.0319861768825897,9.45415540274935e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIP,Gastric inhibitory polypeptide,37628,0.0752486652165197,0.00495008027629988,0.065546507874972,0.0849508225580675,9.49053033621701e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BIN2,Bridging integrator 2,40332,0.131626512637753,0.00866685185050557,0.114639483010762,0.148613542264744,9.90278373432893e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",40411,0.0890240219557978,0.00586405969577357,0.0775304649520816,0.100517578959514,1.08019894161992e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,40063,0.0615730007310029,0.00405819835092444,0.053618931963191,0.0695270694988148,1.25565678486987e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP10,Stromelysin-2,40341,-0.0868770420406344,0.00572665488382798,-0.0981012856129372,-0.0756527984683315,1.27225936667388e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM172A,Cotranscriptional regulator FAM172A,37628,0.0897785488575154,0.00591546450489787,0.0781842384279156,0.101372859287115,1.37194365016178e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSNL1,Visinin-like protein 1,37942,0.0543696880929034,0.00358357882966296,0.047345873586764,0.0613935025990427,1.4454751857089e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK10,Kallikrein-10,40354,0.0568681603256885,0.00375364809761838,0.0495110100543565,0.0642253105970206,1.73047383349235e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,37959,0.134558487243673,0.00887863542635922,0.117156361808009,0.151960612679337,1.85070300360982e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,40422,0.0553978509063788,0.00366008272582954,0.0482240887637529,0.0625716130490047,2.14069252367038e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VASP,Vasodilator-stimulated phosphoprotein,37987,0.10439078523178,0.00689669903130549,0.0908732551304216,0.117908315333139,2.4530669982635e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGAP25,Rho GTPase-activating protein 25,39980,0.0858471797548232,0.0056749801091612,0.0747242187408672,0.0969701407687791,2.48350429036511e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THTPA,Thiamine-triphosphatase,37884,0.128205615337942,0.00847052914668368,0.111603378210442,0.144807852465442,2.50270986902284e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMG3,Proteasome assembly chaperone 3,40341,0.0740602236034219,0.00489803856161107,0.0644600680226643,0.0836603791841796,2.70314858667796e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REEP4,Receptor expression-enhancing protein 4,37959,0.0898690675150898,0.00594486475640035,0.0782171325925451,0.101521002437634,3.27683767275611e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GHRL,Appetite-regulating hormone,40359,0.113829768497243,0.00753931201271145,0.099052716952329,0.128606820042158,3.76561764726013e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTF1,Cardiotrophin-1,40042,0.121978404909337,0.00807863858447145,0.106144273283773,0.137812536534901,3.78718889140824e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALB2,Calretinin,39961,0.0454305765213835,0.00300909916981699,0.0395327421485422,0.0513284108942248,3.86935413661998e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAG6,Large proline-rich protein BAG6,40042,0.0517940589523299,0.00343168809657733,0.0450679502830384,0.0585201676216215,4.14246829742139e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINC1,Antithrombin-III,37981,0.0212549504951358,0.00140776596829426,0.0184957291972791,0.0240141717929926,4.32716615558027e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,37628,0.134626437747739,0.00892925390710263,0.117125100089818,0.152127775405661,6.09985364137708e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DBI,Acyl-CoA-binding protein,40270,0.113550270716568,0.00753713786439298,0.0987774805023581,0.128323060930779,6.16676175250786e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP3R1,Calcineurin subunit B type 1,40228,0.0593962383881303,0.00394736135409709,0.0516594101341,0.0671330666421606,8.12595213527877e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APP,Amyloid-beta precursor protein,40309,0.0961290922422894,0.0064019191156788,0.0835813307755589,0.10867685370902,1.29156490575313e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCARF1,Scavenger receptor class F member 1,40536,0.0607064207142825,0.00404654163999495,0.0527751990998924,0.0686376423286726,1.56378034200112e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HPSE,Heparanase,37848,0.133427309137944,0.00889118850323787,0.116000579671598,0.150854038604291,1.70661261234637e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP2,Caspase-2,40341,0.0968421363099655,0.00645845779444401,0.0841835590328552,0.109500713587076,1.76298204297453e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL11,C-X-C motif chemokine 11,40471,0.113837769234406,0.00759622326171755,0.09894917164144,0.128726366827373,1.98802673990283e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATG4A,Cysteine protease ATG4A,39980,0.0852639601158915,0.00569171454414985,0.0741081996093578,0.0964197206224252,2.21861279562925e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPP1,Tripeptidyl-peptidase 1,40255,0.0639472594229904,0.00427138005971742,0.0555753545059442,0.0723191643400365,2.51009204605356e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSPB1,Heat shock protein beta-1,40116,0.0970190310359821,0.00648046928556696,0.0843173112362708,0.109720750835693,2.53187439639372e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,40338,0.134378462496808,0.00898997028497942,0.116758120738249,0.151998804255368,3.54110227498453e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37990,0.128424617013282,0.00858716235955001,0.111593778788564,0.145255455238,3.60963775532571e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VAV3,Guanine nucleotide exchange factor VAV3,37541,0.142610191499128,0.00954089509572719,0.123910037111502,0.161310345886753,4.20146980646132e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINB6,Serpin B6,40433,0.0852037795409795,0.00570928499244686,0.0740135809557837,0.0963939781261753,5.01823090137054e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPT1,Angiopoietin-1,40263,0.120753251499665,0.00810363657096379,0.104870123820576,0.136636379178754,7.06539376997041e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPC2,NPC intracellular cholesterol transporter 2,37815,0.0442367824446916,0.00296746049308092,0.038420559878253,0.0500530050111301,7.43052894111273e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MESD,LRP chaperone MESD,40332,0.172142961031636,0.0115613868830339,0.149482642740889,0.194803279322382,8.36195017124547e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSR1,Macrophage scavenger receptor types I and II,40471,0.0636032150637966,0.00427399699496098,0.0552261809536731,0.0719802491739202,9.35177861366206e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40341,0.0863994242540246,0.00580899343757577,0.0750137971163761,0.0977850513916731,1.05948462412277e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD207,C-type lectin domain family 4 member K,40029,0.0546012571602048,0.00367185014933439,0.0474044308675094,0.0617980834529002,1.12704246446006e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBC1D5,TBC1 domain family member 5,40341,0.111339101437278,0.00748898734747618,0.0966606862362251,0.126017516638332,1.16331659417557e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C2,Complement C2,40372,0.0340415200444825,0.00229095280548135,0.0295512525457391,0.0385317875432259,1.3055389314071e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCT5,T-complex protein 1 subunit epsilon,39980,0.0645772499118062,0.00434690212783555,0.0560573217412485,0.0730971780823638,1.39463697642689e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALCA,Calcitonin,40192,0.0780264682293089,0.00525819717962793,0.0677204017572381,0.0883325347013796,1.76982111149879e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGCT,Gamma-glutamylcyclotransferase,37978,0.0686492373043543,0.00462564506936999,0.0595829729683892,0.0777155016403195,1.94706629158668e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JPT2,Jupiter microtubule associated homolog 2,37901,0.124457758745294,0.00838679153330047,0.108019647340025,0.140895870150563,1.99387340071717e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOA1,Apolipoprotein A-I,38013,-0.0391613205608576,0.00263925691985179,-0.0443342641237671,-0.0339883769979481,2.02996594878774e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAP3,Cytosol aminopeptidase,40044,0.0696455744508732,0.00469943872035018,0.0604346745589869,0.0788564743427596,2.35790265563237e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB33A,Ras-related protein Rab-33A,37562,0.0946802975020473,0.00638503867747668,0.082165621694193,0.107194973309902,2.40680686392158e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEBPB,CCAAT/enhancer-binding protein beta,40042,0.0535047047391362,0.00361551885388132,0.0464182877855288,0.0605911216927436,3.22558881387826e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS3BP,Galectin-3-binding protein,38013,0.0418948197539775,0.00283331978142624,0.0363415129823821,0.047448126525573,4.3170302185159e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37594,0.0546935913757113,0.0037004272013215,0.0474407540611212,0.0619464286903015,4.85444722623079e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40228,0.133918867438469,0.00906731139210823,0.116146937109937,0.151690797767001,4.90384657381321e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,37562,0.0949213388228596,0.00642239172427113,0.0823334510432882,0.107509226602431,4.90760864593995e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMP1,Metalloproteinase inhibitor 1,40167,0.0396768517775033,0.00268999458720309,0.0344044623865852,0.0449492411684213,6.5528960943045e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTRB1,Chymotrypsinogen B,40332,0.075039478961827,0.00508883975727403,0.0650653530375699,0.0850136048860841,6.88338982686179e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F2,Prothrombin,38013,0.0207674022339332,0.00140771779284531,0.0180082753599564,0.02352652910791,7.08676166771184e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37990,0.0565001068557455,0.00383294958798139,0.048987525663302,0.0640126880481891,8.4415615124461e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40397,0.154970138383717,0.0105211089471537,0.134348764847295,0.175591511920138,8.7256002391172e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANG,Angiogenin,40309,0.0484911314855701,0.00329361473902599,0.0420356465970792,0.054946616374061,9.65810299506798e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP6AP2,Renin receptor,39980,0.0587187318145939,0.00398830774185378,0.0509016486405605,0.0665358149886273,9.81683733491988e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37671,0.0860179323182658,0.00584727685597341,0.0745572696805579,0.0974785949559737,1.33115003141555e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXNDC9,Thioredoxin domain-containing protein 9,37942,0.0747452143268946,0.00508504693994925,0.0647785223245941,0.0847119063291951,1.55154206013495e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,37628,0.103373570818561,0.00703341329281511,0.0895880807646439,0.117159060872479,1.61892665125506e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TADA3,Transcriptional adapter 3,37900,0.0547209630831331,0.00372491593258934,0.047420127855258,0.0620217983110082,1.76014007738202e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MGLL,Monoglyceride lipase,40396,0.120973368893148,0.00824377947821904,0.104815561115838,0.137131176670457,1.94329035682815e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DXO,Decapping and exoribonuclease protein,37942,0.0643233326480211,0.00438465401299646,0.055729410782548,0.0729172545134941,2.36108691947149e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37671,0.0403939458948736,0.00275380415023117,0.0349964897604205,0.0457914020293267,2.4620326210492e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMOT,Angiomotin,37671,0.0585819267187175,0.00399431309031532,0.0507530730616994,0.0664107803757355,2.53752972815491e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37990,0.137363953791799,0.00936702482911558,0.119004585126733,0.155723322456866,2.54853448881104e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMEM106A,Transmembrane protein 106A,37900,0.0982619862826767,0.00670585968331988,0.0851185013033697,0.111405471261984,3.02686908358558e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL4,C-C motif chemokine 4,40376,0.0946167277554308,0.00646618964811474,0.0819429960451259,0.107290459465736,3.5784508119652e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1RL,Complement C1r subcomponent-like protein,37993,0.0271707705993202,0.00185585880583881,0.0235332873398761,0.0308082538587643,3.6126518753091e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGH,Gamma-glutamyl hydrolase,40077,0.0479276175054877,0.00327552071957932,0.0415075968951123,0.0543476381158632,3.65253760310092e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37990,0.104006853170591,0.00710878056713692,0.0900736432590027,0.117940063082179,4.16272768495171e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40341,0.140507237745452,0.00961567019236609,0.121660524168415,0.15935395132249,4.80423300823715e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MCEMP1,Mast cell-expressed membrane protein 1,37598,0.129346999763212,0.00884734951068116,0.112006194722277,0.146687804804147,4.99627911752632e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37901,0.0908604040372799,0.00621941820845063,0.0786703443487167,0.103050463725843,5.72100524118488e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NBN,Nibrin,40044,0.0711359576032226,0.00487354286373835,0.0615838135902955,0.0806881016161498,6.13566310379587e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD83,CD83 antigen,40341,0.0469351701067658,0.00321574627172808,0.0406323074141788,0.0532380327993529,6.13576628966401e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40396,0.106818369839061,0.00732163735945362,0.0924679606145315,0.12116877906359,6.67687847009011e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYO9B,Unconventional myosin-IXb,40044,0.0924927589883665,0.00634425605644441,0.0800580171177355,0.104927500858998,7.88822228105445e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40341,0.0852375511722471,0.00584785178886132,0.0737757616660789,0.0966993406784153,8.13992150911097e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MICALL2,MICAL-like protein 2,37572,0.0955493324901282,0.00655449041358421,0.0827025312795032,0.108396133700753,9.19789236763825e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLAMF6,SLAM family member 6,39980,0.0529348881231577,0.00363661519077353,0.0458071223492415,0.0600626538970738,1.10100409378835e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EHD3,EH domain-containing protein 3,37628,0.163376341461023,0.0112212338289482,0.141382723156285,0.185369959765762,1.18980691238713e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARSA,Arylsulfatase A,40332,0.0619650838459388,0.00426078565080464,0.0536139439703617,0.0703162237215159,1.30670247821417e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40516,0.0518865228622185,0.00356895378530034,0.0448913734430298,0.0588816722814072,1.38941787702589e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37942,0.0538636404685324,0.00370342579810281,0.0466049259042509,0.0611223550328139,1.45403887333361e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSL,Cathepsin L1,40359,0.0336353556646129,0.00231909015775617,0.0290899389554108,0.038180772373815,2.30270173226997e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL8,C-C motif chemokine 8,40470,0.0837226013798417,0.00577272734230479,0.0724080557889243,0.0950371469707591,2.31020095127725e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G15,Phospholipase A2 group XV,40411,0.0356744488580228,0.00245997876888676,0.0308528904710048,0.0404960072450409,2.35617183235892e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40516,0.0528638267571686,0.00364767884614946,0.0457143762187157,0.0600132772956216,2.68801505970641e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40359,0.0887456465876474,0.00612490745721592,0.0767408279715042,0.100750465203791,2.83154754963681e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CERT,Ceramide transfer protein,39961,0.0851653617189132,0.00587825282767356,0.073643986176673,0.0966867372611534,2.92755444556494e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COMT,Catechol O-methyltransferase,39877,0.11774186885914,0.0081321369899208,0.101802880358895,0.133680857359385,3.37409899759906e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPTL3,Angiopoietin-related protein 3,40355,0.0502105292899442,0.00346861192712928,0.0434120499127709,0.0570090086671176,3.44389933495319e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFNA4,Ephrin-A4,40203,0.0407614434668735,0.00281615769009266,0.0352417743942919,0.0462811125394552,3.544710308501e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBCA,Tubulin-specific chaperone A,37671,0.120776278378999,0.0083409236567149,0.104428068011838,0.13712448874616,3.72142657835284e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39980,0.0801584315938666,0.0055400618386844,0.0692999103900452,0.091016952797688,3.86091680621187e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,37714,0.101564745929621,0.00701628364349471,0.0878128299883709,0.11531666187087,3.9522580794548e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,37900,0.130737178577674,0.00903305684166301,0.113032387168014,0.148441969987333,4.04338816880683e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL18,C-C motif chemokine 18,40172,0.0971104336259798,0.00671888962579119,0.0839414099594291,0.110279457292531,4.78244573979839e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37959,0.0659225145636841,0.00455954214307254,0.0569858119632619,0.0748592171641062,4.99760753303436e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSC22D1,TSC22 domain family protein 1,37959,0.0931489596832662,0.00644268295984412,0.0805213010819717,0.105776618284561,5.00066031713701e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA3,Annexin A3,40442,0.0965080752399443,0.00668977840849173,0.0833961095593005,0.109620040920588,6.97343033840787e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP3,Caspase-3,40536,0.121323363360167,0.0084156358012595,0.104828717189698,0.137818009530635,7.98872087788528e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,39980,0.0496166641974392,0.00344168806308454,0.0428709555937935,0.0563623728010849,8.18719974253778e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL2,C-C motif chemokine 2,40203,0.0728854160611081,0.00505785123935212,0.062972027631978,0.0827988044902383,8.83649574155058e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LEPR,Leptin receptor,40359,-0.0422629050490532,0.00293457926626566,-0.0480146804109339,-0.0365111296871725,9.93410489834635e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK13,Kallikrein-13,40032,0.0597116684467748,0.00414809553388295,0.0515814012003642,0.0678419356931854,1.10913036215188e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSAP,Prosaposin,37901,0.0392255726964706,0.00272447634416368,0.0338855990619098,0.0445655463310314,1.19236155590177e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,40332,0.0376187877352754,0.00261483468201923,0.0324937117585177,0.0427438637120331,1.23226593909992e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GMFG,Glia maturation factor gamma,37990,0.0986895952060134,0.0068628667456734,0.0852383763844935,0.112140814027533,1.51631698635138e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37900,0.148446787141961,0.0103347291650575,0.128190717978448,0.168702856305473,1.92334833292567e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,40422,-0.0282730785880987,0.00197093669237054,-0.0321361145051449,-0.0244100426710524,2.22353210721858e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTGDS,Prostaglandin-H2 D-isomerase,40234,0.040515951914795,0.00282580005581387,0.0349773838053998,0.0460545200241902,2.48012651793238e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,40182,0.0408019760157403,0.0028520890695408,0.0352118814394403,0.0463920705920402,3.90902173388338e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BMPER,BMP-binding endothelial regulator protein,37671,0.0307878907329963,0.00215228211888862,0.0265694177799746,0.035006363686018,4.50874281660089e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP170,Centrosomal protein of 170 kDa,37628,0.105816759045715,0.0074080975741058,0.091296887800468,0.120336630290963,6.06936387630754e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRGN,Neurogranin,37987,0.123730086404403,0.00866716500727514,0.106742442990144,0.140717729818663,6.67584362270225e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL2L1,Bcl-2-like protein 1,37942,0.136236165780539,0.00955124215123059,0.117515731164127,0.154956600396951,7.93086017763569e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP7,Matrilysin,40015,0.0658046576972397,0.00461620627692241,0.0567568933944718,0.0748524220000076,8.09098280429313e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,POSTN,Periostin,37998,-0.0516967230899123,0.00362865721240697,-0.05880889122623,-0.0445845549535947,1.00383979253739e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40305,0.128525261245021,0.00902791301593849,0.110830551733782,0.14621997075626,1.04136310563711e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMAD3,Mothers against decapentaplegic homolog 3,37900,0.0690786022230383,0.00485515658676798,0.059562495312973,0.0785947091331035,1.31760656834251e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,37671,0.118942546234337,0.00836007019699581,0.102556808648225,0.135328283820449,1.34295624246033e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37575,0.0486046260556694,0.00342040348558642,0.04190063522392,0.0553086168874188,1.72167032130616e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37628,0.0628510420061798,0.00442631604899807,0.0541754625501436,0.071526621462216,1.99779783262656e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39980,0.0889570662646466,0.006276012633964,0.0766560815020772,0.101258051027216,2.53913130438692e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NACC1,Nucleus accumbens-associated protein 1,37900,0.07456387938693,0.00526280274824112,0.0642487860003774,0.0848789727734826,3.05350793141076e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LONP1,"Lon protease homolog, mitochondrial",37628,0.11768183042153,0.00831097496095898,0.10139231949805,0.133971341345009,3.48241503832593e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRYBB1,Beta-crystallin B1,37990,0.0878074016234574,0.00620372291317673,0.075648104713631,0.0999666985332838,3.70320905060565e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WDR46,WD repeat-containing protein 46,37900,0.0482431348053803,0.0034087065691755,0.0415620699297963,0.0549241996809643,3.7776680476822e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37959,0.134194422420772,0.00948212784867613,0.115609451837366,0.152779393004177,3.79527082983142e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUGT1,Protein SGT1 homolog,39980,0.110130249331432,0.00778803486407176,0.0948657009978516,0.125394797665013,4.04674127581936e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37900,0.0475966147327427,0.00336433978476819,0.041002508754597,0.0541907207108883,4.08194509212301e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39961,0.15172379667408,0.0107332273390827,0.130686671089478,0.172760922258682,4.34768718679631e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40341,0.109465441908926,0.00774565944864283,0.0942839493895859,0.124646934428266,4.49143919468579e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCTD,Deoxycytidylate deaminase,37671,0.127775425531033,0.00904504964052919,0.110047128235596,0.14550372282647,5.5335947437132e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPDC1,Neural proliferation differentiation and control protein 1,40359,0.041864593161594,0.00296703844436044,0.0360491978106475,0.0476799885125404,6.16053581935709e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL32,Interleukin-32,40341,-0.0575896707952179,0.00408602544630048,-0.0655982806699668,-0.0495810609204689,7.66837870014165e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLRD1,Natural killer cells antigen CD94,40516,0.0613444726270668,0.00436274829948005,0.0527934859600859,0.0698954592940478,1.21362736922851e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37628,0.138072335613055,0.00981889753189641,0.118827296450538,0.157317374775572,1.36747862378291e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AIF1,Allograft inflammatory factor 1,39980,0.070911681054926,0.00504888380668502,0.0610158687938234,0.0808074933160287,1.5478946102033e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFB,Complement factor B,37770,0.0441416320688219,0.00314158552479641,0.0379841244402209,0.0502991396974229,1.58458241341607e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL12B,Interleukin-12 subunit beta,40516,0.0728638882587994,0.00519132516831653,0.062688890928899,0.0830388855886998,1.72641975901156e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL16,C-X-C motif chemokine 16,40517,0.0318460947398563,0.00227231871329366,0.0273923500618008,0.0362998394179119,2.30954791109216e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40379,0.0357344539885005,0.00254995451667948,0.0307365431358087,0.0407323648411922,2.3553471516003e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40471,0.0767147276434071,0.00547952027297535,0.0659748679083754,0.0874545873784388,2.83191110151286e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,37598,0.0713027058752409,0.0050903414886175,0.0613256365575506,0.0812797751929312,2.91918008061739e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TREML2,Trem-like transcript 2 protein,40332,0.0448408520480987,0.00320727999609357,0.0385545832557553,0.0511271208404421,3.72215238136766e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL7,Interleukin-7,40341,0.0860051120882247,0.00616262358974277,0.0739263698523289,0.0980838543241206,5.26546479836589e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GP5,Platelet glycoprotein V,37671,0.0479408947344988,0.00343920039040452,0.041200061969306,0.0546817274996917,7.44153937653402e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJC9,DnaJ homolog subfamily C member 9,37901,0.102698178351714,0.00736976577641882,0.0882534374299336,0.117142919273495,7.82121249324434e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINB9,Serpin B9,40228,0.0446846260500077,0.00320968306412324,0.0383936472443261,0.0509756048556892,8.47760706883966e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LARP1,La-related protein 1,37900,0.0846473584608486,0.00608075464388674,0.0727290793588306,0.0965656375628666,9.55845256763255e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FIS1,Mitochondrial fission 1 protein,40354,0.10260606419431,0.00738307482057012,0.0881352375459924,0.117076890842627,1.18113032351032e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMTN,Smoothelin,37905,0.128225892142864,0.00922167819244497,0.110151402885672,0.146300381400056,1.18654913477345e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PMVK,Phosphomevalonate kinase,39951,0.147003110649048,0.010589054228519,0.12624856436115,0.167757656936945,1.47304262947922e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IMMT,MICOS complex subunit MIC60,37900,0.0590568402014026,0.00425823188778474,0.0507107057013445,0.0674029747014607,1.94693897094401e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGR,Tyrosine-protein kinase Fgr,39961,0.0732824872892844,0.00528654907474205,0.0629208511027899,0.0836441234757788,1.95253150527504e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F12,Coagulation factor XII,38013,0.0554388753246393,0.00399924535771056,0.0476003544235266,0.063277396225752,2.11766648053267e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',37942,0.0524135051300592,0.00378635041377709,0.0449922583190561,0.0598347519410623,2.78075155152457e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GP6,Platelet glycoprotein VI,40311,0.116361855412695,0.00841491444604275,0.0998686230984512,0.132855087726939,3.07649350108684e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,40490,0.0423377789126776,0.00306545231480198,0.0363294923756658,0.0483460654496895,3.84890700423534e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37598,0.105549860653414,0.00763846073255779,0.0905784776176007,0.120521243689227,3.96155708454027e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM3C,Protein FAM3C,40330,0.0392069936534572,0.00284077081054931,0.0336390828647805,0.0447749044421338,4.42356679554805e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37990,0.0978562074170874,0.00708936004929213,0.0839610617204748,0.1117513531137,4.76615819347529e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RP2,Protein XRP2,40305,0.054419276387795,0.0039500578955851,0.0466771629124482,0.0621613898631418,6.21022939787947e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC37,Hsp90 co-chaperone Cdc37,40411,0.110251374701816,0.0080039584031128,0.0945636162317149,0.125939133171917,6.37815189115218e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINT2,Kunitz-type protease inhibitor 2,40422,0.0551761698566326,0.00401306559388727,0.0473105612926136,0.0630417784206517,9.03188612520596e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MFAP5,Microfibrillar-associated protein 5,40536,0.0539287338734773,0.00392383469560989,0.0462380178700819,0.0616194498768727,9.66470643412696e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACYP1,Acylphosphatase-1,37622,0.0870365285683227,0.00633754419844416,0.0746149419393721,0.0994581151972732,1.25793900076156e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37628,0.0694839861051044,0.00506179758937189,0.0595628628299354,0.0794051093802733,1.3709088709101e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STXBP1,Syntaxin-binding protein 1,37959,0.101362244988937,0.00741073886484829,0.0868371968138346,0.11588729316404,2.63802633964185e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDT16,U8 snoRNA-decapping enzyme,37880,0.11466090312357,0.00838372802129555,0.0982287962018311,0.13109301004531,2.6896599484537e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DIABLO,"Diablo homolog, mitochondrial",40314,0.142994849355964,0.0104768377404693,0.122460247384644,0.163529451327284,3.55848729535572e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BLNK,B-cell linker protein,37598,0.0501985984867844,0.00367644873227471,0.0429927589715259,0.0574044380020428,3.6989947802257e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37598,0.0638071992002732,0.00468455219915979,0.05462547688992,0.0729889215106264,5.8046851677189e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM3B,Protein FAM3B,40305,0.0468741978922614,0.00345349156755265,0.0401053544198582,0.0536430413646646,9.90677054567796e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTSL2,ADAMTS-like protein 2,37998,0.0402279605173125,0.0029625330910837,0.0344213956587884,0.0460345253758366,1.00154428834314e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,40536,-0.0410143970975524,0.00302397915288396,-0.0469413962372049,-0.0350873979578998,1.12404024983023e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,37671,0.0473397174096555,0.00349127154637465,0.0404968251787612,0.0541826096405499,1.3214783820913e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,40042,0.143326078962237,0.0105769607350874,0.122595235921466,0.164056922003009,1.34833524415145e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37942,0.0990443145035855,0.0073114917936844,0.084713790587964,0.113374838419207,1.55512824237679e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,XCL1,Lymphotactin,40489,0.0730359875917274,0.00539603455585921,0.0624597598622434,0.0836122153212114,1.63995213650589e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSPB6,Heat shock protein beta-6,40489,0.0472221150750193,0.00349165412538286,0.0403784729892689,0.0540657571607697,1.89735582751765e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HNMT,Histamine N-methyltransferase,40147,0.060018987563094,0.00443872397087229,0.0513190885801843,0.0687188865460037,1.98734295748499e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39980,0.0878251344861534,0.00649762930293759,0.0750897810523957,0.100560487919911,2.14294949562119e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",40305,0.0774803480334501,0.00573625331523455,0.0662372915355904,0.0887234045313098,2.40329951390256e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40422,0.153456504764125,0.0113615795335476,0.131187808878372,0.175725200649879,2.41082020912518e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCN1,Ficolin-1,37967,0.0730037820140401,0.0054040992205326,0.0624117475417962,0.083595816486284,2.56671242146012e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERMAP,Erythroid membrane-associated protein,37598,0.058146461026811,0.0043058804896776,0.0497069352670429,0.0665859867865791,2.79196235263139e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BDNF,Brain-derived neurotrophic factor,37998,0.106887695152446,0.00792562273257591,0.0913534745965974,0.122421915708295,3.46978399503459e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOXO3,Forkhead box protein O3,39980,0.125108251580166,0.00928345366189409,0.106912682402853,0.143303820757478,3.66503498778518e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOD1,Superoxide dismutase [Cu-Zn],39978,0.0632446593909755,0.00469456895397265,0.0540433042411891,0.0724460145407619,3.89812691809264e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37990,0.113960198340342,0.00848268534031614,0.0973341350733221,0.130586261607361,6.94178416128865e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS3,Galectin-3,40374,0.0380140130972512,0.00283103196629277,0.0324651904433174,0.0435628357511851,6.95311094169067e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC26,Anaphase-promoting complex subunit CDC26,37879,0.0906535717900794,0.00675054727744692,0.0774224991262834,0.103884644453875,7.49452603455804e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BOLA2_BOLA2B,BolA-like protein 2,37628,0.0722153267368863,0.00537820016775082,0.0616740544080947,0.0827565990656779,7.74982071356384e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FADD,FAS-associated death domain protein,40359,0.097978200197439,0.00730982528193021,0.0836509426448558,0.112305457750022,9.5793130322109e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ABHD14B,Protein ABHD14B,40171,0.0749861425958287,0.0055992087722647,0.0640116934021899,0.0859605917894675,1.12111452873598e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKT2,RAC-beta serine/threonine-protein kinase,37959,0.16120955477437,0.0120340484542938,0.137622819803954,0.184796289744786,1.15784617156006e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40341,0.11771855025864,0.00879266097726253,0.100484934743205,0.134952165774074,1.17602923582087e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,37572,0.0785107938903879,0.00586567344415466,0.0670140739398448,0.0900075138409311,1.36963846883122e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APLP1,Amyloid-like protein 1,40359,-0.0665837692133342,0.00498317039341438,-0.0763507831844264,-0.056816755242242,1.67298272008761e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37628,0.0580096807557507,0.00434194490791381,0.0494994687362397,0.0665198927752618,1.89051298241468e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C19orf12,Protein C19orf12,39961,0.0793672812438965,0.00594409085753086,0.067716863163136,0.091017699324657,1.92055327169458e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGACT,Gamma-glutamylaminecyclotransferase,37990,0.0903027967158759,0.00678756997641158,0.0769991595621092,0.103606433869643,3.91136667094035e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCG2,Secretogranin-2,40392,0.0410601534837009,0.00308816437846178,0.0350073513019158,0.047112955665486,3.9954987994319e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40228,0.0407151860296055,0.00306255150914333,0.0347125850716846,0.0467177869875265,4.09319210694278e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37225,0.13726755660463,0.0103360154856418,0.117008966252772,0.157526146956488,5.52832985720551e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTX3,Pentraxin-related protein PTX3,40341,-0.0624312509297225,0.00470566226228997,-0.0716543489638108,-0.0532081528956341,5.84750370006117e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,37671,0.04643334760199,0.00350031859935347,0.0395727231472572,0.0532939720567228,6.60400108095567e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFT20,Intraflagellar transport protein 20 homolog,37572,0.054820430622564,0.00413712686816599,0.0467116619609586,0.0629291992841693,8.03959500830523e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37337,0.0627264096909263,0.00473802157183776,0.0534398874101243,0.0720129319717283,9.50103852856333e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",37901,0.110558399690942,0.00836596349257518,0.0941611112454948,0.12695568813639,1.26486659755404e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,37746,0.0704947857597836,0.00533622061584496,0.0600357933527275,0.0809537781668397,1.35312069910254e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ING1,Inhibitor of growth protein 1,39925,0.0562782505588555,0.00427180637382793,0.0479055100661528,0.0646509910515583,2.00986655959068e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITPA,Inosine triphosphate pyrophosphatase,37562,0.0858692150052651,0.00651627027953411,0.0730973252573782,0.0986411047531519,2.10010273239886e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37671,0.0522226047394826,0.00396791839196488,0.0444454846912314,0.0599997247877337,2.59185466895293e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPXM1,Probable carboxypeptidase X1,40411,0.0864793411863027,0.00657901201514889,0.0735844776366109,0.0993742047359945,2.91835544719189e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFA,Protransforming growth factor alpha,40341,0.0602706324649944,0.00458835687744385,0.0512774529852044,0.0692638119447843,3.29688868885287e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEMIP2,Cell surface hyaluronidase,37598,0.0425332325578196,0.00324151085241002,0.036179871287096,0.0488865938285433,4.36900971937761e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NADK,NAD kinase,40359,0.0671918402853918,0.00512882089846824,0.057139351324394,0.0772443292463895,5.18448468770606e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37901,0.0965752903573396,0.00737942622949567,0.0821116149475281,0.111038965767151,6.74335720430806e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MDK,Midkine,40352,0.0634790648887689,0.00485308351802264,0.0539670211934445,0.0729911085840933,6.78902079504273e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40182,0.0512886784985937,0.00392229648497319,0.0436009773880462,0.0589763796091411,7.18402367115639e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37628,-0.045628752028276,0.00348856341224704,-0.0524663363162802,-0.0387911677402718,7.52475657117329e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIPC3,PDZ domain-containing protein GIPC3,37901,0.122601279771825,0.00937530957284491,0.104225673009049,0.140976886534601,7.6851392897415e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB10,Ras-related protein Rab-10,37990,0.0671733234720213,0.0051429439033852,0.0570931534213863,0.0772534935226563,9.3985735841511e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TTF2,Transcription termination factor 2,37572,0.0609603139931968,0.00466794556489785,0.051811140685997,0.0701094873003965,9.80022858872392e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGXT,Serine--pyruvate aminotransferase,40359,0.0960547627089349,0.00735998043152209,0.0816292010631516,0.110480324354718,9.92165478418089e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,40044,0.0827732911946351,0.00634516746710066,0.0703367629591178,0.0952098194301524,1.08049659170705e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC27A4,Long-chain fatty acid transport protein 4,39961,0.0828609172909517,0.00636302583371263,0.0703893866568749,0.0953324479250284,1.45657647911381e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FEN1,Flap endonuclease 1,39980,0.0772793275405348,0.0059378901821516,0.0656410627835177,0.0889175922975519,1.60718896811638e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37628,0.059037219162194,0.0045439545100054,0.0501310683225834,0.0679433700018046,2.32205320127873e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEPTIN9,Septin-9,40305,0.0349745158157692,0.00269414262344502,0.0296939962738169,0.0402550353577214,2.437448999733e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,40470,0.0759437553969078,0.00585505172105244,0.064467854023645,0.0874196567701705,2.79844429121969e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNMA1,Paraneoplastic antigen Ma1,37628,0.0696453840921085,0.00536793082106814,0.0591242396828149,0.080166528501402,2.93364759192018e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCAM2,Neural cell adhesion molecule 2,40332,-0.0335193873160337,0.00258684431062382,-0.0385896021648564,-0.028449172467211,3.3223275621918e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICAM1,Intercellular adhesion molecule 1,40291,0.0353571064933838,0.00273065704268833,0.0300050186897147,0.040709194297053,3.75619865797926e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PQBP1,Polyglutamine-binding protein 1,39980,0.0684421371670232,0.00528611787389103,0.0580813461341967,0.0788029281998496,3.8230414687699e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPA2,Carboxypeptidase A2,40398,0.079439983400944,0.00613731266424687,0.0674108505790201,0.0914691162228679,3.96515594913222e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,39897,0.0710226364985502,0.0054866967399351,0.0602687108882774,0.081776562108823,3.98371110335451e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLO1,Lactoylglutathione lyase,40042,0.0733693998759294,0.00567210125994419,0.0622520814064388,0.08448671834542,4.47632066818504e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G4A,Cytosolic phospholipase A2,40422,0.107766497400382,0.00833213267348176,0.0914355173603574,0.124097477440406,4.50318931397226e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,40471,0.0597821942620779,0.00462997493684375,0.0507074433858642,0.0688569451382916,5.95710114733549e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCRG1,Scrapie-responsive protein 1,37990,0.0338893554567533,0.00263202185461972,0.0287305926216986,0.0390481182918079,1.02543906998516e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAP18,Chromatin complexes subunit BAP18,37942,0.0799730145797089,0.00621327603078255,0.0677949935593751,0.0921510356000427,1.08782575304481e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,37562,0.0858766450944784,0.00667405407387109,0.072795499109691,0.0989577910792657,1.16292388914564e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ESAM,Endothelial cell-selective adhesion molecule,40536,0.0385222507666503,0.00299739396624773,0.0326473585928048,0.0443971429404959,1.28506540753952e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40379,0.0405991655852168,0.00317004023155679,0.0343858867313654,0.0468124444390681,2.28619383551786e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,37990,0.0366831788273579,0.00286463781425391,0.0310684887114203,0.0422978689432956,2.51402308572685e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASEH2A,Ribonuclease H2 subunit A,37959,0.0607097425108393,0.00474628503859079,0.0514070238352014,0.0700124611864773,3.02742292898574e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSNAX,Translin-associated protein X,37562,0.0484090403926505,0.00378802674373216,0.0409845079749354,0.0558335728103655,3.55707170011474e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GBP1,Guanylate-binding protein 1,37931,0.0788307543672018,0.00617564678128286,0.0667264866758873,0.0909350220585162,4.22843546444561e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100P,Protein S100-P,40042,0.0655205682427521,0.00513602953737713,0.0554539503494929,0.0755871861360113,4.36473444564262e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37598,0.0694089015627537,0.00543839966213842,0.0587496382249624,0.080068164900545,4.3931447287816e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL26,C-C motif chemokine 26,40341,0.108529156241079,0.0085096582691367,0.0918502260335708,0.125208086448587,4.52127254503615e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MZT1,Mitotic-spindle organizing protein 1,39980,0.0643929025845482,0.00505222950742584,0.0544905327499935,0.0742952724191028,5.066088066185e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INPP1,Inositol polyphosphate 1-phosphatase,40305,0.0655557285703932,0.00515005206814862,0.0554616265168219,0.0756498306239645,6.17610239998914e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SDHB,Succinate dehydrogenase,37901,0.0868751817334662,0.00682310443947037,0.0735018970321043,0.100248466434828,6.372325988243e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40305,0.0469540516547891,0.00369099292655561,0.0397197055187401,0.0541883977908381,6.82532814490515e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BPIFA2,BPI fold-containing family A member 2,37150,-0.135688232985994,0.0106631020575939,-0.156587913018878,-0.11478855295311,7.20861354383998e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFAT5,Nuclear factor of activated T-cells 5,37598,0.106870639749662,0.00840675144321917,0.0903934069209529,0.123347872578372,8.30087708302594e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37942,0.10499493495432,0.00827178114719399,0.0887822439058195,0.12120762600282,1.04633516189137e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MIA,Melanoma-derived growth regulatory protein,40411,0.0449237522000956,0.00354227819926319,0.0379808869295397,0.0518666174706514,1.11610548566522e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NECTIN2,Nectin-2,40330,0.0351167794126113,0.00276960351634184,0.0296883565205812,0.0405452023046413,1.15883837773131e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37959,0.11045463099549,0.00871146449354873,0.0933801605881341,0.127529101402845,1.24642840835552e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AK2,"Adenylate kinase 2, mitochondrial",37942,0.128244173035871,0.0101178089198429,0.108413267552979,0.148075078518763,1.31387354175144e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,40502,0.0616625206145046,0.0048725916470949,0.0521122409861986,0.0712128002428106,1.56940108624343e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EGFL7,Epidermal growth factor-like protein 7,39980,0.048875227838015,0.00386780901521533,0.0412943221681929,0.056456133507837,2.00949360747158e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZNRD2,Protein ZNRD2,37901,0.0824825868608211,0.006524776629592,0.0696940246668207,0.0952711490548214,2.00968513325562e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLF4,Krueppel-like factor 4,37541,0.0474687787812283,0.00375490783766101,0.0401091594194127,0.0548283981430439,2.0269731618749e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGAL,Integrin alpha-L,37598,0.0529033920721194,0.00418665654142531,0.0446975452509258,0.061109238893313,2.17028532883328e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,38484,-0.037851693509754,0.00299771178866328,-0.043727208615534,-0.031976178403974,2.36688666525999e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASAH1,Acid ceramidase,37882,0.0558925139366867,0.00442824561324856,0.0472131525347196,0.0645718753386539,2.57314493911184e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,37942,0.0364778498717701,0.0028924512534957,0.0308086454149185,0.0421470543286217,2.9264810344075e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD164,Sialomucin core protein 24,40332,0.0320351972730091,0.00254181755600012,0.0270532348632489,0.0370171596827694,3.02082779650054e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DBN1,Drebrin,37598,0.0625660960880468,0.00496639262380225,0.0528319665453944,0.0723002256306992,3.5085914254795e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37598,0.0541570104889831,0.00430725804382547,0.0457147847230852,0.062599236254881,4.76526698048613e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCRN1,Secernin-1,40341,0.0676746570164978,0.00538671244113771,0.0571167006318679,0.0782326134011277,4.98709956496634e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37598,0.0521771310944013,0.00415113704299728,0.0440409024901267,0.060313359698676,5.01408227522586e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PECAM1,Platelet endothelial cell adhesion molecule,40332,0.0358967559816683,0.00286724547727171,0.0302769548462157,0.0415165571171208,8.60795899258716e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37901,0.054667409321625,0.00436770167717435,0.0461067140343632,0.0632281046088867,9.61851093548813e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40305,0.0833591451698752,0.00666439254692481,0.0702969357779025,0.0964213545618478,9.93655196493093e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNX9,Sorting nexin-9,40359,0.0822533325845559,0.00658089076442464,0.0693547866862836,0.0951518784828282,1.11460824100114e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39980,0.0737511987295811,0.00590300012480033,0.0621813184849725,0.0853210789741898,1.19681879426043e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,37628,0.0535076203782497,0.00428286432023083,0.0451132063105973,0.0619020344459022,1.29035802747003e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACRBP,Acrosin-binding protein,37900,0.0453287961956832,0.0036325958086896,0.0382089084106515,0.0524486839807148,1.54155723489688e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",40516,0.0827734136692033,0.00664089351117636,0.0697572623872977,0.095789564951109,1.70809593236986e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40042,0.104732411694326,0.00841444759685677,0.0882400944044867,0.121224728984165,2.14581596664751e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40341,0.146063332412474,0.0117361758216697,0.123060427802002,0.169066237022947,2.16153258417833e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGA6,Integrin alpha-6,40341,0.0633307932278019,0.00509146121861959,0.0533515292393075,0.0733100572162963,2.35568342201124e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CORO1A,Coronin-1A,39990,0.107027939601631,0.00862241105190733,0.0901280139398928,0.12392786526337,3.27268615155274e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH3BP1,SH3 domain-binding protein 1,37901,0.0556209610763553,0.00448318535206231,0.0468339177863132,0.0644080043663974,3.7483077885926e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPON2,Spondin-2,40267,-0.0410540390033233,0.00331055595602278,-0.0475427286771279,-0.0345653493295186,3.76216439420144e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VWC2,Brorin,40167,0.0461638803198937,0.00372477208151748,0.0388633270401194,0.0534644335996679,4.12218455070807e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TST,Thiosulfate sulfurtransferase,39923,0.0899510412707989,0.00725812723167278,0.0757251118967202,0.104176970644878,4.17743844038357e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF2,Fibroblast growth factor 2,40341,0.0784870324133387,0.00634259002588551,0.0660555559626031,0.0909185088640743,5.19966537755196e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F11,Coagulation factor XI,37810,0.0358996625973579,0.00290249923412355,0.0302107640984758,0.0415885610962401,6.00822807875877e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HPCAL1,Hippocalcin-like protein 1,40516,0.0867959539173603,0.00702384737648748,0.0730292130594449,0.100562694775276,6.4083481169897e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BGLAP,Osteocalcin,37998,0.108117906286294,0.00875695183032491,0.0909542806988569,0.125281531873731,7.82858807698495e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39961,0.0755628287178837,0.00612689438628974,0.0635541157207558,0.0875715417150116,8.75996365158739e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGMN,Legumain,40422,0.0418917792581926,0.00340013755014813,0.0352275096599022,0.0485560488564829,1.00879107784043e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLRX,Glutaredoxin-1,40260,0.0668014399004688,0.0054294604567383,0.0561596974052617,0.0774431823956759,1.24899685686289e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNF,Tumor necrosis factor,40014,0.046895156607929,0.00381406486889911,0.0394195894648867,0.0543707237509712,1.38888281150555e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA13,Carbonic anhydrase 13,40173,0.1219346787713,0.00992886657057184,0.102474100292979,0.14139525724962,1.65264952705199e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFASC,Neurofascin,40516,0.0320297022353066,0.0026085556047486,0.0269169332499993,0.0371424712206138,1.68293114793561e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PARD3,Partitioning defective 3 homolog,37714,0.0876046697741321,0.00713113240727838,0.0736276502558664,0.101581689292398,1.68301269455866e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL1,Growth-regulated alpha protein,40329,0.114273492714269,0.00931247917012567,0.0960210335408231,0.132525951887716,1.85708997113323e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPPK1,Epiplakin,37628,0.0866913373438609,0.00706658549140151,0.0728408297807139,0.100541844907008,2.0782133634207e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCTN2,Dynactin subunit 2,40305,0.110345654641199,0.00900370842385077,0.0926983861304515,0.127992923151947,2.24387234220091e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTGES2,Prostaglandin E synthase 2,37484,0.0643467841549711,0.00524959638100699,0.0540575752481974,0.0746359930617448,2.36802800049656e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,37562,0.0794441466992803,0.00648834575310817,0.0667269890231882,0.0921613043753723,2.77919523903645e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINB8,Serpin B8,40516,0.0639275073110939,0.00522484674490127,0.0536868076910874,0.0741682069311003,2.86139114310913e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRI1,Methylthioribose-1-phosphate isomerase,37572,0.0806810142669785,0.00661531094345114,0.0677150048178143,0.0936470237161428,4.98261947278387e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD84,SLAM family member 5,40341,0.035901006159096,0.00295111674665558,0.0301168173356511,0.0416851949825409,6.73688845527896e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,37959,0.060756711251603,0.00499237051937861,0.050971665033621,0.0705417574695851,6.76395113325002e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37865,0.0364951705947896,0.0029997935199209,0.0306155752957446,0.0423747658938346,7.12157683675077e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,37990,0.0695604454298615,0.00571934417148339,0.058350530853754,0.0807703600059689,7.40947843917994e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB2B,Ras-related protein Rab-2B,37900,0.0716457299004177,0.00589165702378256,0.0600980821338039,0.0831933776670316,7.5906342793799e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADM,Pro-adrenomedullin,40489,0.0313594922856931,0.00258068539643474,0.026301348908681,0.0364176356627052,7.92099302508602e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD40LG,CD40 ligand,40516,0.0890713758795977,0.00733188864385575,0.0747008741376404,0.103441877621555,8.22192783538823e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FRMD4B,FERM domain-containing protein 4B,37562,0.0822030881953095,0.00676413455169356,0.0689453844739901,0.0954607919166289,8.42496561760596e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FNDC1,Fibronectin type III domain-containing protein 1,37942,0.0533794229416904,0.00440256361018365,0.0447503982657305,0.0620084476176503,1.17042118699569e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,40385,0.138901997453068,0.0114630498463717,0.11643441975418,0.161369575151957,1.20160469545192e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37901,0.135348949420935,0.0111685678450794,0.113458556444579,0.15723934239729,1.2581186763038e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGL1,Fibrinogen-like protein 1,37987,-0.0729742571242605,0.00602309702240419,-0.0847795272881728,-0.0611689869603483,1.3012095934942e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1R,Complement C1r subcomponent,38013,0.0231374496220039,0.00191015211884863,0.0193935514690606,0.0268813477749472,1.3457589499194e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GET3,ATPase GET3,37990,0.0652419944945697,0.00538907190778171,0.0546794135553175,0.0758045754338219,1.45705515170011e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40228,0.0434481822384383,0.00359205395982371,0.0364077564771838,0.0504886079996928,1.56744578274281e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BLMH,Bleomycin hydrolase,40536,0.0374265486866975,0.00309479689348281,0.0313607467754712,0.0434923505979238,1.60032318386281e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OPLAH,5-oxoprolinase,37628,0.0789375149564861,0.00654143511865527,0.0661163021239217,0.0917587277890504,2.35650514690635e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,39980,0.0887864226678103,0.00736149603776459,0.0743578904337917,0.103214954901829,2.39430115088414e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40341,0.0951623310726709,0.00789185064993648,0.0796943037987954,0.110630358346546,2.45182392968456e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DKK4,Dickkopf-related protein 4,40203,0.0526001279982646,0.00436825482248179,0.0440383485462003,0.0611619074503289,3.01117539821553e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASET2,Ribonuclease T2,40465,0.0304751376339364,0.00253101135705998,0.0255143553740988,0.0354359198937739,3.02206545603052e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPK1,Thiamin pyrophosphokinase 1,37990,0.0312596446404989,0.00260014748176132,0.0261633555762467,0.0363559337047511,4.00260810342437e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSME2,Proteasome activator complex subunit 2,40152,0.0425995915683653,0.00355047421768679,0.0356406621016992,0.0495585210350314,5.05856577034722e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PKN3,Serine/threonine-protein kinase N3,37714,0.0889973433051473,0.00741490790604346,0.0744641238093022,0.103530562800993,5.11157665926002e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPM1F,Protein phosphatase 1F,37990,0.0601627087936199,0.00501904986520863,0.050325371057811,0.0700000465294288,6.11133342180321e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJC21,DnaJ homolog subfamily C member 21,37942,0.0432686536857056,0.00361077405661792,0.0361915365347344,0.0503457708366767,6.39336515550079e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40192,0.0849989576899086,0.00710138717510924,0.0710802388266945,0.0989176765531227,7.14375154045974e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARAF,Serine/threonine-protein kinase A-Raf,37714,0.0772458524243092,0.00645620062953995,0.0645916991904109,0.0899000056582075,8.03472287007895e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCN4,CCN family member 4,40489,0.0468984729562223,0.00392240917902771,0.0392105509653279,0.0545863949471166,8.27286288734026e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40228,-0.133866765007172,0.011196738183931,-0.155812371847677,-0.111921158166668,8.38402944883513e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40192,0.109055592649814,0.00912856774687155,0.0911635998659459,0.126947585433682,9.36819348367817e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DMD,Dystrophin,37628,0.0596798332471292,0.00499826536161502,0.0498832331383638,0.0694764333558947,1.07818794321948e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40400,0.0595457230448421,0.00499462574681753,0.0497562565810797,0.0693351895086044,1.25146684918043e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCTN6,Dynactin subunit 6,39961,0.0807591870236549,0.0067785864767865,0.0674731575291534,0.0940452165181564,1.3902854588601e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SWAP70,Switch-associated protein 70,37901,0.0401795128085129,0.00337558289500892,0.0335633703342954,0.0467956552827304,1.66269790566138e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,40291,0.0491642077773851,0.00413766724613681,0.0410543799749569,0.0572740355798132,2.01351023987961e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP1,Interstitial collagenase,39757,0.105933660760819,0.00891508363260302,0.0884600968409167,0.123407224680721,2.02584935777316e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MARCO,Macrophage receptor MARCO,40359,0.0302658698071529,0.00254781914793302,0.0252721442772042,0.0352595953371016,2.08311789864068e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF23,Fibroblast growth factor 23,40469,0.0701371206398921,0.0059096210550813,0.0585542633719327,0.0817199779078514,2.36344386254483e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40044,0.0819719009674219,0.00690707826683351,0.0684340275644283,0.0955097743704156,2.39719460677844e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40228,0.0793756488649076,0.00670112703538176,0.0662414398755593,0.0925098578542558,3.12402536252032e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,39980,0.0564278589123288,0.00476949458734301,0.0470796495211365,0.0657760683035211,3.70991588222636e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NID1,Nidogen-1,40355,0.0447998543905258,0.00378971779762915,0.0373720075071726,0.0522277012738789,4.12286303235014e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,40215,0.106739839483175,0.00902994752468876,0.0890411423347853,0.124438536631565,4.17204655571599e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FXN,"Frataxin, mitochondrial",40489,0.0835242757658549,0.00708732363716944,0.0696331214370028,0.097415430094707,6.31490698786588e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD302,CD302 antigen,40305,0.0339668063750785,0.00288229417476337,0.0283175097925423,0.0396161029576147,6.36551916339409e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAD23B,UV excision repair protein RAD23 homolog B,39980,0.0538385947144276,0.00456892770334155,0.0448834964158781,0.062793693012977,6.48233867425774e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCS,Copper chaperone for superoxide dismutase,40228,0.0544117344557106,0.00462708481043012,0.0453426482272676,0.0634808206841537,8.57682952416154e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40341,0.134277962679024,0.0114314601381533,0.111872300808244,0.156683624549805,9.97411389885599e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTC,Probetacellulin,39980,0.0848514212865435,0.00722638143786843,0.0706877136683214,0.0990151289047656,1.05827228402255e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40384,-0.0344191421707415,0.00293194491954436,-0.0401657542130485,-0.0286725301284346,1.08182335088821e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX58,Antiviral innate immune response receptor RIG-I,39980,0.0644205943343794,0.00548743285710536,0.0536652259344529,0.0751759627343059,1.08638096389394e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,37959,0.0442805884592055,0.00377248671123146,0.0368865145051919,0.0516746624132192,1.16274293215287e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DYNLT3,Dynein light chain Tctex-type 3,37900,0.0489791679215749,0.00417898817537999,0.0407883510978301,0.0571699847453196,1.42781911755371e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGS10,Regulator of G-protein signaling 10,37959,0.0673704828368595,0.00575291054106431,0.0560947781763734,0.0786461874973455,1.59598616723467e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDZD2,PDZ domain-containing protein 2,37562,0.0690921434104378,0.00590164549753754,0.0575249182352642,0.0806593685856114,1.67840520966038e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNAS,Neuroendocrine secretory protein 55,37959,0.101105673938565,0.00866611242073178,0.0841200935939305,0.118091254283199,2.66197205675525e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,40312,0.0991171763319986,0.00851232480679671,0.082433019710677,0.11580133295332,3.29947823561657e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BGN,Biglycan,39956,-0.135779842524712,0.0116623166704329,-0.15863798319876,-0.112921701850663,3.37402296571167e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD46,Membrane cofactor protein,40250,0.0319311871399502,0.00274698431655321,0.0265470978795059,0.0373152764003945,4.16123685653007e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,37628,-0.0709902439783247,0.00611024360850595,-0.0829663214509963,-0.059014166505653,4.71739118477411e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ABCA2,ATP-binding cassette sub-family A member 2,37562,0.0413035340135536,0.00355737462852777,0.0343310797416392,0.048275988285468,5.15773054554902e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UNC79,Protein unc-79 homolog,37482,0.062892656775387,0.00543274093994112,0.0522444845331024,0.0735408290176716,7.66436759952105e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX7,Syntaxin-7,37598,0.0559427370521285,0.00483721956464761,0.0464617867054192,0.0654236873988378,8.72908064793938e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FST,Follistatin,40396,0.0574696757813731,0.00498039384605825,0.0477081038430989,0.0672312477196472,1.1083488761768e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA2,Annexin A2,37441,0.0792069392296136,0.00687399267250219,0.0657339135915093,0.0926799648677179,1.42737511710949e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SF3B4,Splicing factor 3B subunit 4,40305,0.0808781313613922,0.00702825634240269,0.0671027489302829,0.0946535137925014,1.59751523149263e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSE,Cathepsin E,37671,0.0569757320365592,0.00495143330646514,0.0472709227558875,0.0666805413172309,1.70091867887174e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNAP25,Synaptosomal-associated protein 25,37541,0.0517520735708597,0.00449746001014085,0.0429370519509837,0.0605670951907358,1.7057784514021e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAG3,BAG family molecular chaperone regulator 3,40203,0.0436751692034409,0.00380211454870888,0.0362230246879715,0.0511273137189103,2.02516137617314e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDH7,Protocadherin-7,37901,0.038475502155499,0.00334881151603524,0.0319118315840699,0.045039172726928,2.07003619331729e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SFRP1,Secreted frizzled-related protein 1,40178,0.0479327423641444,0.00417794309873062,0.0397439738906324,0.0561215108376565,2.38619780084171e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,40411,0.0965775166828101,0.00842734806694599,0.0800599144715959,0.113095118894024,2.7518672012131e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADA,Adenosine deaminase,40516,0.0373473398647085,0.00326004893403929,0.0309576439539915,0.0437370357754255,2.87394098188733e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCDC134,Coiled-coil domain-containing protein 134,37900,0.0540392277491034,0.00471821751753391,0.044791521414737,0.0632869340834699,3.12508525247698e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37562,0.0307678932796977,0.00269065728174244,0.0254942050074825,0.0360415815519128,3.88002146624778e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37671,0.0975593785739821,0.00854015616991144,0.0808206724809557,0.114298084667009,4.41070661187264e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37628,0.100272975669812,0.0087804052518061,0.0830633813762721,0.117482569963352,4.59610047498855e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COLEC12,Collectin-12,40357,0.0279111571022404,0.00244958120601193,0.023109977938457,0.0327123362660237,5.8363653998559e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,37990,0.0353405401697189,0.00310747906975734,0.0292498811929945,0.0414311991464433,7.80755368657812e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,37900,0.0448361883275631,0.00394821329182278,0.0370976902755904,0.0525746863795357,9.45167040150511e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX16,Syntaxin-16,39980,0.0643196102810803,0.00566887176535133,0.0532086216209917,0.0754305989411689,1.0152158069206e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NGRN,Neugrin,37942,0.0240068357476727,0.00211566231942247,0.0198601376016047,0.0281535338937407,1.04413250690975e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37959,0.0636937564284477,0.00561365986234163,0.0526909830982582,0.0746965297586373,1.05546792078227e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA9,Serpin A9,40228,0.0782760584959993,0.00690922268223603,0.0647339820388166,0.0918181349531819,1.22421327939607e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NID2,Nidogen-2,40332,0.0801203522044694,0.00707392180631652,0.066255465464089,0.0939852389448498,1.26514159697157e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASE6,Ribonuclease K6,37917,0.0320883996077575,0.00283290429110847,0.0265359071971848,0.0376408920183301,1.31249431011795e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRL1,Fc receptor-like protein 1,40359,0.0487159684423567,0.00432031180390945,0.0402481573066942,0.0571837795780193,2.22788115019971e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40044,0.0453185906357461,0.00401996618311567,0.0374394569168394,0.0531977243546528,2.30741271660329e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCF2,Neutrophil cytosol factor 2,40324,0.0898330727472406,0.00797209553309917,0.0742077655023662,0.105458379992115,2.42824017779236e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,39980,0.0585658400178856,0.00520004367260365,0.0483737544195825,0.0687579256161888,2.60894381074677e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP6V1F,V-type proton ATPase subunit F,39925,0.0711837012266941,0.00633581342073098,0.0587655069220614,0.0836018955313268,3.55501407364352e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA4,Annexin A4,40279,0.0770295117269357,0.00688331658692444,0.0635382112165638,0.0905208122373076,5.8130847354034e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPR,Nucleoprotein TPR,37562,0.0505091114336398,0.00451408807935005,0.0416614987981137,0.0593567240691659,6.22674973146106e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IMPA1,Inositol monophosphatase 1,40228,0.0652990182375802,0.00584058217460151,0.0538514771753613,0.0767465592997992,6.54502260151378e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA14,Carbonic anhydrase 14,40489,-0.0369886476628386,0.00331103075694243,-0.0434782679464458,-0.0304990273792315,7.19912631797575e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BOLA1,BolA-like protein 1,37541,0.058890829458945,0.0052711561358977,0.0485593634325855,0.0692222954853044,7.52624645186098e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40305,0.0255636868110235,0.00229415348429388,0.0210671459818075,0.0300602276402395,9.9077162647823e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCARA5,Scavenger receptor class A member 5,40471,0.0312876836730955,0.00281019517475104,0.0257797011305834,0.0367956662156075,1.09660793827895e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA4,Carbonic anhydrase 4,40536,-0.0249026343815027,0.0022404965294323,-0.02929400757919,-0.0205112611838154,1.35119867301281e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",40228,0.0622767225299276,0.00561935936542267,0.0512627781736991,0.073290666886156,1.94192645015222e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WAS,Wiskott-Aldrich syndrome protein,40044,0.0724379810552059,0.00654906032354113,0.0596018228210653,0.0852741392893465,2.47669488636427e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRK5,G protein-coupled receptor kinase 5,40042,0.0558067331747101,0.00504850285456506,0.0459116675797626,0.0657017987696576,2.66742376945462e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL24,C-C motif chemokine 24,40396,0.0878303054633353,0.0079470706105214,0.0722540470667133,0.103406563859957,2.71870715522592e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTA,Lymphotoxin-alpha,40341,0.0426745979859592,0.00386191938929168,0.0351052359829475,0.0502439599889709,2.77588166809102e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMOX1,Heme oxygenase 1,40184,-0.0496882909466972,0.00450207821207852,-0.0585123642423711,-0.0408642176510233,3.22475782061534e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL6A3,Collagen alpha-3(VI) chain,40536,0.0363091712474342,0.00329013235351862,0.0298605118345377,0.0427578306603307,3.24249945815295e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP8,Caspase-8,40434,0.0654933154195347,0.00593546912054871,0.0538597959432592,0.0771268348958101,3.30338646163667e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,40489,0.057149189345162,0.00517960683972614,0.0469971599392987,0.0673012187510252,3.32737137385216e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37562,0.0432879205994953,0.00392212551260171,0.0356005545947959,0.0509752866041946,3.37727560599049e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIF22,Kinesin-like protein KIF22,37562,0.129633142976209,0.011756832186583,0.106589751890506,0.152676534061911,3.7980222321585e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARFIP1,Arfaptin-1,37959,0.0726677968119095,0.00659947840822406,0.0597328191317903,0.0856027744920286,4.44550112928441e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",37628,0.0686168588029541,0.00623558275570501,0.0563951166017722,0.0808386010041359,4.8375195272673e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40450,0.0320297330316493,0.00291280231966483,0.0263206404851062,0.0377388255781923,5.02237151996155e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AK1,Adenylate kinase isoenzyme 1,40359,0.0673997086697781,0.0061343983511755,0.0553762879014742,0.0794231294380821,5.55323559466523e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,37910,0.0433282297554463,0.00394459355300797,0.0355968263915507,0.0510596331193419,5.98269662431871e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37959,0.072067983976977,0.00656496633356152,0.0592006499631964,0.0849353179907576,6.42175016684526e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL20,C-C motif chemokine 20,40516,0.0932443762198944,0.00850570846282344,0.0765731876327605,0.109915564807028,7.26020145213697e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SFRP4,Secreted frizzled-related protein 4,37671,0.0440506726312764,0.00401969984410848,0.0361720609368238,0.051929284325729,7.95180338279256e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RPE,Ribulose-phosphate 3-epimerase,37714,0.0735652414653789,0.00672286994509699,0.0603884163729888,0.086742066557769,9.481518204658e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL14,C-C motif chemokine 14,40309,0.0407920377082073,0.00373922156339539,0.0334631634439524,0.0481209119724623,1.30526021901733e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFCAB2,Dynein regulatory complex protein 8,37714,0.0364844722136847,0.00334331188780943,0.0299315809135782,0.0430373635137912,1.31367094334037e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENTR1,Endosome-associated-trafficking regulator 1,37628,0.0597519180901371,0.00548132848445771,0.0490085142606,0.0704953219196742,1.49465351917813e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TREH,Trehalase,37998,0.077938867941363,0.0071513535948952,0.0639222148953684,0.0919555209873576,1.5249051109026e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMOTL2,Angiomotin-like protein 2,37855,0.0503291629369205,0.00462372265715041,0.0412666665289057,0.0593916593449353,1.77105522933489e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37671,0.0704090046189587,0.00647617823780306,0.0577156952728647,0.0831023139650527,2.04713390990558e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL25,C-C motif chemokine 25,40516,0.0509258109594257,0.00468646183764013,0.041740345757651,0.0601112761612003,2.07161732421827e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENO2,Gamma-enolase,40471,0.0684787641715205,0.00630625821357864,0.0561184980729064,0.0808390302701346,2.25443559191294e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BMP6,Bone morphogenetic protein 6,40024,0.0440744005061513,0.00406013503227137,0.0361165358428994,0.0520322651694032,2.3554189344898e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,37598,0.0423687262682018,0.00390571786235431,0.0347135192579874,0.0500239332784163,2.66385460853252e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,37671,0.0396176105005853,0.00365542112527749,0.0324529850950414,0.0467822359061291,2.95894108561076e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,37901,0.117828866516258,0.0108822421857455,0.0964996718321968,0.139158061200319,3.29739383001734e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40324,0.025256815929029,0.00233711751822941,0.0206760655932994,0.0298375662647587,3.97157628438898e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERI1,3'-5' exoribonuclease 1,37714,0.0349485712763293,0.00323370722194767,0.0286105051213119,0.0412866374313468,4.11014630678689e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37998,0.0644557878066734,0.00596485021135821,0.0527646813924113,0.0761468942209355,4.16150309629211e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,37790,0.0581390086099291,0.00538566917751051,0.0475830970220086,0.0686949201978497,4.69488296933882e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIT,Mast/stem cell growth factor receptor Kit,40372,-0.030680185981674,0.00284353083551329,-0.0362535064192801,-0.025106865544068,4.78802383538263e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPMT,Thiopurine S-methyltransferase,39980,0.0765230627331164,0.00710270457088681,0.0626017617741783,0.0904443636920546,5.70137428273262e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENAH,Protein enabled homolog,40044,0.0489217889563649,0.00454251058191282,0.0400184682158158,0.057825109696914,5.94882085293731e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCOF1,Treacle protein,37990,0.0312859592958015,0.00290419163604739,0.0255937436891486,0.0369781749024543,5.95754680840244e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX6,Syntaxin-6,39980,0.0710142261987777,0.00661024014458663,0.0580581555153879,0.0839702968821675,7.93788256388712e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37901,0.081917798600046,0.00762399152902987,0.0669747752031474,0.0968608219969445,8.06077474681266e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,39961,0.0542439122281025,0.0050529611378108,0.0443401083979934,0.0641477160582117,8.65205754372219e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MNDA,Myeloid cell nuclear differentiation antigen,40333,0.0998229735859798,0.00930868691529018,0.081577947232011,0.118067999939949,9.73397155114308e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAGED1,Melanoma-associated antigen D1,39980,0.0500012697301475,0.00466606269684276,0.0408557868443357,0.0591467526159593,1.06221126462532e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRSF1,G-rich sequence factor 1,37402,0.0811752377228332,0.00759054157161746,0.066297776242463,0.0960526992032035,1.39786426689656e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HLA_E,,40341,0.0295303308089859,0.00276506143068913,0.0241108104048352,0.0349498512131366,1.55673325272654e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPT,Dermatopontin,40536,0.0270654022573637,0.00254044468650019,0.0220861306718233,0.0320446738429041,2.05014474418698e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PIGR,Polymeric immunoglobulin receptor,40154,0.0359485550226522,0.00337467940730062,0.0293341833843429,0.0425629266609614,2.09055574081996e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38013,0.0275958342957684,0.00259154470178767,0.0225164066802645,0.0326752619112722,2.25443374884479e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXN,Thioredoxin,37819,0.0455594374374106,0.00428112768420502,0.0371684271763687,0.0539504476984524,2.42402419781948e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCDC80,Coiled-coil domain-containing protein 80,40359,0.0358315498276772,0.00337287065472944,0.0292207233444075,0.0424423763109469,2.83916425407636e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,37621,0.0292706368911862,0.00275689922842867,0.023867114403466,0.0346741593789064,3.16314379777228e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,37990,0.025588168637779,0.00241570432886556,0.0208533881532026,0.0303229491223555,4.08826863460636e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HDGF,Hepatoma-derived growth factor,40471,0.096743417087896,0.00916108967871815,0.0787876813176084,0.114699152858184,5.5440988173211e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TLR3,Toll-like receptor 3,40516,0.0616879668967159,0.00584192508989614,0.0502377937205195,0.0731381400729124,5.58372138919552e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNLIP,Pancreatic triacylglycerol lipase,37987,0.0611853079559368,0.00579538613454673,0.0498263511322252,0.0725442647796484,5.91066441313879e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DENR,Density-regulated protein,37598,0.0584555136535324,0.00553882982104942,0.0475994072042756,0.0693116201027893,6.19639740723723e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DSCAM,Down syndrome cell adhesion molecule,37959,0.035683226679377,0.00338594163838474,0.0290467810681429,0.0423196722906111,7.22260699703831e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRSS27,Serine protease 27,40314,0.0408613315499449,0.00388392595510188,0.0332488366779452,0.0484738264219446,8.4411131228641e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP12,Macrophage metalloelastase,40346,0.0520859774902389,0.00496852685841755,0.0423476648477405,0.0618242901327373,1.25122626409367e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CIT,Citron Rho-interacting kinase,37572,0.045454954825541,0.00433561159516208,0.0369571560990233,0.0539527535520587,1.29054396591627e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TREML1,Trem-like transcript 1 protein,37987,0.053053720367882,0.00506623913886596,0.0431238916557047,0.0629835490800593,1.45446479491385e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37990,0.0543209530717201,0.0052015845230236,0.0441258474065939,0.0645160587368464,1.96725908366622e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STK4,Serine/threonine-protein kinase 4,40359,0.0861234463161378,0.00824946799490626,0.0699544890461215,0.102292403586154,1.96981749527153e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40341,0.0374805116496269,0.00359229948777942,0.0304396046535793,0.0445214186456746,2.10460790988729e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40377,0.0225898907033522,0.0021660775423516,0.0183443787203431,0.0268354026863613,2.20808522108891e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40332,0.0378410857812306,0.0036353667714781,0.0307157669091335,0.0449664046533276,2.71630018525114e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDA,Cytidine deaminase,37970,0.0458639570716533,0.00440558646630897,0.0372290075976877,0.0544989065456189,2.7697008691803e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASGR2,Asialoglycoprotein receptor 2,37987,0.0258462694753671,0.00248359972462486,0.0209784140151024,0.0307141249356319,2.87572346295528e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGA2,Integrin alpha-2,37671,0.0337984102747577,0.00325427405004829,0.027420033136663,0.0401767874128523,3.59398109051103e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAPG,Macrophage-capping protein,40185,0.0577235552558736,0.00556643798176962,0.0468133368116051,0.0686337737001421,4.09370665184304e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNM1,Dynamin-1,37901,0.11299235694205,0.0109009977994979,0.0916264012550347,0.134358312629066,4.43140463346071e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APRT,Adenine phosphoribosyltransferase,40216,0.0481707087656099,0.00464937605098265,0.0390579317056839,0.0572834858255359,4.50473779394808e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPME1,Protein phosphatase methylesterase 1,40305,0.0608224112689702,0.00587778315387087,0.0493019562873833,0.0723428662505571,5.14123574680461e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,40411,-0.024130218469212,0.00233636268257581,-0.0287094893270606,-0.0195509476113634,6.3003876345284e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSR,"Glutathione reductase, mitochondrial",37944,0.0219401538653586,0.00212729984349543,0.0177706461721076,0.0261096615586096,7.5633400594181e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CBLN4,Cerebellin-4,40489,0.0311022644255458,0.00302263493031632,0.0251778999621258,0.0370266288889658,9.35473524168475e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAST,Gastrin,37942,0.128786886205601,0.0125133301284334,0.104260759153872,0.15331301325733,9.45561713383381e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PALM,Paralemmin-1,37824,0.0289899017911076,0.0028167435160005,0.0234690844997466,0.0345107190824686,9.47150627584794e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,POMC,Pro-opiomelanocortin,37628,0.0675349890063999,0.00656400357054453,0.0546695420081326,0.0804004360046672,9.83028738614244e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40228,0.0342787421408371,0.00333461191881846,0.0277429027799529,0.0408145815017212,1.04124551542065e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAA10,N-alpha-acetyltransferase 10,37562,0.0507640339641071,0.00493900464430869,0.041083584861262,0.0604444830669521,1.09641143860501e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL8,Interleukin-8,40209,0.0668312612476903,0.00650983501602238,0.0540719846162864,0.0795905378790941,1.19659224185401e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STXBP3,Syntaxin-binding protein 3,39980,0.0435552755377668,0.00424298143752092,0.0352390319202258,0.0518715191553078,1.21148058982286e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40403,0.0405784699580433,0.00396722080316779,0.0328027171838344,0.0483542227322521,1.76002771679581e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL19,C-C motif chemokine 19,40471,0.128435084480788,0.0125694902028469,0.103798883683208,0.153071285278368,1.95731796906487e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RANBP1,Ran-specific GTPase-activating protein,37628,0.0521110087137657,0.0051130949641024,0.042089342584125,0.0621326748434065,2.65830771564783e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C7orf50,Uncharacterized protein C7orf50,37942,0.0214324386393139,0.00211047951244042,0.0172958987949307,0.0255689784836971,3.83500607888512e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RPL14,60S ribosomal protein L14,37628,0.0404002815457018,0.003980262430055,0.032598967182794,0.0482015959086096,4.05796753843557e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD248,Endosialin,37998,-0.0390949286187187,0.00385316411366051,-0.0466471302814933,-0.0315427269559441,4.20160276241355e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SV2A,Synaptic vesicle glycoprotein 2A,37572,0.060198431887707,0.00594084688066905,0.0485543720015956,0.0718424917738183,4.83612618963525e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,40305,0.0538192100744789,0.00534226384205846,0.0433483729440443,0.0642900472049134,8.46960911075356e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPPB,Natriuretic peptides B,40042,-0.123602447122037,0.0123286024350784,-0.14776650789479,-0.0994383863492829,1.38587973188867e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTN,Pleiotrophin,40042,0.0483224939967625,0.00482003311264907,0.0388752290959703,0.0577697588975546,1.39036062195368e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOL1,Apolipoprotein L1,37987,0.0626752314265339,0.00625253235114025,0.0504202680182991,0.0749301948347688,1.44509403099443e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MPO,Myeloperoxidase,40332,0.0448864128454068,0.00448858187196363,0.0360887923763581,0.0536840333144556,1.78583838592407e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FRZB,Secreted frizzled-related protein 3,40176,0.0255638692390419,0.00255717127763929,0.0205518135348689,0.0305759249432149,1.84701200425525e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPQ,Carboxypeptidase Q,37986,0.0350803626957429,0.00351366982068432,0.0281935698472016,0.0419671555442842,2.15845109779305e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC4D,C-type lectin domain family 4 member D,40341,0.0585420847795157,0.00587525976474756,0.0470265756406105,0.0700575939184209,2.56012873123092e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA6,Carbonic anhydrase 6,40295,-0.060960281343441,0.00612144133347787,-0.0729583063570576,-0.0489622563298244,2.71107061824081e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,37998,-0.0316087937076845,0.00317365063229109,-0.037829148946975,-0.0253884384683939,2.74898801159803e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,37628,0.0290325934449149,0.00291731059181799,0.0233146646849517,0.0347505222048782,2.99054202711484e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PMM2,Phosphomannomutase 2,37562,0.0579093044575552,0.00581908141476277,0.0465039048846202,0.0693147040304902,2.99970782497136e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTUS1,Microtubule-associated tumor suppressor 1,37714,0.0530521791810998,0.00533243152990899,0.0426006133824782,0.0635037449797214,3.07361150137809e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37900,0.0523615810063548,0.00526374246586213,0.042044645773265,0.0626785162394446,3.10787647110724e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C7,Complement component C7,37678,-0.0301199838694979,0.00302777202478197,-0.0360544170380706,-0.0241855507009252,3.10792514837359e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MET,Hepatocyte growth factor receptor,40375,-0.019178490873943,0.00192885241124274,-0.0229590415999787,-0.0153979401479072,3.16345394963268e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DKK3,Dickkopf-related protein 3,40536,-0.0280823379022032,0.00282685413402379,-0.0336229720048898,-0.0225417037995165,3.44916869331306e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPAG1,Sperm-associated antigen 1,37959,0.0549340349970155,0.00553763667958691,0.0440802671050251,0.0657878028890058,4.08270951895675e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,40042,0.0388007889287334,0.00391280928512342,0.0311316827298915,0.0464698951275753,4.13750634953803e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFBR2,TGF-beta receptor type-2,40411,0.0300387048776799,0.00302934644476889,0.0241011858459329,0.0359762239094269,4.14094225713696e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37598,0.0669212331665385,0.00674695849260138,0.0536971945210398,0.0801452718120373,4.16044080309198e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,40291,0.0276001060947502,0.00278434612792647,0.0221427876840143,0.033057424505486,4.28432826553108e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PVR,Poliovirus receptor,40471,0.0349370750425391,0.00352660712721262,0.0280249250732023,0.0418492250118758,4.53492150719084e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37564,0.0272177089481754,0.00274769705119747,0.0218322227278284,0.0326031951685225,4.74027254252813e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSB,Cathepsin B,40353,-0.0512885230568641,0.00518280263110683,-0.0614468162138335,-0.0411302298998947,5.05475665975502e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THBD,Thrombomodulin,40359,0.0263451949148464,0.00266516700291413,0.0211214675891347,0.0315689222405581,5.63204575614937e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRL,Prolactin,40471,-0.0727422853354887,0.00736445759524867,-0.0871766222221761,-0.0583079484488013,6.06222317385166e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40332,0.0460222467266098,0.00466562809857645,0.0368776156534,0.0551668777998197,6.9304916499918e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HEPH,Hephaestin,37990,0.0237012732297437,0.00240964224498903,0.0189783744295652,0.0284241720299222,9.38887771949494e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL7R,Interleukin-7 receptor subunit alpha,40332,-0.0496057766898021,0.00506058796374263,-0.0595245290987376,-0.0396870242808665,1.27481995891117e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPTL4,Angiopoietin-related protein 4,40396,-0.0428693536753791,0.00437882771405159,-0.0514518559949202,-0.034286851355838,1.43695147152025e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPING1,Plasma protease C1 inhibitor,37981,0.0175017590965869,0.00178813906701744,0.0139970065252327,0.021006511667941,1.51073409863255e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40228,0.0276478224545373,0.00282643451357631,0.0221080108079277,0.0331876341011468,1.56104458974456e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTGR1,Prostaglandin reductase 1,37990,0.0746305509422295,0.00763584829879277,0.0596642882765957,0.0895968136078634,1.73275564945784e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL15,C-C motif chemokine 15,40536,0.04162188973225,0.00427019531294272,0.0332523069188823,0.0499914725456178,2.18988069828103e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLB,Beta-klotho,39961,-0.0687967277580452,0.00705980632019101,-0.0826339481456196,-0.0549595073704708,2.24986627416936e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGF1R,Insulin-like growth factor 1 receptor,40305,0.0205079220224707,0.0021074921475492,0.0163772374132743,0.0246386066316671,2.56891509193841e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLTA,Clathrin light chain A,40042,0.0442290419021377,0.00455105994162303,0.0353089644165566,0.0531491193877189,2.91106597681463e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMS,Spermine synthase,37541,0.0598186883436074,0.00615412912264498,0.0477565952632232,0.0718807814239915,2.94395201490076e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ELOB,Elongin-B,37562,0.0375216344695994,0.00386450483294315,0.0299472049970308,0.0450960639421679,3.26949092204163e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37572,0.0501228378285437,0.00517803455934604,0.0399738900922255,0.060271785564862,4.35131023184302e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,XRCC4,DNA repair protein XRCC4,39961,0.0345461942991629,0.00357483306969369,0.0275395214825632,0.0415528671157625,4.96051579257874e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,37998,0.0207982791731146,0.00215327181306497,0.0165778664195073,0.0250186919267219,5.30530447377807e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRK1,Protein BRICK1,39961,0.0409169022430981,0.00424092389738333,0.0326046914042267,0.0492291130819694,5.7714901636946e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40042,0.0531050417786822,0.00550765878531069,0.0423100305594733,0.0639000529978912,6.11688927084822e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDF1,Endothelial differentiation-related factor 1,37959,0.0645291098587568,0.00669490847857393,0.0514070892407519,0.0776511304767617,6.46607855141884e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLIT2,Slit homolog 2 protein,39961,0.0484655824171468,0.00503410952628303,0.0385987277456321,0.0583324370886616,7.05022317332054e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,37879,0.0385497977911325,0.00400664922592903,0.0306967653083116,0.0464028302739534,7.63394263977695e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD80,T-lymphocyte activation antigen CD80,37990,0.0314635227586665,0.0032730175312481,0.0250484083974202,0.0378786371199128,8.27209600167226e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TF,Serotransferrin,38013,0.0201465800632484,0.00209677502198374,0.0160369010201603,0.0242562591063365,8.64814046046977e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL6R,Interleukin-6 receptor subunit alpha,40273,0.0310287083729612,0.0032308034910414,0.02469633353052,0.0373610832154023,8.81561086282266e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMB1,Laminin subunit beta-1,37628,0.0272755918209831,0.00284173685705313,0.0217057875811589,0.0328453960608072,9.58164473699052e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMA4,Laminin subunit alpha-4,40422,0.0301836179246021,0.0031479647650599,0.0240136069850847,0.0363536288641195,1.02460674751657e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,37959,0.0365927713417048,0.00381877576414436,0.0291079708439819,0.0440775718394278,1.11199391261467e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37628,0.0382760856533694,0.00399753952358907,0.0304409081871348,0.046111263119604,1.19895746525774e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA2,Carbonic anhydrase 2,40291,0.0648565087490798,0.00678533088342663,0.0515572602175636,0.078155757280596,1.36831500888197e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,40291,0.0316708916804315,0.00331561610439115,0.0251722841158248,0.0381694992450381,1.45368954420883e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,37835,0.0539131832899495,0.00564568939829622,0.0428476320692889,0.0649787345106101,1.52719567265083e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHCY,Adenosylhomocysteinase,40359,0.0621430513653277,0.00651036718064214,0.0493827316912691,0.0749033710393863,1.55072347710749e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCRIB,Protein scribble homolog,37628,0.085479862283474,0.00895957863453852,0.0679190881597785,0.103040636407169,1.66613841748514e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40332,0.0264701518490305,0.00277723113184201,0.0210267788306201,0.0319135248674408,1.77579985361879e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37990,0.0279392116436745,0.00293650706187273,0.022183657802404,0.0336947654849451,2.13111080474341e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37714,0.0799040886737634,0.0083995262477521,0.0634410172281693,0.0963671601193575,2.16895765842561e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH5,Cadherin-5,40536,-0.0277169602336591,0.00291639691687282,-0.0334330981907299,-0.0220008222765884,2.30177941650256e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C4BPB,C4b-binding protein beta chain,40411,0.037626963787936,0.00395964694623045,0.0298660557733243,0.0453878718025476,2.33135352654535e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECI2,Enoyl-CoA delta isomerase 2,37562,0.0573499690655368,0.00604246110599339,0.0455067452977897,0.0691931928332838,2.67434994277888e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLSTN3,Calsyntenin-3,37942,0.0278998205371224,0.00294103216774675,0.0221353974883388,0.033664243585906,2.78600814704563e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS7_LGALS7B,Galectin-7,40270,0.0365587446888497,0.00385738329874128,0.0289982734233168,0.0441192159543826,2.96272794217292e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CR1,Complement receptor type 1,37959,0.0329817700988918,0.00348404289615074,0.0261530460224363,0.0398104941753472,3.36566348532534e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37942,0.0434975648349562,0.0046033466324274,0.0344750054353985,0.0525201242345139,3.9714400021287e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPCAM,Epithelial cell adhesion molecule,40358,-0.0905156972542797,0.00958170827795196,-0.109295845479065,-0.0717355490294938,3.97158877947558e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40341,-0.0351108055117494,0.00371972548175936,-0.0424014674559978,-0.0278201435675011,4.27064147007642e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A12,Protein S100-A12,40139,0.0692979113283235,0.00734395315214917,0.0549037631501111,0.0836920595065358,4.40257138066136e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASS1,Argininosuccinate synthase,37562,0.0729313192002855,0.00773063106008367,0.0577792823225216,0.0880833560780495,4.6003268087e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDCD1,Programmed cell death protein 1,40455,0.0395710420891287,0.00420315508580675,0.0313328581209474,0.0478092260573099,5.3810881032447e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PZP,Pregnancy zone protein,38013,0.0589433690205502,0.00626858143609215,0.0466569494058096,0.0712297886352908,6.14190646857787e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WFDC2,WAP four-disulfide core domain protein 2,39535,0.0342764592228224,0.00365853533473697,0.0271057299667379,0.0414471884789069,8.34739415810638e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BST2,Bone marrow stromal antigen 2,40471,0.0480282825846786,0.00514062252327587,0.0379526624390579,0.0581039027302993,1.05814463709316e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ULBP2,UL16-binding protein 2,40228,0.0333914543224282,0.00357918068276858,0.0263762601842018,0.0404066484606547,1.20377222720904e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOBR,Apolipoprotein B receptor,37628,-0.0380862106476478,0.00408490473709653,-0.046092623932357,-0.0300797973629386,1.30081985853278e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUSD2,Sushi domain-containing protein 2,40332,-0.0256081580760375,0.00275065786962661,-0.0309994475005057,-0.0202168686515694,1.44439497426517e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,37900,0.0587765135857052,0.0063229760676025,0.0463834804932043,0.0711695466782061,1.68446393219265e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTN1,Contactin-1,40536,-0.0245589242551452,0.00265172459922094,-0.0297563044696183,-0.0193615440406722,2.26527785990342e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD28,T-cell-specific surface glycoprotein CD28,39980,0.0319895069145786,0.00345810883901657,0.0252116135901061,0.038767400239051,2.51798625082538e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40359,0.030087471289652,0.00325271225133597,0.0237121552770335,0.0364627873022705,2.52520724350997e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEK7,Serine/threonine-protein kinase Nek7,37714,0.0675108346488793,0.00730500051385966,0.0531930336417144,0.0818286356560443,2.79027109242621e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAM,Signal transducing adapter molecule 1,37900,0.033364345987089,0.003612909580878,0.0262830432085682,0.0404456487656099,2.97110590983645e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRYGD,Gamma-crystallin D,37942,0.085189493654568,0.00923103435180403,0.0670966663250321,0.103282320984104,3.14457228741632e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXADR,Coxsackievirus and adenovirus receptor,40341,0.047006588134879,0.00509684176630387,0.0370167782729234,0.0569963979968345,3.25404862424269e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37959,0.059201443167759,0.00642194240967001,0.0466144360448058,0.0717884502907122,3.44873626440226e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AFP,Alpha-fetoprotein,40182,0.0614088395482668,0.00667485755541536,0.0483261187396527,0.0744915603568809,4.01940557066929e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD300E,CMRF35-like molecule 2,40436,0.0353011510611036,0.00383718732236346,0.0277802639092712,0.0428220382129359,4.02228019687802e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD300A,CMRF35-like molecule 8,37671,0.0261761049065146,0.00284716854139023,0.0205956545653897,0.0317565552476394,4.35465993432791e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAX,Apoptosis regulator BAX,39934,0.0787359014492023,0.00857268660197158,0.061933435709338,0.0955383671890666,4.64817705500038e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MATN2,Matrilin-2,40379,0.0261470741580121,0.00284899147366335,0.020563050869632,0.0317310974463923,4.93559763579699e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40305,0.0483795780758382,0.00527219874671527,0.0380460685322763,0.0587130876194002,4.99796725961576e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP3,Stromelysin-1,40332,-0.0425660957042354,0.00464182770028873,-0.0516640779968013,-0.0334681134116695,5.29336288167995e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRL2,Fc receptor-like protein 2,40442,0.042835288337796,0.00467437481067861,0.033673513708866,0.0519970629667261,5.60375793795703e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37628,0.0443230452709189,0.00483662470308987,0.0348432608528627,0.053802829688975,5.72934342252848e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNGR2,Interferon gamma receptor 2,40228,0.0453620085724503,0.00495466340327619,0.035650868302029,0.0550731488428716,6.06616257632747e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40489,0.0274244898267449,0.00299568158435782,0.0215529539214036,0.0332960257320863,6.09655155729278e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37901,0.0896649245111821,0.0098056912507515,0.0704457696597092,0.108884079362655,6.86026126647033e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNX5,Sorting nexin-5,37628,0.0264032851188015,0.00288807857528045,0.0207426511112518,0.0320639191263512,7.00723384105876e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRC25,Leucine-rich repeat-containing protein 25,40305,0.034052269533689,0.00372816498569457,0.0267450661617276,0.0413594729056504,7.39809445700465e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRN,Progranulin,40262,0.0211290759243017,0.00233076474539743,0.0165607770233227,0.0256973748252807,1.38575321179406e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,40453,0.0575971122196055,0.00635529868564113,0.0451407267957489,0.0700534976434621,1.41522745188728e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL6,Interleukin-6,40305,0.0634828457327301,0.00700515620727056,0.0497527395664798,0.0772129518989804,1.42372318382474e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WFDC1,WAP four-disulfide core domain protein 1,37653,0.0475809592751958,0.00525011485728693,0.0372907341549134,0.0578711843954781,1.44785655548958e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSNK1D,Casein kinase I isoform delta,37598,0.0555861872435883,0.00613639376041605,0.0435588554731728,0.0676135190140037,1.50784908290467e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",40359,0.0628851873548496,0.00695695429187261,0.0492495569427793,0.0765208177669199,1.75692112638857e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPRR3,Small proline-rich protein 3,37942,0.0619226474506029,0.00685127488517408,0.0484941486756617,0.0753511462255441,1.80822159324899e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,37628,0.0437483256160025,0.00485172669458037,0.034238941294625,0.05325770993738,2.19576616083856e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,40044,0.0329733375689278,0.00365803319224163,0.0258035925121342,0.0401430826257214,2.2144444262365e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CBLIF,Cobalamin binding intrinsic factor,40330,0.0629406765864585,0.00701454184320817,0.0491921745737705,0.0766891785991466,3.20581031493098e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PER3,Period circadian protein homolog 3,37598,0.102025651661752,0.0113698750547536,0.0797406965544351,0.124310606769069,3.26256341325025e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHL1,Neural cell adhesion molecule L1-like protein,40379,-0.0272777045884564,0.00304236374759517,-0.033240737533743,-0.0213146716431699,3.41171995337477e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHI3L1,Chitinase-3-like protein 1,40054,0.0639649737975485,0.00714593568339176,0.0499589398581007,0.0779710077369964,3.90458934099637e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LIPF,Gastric triacylglycerol lipase,37628,0.0515347930099026,0.00575665381697424,0.0402517515286331,0.0628178344911721,3.94575322572752e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,38013,-0.0219730208136084,0.00245962503134447,-0.0267938858750436,-0.0171521557521733,4.65371883124251e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40044,0.0497164908306193,0.00557395163277045,0.0387915456303892,0.0606414360308494,5.1987424091983e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RARRES1,Retinoic acid receptor responder protein 1,39980,0.0300483820108259,0.00337075236558104,0.023441707374287,0.0366550566473647,5.43931675515591e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37714,0.0316818012503717,0.00356031461766915,0.0247035845997401,0.0386600179010032,6.38125654332642e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37562,0.0574452978363071,0.0064660315350514,0.0447718760276063,0.0701187196450078,7.27079764148258e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLITRK6,SLIT and NTRK-like protein 6,40042,-0.0290733901627559,0.00328147648003935,-0.035505084063633,-0.0226416962618788,8.86349655747052e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGAP1,Rho GTPase-activating protein 1,39980,0.0389808628003891,0.00440783555329584,0.0303415051159293,0.047620220484849,1.02553061672297e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40305,-0.0355682705541761,0.00402520228208119,-0.0434576670270553,-0.027678874081297,1.09066817810286e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37959,0.0402386070028982,0.00456697211425632,0.0312873416589558,0.0491898723468406,1.39274514666592e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40403,0.0360234843794587,0.00409005262641364,0.028006981231688,0.0440399875272294,1.40814878265191e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BSG,Basigin,40502,0.0170497833785078,0.00193931553785253,0.0132487249243168,0.0208508418326988,1.62090777470351e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL2A1,Collagen alpha-1(II) chain,37628,0.0696086992491413,0.00792764932345882,0.054070506575162,0.0851468919231206,1.82633819621144e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C5,Complement C5,38013,0.0129141786572278,0.001471189856356,0.01003064653877,0.0157977107756855,1.86019255688491e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,40422,0.0217297397401037,0.00248196913570816,0.0168650802341157,0.0265943992460917,2.24153547846495e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDIA3,Protein disulfide-isomerase A3,37671,0.0214933470510853,0.00245955982099809,0.0166726098019291,0.0263140843002416,2.63954475680397e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40359,0.0409558358672846,0.00469122330345806,0.0317610381925068,0.0501506335420624,2.78834663166531e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD1C,T-cell surface glycoprotein CD1c,40411,0.0200671971058039,0.00229890609025278,0.0155613411689085,0.0245730530426994,2.81933547521268e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAPK2,Death-associated protein kinase 2,37598,0.0439429382160174,0.00504448947236885,0.0340557388501745,0.0538301375818604,3.36654269729868e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL18BP,Interleukin-18-binding protein,40403,0.0254222200417642,0.00292893897782729,0.0196814996452227,0.0311629404383057,4.34744894909966e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP6,Gastrotropin,40017,0.0465855862620366,0.00536799548074098,0.0360643151197842,0.0571068574042889,4.40606135603323e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSTN,Growth/differentiation factor 8,40042,0.0426338822513428,0.00491366296029686,0.033003102849161,0.0522646616535247,4.47517854889849e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD300C,CMRF35-like molecule 6,40471,0.0283892041927024,0.00327554358196058,0.0219691387720597,0.0348092696133451,4.85401683649741e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASE3,Eosinophil cationic protein,40288,0.0904189379611007,0.0104406368675768,0.0699552897006501,0.110882586221551,5.15331660906681e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OMD,Osteomodulin,40422,-0.0368663266488787,0.00425718661200334,-0.0452104124084052,-0.0285222408893521,5.17207273886949e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRDX6,Peroxiredoxin-6,40489,-0.0496446179076622,0.00574409445270735,-0.0609030430349687,-0.0383861927803558,5.99991275182637e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZBP1,Z-DNA-binding protein 1,37598,0.0334934402370234,0.0038802095358995,0.0258882295466604,0.0410986509273864,6.7243332506274e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIMAP8,GTPase IMAP family member 8,37482,0.0430092618132279,0.00498594151930713,0.033236816435386,0.0527817071910699,7.07619107848855e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REG4,Regenerating islet-derived protein 4,40379,0.0402105937972925,0.00467215808015223,0.0310531639601941,0.0493680236343909,8.23186114811904e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39925,0.0393679265129574,0.00458089059128505,0.0303893809540387,0.0483464720718761,9.1966379684792e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SRPX,Sushi repeat-containing protein SRPX,37990,-0.0270049287649038,0.00314648985056997,-0.0331720488720209,-0.0208378086577866,1.02805424935748e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRYM,Ketimine reductase mu-crystallin,37541,0.0637243642995889,0.00742619586861036,0.0491690203971126,0.0782797082020652,1.04543071421073e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHCHD6,MICOS complex subunit MIC25,37900,0.0239269320370227,0.00279190937486965,0.0184547896622782,0.0293990744117672,1.1457352513701e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KITLG,Kit ligand,40359,-0.0299318842953301,0.00349790504083797,-0.0367877781753725,-0.0230759904152877,1.26185413847741e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37598,0.029300711069859,0.00342568242497337,0.0225863735169112,0.0360150486228068,1.32810355066659e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALCAM,CD166 antigen,40536,0.0159283662908503,0.00186321156192318,0.0122764716294809,0.0195802609522198,1.35321789660288e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLXNB2,Plexin-B2,40472,0.0191073354603217,0.00223913618359436,0.0147186285404768,0.0234960423801667,1.54742528345959e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP9,Caspase-9,37598,0.0513152872555655,0.00601697834150583,0.0395220097062141,0.063108564804917,1.6445942942556e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLGN,Calmegin,37572,0.0364851371913862,0.00428228222579071,0.0280918640288364,0.0448784103539359,1.76791727066019e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSDE1,Cold shock domain-containing protein E1,37562,0.0958953727076009,0.0112771585852219,0.073792141880566,0.117998603534636,2.03719561447905e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39925,0.0384298013163845,0.00452268648506569,0.0295653358056558,0.0472942668271133,2.11869134503867e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40502,0.0309585983136831,0.00364571340756537,0.023813000034855,0.0381041965925113,2.21101546911455e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMARCA2,Probable global transcription activator SNF2L2,39961,0.0595843812063265,0.00703076713618626,0.0458040776194014,0.0733646847932515,2.56413230349528e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40310,0.0512914752604819,0.00605901675324783,0.0394158024241162,0.0631671480968476,2.77561130143391e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,40305,0.0288776795651142,0.00341522307987774,0.0221838423285539,0.0355715168016746,3.01627130400657e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40442,0.0226331520665225,0.00267729954499434,0.0173856449583336,0.0278806591747114,3.06215056010822e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINI2,Serpin I2,37901,0.0455157960576816,0.00538594642380952,0.034959341067015,0.0560722510483483,3.18695263554864e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INSL5,Insulin-like peptide INSL5,37901,0.0762232060895406,0.00904125128373929,0.0585023535734116,0.0939440586056696,3.7860951574937e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,40516,0.0266414651099798,0.00316449990443272,0.0204390452972917,0.0328438849226679,4.11903677803129e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CX3CL1,Fractalkine,40228,-0.027565793876471,0.00328395982657527,-0.0340023551365585,-0.0211292326163834,5.09034026264493e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GDNF,Glial cell line-derived neurotrophic factor,39961,0.0308750527735885,0.00367845189503242,0.0236652870593249,0.038084818487852,5.12252559993877e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA7,Thyroxine-binding globulin,38013,0.0150945416693169,0.00179967836538453,0.0115671720731632,0.0186219112654706,5.45925754597872e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CBS,Cystathionine beta-synthase,37628,0.0409650105740484,0.00489368947453428,0.0313733792039612,0.0505566419441356,6.28616688449335e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPP7,Dipeptidyl peptidase 2,40251,0.0466246036282981,0.00557489106980867,0.0356978171314731,0.0575513901251231,6.60147825628383e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD59,CD59 glycoprotein,39665,0.0180950584050654,0.00217046286685449,0.0138409511860306,0.0223491656241002,8.2691211072093e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAP,Prolyl endopeptidase FAP,40536,0.0216509481245926,0.00259828996895413,0.0165582997854425,0.0267435964637427,8.528320943135e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRDT,Bromodomain testis-specific protein,37562,0.0298606346769718,0.00358759687581921,0.0228289448003662,0.0368923245535775,9.39642665426818e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,40359,0.033602458057612,0.00404182646550615,0.0256804781852199,0.041524437930004,1.00205775096177e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPTLC1,Serine palmitoyltransferase 1,37942,0.0287323629905524,0.00345777925796327,0.0219551156449444,0.0355096103361605,1.05232663893546e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C2orf69,UPF0565 protein C2orf69,37572,0.0482801503327016,0.00581078082840135,0.036891019909035,0.0596692807563683,1.0617918781671e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL21,C-C motif chemokine 21,40422,0.0339060125116339,0.0040834058728803,0.0259025370007885,0.0419094880224793,1.09231062351283e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40228,0.0326209938393629,0.0039288298818109,0.0249204872710136,0.0403215004077123,1.0968801393238e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FSTL3,Follistatin-related protein 3,40293,0.0249103327397404,0.0030009962380836,0.0190283801130965,0.0307922853663843,1.11780185388384e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGA11,Integrin alpha-11,40341,-0.0271292104070885,0.00327321087149883,-0.0335447037152262,-0.0207137170989508,1.2401751352771e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40341,0.0358425212787701,0.00433921273427991,0.0273376643195814,0.0443473782379587,1.56855162148063e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLITRK2,SLIT and NTRK-like protein 2,40489,0.0299824611247217,0.00364132271756275,0.0228454685982987,0.0371194536511447,1.94967816656074e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC3B,Tetranectin,37681,0.0166968804459324,0.00202828229654736,0.0127214471446996,0.0206723137471652,2.01205847842735e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNX2,Sorting nexin-2,37900,0.0618183445384005,0.00751071790561323,0.0470973374433986,0.0765393516334025,2.03174611645632e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ROBO1,Roundabout homolog 1,40379,0.0190296677400906,0.00231309864748785,0.0144959943910144,0.0235633410891667,2.06809832232035e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,40522,0.0435841114877246,0.00530871765167076,0.0331790248904499,0.0539891980849993,2.38006148024657e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40432,0.0220445110947281,0.00268563420460667,0.0167806680536991,0.0273083541357572,2.41295147468658e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SFTPD,Pulmonary surfactant-associated protein D,40359,0.0522274041854126,0.00638571893713335,0.0397113950686312,0.064743413302194,3.08197949744529e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRP2,Neuropilin-2,40332,-0.0228068403882168,0.00279240305504001,-0.0282799503760952,-0.0173337304003384,3.38442757670864e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,39961,0.0655362691122267,0.00804545101140134,0.0497671851298801,0.0813053530945734,4.05423928725496e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A11,Protein S100-A11,40207,0.0351894102931316,0.00432274130073028,0.0267168373437003,0.043661983242563,4.22747653523477e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS4,Galectin-4,40357,0.0412888634083794,0.00507241305345494,0.0313469338236078,0.0512307929931511,4.24711433865995e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGMB,RGM domain family member B,40471,0.0202932204135191,0.00249429057805314,0.0154044108805349,0.0251820299465032,4.38755428983589e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRSS22,Brain-specific serine protease 4,37598,0.0277309553458995,0.00340824504833963,0.0210507950511539,0.0344111156406452,4.4346135934733e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VEGFD,Vascular endothelial growth factor D,40483,-0.0260035824131853,0.00320016537937242,-0.0322759065567553,-0.0197312582696154,4.76964841202966e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,37598,0.0306738892562047,0.00377469032892408,0.0232754962115135,0.0380722823008959,4.82322052518222e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DHPS,Deoxyhypusine synthase,37900,0.0322241075268477,0.00396597576805055,0.0244507950214686,0.0399974200322268,4.85610464010372e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40536,0.0178133549519826,0.00219921266155162,0.0135028981353414,0.0221238117686237,5.89291843067778e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGR2,Anterior gradient protein 2 homolog,39839,0.0787882306947777,0.00973514979341356,0.0597073370996872,0.0978691242898683,6.24470977065674e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,40359,-0.0208903541489452,0.00258382345153933,-0.0259546481139623,-0.0158260601839281,6.65756320314128e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40042,0.0379335892227978,0.00469532457973852,0.0287307530465103,0.0471364253990853,7.004133991287e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LMNB2,Lamin-B2,37942,0.0212728553382322,0.0026337947169103,0.016110617693088,0.0264350929833764,7.20490912417972e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HRG,Histidine-rich glycoprotein,37934,0.0244231933082651,0.0030326031296159,0.0184792911742179,0.0303670954423123,8.71437661147289e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DGKZ,Diacylglycerol kinase zeta,40044,0.0270845040609712,0.0033719935182126,0.0204753967652745,0.0336936113566679,1.02544461395692e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,37900,0.0443357974353348,0.00552929067305371,0.0334983877161495,0.0551732071545201,1.15980248308626e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COPB2,Coatomer subunit beta',37562,0.0333305187066146,0.0041650891864753,0.025166943901123,0.0414940935121061,1.32277370441229e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40359,0.0447987612083517,0.00560211349802696,0.0338186187522189,0.0557789036644845,1.36462393954662e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD276,CD276 antigen,40357,-0.0276034932040121,0.00345745080469916,-0.0343800967812225,-0.0208268896268018,1.51564445173325e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,40359,-0.0218616586890874,0.00273828934299297,-0.0272287058013536,-0.0164946115768212,1.51659101927874e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39980,0.0366988752921792,0.00460287666481028,0.0276772370291511,0.0457205135552074,1.65544614151595e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37598,0.0330056635014214,0.00415441153747679,0.0248630168879669,0.0411483101148759,2.10386770799768e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,39961,0.0491529241536095,0.00619458571271759,0.037011536156683,0.061294312150536,2.25123982397257e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK7,Kallikrein-7,37352,0.0295807993050371,0.0037357735334868,0.022258683179403,0.0369029154306713,2.60501413008878e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC5A,C-type lectin domain family 5 member A,40314,-0.021423732472698,0.00271657128573219,-0.0267482121927331,-0.0160992527526629,3.31400303129484e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFNA1,Ephrin-A1,40303,0.020679309568514,0.00262423277451002,0.0155358133304743,0.0258228058065536,3.48152261194105e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNAR1,Interferon alpha/beta receptor 1,37901,0.020048246946866,0.00254376597150956,0.0150624656427072,0.0250340282510247,3.48732985534417e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEL1L,Protein sel-1 homolog 1,37628,0.0246357883688297,0.00313081414491283,0.0184993926448005,0.0307721840928588,3.85848358158019e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEP1B,Meprin A subunit beta,40359,0.0893701957184325,0.0113814825365098,0.0670624899468732,0.111677901489992,4.34580963446162e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPL,Periplakin,37598,0.0248784243512516,0.00318127295173093,0.018643129365859,0.0311137193366442,5.67123414220166e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD93,Complement component C1q receptor,39725,-0.0237008769967813,0.00303422933194915,-0.0296479664874017,-0.017753787506161,6.0329731098945e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HPGDS,Hematopoietic prostaglandin D synthase,39980,0.0280463001074015,0.00361452946217713,0.0209618223615343,0.0351307778532687,9.06759467188615e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,40203,0.018001295329461,0.00232591710100344,0.0134424978114942,0.0225600928474277,1.05891408891416e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39980,0.0325624518878281,0.0042107354799801,0.0243094103470671,0.0408154934285891,1.11289536046351e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRG2,Bone marrow proteoglycan,37998,-0.0388758846998511,0.00502888915520213,-0.0487325074440473,-0.029019261955655,1.14641540062792e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HEPACAM2,HEPACAM family member 2,37942,-0.0302904473520404,0.00392217646133025,-0.0379779132162477,-0.0226029814878331,1.21735480341552e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40305,-0.0147518688514265,0.00191085240440905,-0.0184971395640682,-0.0110065981387848,1.2319934881489e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL15A1,Collagen alpha-1(XV) chain,37998,0.0192654921754973,0.00249698316497136,0.0143714051721534,0.0241595791788412,1.28901893619105e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSC,Dipeptidyl peptidase 1,40349,0.031552554762782,0.00409211357469972,0.0235320121563706,0.0395730973691935,1.32637279842517e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AZU1,Azurocidin,39809,0.0575077684293308,0.00748430116955605,0.042838538137001,0.0721769987216607,1.63760572168678e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAT,Catalase,37786,0.0402834475955502,0.00524307655991787,0.0300070175381111,0.0505598776529892,1.66009750157506e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYOM3,Myomesin-3,37671,-0.0665556508105086,0.00868435167944329,-0.0835769801022175,-0.0495343215187998,1.92978369344144e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40379,-0.0251951834213692,0.00329790609330595,-0.0316590793642488,-0.0187312874784895,2.2998272329228e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD209,CD209 antigen,40382,-0.028473652235746,0.0037358094589179,-0.0357958387752251,-0.021151465696267,2.64178678336276e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PI3,Elafin,40074,0.0391848005365549,0.00514788369549718,0.0290949484933804,0.0492746525797294,2.85649996739124e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTSL4,ADAMTS-like protein 4,37628,0.0172373265110151,0.00226613048394444,0.012795710762484,0.0216789422595462,3.00678652390194e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,39980,0.0377125431515755,0.0049611256486716,0.0279887368801791,0.0474363494229718,3.09149817030975e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,37562,0.0334234811254385,0.00440367411635028,0.0247922798573919,0.042054682393485,3.41726016083727e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LBP,Lipopolysaccharide-binding protein,40403,-0.0423929156379258,0.00559589131460309,-0.0533608626145478,-0.0314249686613037,3.7668153562176e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLRK1,NKG2-D type II integral membrane protein,37942,0.0335863500951106,0.00444235561797685,0.024879333083876,0.0422933671063452,4.27468789688266e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37562,0.0259807302867337,0.00344680511549977,0.0192249922603541,0.0327364683131132,5.09991154799578e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VCAM1,Vascular cell adhesion protein 1,40372,-0.0195766027270466,0.00259773515975634,-0.024668163640169,-0.0144850418139242,5.1051719329425e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TAFA5,Chemokine-like protein TAFA-5,40305,0.0259374939443666,0.00344728168170239,0.0191808218482299,0.0326941660405033,5.59532799247347e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL9,C-X-C motif chemokine 9,40422,0.0489170790877343,0.00650846008351269,0.0361604973240495,0.0616736608514192,5.95029713821311e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INSR,Insulin receptor,37598,0.0122354061131044,0.0016288941540286,0.00904277357120833,0.0154280386550005,6.22326038743481e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40332,0.0259743674684043,0.00346239039190344,0.0191880823002735,0.032760652636535,6.6243761877518e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBP2,Retinol-binding protein 2,40305,-0.0548269913766702,0.00731284244177037,-0.0691601625625401,-0.0404938201908003,6.85563969023804e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFHR2,Complement factor H-related protein 2,37911,0.0412517076394201,0.00550438742972623,0.0304631082771567,0.0520403070016836,7.07926352990778e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF1,Macrophage colony-stimulating factor 1,40422,0.0194908913092119,0.0026012464108198,0.0143924483440051,0.0245893342744188,7.08884833905808e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGHMBP2,DNA-binding protein SMUBP-2,37562,0.0401632244535348,0.00536150318933217,0.0296546782024438,0.0506717707046259,7.27013943455245e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFC1,Cryptic protein,39980,0.0332487588916778,0.00444052559693026,0.0245453287216945,0.0419521890616611,7.39237320641757e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OSM,Oncostatin-M,40268,0.0520969229243533,0.00696997662979448,0.0384357687299561,0.0657580771187505,8.15652821961526e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40305,0.0266288584340449,0.00357381437575395,0.0196241822575672,0.0336335346105226,9.73313107473054e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFB103A_DEFB103B,Beta-defensin 103,37539,0.0295368598359045,0.00397292719346747,0.0217499225367082,0.0373237971351007,1.11458668194757e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LY75,Lymphocyte antigen 75,40341,0.027800405048288,0.00374085155693332,0.0204683359966987,0.0351324740998773,1.12772400347164e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RHOC,Rho-related GTP-binding protein RhoC,40152,0.0828501127639255,0.011152679677651,0.0609908605957295,0.104709364932122,1.15291420313848e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40305,0.0247201801521419,0.0033292372983136,0.0181948750474473,0.0312454852568366,1.18349093293505e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39980,0.036522015322243,0.0049215020069201,0.0268758713886796,0.0461681592558064,1.2234076876703e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37998,-0.0184995444387643,0.00249559978963618,-0.0233909200264512,-0.0136081688510774,1.30926164855251e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MANSC1,MANSC domain-containing protein 1,40411,-0.0195317376002922,0.00263538487253358,-0.024697091950458,-0.0143663832501264,1.31288509441991e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD101,Immunoglobulin superfamily member 2,37901,0.0301606389328954,0.00409659746202974,0.0221313079073172,0.0381899699584737,1.9117805238586e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CST5,Cystatin-D,40070,0.0390220429632122,0.00530366667024269,0.0286268562895365,0.0494172296368879,1.9661426099515e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCGB3A1,Secretoglobin family 3A member 1,37671,-0.0177169498643003,0.00241098025314084,-0.0224424711604563,-0.0129914285681442,2.12295942539844e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37598,0.0316788541718573,0.00431148307063608,0.0232283473534106,0.040129360990304,2.13773391853043e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHISA5,Protein shisa-5,37998,0.0175900569265477,0.00239657678681968,0.0128927664243811,0.0222873474287143,2.2633320165048e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39980,0.056626628629705,0.00771633903473729,0.04150260412162,0.0717506531377901,2.26630350276911e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCARF2,Scavenger receptor class F member 2,40471,-0.0209574371499577,0.00285767211141351,-0.0265584744883282,-0.0153563998115872,2.3451087935181e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SBSN,Suprabasin,37977,-0.0237106307307103,0.00323759355475828,-0.0300563140980366,-0.0173649473633841,2.55176518613257e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICAM4,Intercellular adhesion molecule 4,40341,-0.0371419723178361,0.00507406268971344,-0.0470871351896744,-0.0271968094459977,2.59900191070479e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PVALB,Parvalbumin alpha,40417,0.0794340760898059,0.0108644186114181,0.0581398156114264,0.100728336568185,2.76909655590909e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37628,0.0482944510482644,0.00661456393544253,0.0353299057347971,0.0612589963617318,3.01505783649775e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,B2M,Beta-2-microglobulin,38013,0.0222438348230544,0.00305496219983575,0.0162561089113764,0.0282315607347325,3.49050259035089e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GDF2,Growth/differentiation factor 2,40359,0.0249990348892232,0.00343549484904857,0.018265464985088,0.0317326047933584,3.58073841908263e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSPA2,Heat shock-related 70 kDa protein 2,37900,0.023252658833015,0.00320212649376615,0.0169764909052334,0.0295288267607967,4.0346962925378e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37628,0.0199854313958705,0.002756383554228,0.0145829196295836,0.0253879431621574,4.38075434356007e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VEGFB,Vascular endothelial growth factor B,37598,0.0199396403268816,0.0027520802927475,0.0145455629530965,0.0253337177006666,4.55542453305534e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37628,0.0544405047681848,0.00751488650218623,0.0397113272238998,0.0691696823124699,4.58652287511488e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",37998,0.0280523814456939,0.0038773153179859,0.0204528434224416,0.0356519194689463,4.90544675181851e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CKAP4,Cytoskeleton-associated protein 4,40457,0.0181576744769199,0.00251344800320168,0.0132313163906446,0.0230840325631952,5.26733121373489e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFIC,Nuclear factor 1 C-type,37959,0.0303656903358902,0.00420587570285686,0.0221221739582907,0.0386092067134896,5.48365279903112e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40470,0.020395949204871,0.0028292347640732,0.0148506490672875,0.0259412493424545,5.88807754304889e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QA,Complement C1q subcomponent subunit A,40442,-0.0157424733677291,0.00218545645493842,-0.0200259680194084,-0.0114589787160498,6.13973540965696e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPTL1,Angiopoietin-related protein 1,40136,0.020486206859522,0.00284412092784,0.0149117298409556,0.0260606838780885,6.15786810599729e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VCAN,Versican core protein,40471,-0.0208028477801977,0.00289059853006443,-0.026468420899124,-0.0151372746612714,6.44091996466344e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CENPF,Centromere protein F,37714,0.0379029725700604,0.00526779954175845,0.0275780854682138,0.0482278596719069,6.57104221295552e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGA,Fibrinogen alpha chain,37698,0.0212440664873819,0.00296481492299283,0.015433029238316,0.0270551037364479,8.16658766930228e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VAMP5,Vesicle-associated membrane protein 5,40042,0.0385961235652385,0.00538746274428717,0.0280366965864356,0.0491555505440413,8.18251123036517e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC16A1,Monocarboxylate transporter 1,39961,0.0413748270378342,0.00577646105454333,0.0300529633709293,0.0526966907047391,8.26833634784671e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40357,0.026416089411822,0.00368966502147188,0.0191843459697371,0.0336478328539069,8.45243456549839e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,QPCT,Glutaminyl-peptide cyclotransferase,40373,0.0184578241261515,0.00258560818392952,0.0133900320856496,0.0235256161666534,9.83021061776872e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,40009,0.0354773472445523,0.00497235812551755,0.0257315253185379,0.0452231691705667,1.01120679901853e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,39925,0.0300315245225827,0.00421018602879766,0.0217795599061393,0.0382834891390261,1.0250945154739e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MCTS1,Malignant T-cell-amplified sequence 1,37901,0.0178693820126724,0.00250801344144742,0.0129536756674354,0.0227850883579093,1.09446559033889e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSF,Cathepsin F,40411,0.02737738853177,0.00384571005770224,0.0198397968186736,0.0349149802448664,1.13391814383447e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RSPO3,R-spondin-3,40489,0.0195556742157592,0.00274800538436617,0.0141695836624015,0.0249417647691169,1.15542406281546e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRLB,Fc receptor-like B,39980,0.0416432091879945,0.00587366992283341,0.030130816139241,0.053155602236748,1.40082887446902e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP2,"Fatty acid-binding protein, intestinal",40359,-0.0526679734957449,0.0074355208850226,-0.0672415944303892,-0.0380943525611006,1.46666066237452e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLSTN2,Calsyntenin-2,40516,-0.0265555184193423,0.00375355733655966,-0.0339124907989993,-0.0191985460396854,1.558870309573e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YAP1,Transcriptional coactivator YAP1,37942,0.018125403083792,0.00256658350754228,0.0130948994090092,0.0231559067585749,1.72068626887737e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC4M,C-type lectin domain family 4 member M,37969,-0.032995649090007,0.00467333281242982,-0.0421553814023695,-0.0238359167776446,1.7411692083379e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RALY,RNA-binding protein Raly,37900,0.0328360071252452,0.00465240561823716,0.0237172921135004,0.04195472213699,1.7737899046796e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNDP1,Beta-Ala-His dipeptidase,40403,0.0309472482925861,0.00439209600759681,0.0223387401176963,0.0395557564674758,1.9149758609442e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,37900,0.027814876877714,0.00395095730546522,0.0200710005590022,0.0355587531964259,2.01516306813549e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PON1,Serum paraoxonase/arylesterase 1,37987,-0.0175018730606322,0.00249402365942517,-0.0223901594331055,-0.0126135866881588,2.36578737418167e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40489,0.0227613445991774,0.00325084815945431,0.016389682206647,0.0291330069917078,2.62974793975053e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,40305,-0.0177692768388128,0.00253851267347808,-0.0227447616788299,-0.0127937919987958,2.66458989697122e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDC,Aromatic-L-amino-acid decarboxylase,40330,-0.0327301116697256,0.004676379819353,-0.0418958161156574,-0.0235644072237937,2.68057826479654e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37572,0.0366238544562232,0.00526000095764101,0.0263142525792469,0.0469334563331996,3.4967987741242e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD300LF,CMRF35-like molecule 1,40489,0.0406246136248387,0.00583929696031216,0.0291795915826269,0.0520696356670505,3.60762198762003e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,37942,0.0238929035104547,0.0034380482708317,0.0171543288996246,0.0306314781212848,3.83268137718055e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEZ6L2,Seizure 6-like protein 2,40305,-0.015832536215951,0.00228278843410084,-0.0203068015467886,-0.0113582708851133,4.20095223027373e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFYA,Nuclear transcription factor Y subunit alpha,37562,0.0257254146282434,0.00370872781533976,0.0184563081101774,0.0329945211463093,4.20933427292454e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37714,0.0495770647615344,0.00715295114341317,0.0355572805204446,0.0635968490026242,4.3720988465651e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37900,0.0246352003495908,0.00356118190045949,0.0176552838246902,0.0316151168744914,4.79783162492538e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPR15L,Protein GPR15L,37901,0.0401795378760438,0.00580954563357957,0.0287928284342279,0.0515662473178598,4.85139375576702e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40305,0.0378497994617553,0.00548761141206422,0.0270940810941095,0.0486055178294012,5.49967623908521e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37901,0.0279774484251731,0.00405656946739966,0.0200265722690698,0.0359283245812764,5.55535940488546e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRH,Corticoliberin,39947,0.0574883238948706,0.00836130976030417,0.0411001567646744,0.0738764910250667,6.41252644963316e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPTX2,Neuronal pentraxin-2,37998,-0.0216423043378232,0.00314892008735817,-0.0278141877090453,-0.0154704209666012,6.56479516305809e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LCP1,Plastin-2,37998,0.0311819781820257,0.00453869066455277,0.0222861444795022,0.0400778118845491,6.68844039021601e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP3,"Fatty acid-binding protein, heart",37990,0.0314323099634707,0.00457883082733633,0.0224578015418915,0.0404068183850499,6.9532320310378e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMIGO2,Amphoterin-induced protein 2,40305,0.0148721339081789,0.00216690214218715,0.0106250057094921,0.0191192621068657,6.97738147776303e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRL3,Fc receptor-like protein 3,40044,0.0361684274790355,0.00527006082561802,0.0258391082608242,0.0464977466972468,6.99704019891435e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,37959,0.0247532798996614,0.00361277720089309,0.017672236585911,0.0318343232134119,7.61961797179256e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37598,0.0400796285324256,0.00585002191921572,0.0286135855707628,0.0515456714940884,7.64978498718407e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,40311,0.0577533734912874,0.00843214162570562,0.0412263759049044,0.0742803710776704,7.69962380705388e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL24A1,Collagen alpha-1(XXIV) chain,37901,0.0362633761164631,0.00529931220053623,0.0258767242034121,0.0466500280295141,8.08901495627655e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40332,0.0158386167180425,0.00231981498451618,0.0112917793483908,0.0203854540876942,8.95166691556196e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1B,Interleukin-1 beta,39946,0.0370111526994105,0.0054268196804821,0.0263745861256655,0.0476477192731554,9.4378837964656e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,37572,0.0477541288518956,0.00700151062621413,0.0340311680245159,0.0614770896792753,9.46696159634792e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MOG,Myelin-oligodendrocyte glycoprotein,40489,0.0212309188941147,0.00312054060861695,0.0151146593012255,0.0273471784870039,1.05644292297905e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENSA,Alpha-endosulfine,37900,0.0346228978227572,0.00508859095178233,0.0246492595572638,0.0445965360882506,1.06042153610888e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37482,0.0437103169816059,0.00642410602380782,0.0311190691749426,0.0563015647882692,1.06120975530108e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAS2,Growth arrest-specific protein 2,37714,0.0351180607564877,0.00516312472089781,0.024998336303528,0.0452377852094474,1.07819140833616e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FES,Tyrosine-protein kinase Fes/Fps,39980,0.0309840335256727,0.00457386925998038,0.0220192497761112,0.0399488172752343,1.29644313475232e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFHR5,Complement factor H-related protein 5,37785,0.0271870644797336,0.00402634453492819,0.0192954291912743,0.0350786997681928,1.51551882229842e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,37628,-0.0169796198234559,0.00251654810608454,-0.0219120541113816,-0.0120471855355302,1.57038816461806e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GBP4,Guanylate-binding protein 4,39961,0.0319548288300023,0.00474131565584352,0.022661850144549,0.0412478075154556,1.64360192543088e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYZL2,Lysozyme-like protein 2,37482,0.0232545886047824,0.00346012024300648,0.0164727529284897,0.0300364242810751,1.88319745284984e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40411,0.0171112869160388,0.00254890438820025,0.0121154343151664,0.0221071395169113,1.96829648325909e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSLN,Mesothelin,40271,0.0349625896328946,0.00520837971369955,0.0247541653940434,0.0451710138717457,1.97474359001033e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCAM,Basal cell adhesion molecule,40332,-0.0152929574274335,0.0022785225784563,-0.0197588616812079,-0.0108270531736592,1.98763696874921e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A13,Protein S100-A13,37598,0.0224924791191007,0.0033620700397701,0.0159028218411513,0.0290821363970501,2.32098068977887e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPARCL1,SPARC-like protein 1,40346,-0.0177329416305091,0.00265362758087707,-0.0229340516890281,-0.01253183157199,2.4266057322476e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37959,0.0467377153908354,0.00700367010178042,0.0330105219913458,0.060464908790325,2.59836989328807e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LACRT,Extracellular glycoprotein lacritin,37863,0.034245443087163,0.00513274088652714,0.0241852709495698,0.0443056152247562,2.62316000802458e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDIA5,Protein disulfide-isomerase A5,37482,0.0395164373222285,0.00592333263884943,0.0279067053500836,0.0511261692943733,2.63758355982193e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GC,Vitamin D-binding protein,38013,0.0166905865373062,0.00250335685178655,0.0117840071078046,0.0215971659668079,2.70668385482317e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPE,Carboxypeptidase E,40360,-0.0245051060777277,0.00367841485161465,-0.0317147991868924,-0.017295412968563,2.79241668138503e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCN5,CCN family member 5,40332,0.0251207405727824,0.00377361208931567,0.0177244608777237,0.0325170202678411,2.8873148271864e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL2,Apoptosis regulator Bcl-2,37901,0.0346825588559088,0.00521048977050043,0.024469998905728,0.0448951188060896,2.91703487667284e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,37562,0.0649581044075868,0.00977542451059618,0.0457982723668183,0.0841179364483553,3.15112172822652e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGAM,Integrin alpha-M,40332,-0.0202171114768744,0.00304699559137074,-0.0261892228359611,-0.0142450001177878,3.34776306896361e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,40305,-0.0208938034699867,0.00315357431702596,-0.0270748091313576,-0.0147127978086159,3.57376936802557e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSTT2B,Glutathione S-transferase theta-2B,37942,0.152365435602711,0.0230093681582611,0.107267074012519,0.197463797192903,3.68069738913475e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ROBO2,Roundabout homolog 2,40471,0.0148189135538118,0.00223905277746305,0.0104303701099842,0.0192074569976394,3.74668377511911e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALPP,"Alkaline phosphatase, placental type",40305,0.0655315406190507,0.00990421043277583,0.0461192881708101,0.0849437930672914,3.79499849431266e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RCOR1,REST corepressor 1,40042,0.0284526923752549,0.00430955487567623,0.0200059648189295,0.0368994199315803,4.18089851636097e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH1,Cadherin-1,39806,0.0254183625552091,0.00385896349281177,0.017854794109298,0.0329819310011202,4.63900791707941e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGER,Advanced glycosylation end product-specific receptor,40311,0.0256498298513039,0.00389625127436729,0.018013177353544,0.0332864823490638,4.74857847722005e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA1,Annexin A1,37608,0.0263268572117682,0.0039990634806545,0.0184886927896853,0.034165021633851,4.77721241115254e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RABEPK,Rab9 effector protein with kelch motifs,39980,0.0380680717060578,0.00578756390447994,0.0267244464532772,0.0494116969588385,4.93500953221111e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATXN10,Ataxin-10,39961,0.0457895394551991,0.00696488127299262,0.0321383721601336,0.0594407067502647,5.04280680842914e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSH,Pro-cathepsin H,40013,0.0457287978994229,0.00696416708402094,0.0320790304147418,0.0593785653841039,5.32151864138475e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VGF,Neurosecretory protein VGF,37959,0.0191869906879725,0.00293923720944601,0.0134260857574583,0.0249478956184866,6.90895779723064e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GM2A,Ganglioside GM2 activator,37714,0.02421053126529,0.00371044373958823,0.016938061535697,0.0314830009948829,7.04863633584204e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP1,"Fatty acid-binding protein, liver",40357,0.0582818170741395,0.00893372233231634,0.0407717213027994,0.0757919128454795,7.06176319403237e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40403,-0.027628375232828,0.00426003228144762,-0.0359780385044654,-0.0192787119611907,9.1047807763529e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1RAP,Interleukin-1 receptor accessory protein,40332,-0.0267924454248829,0.00414414075784403,-0.0349149613102572,-0.0186699295395086,1.04158491115072e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,37598,0.0240318152168579,0.00371952951417111,0.0167415373690825,0.0313220930646333,1.07691728716574e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CST7,Cystatin-F,40376,0.0568504614281937,0.00884876353063637,0.0395068849081464,0.0741940379482409,1.35898617922696e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17D,Interleukin-17D,40044,0.0211839733679915,0.00329919450420547,0.0147175521397488,0.0276503945962342,1.39340663254729e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAGA,Alpha-N-acetylgalactosaminidase,37567,0.0368538800967864,0.00574045874771996,0.0256025809512553,0.0481051792423175,1.40947013307253e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSPAN1,Tetraspanin-1,40042,0.0188531184520379,0.00293734909884569,0.0130959142183003,0.0246103226857754,1.41679787042078e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CABP2,Calcium-binding protein 2,37572,0.0405098679676589,0.00631082764187098,0.0281406457895918,0.052879090145726,1.41795049536176e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASE1,Ribonuclease pancreatic,37987,0.0149129534864499,0.00232743121246344,0.0103511883100215,0.0194747186628782,1.52848974024621e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSBP1,Heat shock factor-binding protein 1,37628,0.0589852274583632,0.00921921964981105,0.0409155569447336,0.0770548979719929,1.62673667335115e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,37598,0.0193614731624296,0.00302922538071861,0.0134241914162211,0.0252987549086381,1.69747054075794e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGBL1,Integrin beta-like protein 1,37998,0.0214715981390596,0.00336632851269222,0.0148735942541829,0.0280696020239364,1.84829590121748e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GZMH,Granzyme H,40042,0.0457637643391129,0.00717893228707483,0.0316930570564462,0.0598344716217796,1.8843641805489e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGT,Angiotensinogen,37987,0.0148565905009814,0.00233370359028742,0.0102825314640181,0.0194306495379448,2.00151196083244e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,40305,0.012936131547701,0.00203264850918801,0.00895214046969255,0.0169201226257095,2.01733067077505e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGA4,Pepsin A-4,37987,0.0416961612285311,0.00655343654571421,0.0288514255989313,0.054540896858131,2.04902331673832e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PFDN2,Prefoldin subunit 2,39961,0.0343634211709174,0.00540197778983816,0.0237755447028346,0.0449512976390002,2.05704364815151e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MST1,Hepatocyte growth factor-like protein,37787,0.0377057346316207,0.00593235351790023,0.0260783217365363,0.0493331475267052,2.13886688049278e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37628,0.0223550434545055,0.00352864718339452,0.0154388949750522,0.0292711919339587,2.4458240645338e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,37901,0.0292254913998305,0.00462528944307392,0.0201599240914056,0.0382910587082553,2.72212068949093e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEPTIN8,Septin-8,37921,0.0193945345534389,0.00307009750943627,0.0133771434349438,0.025411925671934,2.74655202136634e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNC,Tenascin,40403,-0.0287039500235691,0.00454547276329273,-0.0376130766396229,-0.0197948234075154,2.7759066241823e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",40422,0.0166401675304631,0.00263515363601077,0.011475266403882,0.0218050686570442,2.77864695051036e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIMAP7,GTPase IMAP family member 7,37671,-0.0197449055490789,0.00312805560005794,-0.0258758945251924,-0.0136139165729653,2.83890487481434e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCAM1,Neural cell adhesion molecule 1,40403,-0.0167534439706343,0.00265730390844119,-0.021961759631179,-0.0115451283100896,2.96388022368396e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AFAP1,Actin filament-associated protein 1,37671,0.0514374952325284,0.00816664863980147,0.0354308638985175,0.0674441265665393,3.10094848050591e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37482,-0.018360706178472,0.00291580881175826,-0.0240756914495181,-0.0126457209074258,3.13304654042581e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DGCR6,Protein DGCR6,37541,0.0275803256148741,0.00438705143008441,0.0189817048119087,0.0361789464178396,3.3446256447102e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTN4,Contactin-4,40332,-0.0146923183668548,0.00233854518719113,-0.0192758669337495,-0.0101087697999602,3.41466435994228e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LMOD1,Leiomodin-1,37959,-0.0219306687548558,0.00349603013830882,-0.028782887825941,-0.0150784496837705,3.64910718724315e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL2L15,Bcl-2-like protein 15,37598,0.0341661026080842,0.00545138854499015,0.0234813810599035,0.0448508241562649,3.78563420829826e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REG3G,Regenerating islet-derived protein 3-gamma,37900,0.0243801009415037,0.00389197691587374,0.0167518261863912,0.0320083756966162,3.86174329024255e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD7,T-cell antigen CD7,37567,0.025917254634081,0.00414245622663518,0.0177980404298761,0.034036468838286,4.05970946711122e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJB8,DnaJ homolog subfamily B member 8,40042,0.035344921486917,0.00565179220781296,0.0242674087596036,0.0464224342142304,4.11142746070682e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FSHB,Follitropin subunit beta,37628,0.0421308416477565,0.00674368793167713,0.0289132133016693,0.0553484699938437,4.30052009468307e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA1,Carbonic anhydrase 1,40003,0.0375815405367359,0.00601793548781261,0.0257863869806232,0.0493766940928487,4.35026429867608e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRC1,Macrophage mannose receptor 1,37987,0.0169924392447846,0.002723091129975,0.0116551806300336,0.0223296978595356,4.50243910268504e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBC1D17,TBC1 domain family member 17,39961,0.0275527026766149,0.00442420780267328,0.0188812553833753,0.0362241499698546,4.8548510627999e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OLFM4,Olfactomedin-4,37177,0.0739462070748818,0.0118776831490008,0.0506659481028403,0.0972264660469233,4.94666251543754e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37628,-0.0123109308969456,0.00197861953295397,-0.0161890251815354,-0.00843283661235587,5.05785703354093e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,37987,0.0235979673831532,0.00379606269532479,0.0161576845003166,0.0310382502659898,5.23519236808265e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTB,Lymphotoxin-beta,37900,0.0212472526307365,0.00341884359336841,0.0145463191877345,0.0279481860737386,5.29247419939631e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC1,Sialoadhesin,40422,0.0257588252862711,0.00416509325768265,0.0175952425012131,0.0339224080713291,6.38347226912385e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,39980,0.0241750735048938,0.00391090774695074,0.0165096943208703,0.0318404526889172,6.51035253530956e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIRPB1,Signal-regulatory protein beta-1,40335,0.0266476567655544,0.00431903808542812,0.0181823421181153,0.0351129714129935,7.00285279108344e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PADI4,Protein-arginine deiminase type-4,39934,0.0412253267582639,0.00668203597706318,0.02812853624322,0.0543221172733077,7.01768469939249e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCN4B,Sodium channel subunit beta-4,37628,0.0249647719960615,0.00404741650053947,0.0170318356550042,0.0328977083371189,7.11483677852284e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A14,Protein S100-A14,37959,0.0319932157878216,0.00518747962801608,0.0218257557169101,0.0421606758587331,7.14057899210268e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40042,-0.0179873322281267,0.00291869971741508,-0.0237079836742603,-0.0122666807819932,7.32323644205211e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGLYRP1,Peptidoglycan recognition protein 1,40451,0.0252726004622499,0.00411499562919473,0.0172072090290283,0.0333379918954716,8.3632568140417e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPHS1,Nephrin,37598,0.0204621359122034,0.00334857805783982,0.0138989229188374,0.0270253489055695,1.02002200353352e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GBA,Lysosomal acid glucosylceramidase,37572,0.0311424998747879,0.00510001670899852,0.0211464671251508,0.041138532624425,1.04812115736156e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BOC,Brother of CDO,40042,-0.0138593777400225,0.0022719583958374,-0.0183124161958638,-0.00940633928418117,1.08445305323542e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40517,0.0159211895490307,0.00261585447683557,0.010794114774433,0.0210482643236284,1.18085974595742e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA12,Carbonic anhydrase 12,40305,-0.0188678721203397,0.00310560907479337,-0.0249548659069347,-0.0127808783337447,1.26492292046133e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,37714,0.0251681011000308,0.00415437254173669,0.0170255309182269,0.0333106712818347,1.4136257571516e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLAMF8,SLAM family member 8,39980,0.0312016399993184,0.00515321168594279,0.0211013450948706,0.0413019349037663,1.43834787803033e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK6,Kallikrein-6,40387,0.0176872411524229,0.00292757019175229,0.0119492035765884,0.0234252787282574,1.55976997927313e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PREB,Prolactin regulatory element-binding protein,40044,0.0172172679977154,0.00285589320916921,0.0116197173077438,0.0228148186876871,1.69030983787251e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIF1C,Kinesin-like protein KIF1C,37562,0.0217844495961865,0.00362960272921591,0.0146704282469233,0.0288984709454496,2.00191517409875e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCT,Secretin,37572,0.026615859482141,0.00443503223543047,0.0179231963006973,0.0353085226635848,2.00933029937529e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40332,0.0242993472259381,0.00404965583875721,0.016362021781974,0.0322366726699023,2.01172565306612e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CYTL1,Cytokine-like protein 1,37998,0.0132937814601388,0.00221731068118958,0.00894785252500718,0.0176397103952704,2.08079901998075e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,40305,0.0315176391783772,0.00525849011524378,0.0212109985524994,0.041824279804255,2.09607255268007e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LY9,T-lymphocyte surface antigen Ly-9,40182,0.0165374008436266,0.00276502858872926,0.0111179448097172,0.021956856877536,2.26693793705077e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37990,0.01923027627926,0.00321844498794445,0.0129221241028889,0.0255384284556312,2.35836731756901e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JAM2,Junctional adhesion molecule B,40471,0.0149940141966357,0.0025110996757621,0.010072258832142,0.0199157695611294,2.40646081463475e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA7,Carbonic anhydrase 7,37714,-0.0202681494497426,0.00339705999865764,-0.0269263870471116,-0.0136099118523737,2.48758703134843e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCN3,CCN family member 3,40522,0.0193389731697446,0.00324736163261762,0.012974144369814,0.0257038019696751,2.65025559642647e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD14,Monocyte differentiation antigen CD14,40048,0.0237533468388185,0.00399695222075954,0.0159193204861298,0.0315873731915072,2.86050840428022e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLIN3,Perilipin-3,40359,0.0242605351635242,0.00408329754863298,0.0162572719682035,0.0322637983588448,2.88481303949114e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP1,Caspase-1,39961,0.0384074354139741,0.00646989063786449,0.0257264497637597,0.0510884210641884,2.9768291155364e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37562,0.0483982944135067,0.00816083584547851,0.0324030561563688,0.0643935326706445,3.09513620583578e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40044,0.0206365980202315,0.00348059482078632,0.0138146321714903,0.0274585638689727,3.11138955773193e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CILP,Cartilage intermediate layer protein 1,37998,0.0307388911483479,0.0051907509758553,0.0205650192356715,0.0409127630610243,3.26035165438165e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,40516,0.0250213492159459,0.00424688003049054,0.0166974643561844,0.0333452340757073,3.8987985543499e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MDM1,Nuclear protein MDM1,37572,0.0177848922518402,0.00301909065535418,0.011867474567346,0.0237023099363344,3.93722936594571e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYAR,Cell growth-regulating nucleolar protein,39980,0.0296366429213442,0.00506203575010018,0.0197150528511479,0.0395582329915406,4.87548308590763e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF3,Granulocyte colony-stimulating factor,40044,0.0275309489535973,0.00470404884662883,0.0183110132142048,0.0367508846929898,4.93638045441468e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37901,0.0121219037603958,0.00207119625683856,0.0080623590969922,0.0161814484237993,4.95191892087373e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LIF,Leukemia inhibitory factor,39961,0.0294493897983709,0.00506537895999442,0.0195212470367819,0.03937753255996,6.22495143667899e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCGB1A1,Uteroglobin,40384,0.0316718304505393,0.00545652270839907,0.0209770459420772,0.0423666149590015,6.58254940866551e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEPE,Matrix extracellular phosphoglycoprotein,40357,0.0148368030810205,0.00255814877043414,0.00982283149096959,0.0198507746710714,6.76461735200885e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40044,0.0234613554856472,0.00404962045903888,0.015524099385931,0.0313986115853635,7.02762249829685e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,40536,0.00864885884510978,0.00149297530737884,0.00572262724264726,0.0115750904475723,7.04169950831038e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LPA,Apolipoprotein(a),37735,-0.0980244426318845,0.0169336724952377,-0.13121444072255,-0.0648344445412186,7.25233865030252e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TEK,Angiopoietin-1 receptor,40411,0.0119492408270215,0.00207020161478556,0.00789164566204184,0.0160068359920012,7.97818564407294e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37598,0.0201634842393365,0.00349488660024269,0.0133135065028609,0.0270134619758122,8.13351660187309e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNLY,Granulysin,40332,0.0281306300546221,0.00488466904325883,0.0185566787298348,0.0377045813794094,8.6197092691962e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAEP,Glycodelin,40228,-0.0728006337700712,0.012650599348821,-0.0975958084937604,-0.048005459046382,8.83973263309034e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40341,0.0185496153798608,0.00323178005448877,0.0122153264730628,0.0248839042866588,9.65449358718068e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC6A,C-type lectin domain family 6 member A,39980,0.0258747314706334,0.00450863717220771,0.0170378026131063,0.0347116603281605,9.7056996169141e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F3,Tissue factor,40393,-0.0154721875944127,0.0027026119932535,-0.0207693071011896,-0.0101750680876359,1.0535634917392e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB44,Ras-related protein Rab-44,37900,0.0219445652312748,0.00384475096386442,0.0144088533421006,0.0294802771204491,1.16952081844862e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNG,Interferon gamma,40044,0.0622899993138392,0.0109472674155315,0.0408333551793975,0.0837466434482809,1.29318655492183e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTPN,Myotrophin,40042,0.0181448099518821,0.0031895521193953,0.0118932877978673,0.0243963321058969,1.30211789145056e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPOCK1,Testican-1,40228,0.0137574205702213,0.00241976378270291,0.00901468355612364,0.0185001575843191,1.32786201474269e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMPRSS11D,Transmembrane protease serine 11D,37921,0.0211292243172267,0.00372257114804266,0.0138329848670631,0.0284254637673903,1.40744165895521e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECE1,Endothelin-converting enzyme 1,39961,0.0192328274842988,0.00339218842682402,0.0125841381677237,0.0258815168008739,1.45561730538041e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RPS10,40S ribosomal protein S10,37562,-0.0231515030560302,0.0040862845014644,-0.0311606206789004,-0.01514238543316,1.4954066747743e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNXB,Tenascin-X,40332,-0.0138839400967389,0.00245161134298257,-0.0186890983289848,-0.00907878186449311,1.5115762301833e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRLF1,Cytokine receptor-like factor 1,40422,0.0143164688297783,0.00252828297496314,0.00936103419885056,0.019271903460706,1.51727520918834e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40396,0.0482770208810538,0.00852871627091916,0.0315607369900522,0.0649933047720553,1.53507434537656e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DSG3,Desmoglein-3,40419,0.0181637314477497,0.00322109590776846,0.0118503834685235,0.0244770794269759,1.73945935411311e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BLVRB,Flavin reductase,40332,0.0359384171279295,0.00638319035649066,0.0234273640292078,0.0484494702266512,1.83083882101012e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MUC16,Mucin-16,40305,0.1011555099978,0.0180204426247473,0.0658354424532956,0.136475577542305,2.01742129379546e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD48,CD48 antigen,40396,0.0157885108245865,0.00282189076230276,0.0102576049304731,0.0213194167186999,2.24235780023729e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DSG4,Desmoglein-4,40250,0.0273635092603478,0.0048942546505641,0.0177707701452422,0.0369562483754535,2.2957529633033e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,40536,-0.0130066196491617,0.00232910495487197,-0.0175716653607108,-0.00844157393761269,2.38323404919029e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MBL2,Mannose-binding protein C,37810,-0.0573938050185083,0.0102773264122755,-0.0775373647865683,-0.0372502452504483,2.38936862494736e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37598,0.0189277649825805,0.00339622669008852,0.012271160670007,0.025584369295154,2.55059520180932e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OBP2B,Odorant-binding protein 2b,40184,-0.0354759082843933,0.00637292183234996,-0.0479668350757992,-0.0229849814929874,2.63907473056755e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,40042,0.0294805301743357,0.0053373682540003,0.0190192883964951,0.0399417719521763,3.37780961584547e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOC1,Apolipoprotein C-I,37981,0.0192278779625198,0.0034886680016992,0.0123900886791894,0.0260656672458503,3.6224897810234e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIPC2,PDZ domain-containing protein GIPC2,37942,0.0154828546753006,0.00281103089356106,0.00997323412392096,0.0209924752266803,3.69803288145835e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PROCR,Endothelial protein C receptor,37562,-0.0196399713842109,0.00357102387430932,-0.0266391781778571,-0.0126407645905646,3.87310863518195e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RETN,Resistin,40283,0.0218536017794525,0.00398882769732735,0.0140354994926909,0.0296717040662141,4.34993339110453e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GZMB,Granzyme B,40341,0.0331683401946648,0.00605568394023336,0.0212991996718074,0.0450374807175221,4.3861093779501e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOLR2,Folate receptor beta,40471,-0.0155080249962937,0.00283368222751898,-0.0210620421622309,-0.00995400783035653,4.49767032344973e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,XG,Glycoprotein Xg,40458,0.0156968982216098,0.00288079399800045,0.0100505419855289,0.0213432544576907,5.14571561595753e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GBP2,Guanylate-binding protein 2,40044,0.031193503511978,0.00573331783689981,0.0199562005516544,0.0424308064723017,5.38592435436395e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,40305,0.0161774813516216,0.00297901802791463,0.0103386060169089,0.0220163566863343,5.70318434030961e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLYR1,Putative oxidoreductase GLYR1,37900,0.0317324369078811,0.00584854059029109,0.0202692973509106,0.0431955764648516,5.87267644192978e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCAR,Immunoglobulin alpha Fc receptor,40341,0.0245068161477612,0.0045272383953901,0.0156334288927966,0.0333802034027258,6.28087382215145e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA12,Serpin A12,39903,0.0595568520791346,0.0110047323912914,0.0379875765922033,0.0811261275660658,6.3278146078149e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATXN2,Ataxin-2,37541,0.0601910412984466,0.0111242967450228,0.0383874196782019,0.0819946629186912,6.38579452052823e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLU,Clusterin,38013,0.0172026704175988,0.00318992389537286,0.010950419582668,0.0234549212525296,7.05251479212163e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,39980,0.021561560377742,0.00399993227174928,0.0137216931251134,0.0294014276303706,7.12954463253702e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37901,0.0264827292080585,0.00491979949792438,0.0168399221921267,0.0361255362239903,7.45305475402979e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH3,Cadherin-3,40471,0.0183303805949699,0.00341023704210353,0.0116463159924469,0.0250144451974928,7.76096038402443e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CREBZF,CREB/ATF bZIP transcription factor,37482,-0.0136988406740983,0.00255068687725615,-0.0186981869535204,-0.00869949439467624,7.98018261233087e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",39961,0.0142625427323239,0.00265632850158449,0.00905613886921835,0.0194689465954295,8.01947136041499e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,37900,0.0234648141328622,0.00437045921115784,0.0148987140789929,0.0320309141867316,8.05086258180865e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPM1A,Protein phosphatase 1A,39980,0.0160149857498957,0.00298970527122441,0.0101551634182958,0.0218748080814955,8.59585097220658e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40228,0.0131416115272691,0.00245622265816643,0.00832741511726293,0.0179558079372754,8.90177031528885e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37901,-0.016986884282879,0.00317476117457162,-0.0232094161850394,-0.0107643523807187,8.90992888391008e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL28,C-C motif chemokine 28,40278,0.030665153306883,0.00573889730575118,0.0194169145876107,0.0419133920261554,9.24884650596439e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,40044,0.022438627762582,0.00420652736514793,0.0141938341268921,0.030683421398272,9.72849457891596e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39961,0.0155517357253795,0.0029156543387159,0.0098370532214963,0.0212664182292626,9.74878378894088e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK11,Kallikrein-11,40260,0.0152493514820292,0.00285980502822083,0.00964413362671635,0.020854569337342,9.83075165152478e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CR2,Complement receptor type 2,40403,0.0238487946716324,0.00447273962636192,0.0150822250039631,0.0326153643393018,9.84424703635471e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHA2,Ephrin type-A receptor 2,39759,0.0158086984347366,0.00296526057550692,0.00999678770674305,0.0216206091627302,9.88952486145758e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPM3,Tropomyosin alpha-3 chain,37562,-0.0218512104282686,0.00410253844815117,-0.0298921857866448,-0.0138102350698923,1.01909152406527e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB37,Ras-related protein Rab-37,40044,0.0427440269597579,0.00802968974887799,0.0270058350519571,0.0584822188675588,1.0334255308781e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGT5,Glutathione hydrolase 5 proenzyme,40228,0.0116044075605574,0.00218004222516044,0.0073315247992429,0.0158772903218718,1.03455406927251e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GDF15,Growth/differentiation factor 15,40536,0.0219893446422624,0.00413816764777068,0.0138785360526319,0.030100153231893,1.08801019280503e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEDD9,Enhancer of filamentation 1,37598,0.0169538222766056,0.00319236818615924,0.0106967806317335,0.0232108639214777,1.10962876838108e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VIT,Vitrin,37990,0.0188711282607499,0.00355424726992646,0.0119048036116941,0.0258374529098058,1.1168913619453e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPC1,Glypican-1,40489,0.0149872892827557,0.00282493580113622,0.00945041511252868,0.0205241634529827,1.13947771400238e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHRM1,Muscarinic acetylcholine receptor M1,37572,-0.0192776340898317,0.00363722942746416,-0.0264066037676615,-0.0121486644120019,1.17622229969858e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,37562,0.0182536897776666,0.0034470788178122,0.0114974152947546,0.0250099642605785,1.20669301917577e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37572,0.0530760836950382,0.0100275756764183,0.0334220353692584,0.0727301320208179,1.22256600175473e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40379,0.0170062068844093,0.00321351334798431,0.0107077207223601,0.0233046930464585,1.22527636703905e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPP4,Dipeptidyl peptidase 4,40068,0.0151383056965692,0.0028756857923591,0.00950196154354538,0.0207746498495931,1.42632922012804e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,40332,0.0218813860332389,0.004171444241766,0.0137053553193776,0.0300574167471003,1.57844923744729e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMPD3,AMP deaminase 3,37942,0.036557526114723,0.00699535981410157,0.0228466208790839,0.0502684313503621,1.75829684753404e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DUSP3,Dual specificity protein phosphatase 3,39961,0.0425575798246786,0.00816225533540685,0.0265595593672812,0.058555600282076,1.87237117712672e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EBI3_IL27,Interleukin-27,40453,-0.0156357691842878,0.0030012575143719,-0.0215182339124567,-0.00975330445611888,1.91452645125591e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THBS4,Thrombospondin-4,40355,0.0225892952501833,0.00433898954034636,0.0140848757511044,0.0310937147492622,1.952321800183e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,39980,0.0269166039117591,0.00518136326798826,0.0167611319065021,0.0370720759170161,2.07433341011454e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC10A,C-type lectin domain family 10 member A,40228,-0.0180242434297552,0.00347040842462353,-0.0248262439420174,-0.0112222429174931,2.08724447008428e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37901,-0.0344700434718408,0.00666783783104368,-0.0475390056206864,-0.0214010813229952,2.37961513672043e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKD2,Serine/threonine-protein kinase D2,37562,0.0236779043317584,0.0045826177743821,0.0146959734939695,0.0326598351695474,2.41509563889062e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCN,Decorin,40042,-0.011316000033019,0.00219516561666826,-0.0156185246416888,-0.00701347542434919,2.56780560055158e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMBS,Porphobilinogen deaminase,40489,0.0224953361757591,0.00437445795565672,0.0139213985826719,0.0310692737688462,2.74402234780245e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,39961,0.0202645007052944,0.00394227898471072,0.0125376338952614,0.0279913675153274,2.77632316525572e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL5RA,Interleukin-5 receptor subunit alpha,40341,-0.0271967186405832,0.00530609629070054,-0.0375966673703563,-0.0167967699108102,3.0013325021536e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BMP10,Bone morphogenetic protein 10,37671,-0.0141858956739169,0.00276974773425616,-0.0196146012330589,-0.0087571901147748,3.07007859394739e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,39980,0.0289343132513414,0.00565179068439575,0.0178568035099257,0.040011822992757,3.10015714052546e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB6,Integrin beta-6,40044,0.0148721654071093,0.00290690733753174,0.00917462702554707,0.0205697037886715,3.15541296889984e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CGA,Glycoprotein hormones alpha chain,40332,0.0440508037521697,0.00862225469223172,0.0271511845553955,0.0609504229489438,3.27681296556325e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOLR1,Folate receptor alpha,40299,0.0139303940370372,0.00273049575290835,0.00857862236133681,0.0192821657127375,3.40356676532093e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPSAB1,Tryptase alpha/beta-1,40498,0.0258536509797943,0.00507305625710277,0.0159104607158729,0.0357968412437158,3.50350744017703e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF5,Eukaryotic translation initiation factor 5,37562,0.0223738350512774,0.00439054957114745,0.0137683578918284,0.0309793122107264,3.51903298086577e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIAA1549L,UPF0606 protein KIAA1549L,37714,-0.0143106935468631,0.00280869956568524,-0.0198157446956062,-0.00880564239812001,3.53289391996599e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40434,0.0165631281941443,0.00325138204315904,0.0101904193895526,0.022935836998736,3.54240447693902e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSHB,Thyrotropin subunit beta,40359,0.0410266822621673,0.0080729777955984,0.0252036457827945,0.0568497187415402,3.77761682137924e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C8B,Complement component C8 beta chain,38013,0.014959086814329,0.00294446815317009,0.00918792923411558,0.0207302443945423,3.81639107444252e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,40516,0.0177963862803691,0.00351165311307889,0.0109135461787345,0.0246792263820038,4.0688931808657e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LUZP2,Leucine zipper protein 2,37900,0.0218147838374213,0.00431157403486589,0.0133640987290841,0.0302654689457584,4.25707676841353e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRD1,Bromodomain-containing protein 1,37714,-0.0151522073441089,0.00299700287507043,-0.021026332979247,-0.00927808170897089,4.34336758094879e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,37541,-0.0162377332544454,0.00321462648323282,-0.0225384011615818,-0.00993706534730912,4.44947005437312e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLAUR,Urokinase plasminogen activator surface receptor,40264,0.0129603599599311,0.00256913834059043,0.00792484881237383,0.0179958711074883,4.59428066296139e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,39865,0.0183134366288032,0.00363771783024251,0.0111835096815279,0.0254433635760785,4.84956501206553e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37562,0.0237559013889986,0.00472074985524719,0.0145032316727141,0.0330085711052831,4.91229745423571e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EGFLAM,Pikachurin,37901,0.0149205345739214,0.00296835415280134,0.00910256043443081,0.0207385087134121,5.05844262642088e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRUNE2,Protein prune homolog 2,37714,0.0143269694547857,0.00285582413337068,0.00872955415337919,0.0199243847561922,5.32316957625531e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,39961,0.0687335660703718,0.013701802013249,0.0418780341244038,0.0955890980163397,5.32338259134294e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37942,0.0301193611796204,0.0060100201138817,0.0183397217564122,0.0418990006028285,5.46848324337143e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNPY2,Protein canopy homolog 2,40042,0.0294081252331919,0.00588545820641392,0.0178726271486207,0.0409436233177632,5.89381035634562e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40422,0.0126626164338508,0.00254082841904886,0.00768259273251504,0.0176426401351866,6.30467878727055e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD160,CD160 antigen,40516,0.0218513502809078,0.00439631313218226,0.0132345765418306,0.030468124019985,6.75096594274411e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40332,0.0126440093453881,0.00254700101286386,0.00765188736017491,0.0176361313306012,6.96737287947729e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MATN3,Matrilin-3,40203,-0.0149028000575077,0.00300870379116189,-0.020799859488185,-0.00900574062683038,7.37483087152578e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK8,Kallikrein-8,39801,0.0168992816117659,0.00342113808170559,0.010193850971623,0.0236047122519089,7.90798172658982e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH15,Cadherin-15,40435,0.0210041978225982,0.00426340589559032,0.0126479222672412,0.0293604733779553,8.44993207618225e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1R1,Interleukin-1 receptor type 1,40303,-0.0105437703468491,0.00214899884653526,-0.0147558080860582,-0.00633173260763998,9.37012728479656e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNPEP,Aspartyl aminopeptidase,37942,0.0281298029538618,0.00573425303250765,0.0168906670101468,0.0393689388975768,9.42410552095119e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENO1,Alpha-enolase,40299,0.037260073560953,0.00762887462073448,0.0223074793043135,0.0522126678175926,1.04923838652285e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,40359,0.0270003327918095,0.00553286198362974,0.0161559233038952,0.0378447422797238,1.07116813159479e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEZ6,Seizure protein 6 homolog,37572,-0.0146910618813793,0.00302175761490232,-0.0206137068065878,-0.00876841695617075,1.17694255323825e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD27,CD27 antigen,40411,0.0190056003364413,0.00391489433588974,0.0113324074380974,0.0266787932347852,1.21715957072565e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHB6,Ephrin type-B receptor 6,40192,0.0145740181969244,0.00300412190083614,0.00868593927128553,0.0204620971225632,1.23803382172624e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCR1,Natural cytotoxicity triggering receptor 1,40306,0.0168210759628644,0.00346807953693336,0.010023640070475,0.0236185118552538,1.24472272030894e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINI1,Neuroserpin,37642,0.0149032891858945,0.00307853712641394,0.00886935641812317,0.0209372219536658,1.30632268014179e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF16,Fibroblast growth factor 16,37598,0.0229831534854437,0.00474953519399197,0.0136740645052195,0.032292242465668,1.31954443820737e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39823,-0.0403648943930587,0.00834277706738774,-0.0567167374451387,-0.0240130513409787,1.32221659771981e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UROS,Uroporphyrinogen-III synthase,37572,0.0326532363315245,0.00677925564947451,0.0193658952585544,0.0459405774044945,1.47627026271191e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD200,OX-2 membrane glycoprotein,40341,-0.0120516915899609,0.0025033153981215,-0.0169581897702791,-0.00714519340964277,1.49082128054623e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LHB,Lutropin subunit beta,39980,0.0392844809221169,0.00817765133158019,0.0232562843122197,0.055312677532014,1.57071141705251e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTN5,Contactin-5,40367,-0.0170898634223832,0.003566166627014,-0.0240795500113306,-0.0101001768334358,1.66432850688601e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA9,Carbonic anhydrase 9,40489,-0.0207138963800703,0.0043322545388936,-0.0292051152763018,-0.0122226774838389,1.75694001098458e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOSB,Protein fosB,39961,0.0179325155271638,0.0037641320092423,0.0105548167890489,0.0253102142652787,1.91463080318692e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECM1,Extracellular matrix protein 1,37655,0.0169309875166005,0.00357120081525485,0.00993143391870095,0.0239305411145,2.14909910213536e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,40341,0.0297857295956907,0.00628749488745366,0.0174622396162815,0.0421092195750998,2.18460930875309e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLASP1,CLIP-associating protein 1,37482,0.0326721462009097,0.00689997552900766,0.0191481941640547,0.0461960982377647,2.21242315155757e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40516,0.0158179033281668,0.00335689371597617,0.00923839164485355,0.0223974150114801,2.47273242746747e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSN,Gelsolin,37928,-0.00862288097787688,0.00183379455534331,-0.0122171183063498,-0.00502864364940399,2.59916484358111e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLPS,Colipase,40311,0.0309687664951518,0.00660015155901624,0.01803246943948,0.0439050635508236,2.72633564824768e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37901,0.0178310273786116,0.00380172522683435,0.0103796459340163,0.0252824088232069,2.75560919009628e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ELAVL4,ELAV-like protein 4,37541,0.0394454871239328,0.0084239779601635,0.0229344903220123,0.0559564839258532,2.86209091481685e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD99,CD99 antigen,40332,-0.00875088509980807,0.00186943867479561,-0.0124149849024075,-0.00508678529720867,2.87806032018206e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37635,-0.0219426684683367,0.00468907610273717,-0.0311332576297015,-0.0127520793069718,2.90395028705755e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH6,Cadherin-6,40359,-0.0170368725711466,0.00365145732856123,-0.0241937289351266,-0.00988001620716656,3.09963118475802e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUCA1,Tissue alpha-L-fucosidase,40437,0.0363901037863369,0.00781174159271053,0.0210790902646243,0.0517011173080496,3.21266907109227e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PADI2,Protein-arginine deiminase type-2,40044,0.0251679209981534,0.00540660849158649,0.0145709683546439,0.0357648736416629,3.26603317573471e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CST6,Cystatin-M,39992,0.0214011792966264,0.00460572177641428,0.0123739646148544,0.0304283939783984,3.40137485235032e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD109,CD109 antigen,40332,-0.0149460207419536,0.00321681182988782,-0.0212509719285338,-0.0086410695553735,3.40784392120819e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,37998,0.0222692548146538,0.00480380169314724,0.0128538034960852,0.0316847061332224,3.58954988450648e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRISP3,Cysteine-rich secretory protein 3,37875,-0.0120515833545095,0.0026048076292325,-0.0171570063078052,-0.0069461604012138,3.75068317663863e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,37714,0.0306272582496829,0.00662901492797473,0.0176343889908524,0.0436201275085134,3.87012463644116e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSPN,Persephin,40341,0.044105391554006,0.00956763398975167,0.0253528289340927,0.0628579541739193,4.06090186365108e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICAM5,Intercellular adhesion molecule 5,40359,0.0195597296726324,0.00424850283603716,0.0112326641139995,0.0278867952312652,4.17838135606852e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DLL4,Delta-like protein 4,37628,0.0374882200689142,0.00814999951306171,0.0215142210233133,0.0534622191145152,4.26873804490419e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICOSLG,ICOS ligand,40305,0.00845110292423406,0.00183906698775343,0.00484653162823733,0.0120556742202308,4.35415092103028e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP6V1D,V-type proton ATPase subunit D,40305,0.0116186508808746,0.00253089578094978,0.00665809515021304,0.0165792066115362,4.45097737555982e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PODXL,Podocalyxin,40305,0.00670435402438841,0.00146219101400291,0.00383845963694269,0.00957024841183412,4.57145164951479e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EP300,Histone acetyltransferase p300,37598,0.0132064068699027,0.00288327872099491,0.00755518057675264,0.0188576331630527,4.68477622524892e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL1A1,Collagen alpha-1(I) chain,40536,-0.01139373585139,0.0025001414109936,-0.0162940130169374,-0.00649345868584251,5.22124883453685e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFHR4,Complement factor H-related protein 4,37973,0.0320588647312666,0.00707586816150716,0.0181901631347125,0.0459275663278206,5.92830237943691e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37628,0.0149237445185728,0.00330132549084545,0.00845314655651569,0.0213943424806299,6.22222262852155e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPR1,Atrial natriuretic peptide receptor 1,37562,-0.017569359908129,0.00389628309096912,-0.0252060747664285,-0.00993264504982953,6.56179641693861e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHX2,Bifunctional epoxide hydrolase 2,40042,0.0271930864401414,0.00603542906040345,0.0153636454817507,0.0390225273985322,6.66741342019076e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37714,0.0191628260932123,0.00425753023057635,0.0108180668412827,0.027507585345142,6.82343048666109e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT19,"Keratin, type I cytoskeletal 19",40310,0.029357470379139,0.00654473076501435,0.0165297980797109,0.0421851426785671,7.31974322270512e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RPA2,Replication protein A 32 kDa subunit,37598,0.014141878293259,0.00315391553643388,0.00796020384184856,0.0203235527446694,7.3907478803855e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOD3,Extracellular superoxide dismutase,37987,-0.0255699641695951,0.00570337139728696,-0.0367485721082775,-0.0143913562309126,7.40990583941084e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHRDL1,Chordin-like protein 1,40396,0.0131548037225445,0.00293599530141318,0.00740025293177464,0.0189093545133143,7.49771913640062e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDCD6,Programmed cell death protein 6,40359,-0.0299674147374319,0.00672161058072266,-0.0431417714756483,-0.0167930579992155,8.3150920473319e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITM2A,Integral membrane protein 2A,40341,-0.0253595162361911,0.00569258948055284,-0.0365169916180747,-0.0142020408543075,8.45331079761903e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL10RA,Interleukin-10 receptor subunit alpha,40044,0.0257515352987108,0.00580579134806175,0.0143721842565098,0.0371308863409119,9.24912996629406e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40305,0.0191530077940216,0.00432672765326741,0.0106726215936175,0.0276333939944258,9.63368805458784e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTRL,Chymotrypsin-like protease CTRL-1,37942,-0.0278936178650182,0.00633370921378467,-0.0403076879240361,-0.0154795478060002,1.07094113113468e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ROBO4,Roundabout homolog 4,37628,-0.00759651499114202,0.00172760531078695,-0.0109826214002844,-0.0042104085819996,1.10548354891951e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37541,0.0262829618467092,0.00598335407321262,0.0145555878632125,0.038010335830206,1.12841506353634e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGMA,Repulsive guidance molecule A,40471,-0.0130602042060931,0.00297769771428699,-0.0188964917260956,-0.00722391668609061,1.16186790506186e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYL3,Myosin light chain 3,37628,-0.0288795772904125,0.00660612490931077,-0.0418275821126616,-0.0159315724681634,1.24263778292402e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL31RA,Interleukin-31 receptor subunit alpha,37544,0.0170549889779323,0.00391207513277825,0.00938732171768693,0.0247226562381777,1.31309249180683e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA3,Alpha-1-antichymotrypsin,37958,0.00619472861049829,0.00142122753765707,0.00340912263669044,0.00898033458430614,1.31794234010425e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCG3,Secretogranin-3,40379,-0.0139921447333642,0.00321077886491096,-0.0202852713085896,-0.00769901815813867,1.32158922547767e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRC38,Leucine-rich repeat-containing protein 38,37572,0.0207781709905896,0.00478006142968795,0.0114092505884012,0.0301470913927779,1.39151855890372e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM3D,Protein FAM3D,37901,0.0344153015123698,0.00793874224441934,0.0188553667133079,0.0499752363114317,1.46748126160111e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCGB2A2,Mammaglobin-A,37562,-0.0134174602515319,0.00309992631506188,-0.0194933158290532,-0.00734160467401067,1.51367950381908e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,37482,0.0248690744093732,0.00574662630880394,0.0136056868441175,0.036132461974629,1.51869847246291e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HYAL1,Hyaluronidase-1,40214,0.00954084951951434,0.00221246007003234,0.00520442778225095,0.0138772712567777,1.62527676134419e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,39980,0.0235610196594868,0.00548630267597833,0.0128078664145693,0.0343141729044044,1.76137292711029e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYOM2,Myomesin-2,37562,-0.0194864659078905,0.00454193320253913,-0.0283886549848672,-0.0105842768309138,1.79673699051613e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,39980,0.0124752438584419,0.00291062521482298,0.00677041843738889,0.018180069279495,1.82929439868964e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC7A,C-type lectin domain family 7 member A,40516,0.0241557142537393,0.0056386524791032,0.013103955394697,0.0352074731127815,1.84670456906751e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDI2,Protein DDI1 homolog 2,37671,0.0322946873838427,0.0075478930582905,0.0175008169895933,0.0470885577780921,1.89365072169142e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAPK13,Mitogen-activated protein kinase 13,37482,0.0170485242254781,0.00399050050198105,0.00922714324159524,0.0248699052093609,1.94860177727111e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNX18,Sorting nexin-18,37901,0.0186841490961117,0.00438807369536182,0.0100835246532026,0.0272847735390209,2.07721013199334e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALB1,Calbindin,40305,0.0173590934871589,0.00408021135527796,0.00936187923081411,0.0253563077435037,2.10757285849358e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFPI2,Tissue factor pathway inhibitor 2,40357,0.01626573689873,0.00383138412566352,0.0087562240124295,0.0237752497850305,2.19447251427833e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40471,0.0294699811537799,0.00694909622434338,0.0158497525540669,0.0430902097534929,2.23937587998172e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,40332,0.0140395026700952,0.00331294034782094,0.00754613958836611,0.0205328657518242,2.27017790247253e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFB2,Transforming growth factor beta-2 proprotein,37900,0.0216382917836154,0.00511258608832313,0.011617623050502,0.0316589605167287,2.32788741708503e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFRAL,GDNF family receptor alpha-like,37477,-0.0253113882735881,0.00598216315676063,-0.0370364280608389,-0.0135863484863372,2.34097739047157e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40332,0.0147594674073942,0.00349413930089619,0.00791095437763769,0.0216079804371508,2.41273565595662e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,37714,0.0241285540834368,0.00571927782304528,0.012918769550268,0.0353383386166055,2.47225877917437e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40042,-0.00847036363096591,0.00201248612511708,-0.0124148364361954,-0.00452589082573644,2.58048128791986e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNR,Tenascin-R,40228,-0.0171872791935615,0.0040848486246675,-0.0251935824979098,-0.00918097588921325,2.59560513935276e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37959,0.019721828377997,0.00468762152841991,0.010534090182294,0.0289095665737,2.60207305505401e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SATB1,DNA-binding protein SATB1,37959,0.0122068352733295,0.00290847704804751,0.00650622025915638,0.0179074502875026,2.72221959197451e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP9,Fatty acid-binding protein 9,40341,0.0225625047456685,0.00537978458974555,0.0120181269497672,0.0331068825415698,2.75634310750095e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37959,0.017696973168428,0.004219531691919,0.00942669105226681,0.0259672552845893,2.75752523392428e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFF3,Trefoil factor 3,40309,0.0215530190826917,0.00514179022462152,0.0114751102424336,0.0316309279229499,2.78330752193467e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,37998,0.0237718012151305,0.00568570648982751,0.0126278164950685,0.0349157859351924,2.92085515134348e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA7A,Semaphorin-7A,40490,0.0108211593486423,0.00258902026049766,0.00574667963806684,0.0158956390592177,2.93525411217955e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPEP1,Dipeptidase 1,40192,-0.0204415501455836,0.00489131741056492,-0.0300285322702908,-0.0108545680208764,2.94180314429383e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,37998,-0.0085193020594493,0.00204413300142608,-0.0125258027422444,-0.00451280137665417,3.09620124846373e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRTAP,Cartilage-associated protein,37572,0.0194952535605617,0.00468089420148742,0.0103207009256464,0.0286698061954771,3.13540960656779e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDN1,Endothelin-1,37628,0.0117059131950631,0.00281145531060909,0.00619546078626931,0.017216365603857,3.15194032748424e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL19,Interleukin-19,39924,0.0271366761981057,0.00654305823695444,0.014312282053675,0.0399610703425364,3.38067430333573e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX5,Syntaxin-5,37598,0.0167426314696704,0.00404930002206088,0.00880600342643112,0.0246792595129098,3.57629139874673e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD58,Lymphocyte function-associated antigen 3,40335,-0.00703203174582196,0.00170210544695522,-0.0103681584218542,-0.00369590506978973,3.62450481291664e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNU13,NHP2-like protein 1,37562,0.0249030451039302,0.00602893048617597,0.0130863413510253,0.0367197488568351,3.64076501531223e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMG4,Proteasome assembly chaperone 4,37598,0.0225080288094674,0.00545284757754942,0.0118204475574705,0.0331956100614643,3.68579318720796e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38013,-0.0077894526545063,0.00188760476729918,-0.0114891579984127,-0.0040897473105999,3.70311950105419e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTK7,Inactive tyrosine-protein kinase 7,39961,0.0152931274273719,0.00371368146113508,0.00801431176354719,0.0225719430911967,3.84070898544523e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOB,Apolipoprotein B-100,37987,0.00886727104668781,0.00215385430250175,0.00464571661378439,0.0130888254795912,3.86227593843231e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37942,0.0215369598360088,0.00523184975432287,0.0112825343175359,0.0317913853544816,3.86941985916054e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FSTL1,Follistatin-related protein 1,37628,-0.00894497006411428,0.00217329975186387,-0.0132046375777675,-0.00468530255046111,3.88108198392235e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MILR1,Allergin-1,40044,-0.0198072381668891,0.00481288925139417,-0.0292405010996217,-0.0103739752341565,3.88399945164791e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAG3,Lymphocyte activation gene 3 protein,40305,-0.0161867846328713,0.00395717068311085,-0.0239428391717685,-0.00843073009397402,4.32581414237898e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERC2,ERC protein 2,37572,0.0303824013843686,0.00743678653499033,0.0158062997757876,0.0449585029929497,4.42585640094145e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAA4,Serum amyloid A-4 protein,38013,0.0128401673135144,0.0031494134760883,0.0066673169003813,0.0190130177266475,4.5880252058883e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COMMD9,COMM domain-containing protein 9,37900,0.0154513602506801,0.00379082279803581,0.00802134756652992,0.0228813729348303,4.60821375768382e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37628,0.0243883399147422,0.00598799391905279,0.0126518718333987,0.0361248079960856,4.6708372526291e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37562,0.0220803156956822,0.00542445542916467,0.0114483830545194,0.0327122483368449,4.71849548835551e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37598,0.0171910834961991,0.00422665057695014,0.00890684836537682,0.0254753186270214,4.78370878129309e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIL1,Nucleotide exchange factor SIL1,37628,0.0125543598057006,0.00309312125042833,0.00649184215486106,0.0186168774565401,4.96103778647473e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB39B,Ras-related protein Rab-39B,37562,0.0348524662947557,0.00861336811217361,0.0179702647948954,0.051734667794616,5.2326917115311e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARG1,Arginase-1,40227,0.0205580282925559,0.00508965360768065,0.0105823072215018,0.0305337493636099,5.38922039204398e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NME1,Nucleoside diphosphate kinase A,37598,-0.00856256665095931,0.0021237894119995,-0.0127251938984783,-0.00439993940344029,5.56777846865187e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDHB15,Protocadherin beta-15,37900,-0.0156699642524146,0.0038912881065025,-0.0232968889411595,-0.00804303956366967,5.68188737679768e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40228,0.0404902448095471,0.0100575351709566,0.0207774758744721,0.0602030137446221,5.70323797417741e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDH1,Protocadherin-1,40475,0.00840808531998567,0.00209646421233741,0.00429901546380434,0.012517155176167,6.08386145135164e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHAD,Chondroadherin,37671,0.020788373884734,0.00519015952127562,0.0106156612230338,0.0309610865464342,6.22662039675105e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK4,Kallikrein-4,40489,-0.0234409181888928,0.00585644629788535,-0.034919552932748,-0.0119622834450375,6.29362017285372e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PMS1,PMS1 protein homolog 1,37572,0.0201133312080587,0.0050266481661404,0.0102611008024235,0.0299655616136938,6.33305957332442e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,37900,0.0137630401196115,0.00344132062707493,0.00701805169054465,0.0205080285486784,6.38568449896098e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL15RA,Interleukin-15 receptor subunit alpha,40044,0.013709578138827,0.00343423268458863,0.00697848207703327,0.0204406742006207,6.58086444137554e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37990,0.0101872515799065,0.00255497752520942,0.005179495630496,0.0151950075293169,6.7203795740587e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL34,Interleukin-34,39934,0.0137635207154972,0.00345559807439153,0.0069905484896898,0.0205364929413046,6.83724779150121e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AOC3,Membrane primary amine oxidase,40403,-0.0116478872734879,0.00292603578663086,-0.0173829174152844,-0.00591285713169143,6.89954637948137e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37562,-0.0200248064465094,0.00503731760288037,-0.0298979489481549,-0.0101516639448638,7.06700230626803e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC13A1,Solute carrier family 13 member 1,37900,0.0238095466221913,0.0059980696115548,0.0120533301835439,0.0355657630608388,7.2387452013993e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,37919,0.0146360497620548,0.00368815829679305,0.00740725950034044,0.0218648400237692,7.27351575841727e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HGFAC,Hepatocyte growth factor activator,37849,0.0110600558722714,0.00279277829219167,0.00558621041957567,0.016533901324967,7.52636230953092e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40489,0.00963934289375698,0.00243656053722092,0.00486368424080397,0.01441500154671,7.65024468470555e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLP1R,Glucagon-like peptide 1 receptor,37541,-0.0146399018171592,0.00371544682095492,-0.0219221775862308,-0.00735762604808751,8.18092011790581e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NTRK2,BDNF/NT-3 growth factors receptor,40359,0.00978075757241543,0.00248240791999298,0.0049152380492292,0.0146462770956017,8.1819996029941e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,39961,0.0150036372085434,0.00381460569251769,0.00752701005120877,0.0224802643658781,8.41845287198276e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGAP5,Rho GTPase-activating protein 5,37482,0.0293840720813461,0.00747530328755023,0.0147324776377476,0.0440356665249445,8.50943292045827e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JUN,Transcription factor AP-1,40044,0.0196252612189811,0.00499865624885106,0.00982789497123307,0.0294226274667292,8.67028520227197e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40228,0.0262607868413344,0.0067058388223036,0.0131173427496193,0.0394042309330494,9.03688368065136e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PI16,Peptidase inhibitor 16,37987,-0.00929276128617897,0.00237636541586694,-0.0139504375012782,-0.00463508507107976,9.25573060324039e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37562,-0.0119571013945219,0.00307723319903026,-0.0179884784646212,-0.00592572432442258,0.000102551583447541
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKAP12,A-kinase anchor protein 12,37671,-0.00814449681868507,0.00210549327268902,-0.0122712636331555,-0.0040177300042146,0.000110161620686888
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40330,0.0117015145778728,0.00303502718447387,0.00575286129630402,0.0176501678594416,0.000115953766709667
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37714,0.0267306010257892,0.0069359465759831,0.0131361457368623,0.0403250563147161,0.000116788342447819
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TYMP,Thymidine phosphorylase,40257,0.0247230638086938,0.00641940379571894,0.0121410323690847,0.0373050952483029,0.000117954855948828
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYOM1,Myomesin-1,37541,0.0174416528446117,0.00452900880018609,0.008564795596247,0.0263185100929765,0.000118149957614297
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SDC1,Syndecan-1,40359,0.0148393958488318,0.00385391718688069,0.00728571816254562,0.0223930735351179,0.000118352605500739
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFBR3,Transforming growth factor beta receptor type 3,40536,-0.0122125722604314,0.00318055272091698,-0.0184464555934287,-0.00597868892743416,0.00012362452420839
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACTN2,Alpha-actinin-2,37562,-0.0202780541978654,0.00528542697979885,-0.0306374910782711,-0.00991861731745964,0.000125335730008905
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX25,ATP-dependent RNA helicase DDX25,37572,-0.0145501590557802,0.00379274064159997,-0.0219839307133162,-0.0071163873982443,0.000125477629302697
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37714,0.0133171449308453,0.00347939360005735,0.00649753347473291,0.0201367563869577,0.000130081480726234
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,39961,0.0178377889936224,0.00468228790587388,0.00866050469810962,0.0270150732891352,0.000139711322192416
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37900,0.016174134217029,0.00425343038760787,0.00783741065731757,0.0245108577767404,0.000143812803878675
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDKL5,Cyclin-dependent kinase-like 5,37541,-0.0199673771716159,0.00525141614666489,-0.030260152819079,-0.00967460152415268,0.000144018875011578
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEFL,Neurofilament light polypeptide,39903,0.0156270476909214,0.00411108720415333,0.00756931677078084,0.0236847786110619,0.000144552426411799
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCAN,Brevican core protein,40228,-0.0122560620109918,0.00322677322578547,-0.0185805375335313,-0.00593158648845227,0.000146273159435656
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSH3,Protein phosphatase Slingshot homolog 3,37482,0.0107073823574383,0.00282241296515571,0.00517545294573315,0.0162393117691435,0.000149091235315451
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NMI,N-myc-interactor,37857,0.0262115696727467,0.0069113641642878,0.0126652959107426,0.0397578434347508,0.000149773592301886
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,40357,0.0139307430316314,0.00367762979502291,0.00672258863338645,0.0211388974298763,0.000152443790272847
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP9,Matrix metalloproteinase-9,40312,0.0220267751119112,0.00588587479859777,0.0104904605066596,0.0335630897171628,0.000182978718241126
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,40044,0.0138903586349679,0.00371389914387144,0.00661111631297991,0.0211696009569559,0.000184604759112184
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRL6,Fc receptor-like protein 6,40341,0.0243097537639886,0.00650196901896985,0.0115658944868077,0.0370536130411695,0.000185527735479822
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40167,0.0115682333382471,0.0031047757048053,0.00548287295682872,0.0176535937196655,0.000195263799750313
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL9A2,Collagen alpha-2(IX) chain,37714,0.0167132557050128,0.00448554021510207,0.00792159688341277,0.0255049145266129,0.00019532698119871
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39961,0.0198123777495039,0.00532309995648955,0.00937910183478439,0.0302456536642234,0.000198379129252497
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MFAP4,Microfibril-associated glycoprotein 4,37671,-0.0112621185396146,0.00302745523204215,-0.0171959307944172,-0.00532830628481195,0.000200051279678166
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP8,Neutrophil collagenase,40442,0.0261666751906811,0.00704746741164662,0.0123536390638537,0.0399797113175085,0.000205578422652463
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NMRK2,Nicotinamide riboside kinase 2,37482,-0.015628061169048,0.00421825406894717,-0.0238958391441845,-0.00736028319391156,0.000212378117487792
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39961,0.0176548088333074,0.00476762818457156,0.00831025759154716,0.0269993600750677,0.00021375381391117
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFD,Complement factor D,38013,0.00678690356805395,0.00183662542447644,0.00318711773608011,0.0103866894000278,0.000220481271269314
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37628,-0.0095260735457666,0.00257849082118324,-0.0145799155552858,-0.00447223153624745,0.00022126567014748
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUP50,Nuclear pore complex protein Nup50,37562,-0.0126982586858534,0.00343722075056294,-0.0194352113569568,-0.00596130601475006,0.000221355977412291
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ART3,Ecto-ADP-ribosyltransferase 3,40403,-0.0118162696782676,0.00319917917908184,-0.018086660869268,-0.00554587848726723,0.00022189928486702
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LIFR,Leukemia inhibitory factor receptor,40341,-0.00869815242022657,0.00235768624966468,-0.0133192174695694,-0.00407708737088379,0.000225644705086999
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EXTL1,Exostosin-like 1,37562,0.0170187049870033,0.00461590873740746,0.00797152386168469,0.0260658861123219,0.000227858342550287
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NECTIN1,Nectin-1,37598,0.0113730359494452,0.00308727390240381,0.00532197910073372,0.0174240927981566,0.000230664463494476
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RLN2,Prorelaxin H2,37643,0.0500626119559874,0.0136186973621156,0.0233699651262408,0.0767552587857339,0.000237840077255716
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHNAK2,Protein AHNAK2,37628,0.0101517875338894,0.00276679142176808,0.00472887634722393,0.0155746987205548,0.000244312780240006
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FMR1,Synaptic functional regulator FMR1,39980,0.0124118722312079,0.0033856909112462,0.00577591804516533,0.0190478264172504,0.000247215606119321
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,37959,0.00950897057529971,0.00259611809920808,0.00442057910085188,0.0145973620497475,0.000250460860338671
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RCC1,Regulator of chromosome condensation,37900,0.0180450340361076,0.00493484468561351,0.00837273845230512,0.0277173296199101,0.00025650062657593
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37900,0.0182571517379017,0.0049952995089406,0.00846636470037813,0.0280479387754253,0.000258295711526858
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM26,Tripartite motif-containing protein 26,37482,0.0194303948682627,0.00531941244365408,0.00900434647870073,0.0298564432578247,0.000260481025803544
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40341,0.052893412092443,0.0144848942259445,0.0245030194095917,0.0812838047752943,0.000261422226668859
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDRG1,p53 and DNA damage-regulated protein 1,37572,0.0189786211638362,0.00520502893287785,0.00877676445539559,0.0291804778722768,0.000267167377923506
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NXPH1,Neurexophilin-1,39961,0.0131709361546695,0.00363035254803277,0.00605544516052526,0.0202864271488137,0.000286537063697524
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIAA1549,UPF0606 protein KIAA1549,37714,0.0248052450768443,0.0068553011926674,0.0113688547392162,0.0382416354144724,0.00029752826410771
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,40471,0.0080196477117017,0.00221735910119379,0.00367362387336188,0.0123656715500415,0.000299234338643567
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40286,0.0625012689162886,0.0173105099002125,0.0285726695118722,0.0964298683207051,0.000306436946661347
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHRDL2,Chordin-like protein 2,40359,0.0197940320024431,0.00548400768443551,0.00904537694094949,0.0305426870639367,0.000307836576058325
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TK1,"Thymidine kinase, cytosolic",37714,0.0155571948514695,0.00432393040327028,0.00708229126105979,0.0240320984418793,0.000321928606315411
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TDO2,"Tryptophan 2,3-dioxygenase",37572,0.0134607135054859,0.00375210441854628,0.00610658884513515,0.0208148381658366,0.000335065532512122
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G1B,Phospholipase A2,40514,-0.0144649711723791,0.00403574044886652,-0.0223750224521575,-0.00655491989260072,0.00033909183948296
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARTN,Artemin,40044,0.0153581842284641,0.00429457920267237,0.00694080899122627,0.023775559465702,0.000349707875304642
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALCB,Calcitonin gene-related peptide 2,37942,0.0137719828876129,0.00385250110794824,0.00622108071603437,0.0213228850591915,0.000351698376844932
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYOC,Myocilin,40332,-0.0157690592582042,0.0044145179465206,-0.0244215144333845,-0.00711660408302378,0.000355190132887704
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37562,-0.0140548565662548,0.00395061426516084,-0.02179806052597,-0.00631165260653955,0.000375525090167378
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT8,"Keratin, type II cytoskeletal 8",37541,0.0211714784062561,0.00595393304411979,0.00950176963978136,0.0328411871727309,0.000378043844608351
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,37541,-0.0117334667892948,0.00331366763445037,-0.0182282553528175,-0.00523867822577202,0.000400103762195109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH23,Cadherin-23,37942,-0.00903539722178542,0.00255267003666907,-0.0140386304936568,-0.00403216394991404,0.000402102819325192
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FDX2,"Ferredoxin-2, mitochondrial",37562,0.0195155263432093,0.00556720708697664,0.00860380045273507,0.0304272522336835,0.000457371028046358
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VWF,von Willebrand factor,40536,-0.0240582300044136,0.00688227904522496,-0.0375474969330545,-0.0105689630757726,0.000474133187532995
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DRAXIN,Draxin,40228,0.0145606636212868,0.00417014732535974,0.00638717486358171,0.0227341523789919,0.000481373185369453
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRDX1,Peroxiredoxin-1,39953,-0.0298664380583535,0.00858599497819569,-0.046694988215617,-0.0130378879010899,0.000505600305707299
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PKD1,Polycystin-1,37990,0.00868175577239975,0.00249599932602383,0.00378959709339304,0.0135739144514065,0.000506249856818248
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,37900,0.00955017280254922,0.00274597506641405,0.00416806167237768,0.0149322839327208,0.000506993351890106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRELP,Prolargin,40357,0.00776473647453253,0.00223333593620191,0.0033873980395768,0.0121420749094883,0.000508897856606193
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFF2,Trefoil factor 2,40396,0.0190081611423554,0.00548640187582358,0.00825481346574116,0.0297615088189696,0.000532426176685695
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX3,Syntaxin-3,37942,0.0129406173740657,0.0037365723108587,0.00561693564478268,0.0202642991033488,0.000535383665959954
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40228,0.0201841591202843,0.0058399465410911,0.00873786389974578,0.0316304543408229,0.000549243601338601
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCN2B,Sodium channel subunit beta-2,37572,-0.00991222827430846,0.00286897121548783,-0.0155354118566646,-0.00428904469195231,0.000552080865402952
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37998,-0.0129054448109538,0.00374023600750704,-0.0202363073856676,-0.00557458223623998,0.00056138756934098
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBPMS,RNA-binding protein with multiple splicing,37598,0.0214762412073943,0.0062506697249027,0.00922492854658497,0.0337275538682036,0.000592566628519076
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPA4,Carboxypeptidase A4,37410,0.0145266977379738,0.00424388385131984,0.00620868538938691,0.0228447100865607,0.000621318916514914
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CYB5A,Cytochrome b5,37482,0.0241544773037221,0.00709919999113891,0.0102400453210899,0.0380689092863544,0.00066992168491722
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAFB2,Scaffold attachment factor B2,37959,0.00904651585205163,0.00267420333947666,0.00380507730667737,0.0142879543974259,0.000719329700236768
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INHBB,Inhibin beta B chain,37671,0.0167787414269149,0.00497495059110097,0.00702783826835695,0.0265296445854728,0.000746635065014018
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40306,-0.0224850113336972,0.0066702233416922,-0.0355586490834139,-0.00941137358398048,0.000750873835387476
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,40325,0.00723460882295754,0.00215327923526397,0.00301418152184017,0.0114550361240749,0.000781798311398224
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37598,0.0285049603915496,0.00848864263157487,0.0118672208336629,0.0451426999494364,0.000787281657550382
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40159,0.0190439778187887,0.00569875810582611,0.00787441193136953,0.0302135437062079,0.000834381764264967
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDK1,Cyclin-dependent kinase 1,37482,0.0118146432113105,0.00353956854998841,0.00487708885333321,0.0187521975692878,0.000846576544695696
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MKI67,Proliferation marker protein Ki-67,37598,0.0121187699537457,0.00365124136659343,0.00496233687522261,0.0192752030322689,0.000905593748015808
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,40225,0.0186171057261904,0.00562115857720305,0.00759963491487242,0.0296345765375084,0.000928498516848396
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM171B,Protein FAM171B,37900,0.0088581875116865,0.0026752152905581,0.00361476554219263,0.0141016094811804,0.000931396583754154
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC12A,C-type lectin domain family 12 member A,37598,0.00653964359346591,0.0019790171319835,0.00266077001477825,0.0104185171721536,0.000954036178502978
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QL2,Complement C1q-like protein 2,37598,0.0136960285858937,0.00415296097162647,0.00555622508150586,0.0218358320902816,0.000976712051169775
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFF1,Trefoil factor 1,40261,0.0246837324815259,0.00748541243385036,0.0100123241111792,0.0393551408518726,0.000977377063386252
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LEO1,RNA polymerase-associated protein LEO1,37959,0.00984689875801619,0.00299180424427966,0.00398296243922805,0.0157108350768043,0.000999844058792687
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD2,T-cell surface antigen CD2,37562,0.0121419512043494,0.00369492396910432,0.00489990022490496,0.0193840021837939,0.00101845771629173
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKCQ,Protein kinase C theta type,40044,0.0140404711896277,0.00427964378469965,0.00565236937161637,0.022428573007639,0.00103756172170117
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBM19,Probable RNA-binding protein 19,37562,-0.0151775163427098,0.00463118779199673,-0.0242546444150234,-0.00610038827039624,0.00105099656692379
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLIC5,Chloride intracellular channel protein 5,37572,-0.0102204599432637,0.00312066944159598,-0.0163369720487919,-0.00410394783773561,0.00105903755165035
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40042,0.0110267082158402,0.00337184765698115,0.00441788680815718,0.0176355296235233,0.00107694240423549
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REG1B,Lithostathine-1-beta,40536,0.0174543529784779,0.0053801881139205,0.00690918427519372,0.0279995216817621,0.00118025580849737
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,37628,0.0131268391061126,0.0040889501046432,0.0051124969010119,0.0211411813112133,0.00132905101354496
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TERF1,Telomeric repeat-binding factor 1,37598,-0.00922411396251101,0.0028747157272845,-0.0148585567879886,-0.00358967113703339,0.00133654182766445
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NTF4,Neurotrophin-4,39980,0.012618392089511,0.00393546468418946,0.00490488130849962,0.0203319028705223,0.00134712722872721
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LXN,Latexin,40183,-0.0204569966702916,0.0063855562995154,-0.0329726870173418,-0.00794130632324141,0.00135974450587366
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",40332,0.011431236835766,0.00356959362605979,0.00443483332868885,0.0184276403428432,0.00136560214491822
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUSD5,Sushi domain-containing protein 5,37604,-0.0105756750453358,0.00330630093336328,-0.0170560248747278,-0.00409532521594381,0.00138403473058121
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37714,0.0205746572197537,0.00643498063102459,0.00796209518294553,0.0331872192565619,0.00139039105319514
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMP2,Metalloproteinase inhibitor 2,37990,-0.00768385932279639,0.00240937053928593,-0.0124062255797968,-0.00296149306579598,0.00143013642056686
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPO,Erythropoietin,40341,0.0239586386167248,0.00753795425125522,0.00918424828426457,0.038733028949185,0.00148373737104409
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAT1,Diamine acetyltransferase 1,37562,-0.0160418110424556,0.00505479212317751,-0.0259492036038835,-0.00613441848102767,0.00150916726652709
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENG,Endoglin,40536,-0.00519932096398482,0.00164115323154417,-0.0084159812978114,-0.00198266063015824,0.00153731077291266
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIRREL2,Kin of IRRE-like protein 2,39961,0.0122476049866651,0.00386612777589926,0.00466999454590257,0.0198252154274277,0.00153828596009071
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CST1,Cystatin-SN,36179,0.0318581484136092,0.0100709309557655,0.0121191237403089,0.0515971730869096,0.00156348356805801
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACRV1,Acrosomal protein SP-10,37598,0.010781380688628,0.00340922630246053,0.00409929713580536,0.0174634642414507,0.00156823379563993
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37714,0.0162307204593556,0.00513254807771246,0.00617092622703913,0.026290514691672,0.00156874271799924
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMPRSS5,Transmembrane protease serine 5,40159,-0.0115016868805537,0.00363728722863128,-0.018630769848671,-0.0043726039124364,0.0015690098520866
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD86,T-lymphocyte activation antigen CD86,37901,0.00892249639519568,0.00282167208915369,0.00339201910045446,0.0144529736899369,0.00156967124829839
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCN1,Transcobalamin-1,37766,0.0100786211122934,0.0031907624137166,0.00382472678140889,0.0163325154431779,0.00158835614126306
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SDK2,Protein sidekick-2,37671,0.0116292120916092,0.00368484587853854,0.00440691416967369,0.0188515100135448,0.0016033190361504
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37598,0.00957589064602008,0.00303655106738305,0.00362425055394931,0.0155275307380909,0.00161665117026541
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1RL1,Interleukin-1 receptor-like 1,40490,-0.01372825355624,0.00436247782775442,-0.0222787100986387,-0.00517779701384133,0.00165316982423582
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRTG,Protogenin,40489,0.00762181264508471,0.00242385946141356,0.00287104810071414,0.0123725771894553,0.00166677699787839
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDA1,DET1- and DDB1-associated protein 1,37562,0.0123866894022792,0.00394304517632072,0.00465832085669057,0.0201150579478678,0.00168515217584854
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37541,-0.0185856423251136,0.00594468233578406,-0.0302372197032504,-0.00693406494697688,0.00177329105839476
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37998,0.010784208394586,0.00345005379526873,0.00402210295585935,0.0175463138333127,0.00177691666167595
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNN,Tenascin-N,37998,0.0132069056295143,0.00422639201131681,0.00492317728733335,0.0214906339716953,0.00178262148438327
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL11,Interleukin-11,40044,0.0192115964266635,0.00616003710829734,0.00713792369440067,0.0312852691589262,0.00181952704273486
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40357,0.00888635550295756,0.00285311538950896,0.00329424933951999,0.0144784616663951,0.0018451249657563
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHB4,Ephrin type-B receptor 4,40536,-0.00734885395374151,0.00237097288233436,-0.0119959608031169,-0.00270174710436618,0.00194175634473412
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NELL1,Protein kinase C-binding protein NELL1,40411,-0.0126710252642528,0.00408941816063197,-0.0206862848590914,-0.00465576566941412,0.00194846813174647
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37562,-0.0179544694077682,0.00579777539234921,-0.0293181091767727,-0.00659082963876378,0.00196044011018882
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FDX1,"Adrenodoxin, mitochondrial",37562,0.0187929342923106,0.00608131282815312,0.00687356114913043,0.0307123074354907,0.00200389513545626
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37959,-0.0112827554316049,0.00365349651210733,-0.0184436085953353,-0.00412190226787452,0.00201776162638334
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFRA2,GDNF family receptor alpha-2,40305,0.00626890715481681,0.00204358265022022,0.00226348516038518,0.0102743291492484,0.00216144419309033
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK14,Kallikrein-14,40489,-0.0134950319735898,0.00442457098299757,-0.022167191100265,-0.00482287284691454,0.00229199174505165
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MANSC4,MANSC domain-containing protein 4,37562,0.0193414829923257,0.00635758371724754,0.00688061890652052,0.0318023470781309,0.0023526595638888
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA3G,Semaphorin-3G,37671,0.0126811879600715,0.00417496138465358,0.00449826364615044,0.0208641122739925,0.0023906346215385
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMOD4,Tropomodulin-4,37482,-0.0122918488227775,0.00405136602402077,-0.0202325262298582,-0.00435117141569676,0.00241809053651007
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSB,Lupus La protein,39961,0.0176461425091507,0.00582011534155926,0.00623871643969453,0.0290535685786068,0.00243402244301291
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,QSOX1,Sulfhydryl oxidase 1,37761,0.0131252611829533,0.0043291845920423,0.00464005938255039,0.0216104629833562,0.00243560556634493
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLAMF7,SLAM family member 7,40341,-0.0168397778157677,0.00555719562711033,-0.027731881244904,-0.00594767438663148,0.00244731861534121
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDHR1,Cadherin-related family member 1,39961,0.0127770448380179,0.00423453559578322,0.00447735507028281,0.021076734605753,0.00255415042232103
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSAP,Gamma-secretase-activating protein,39980,0.0259334030689002,0.00861684710166412,0.00904438274963855,0.0428224233881619,0.00261997800964775
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37598,0.00884704330796291,0.00294399552557301,0.00307681207783981,0.014617274538086,0.00265981602708782
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLITRK1,SLIT and NTRK-like protein 1,37598,-0.0093538080847823,0.00311655990551333,-0.0154622654995884,-0.00324535066997618,0.00269312358718244
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37900,0.0145694287738674,0.00486414581444535,0.00503570297755451,0.0241031545701803,0.00274701661160092
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,37598,-0.0180866954597068,0.00604827707956105,-0.0299413185356464,-0.00623207238376714,0.00279139302138959
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,L1CAM,Neural cell adhesion molecule L1,40411,-0.00812963436946704,0.00272479587216323,-0.013470234278907,-0.00278903446002711,0.00285332714180533
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRXN3,Neurexin-3,37572,0.0100559681229077,0.00337109974742428,0.0034486126179561,0.0166633236278593,0.00285969171207555
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD5L,CD5 antigen-like,37934,0.0133532124941966,0.00449718435182015,0.00453873116462909,0.0221676938237641,0.00299064255446199
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAPS,Calcyphosin,37942,0.0272055077652781,0.00916496317469137,0.00924217994288297,0.0451688355876731,0.00299855863104279
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CENPJ,Centromere protein J,37714,0.0210169697578758,0.00709217924571244,0.00711629843627938,0.0349176410794722,0.00304800539140338
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,37901,0.0158067858456884,0.00533612230089165,0.00534798613594081,0.0262655855554361,0.00305960375063426
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NINJ1,Ninjurin-1,39980,0.016043320725617,0.00543081065824103,0.00539893183546453,0.0266877096157694,0.00314022124050835
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL5A1,Collagen alpha-1(V) chain,37671,0.0113243737074112,0.0038387457154356,0.00380043210515744,0.018848315309665,0.00318311129750179
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37562,-0.013759123735845,0.0046915269944774,-0.0229545166450207,-0.00456373082666928,0.00336544504875778
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP290,Centrosomal protein of 290 kDa,37714,0.0151060529423453,0.00515701021372139,0.00499831292345137,0.0252137929612392,0.00340384911709556
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD33,Myeloid cell surface antigen CD33,40411,0.0223756762809125,0.0076423490433127,0.00739667215601958,0.0373546804058053,0.00341793232507004
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37541,-0.0184709783430672,0.0063122723179092,-0.0308430320861693,-0.00609892459996517,0.00343718811054219
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40536,0.00826949471226896,0.00282640069068608,0.00272974935852424,0.0138092400660137,0.003440475094807
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTTG1,Securin,37714,0.0116553922421822,0.0039998524285594,0.00381568148220577,0.0194951030021586,0.00357476953046183
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VIM,Vimentin,40042,0.0332006573695929,0.0114097566195718,0.0108375343952321,0.0555637803439537,0.00362115851930874
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,37901,0.00766531806798136,0.00263510228687391,0.00250051758570849,0.0128301185502542,0.0036326622907194
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSC1,Hamartin,37598,0.0214316652862601,0.00737778539171753,0.00697120591849372,0.0358921246540264,0.00367992797673546
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH17,Cadherin-17,40359,-0.0189422289951744,0.00652393486473193,-0.031729141330049,-0.00615531666029982,0.00369527150928714
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAPRT,Nicotinate phosphoribosyltransferase,37942,0.00927689648315809,0.00319617792067422,0.00301238775863662,0.0155414052076796,0.00370800238921247
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA3,Carbonic anhydrase 3,40500,0.0170302833172143,0.00587750840411403,0.00551036684515075,0.0285501997892778,0.00376617080263585
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39757,0.0181747727197676,0.00628177282158856,0.00586249798945407,0.0304870474500812,0.00381809041646016
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTRC,Chymotrypsin-C,40360,0.017453661141518,0.00603825546354308,0.00561868043297361,0.0292886418500625,0.00385132744561685
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ODAM,Odontogenic ameloblast-associated protein,39934,0.0149063694096777,0.00516092864492584,0.00479094926562306,0.0250217895537324,0.00387852901306059
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH3GL3,Endophilin-A3,37643,0.0231689448217374,0.00802174640191732,0.00744632187397945,0.0388915677694954,0.00388001078980867
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NDRG1,Protein NDRG1,39961,0.0191142186058282,0.00662512318809363,0.0061289771571647,0.0320994600544917,0.00391814287413353
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TEF,Thyrotroph embryonic factor,37562,0.0120103931117985,0.00416695764644939,0.00384315612475767,0.0201776300988393,0.00395433652058368
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37942,-0.00725802072163745,0.00251836910808337,-0.0121940241734809,-0.00232201726979404,0.00395742953880803
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OMG,Oligodendrocyte-myelin glycoprotein,40305,-0.0174430881278534,0.00605670532254361,-0.0293142305600389,-0.00557194569566796,0.00398254319484994
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",39961,0.011931872944263,0.00415268503034564,0.00379261028478551,0.0200711356037404,0.00406771083408423
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40228,-0.00782627667156892,0.00272696258724839,-0.0131711233425758,-0.00248143000056209,0.00411067805317957
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SYT1,Synaptotagmin-1,37942,0.0108371647638142,0.00377864386680015,0.00343102278488592,0.0182433067427425,0.00413711070221551
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39980,-0.00895118673916924,0.00312748577758127,-0.0150810588632285,-0.00282131461510996,0.0042140258014782
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,37572,0.0166130002604498,0.0058468664192311,0.00515314207875687,0.0280728584421428,0.00449920587713707
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEPTIN7,Septin-7,37714,0.014415192392446,0.00507923634810261,0.00445988915016486,0.0243704956347271,0.00454571441662737
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL20RA,Interleukin-20 receptor subunit alpha,40044,0.012624769438807,0.00446186704556532,0.00387951002949894,0.021370028848115,0.00466830716574828
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAG,S-arrestin,37541,-0.014605533987574,0.00516855078675969,-0.024735893529623,-0.00447517444552498,0.00472271930994246
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37900,0.025889863347015,0.00916786583398334,0.00792084631240762,0.0438588803816223,0.00475011985693111
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,37482,0.0241829647821871,0.00860611310173372,0.00731498310278902,0.0410509464615852,0.00496191689859187
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMBN,Ameloblastin,40044,-0.00802614319655237,0.00286349211077109,-0.0136385877336637,-0.00241369865944104,0.00507045312541499
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOA4,Apolipoprotein A-IV,38013,0.00994227940927201,0.00355081378838115,0.00298268438404495,0.0169018744344991,0.00511748330262805
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FBLN2,Fibulin-2,37998,-0.00829222418954307,0.0029783964146413,-0.01412988116224,-0.00245456721684612,0.0053746989759995
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MELTF,Melanotransferrin,37990,0.00784609582873094,0.0028183726172446,0.00232208549893152,0.0133701061585304,0.00537824379221986
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPR101,Probable G-protein coupled receptor 101,37541,-0.0174015204631833,0.00625135718769924,-0.0296541805510738,-0.00514886037529282,0.00538299608179069
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLSPN,Claspin,39925,0.00912358994500191,0.00328867936626685,0.00267777838711889,0.0155694015028849,0.00553969522091183
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC14A,C-type lectin domain family 14 member A,40332,-0.00838179121612148,0.00302908725528827,-0.0143188022364865,-0.00244478019575648,0.00566226256441114
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G2A,"Phospholipase A2, membrane associated",40293,-0.0153614502342186,0.00556825953681318,-0.0262752389263725,-0.00444766154206479,0.0058089027146584
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOLH1,Glutamate carboxypeptidase 2,37598,0.0286444045064298,0.01041592853328,0.00822918458120095,0.0490596244316586,0.00596662295832128
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTNNA1,Catenin alpha-1,37541,-0.00965119347141747,0.00351221803826865,-0.016535140826424,-0.0027672461164109,0.00600620091949325
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TUBB3,Tubulin beta-3 chain,37541,-0.00739235568510056,0.00269181498249104,-0.012668313050783,-0.00211639831941812,0.00603659822558811
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRCAM,Neuronal cell adhesion molecule,40359,0.0073905477278064,0.00269531013952616,0.00210773985433514,0.0126733556012777,0.00611341016705536
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACE,Angiotensin-converting enzyme,37987,-0.00675873886065412,0.00246515368206299,-0.0115904400774976,-0.00192703764381066,0.00612003721081032
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYH4,Myosin-4,37562,-0.0125437709314586,0.00460486313117719,-0.0215693026685659,-0.00351823919435128,0.00645766951390436
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHA4,Ephrin type-A receptor 4,37671,0.00739318358094532,0.00272210175179855,0.00205786414742017,0.0127285030144705,0.00661651027679579
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXNL1,Thioredoxin-like protein 1,37525,0.0250693760372616,0.00923058261408049,0.00697743411366386,0.0431613179608594,0.00661819578458626
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYH7B,Myosin-7B,37482,-0.0119864929145205,0.00442174214644899,-0.0206531075215605,-0.00331987830748045,0.00672074444590878
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37572,0.00957516106093119,0.00353355185968518,0.00264939941594823,0.0165009227059141,0.00674145729029514
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37562,-0.00999436125264955,0.00369605407293137,-0.017238627235595,-0.00275009526970407,0.006858578181376
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAL,Galanin peptides,40422,-0.0162385606803703,0.00601042197201136,-0.0280189877455126,-0.00445813361522807,0.00690517806403997
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LMNB1,Lamin-B1,37874,0.0148297740418446,0.0054990207045726,0.00405169346088231,0.0256078546228069,0.00700961134711122
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYO6,Unconventional myosin-VI,37959,0.00967707441732751,0.00361873148241849,0.00258436071178728,0.0167697881228677,0.00750063954508709
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37900,0.0176132688702536,0.00660816180139731,0.00466127173951487,0.0305652660009923,0.00769930069450212
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37457,0.022973891921342,0.00862464560658962,0.00606958653242633,0.0398781973102577,0.00773704220420724
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",37460,0.0065075606359179,0.00244512507041432,0.00171511549790583,0.01130000577393,0.00779021301196788
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37572,-0.00823048240602696,0.00310745000384553,-0.0143210844135642,-0.00213988039848972,0.00809157337285744
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFRA3,GDNF family receptor alpha-3,40194,-0.00721548125548451,0.00274885333668025,-0.0126032337953778,-0.00182772871559122,0.00867566653649899
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLT1,Vascular endothelial growth factor receptor 1,40272,0.0058465976562502,0.00222880958516321,0.00147813086933031,0.0102150644431701,0.00871934692290652
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC12A2,Solute carrier family 12 member 2,37562,-0.00725727729889693,0.00276706096521821,-0.0126807167907246,-0.00183383780706924,0.00873270961040794
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL33,Interleukin-33,40044,0.00969041852991087,0.00373150090689814,0.00237667675239052,0.0170041603074312,0.00941514716173252
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,40357,0.0729259111562763,0.0281709768345787,0.017710796560502,0.128141025752051,0.0096429609431237
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,39980,0.0128123951744048,0.00495908102458444,0.00309259636621932,0.0225321939825903,0.00978591405097337
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL2RA,Interleukin-2 receptor subunit alpha,40208,0.0100154149099658,0.00388361058369921,0.00240353816591532,0.0176272916540162,0.00992074144949508
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,40451,0.00740273077987827,0.00287366314904699,0.00177035100774618,0.0130351105520104,0.0100021949159307
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37562,-0.0102547801176821,0.00398353329109221,-0.0180625053682229,-0.00244705486714141,0.0100554029513524
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",37562,0.00997434197940112,0.00387593490601722,0.00237750956360737,0.0175711743951949,0.0100812788280788
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALPI,Intestinal-type alkaline phosphatase,37598,0.0301990021488586,0.0117378187591372,0.00719287738094965,0.0532051269167675,0.0100989601991599
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GUK1,Guanylate kinase,37562,-0.00999009063341209,0.00388645727073219,-0.0176075468840472,-0.00237263438277699,0.0101664787778663
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRD3,Bromodomain-containing protein 3,37562,0.0120313178503022,0.00468347517226023,0.00285170651267214,0.0212109291879322,0.0102135380441774
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK1,Kallikrein-1,40209,-0.0315007683684029,0.0122881490236697,-0.0555855404547955,-0.00741599628201027,0.0103712252237271
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGFR4,Fibroblast growth factor receptor 4,37671,0.0132287275628828,0.00516722753217296,0.00310096159982382,0.0233564935259418,0.0104745885762828
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL6ST,Interleukin-6 receptor subunit beta,40359,0.00429403371931415,0.00168354907418297,0.000994277533915523,0.00759378990471278,0.0107635374571178
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP164,Centrosomal protein of 164 kDa,40044,0.0157275109187767,0.00617086607326418,0.00363261341517893,0.0278224084223745,0.0108229067232025
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL14,C-X-C motif chemokine 14,40044,0.0150324481460899,0.00592715931405476,0.0034152158905426,0.0266496804016373,0.0112160170843824
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RALB,Ras-related protein Ral-B,37598,0.00726525610556491,0.00286506558451484,0.00164972755991583,0.012880784651214,0.0112303046394011
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OPTC,Opticin,40305,-0.0109988404344074,0.00433791032556558,-0.0195011446725159,-0.00249653619629882,0.0112377084555051
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL15,Interleukin-15,40341,0.00800235986673692,0.00315725019951239,0.00181414947569262,0.0141905702577812,0.011267160328742
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPON1,Spondin-1,40379,0.00802606974457457,0.00316735857975762,0.00181804692824964,0.0142340925608995,0.0112865457169014
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSAPL1,Proactivator polypeptide-like 1,37901,-0.0123556919719749,0.00488518140022799,-0.0219306475164217,-0.00278073642752799,0.0114430082812811
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17A,Interleukin-17A,40028,0.0103906795085741,0.00411591176147323,0.00232349245608662,0.0184578665610617,0.0115956672691511
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRR4,Proline-rich protein 4,37577,-0.0167935433176604,0.00665936671985225,-0.0298459020885708,-0.00374118454674995,0.0116875796734204
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37598,0.0150671953830657,0.00598116436804683,0.00334411322169387,0.0267902775444374,0.0117770382209324
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37572,-0.0160126857634634,0.00637599953979548,-0.0285096448614625,-0.00351572666546426,0.0120372479278325
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39961,0.0120281778231306,0.00479302282566471,0.0026338530848278,0.0214225025614335,0.0120997067957116
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37671,0.00973405744112763,0.00389984170242003,0.00209036770438438,0.0173777471778709,0.0125718696602908
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAD51,DNA repair protein RAD51 homolog 1,37714,0.0131113327137769,0.00525698633615815,0.00280763949490696,0.0234150259326469,0.0126405677237486
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPTX1,Neuronal pentraxin-1,40332,0.00942887859144508,0.00379927779289223,0.00198229411737631,0.0168754630655139,0.0130839574243664
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IDS,Iduronate 2-sulfatase,40516,0.00206533044423091,0.000832578234060177,0.000433477105472964,0.00369718378298886,0.0131246783608847
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRDX2,Peroxiredoxin-2,37763,0.0150057203831193,0.00605361424924234,0.00314063645460428,0.0268708043116342,0.0131946838073096
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINT1,Kunitz-type protease inhibitor 1,40278,0.00610846230788655,0.00246498245168704,0.00127709670257995,0.0109398279131931,0.0132189231406668
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCP2,Non-specific lipid-transfer protein,39980,0.01864076132375,0.00752292677325017,0.00389582484817962,0.0333856977993203,0.013227842235378
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,40309,0.00929042192410308,0.00375617278526609,0.00192832326498154,0.0166525205832246,0.0133947785255735
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LEG1,Protein LEG1 homolog,37231,-0.0166472022299602,0.00673052113398208,-0.0298390236525651,-0.00345538080735537,0.0133967099170122
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAMDC2,MAM domain-containing protein 2,37990,-0.00807429476418862,0.00327876755939097,-0.0145006791805949,-0.00164791034778232,0.0138057088890285
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GBP6,Guanylate-binding protein 6,37562,-0.0113036636378734,0.00459455179396616,-0.0203089851540471,-0.00229834212169974,0.0138975244865648
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLI2,Zinc finger protein GLI2,37598,-0.0079941022386508,0.00325802229150856,-0.0143798259300076,-0.00160837854729403,0.0141536635040242
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EGFR,Epidermal growth factor receptor,40536,0.00386129844633831,0.00157564824566546,0.000773027884834015,0.00694956900784261,0.0142720332342251
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,37598,0.0087478127807707,0.00357285043071097,0.00174502593657721,0.0157505996249642,0.0143616891677418
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37959,0.0162479720599242,0.00667406041670623,0.00316681364317997,0.0293291304766684,0.0149254159939283
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17RA,Interleukin-17 receptor A,40332,0.0102697298970373,0.00422542318897844,0.00198790044663958,0.0185515593474351,0.0150905921253649
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOE,Apolipoprotein E,38013,0.017530175796013,0.00723175938890537,0.00335592739375849,0.0317044241982675,0.0153613087878728
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37562,-0.0103505058119714,0.00427151163127,-0.0187226686092606,-0.00197834301468219,0.015400098875284
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDGFRB,Platelet-derived growth factor receptor beta,40536,0.00812067067628013,0.00335284522409596,0.00154909403705204,0.0146922473155082,0.0154453229820284
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,37714,0.0213508417326451,0.00886824771313451,0.00396907621490146,0.0387326072503888,0.0160730751944176
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH22,Cadherin-22,37714,-0.00686567445670314,0.00285339939420667,-0.0124583372693482,-0.00127301164405807,0.0161357394188843
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLNS1A,Methylosome subunit pICln,37572,0.0077720789337531,0.00325127361048108,0.00139958265721018,0.014144575210296,0.0168407429406308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALY,Neuron-specific vesicular protein calcyon,37562,-0.00884045451649085,0.00370312484455064,-0.0160985792118101,-0.0015823298211716,0.0169869104962862
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,40284,0.00798939978789092,0.00335758376339797,0.00140853561163091,0.0145702639641509,0.0173475093793247
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,40359,0.00645886645248042,0.00272061005506862,0.00112647074454593,0.0117912621604149,0.017605929977413
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DKKL1,Dickkopf-like protein 1,40305,-0.0200821426955832,0.00846571067608713,-0.0366749356207139,-0.0034893497704524,0.0176956059818125
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37900,0.0109640670915911,0.00462360498069368,0.00190180132943153,0.0200263328537508,0.0177384738705973
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOP56,Nucleolar protein 56,37562,0.0253848235648003,0.0107081861007244,0.00439677880738052,0.0463728683222201,0.0177736287069341
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37572,-0.0112359908587586,0.00474284331403276,-0.0205319637542628,-0.00194001796325439,0.0178486657679224
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,37541,-0.00652112366947569,0.00276199577833919,-0.0119346353950205,-0.00110761194393087,0.0182393838213186
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37562,-0.00461019783962527,0.00195447899281047,-0.00844097666553378,-0.000779419013716746,0.0183494098772424
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GUCA2A,Guanylin,40276,-0.007602877223495,0.00322538882278588,-0.0139246393161553,-0.00128111513083467,0.0184255791384989
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTA4H,Leukotriene A-4 hydrolase,40489,0.0130745795208355,0.00557939797097535,0.00213895949772376,0.0240101995439471,0.0191227011398668
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CORO6,Coronin-6,37541,-0.00822385772326806,0.00352768751449533,-0.0151381252516789,-0.00130959019485721,0.0197562355166345
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",37598,0.00653491720412566,0.0028086516007845,0.00102996006658803,0.0120398743416633,0.0199958319269932
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COMP,Cartilage oligomeric matrix protein,40198,0.00755254087838282,0.00325693854484229,0.00116894133049194,0.0139361404262737,0.0204127598190424
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CADPS,Calcium-dependent secretion activator 1,37572,-0.0100787703461805,0.00435847354698636,-0.0186213784982738,-0.00153616219408728,0.0207680666417607
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AIF1L,Allograft inflammatory factor 1-like,37628,0.0129652287449835,0.00560721603242266,0.00197508532143514,0.023955372168532,0.0207798026265446
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGSF21,Immunoglobulin superfamily member 21,37628,0.00872531308588698,0.00378068809508215,0.00131516441952597,0.016135461752248,0.0210221289208509
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL2RG,Cytokine receptor common subunit gamma,37900,0.00861172895317521,0.00373264869053365,0.00129573751972926,0.0159277203866212,0.0210623429446744
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37959,-0.00593235123624095,0.00257519639529041,-0.0109797361710102,-0.000884966301471737,0.0212574063972296
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPN1,Epsin-1,37714,0.00986004004065182,0.00428037639551492,0.00147050230544257,0.0182495777758611,0.0212635831169681
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NGF,Beta-nerve growth factor,40228,0.00269439755467282,0.00117449188585556,0.000392393458395921,0.00499640165094972,0.02179804108636
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNW1,Interferon omega-1,37562,-0.00816739857245465,0.00356213708225459,-0.0151491872536736,-0.00118560989123565,0.0218731673944779
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAD1,Glutamate decarboxylase 1,37482,-0.005730577472841,0.0025021333468852,-0.010634758832736,-0.000826396112946015,0.02202118751355
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HTR1B,5-hydroxytryptamine receptor 1B,37541,-0.00942143487210607,0.00411922550281745,-0.0174951168576283,-0.00134775288658386,0.0222008528577815
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA1,Alpha-1-antitrypsin,37779,-0.00179080244379473,0.000783835766704565,-0.00332712054653568,-0.000254484341053788,0.0223480995831805
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37541,-0.0121751759070345,0.00533128914394787,-0.0226245026291723,-0.00172584918489669,0.02240388985833
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOM,Apolipoprotein M,40372,0.00587494938548589,0.00257287550699502,0.000832113391775648,0.0109177853791961,0.022418891349472
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNGR1,Interferon gamma receptor 1,40422,0.00449343367306828,0.00197197524912666,0.000628362184780022,0.00835850516135654,0.0227012542325592
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UNG,Uracil-DNA glycosylase,37900,0.00745657480006925,0.00327505021779583,0.00103747637318942,0.0138756732269491,0.022814896441886
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCAN,Neurocan core protein,40471,-0.00816214557278881,0.00358914402884624,-0.0151968678693274,-0.00112742327625018,0.022971916933247
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TJP3,Tight junction protein ZO-3,37541,-0.00967542283768316,0.00425503066920436,-0.0180152829493237,-0.00133556272604262,0.0229894107231494
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRSS53,Serine protease 53,37942,0.0080614217492409,0.00354622665951614,0.00111081749658927,0.0150120260018925,0.0230274151398493
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSLNL,Mesothelin-like protein,37572,-0.00825819121565614,0.00363846836370281,-0.0153895892085137,-0.00112679322279863,0.0232426210102077
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OGN,Mimecan,40332,0.00887988937099146,0.00392192153995998,0.00119292315266991,0.016566855589313,0.0235772092771619
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX1B,Syntaxin-1B,37572,0.0093920030757993,0.00415677164103386,0.00124473065937293,0.0175392754922257,0.0238719608102766
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFAP,Glial fibrillary acidic protein,39959,0.0101886727080616,0.00451625017276791,0.00133682236943645,0.0190405230466867,0.0240843320624743
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMC3,26S proteasome regulatory subunit 6A,37482,-0.00657514824857414,0.00292166978592749,-0.012301621028992,-0.000848675468156265,0.0244353408645354
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,37541,-0.0109234419822174,0.00485579672556145,-0.0204408035643179,-0.00140608040011699,0.0244929680802875
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40042,0.00585801004162231,0.00261104114267344,0.000740369401982367,0.0109756506812622,0.0248751367818863
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPNMB,Transmembrane glycoprotein NMB,39957,0.00610447235778285,0.00272345991945296,0.000766490915655044,0.0114424537999106,0.0250116691004022
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37562,-0.00723681144945006,0.00324440315870168,-0.0135958416405053,-0.000877781258394777,0.0257276429173454
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERVV_1,,37562,-0.0104172717408172,0.00467893079607963,-0.0195879761011333,-0.00124656738050115,0.0260028933039631
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40451,0.0074153152693677,0.00333346073035977,0.000881732237862546,0.0139488983008729,0.026128076704676
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KEL,Kell blood group glycoprotein,39961,0.00762529581649444,0.00343104837374172,0.000900441003960683,0.0143501506290282,0.0262680165712964
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37572,-0.0112250564885925,0.00505091220870259,-0.0211248444176496,-0.00132526855953544,0.026274482788866
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37562,0.0111811820809498,0.00503736296965088,0.00130795066043406,0.0210544135014655,0.0264595879614259
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFHD1,EF-hand domain-containing protein D1,37959,0.00743846717819262,0.00335244321567145,0.000867678475476576,0.0140092558809087,0.0265155476428797
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ID4,DNA-binding protein inhibitor ID-4,37714,-0.00977100188628777,0.00440758151757612,-0.018409861660737,-0.00113214211183858,0.026649390116045
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,37572,0.00631132264337839,0.00285338721754039,0.000718683696999219,0.0119039615897576,0.0269927889687891
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADA2,Adenosine deaminase 2,40258,0.00886067331402889,0.00403439809652382,0.000953253044842209,0.0167680935832156,0.0280862834580155
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,37598,0.0144880003706097,0.00660779825196185,0.00153671579676448,0.0274392849444549,0.0283564919815017
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA10,Annexin A10,39961,0.0173805131198136,0.00795281632667184,0.00179299311953679,0.0329680331200904,0.0288704919061904
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40044,0.0120249707660519,0.00553277631376642,0.00118072919106966,0.022869212341034,0.0297647526683863
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP1B4,Protein ATP1B4,37482,-0.008864554648698,0.00409217128818822,-0.0168852103735469,-0.000843898923849101,0.0303122395133076
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AIDA,"Axin interactor, dorsalization-associated protein",37572,0.0174126837509346,0.00809146335822361,0.00155341556881631,0.0332719519330529,0.0314169577548563
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIAA2013,Uncharacterized protein KIAA2013,37900,0.0119613741498632,0.00555906524245761,0.00106560627464634,0.0228571420250802,0.0314396826796207
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100G,Protein S100-G,37959,-0.0092320007385712,0.00429735238136013,-0.0176548114060371,-0.000809190071105345,0.0317076833502926
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BMP4,Bone morphogenetic protein 4,40203,-0.00935491845592413,0.00437352751266747,-0.0179270323807524,-0.000782804531095898,0.0324520526716541
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,40536,0.00854695749812427,0.00399886239995541,0.000709187194211655,0.0163847278020369,0.0325847951203662
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGAV,Integrin alpha-V,40489,-0.00336136381297177,0.00157651741513941,-0.00645133794664501,-0.000271389679298528,0.0330100738366667
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,37482,-0.0118710500613006,0.00557042603394743,-0.0227890850878376,-0.000953015034763664,0.0331008239110096
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGS8,Regulator of G-protein signaling 8,40044,0.0136567282605602,0.00641423501762566,0.00108482762601391,0.0262286288951065,0.0332592849526461
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL25,Interleukin-25,37429,0.00718346929954513,0.00337946173627932,0.000559724296437672,0.0138072143026526,0.0335533047184288
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSPAN8,Tetraspanin-8,37901,0.0213223556345842,0.0100311964959037,0.00166121050261293,0.0409835007665554,0.0335543822239632
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37714,0.0115411459290084,0.00543733400291705,0.000883971283290989,0.0221983205747258,0.0338080092365324
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HBQ1,Hemoglobin subunit theta-1,40489,-0.012054296930774,0.00569073939087548,-0.0232081461368899,-0.000900447724658044,0.0341709011526758
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,37541,-0.00846260741593234,0.0039963900399048,-0.0162955318941458,-0.000629682937718933,0.0342309035114016
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCN2,Transcobalamin-2,40497,0.00608312920508582,0.00287533364669137,0.000447475257570736,0.0117187831526009,0.0343920356145834
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA11,Carbonic anhydrase-related protein 11,39980,0.00673718770044611,0.00319147871997126,0.000481889409302444,0.0129924859915898,0.0347888953393406
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCC,Netrin receptor DCC,37572,0.00476011904326224,0.00225961519628354,0.0003312732585465,0.00918896482797798,0.0351706794177047
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,37628,0.00663167436795859,0.00316764000761892,0.000423099953025504,0.0128402487828917,0.0363174173235551
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HDDC2,5'-deoxynucleotidase HDDC2,37901,0.00874637287081897,0.00419926293972984,0.000515817508948477,0.0169769282326895,0.0372850900074891
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,40203,-0.00673403568601271,0.0032343798656308,-0.0130734202226491,-0.000394651149376339,0.0373569684117591
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADRA2A,Alpha-2A adrenergic receptor,37562,-0.0144983095501204,0.00696403339202044,-0.0281478149984804,-0.000848804101760312,0.0373724175767182
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTO1,Protein LTO1 homolog,40044,0.00825859414921369,0.00397130765439819,0.000474831146593231,0.0160423571518341,0.0375817095000546
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD55,Complement decay-accelerating factor,39802,0.00524236326049521,0.00253199350926103,0.0002796559823436,0.0102050705386468,0.0384270031299978
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SELENOP,Selenoprotein P,38013,-0.00450586528584958,0.00218053494611136,-0.00877971378022784,-0.000232016791471316,0.0388093267278528
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC4A1,Band 3 anion transport protein,37998,-0.00921052276896845,0.00446189202252691,-0.0179558311331212,-0.000465214404815707,0.0390116935708259
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAPPA,Pappalysin-1,40044,0.00927954229192072,0.0045364644636549,0.000388071943157117,0.0181710126406843,0.0408179007244698
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP152,Centrosomal protein of 152 kDa,37482,0.0082173420926661,0.0040193673273146,0.000339382131129495,0.0160953020542027,0.0409304792753647
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MN1,Transcriptional activator MN1,37572,-0.0118030811412606,0.00577407689534586,-0.0231202718561385,-0.000485890426382713,0.0409586208671991
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRTN3,Myeloblastin,39897,0.00925382156077088,0.00453339988376679,0.000368357788587969,0.0181392853329538,0.0412425268418012
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",37482,0.0178829543620044,0.00876898791708798,0.000695738044511954,0.0350701706794969,0.0414361646085437
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPP1,Osteopontin,40497,-0.00935162596737542,0.00458580474441913,-0.0183398032664369,-0.000363448668313913,0.0414409194365246
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40355,-0.00969643117096366,0.00480164089973309,-0.0191076473344405,-0.000285215007486799,0.0434624567953523
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,37482,-0.00495568946414068,0.00247201581147223,-0.00980084045462626,-0.000110538473655104,0.0450140751458812
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJA4,DnaJ homolog subfamily A member 4,37942,0.0137746388495008,0.00688179636389331,0.000286317976269882,0.0272629597227317,0.0453472073959566
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37562,0.00957889818694161,0.00479485969969508,0.000180973175539263,0.018976823198344,0.0457651367634281
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSLP,Thymic stromal lymphopoietin,40042,0.0117108590971402,0.00587266354020102,0.000200438558346238,0.0232212796359342,0.0461551520691561
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSMB,Beta-microseminoprotein,40236,0.0132534040884725,0.00666941425963309,0.000181352139591666,0.0263254560373534,0.0469184222685988
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,POF1B,Protein POF1B,37598,0.00890298215489807,0.004488721466599,0.000105088080364031,0.0177008762294321,0.0473422456194251
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NELL2,Protein kinase C-binding protein NELL2,40422,0.0053889039318544,0.00272003614073823,5.76330960074811e-05,0.0107201747677013,0.0475872783376585
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNL1,Interferon lambda-1,39961,0.00864430578984576,0.00436729477095465,8.44080387746495e-05,0.0172042035409169,0.0477968221639756
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40411,-0.00848523358378464,0.00431730948371627,-0.0169471601718685,-2.33069957007569e-05,0.0493854481380248
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZP4,Zona pellucida sperm-binding protein 4,37482,-0.00616306055579613,0.00314974923645187,-0.0123365690592418,1.04479476495277e-05,0.0504060848510039
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF5,Fibroblast growth factor 5,40044,-0.00608636175432594,0.0031111387116025,-0.0121841936290668,1.14701204149553e-05,0.0504460954919969
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RASA1,Ras GTPase-activating protein 1,39961,0.00612812711756769,0.00313923315053175,-2.47698574745384e-05,0.0122810240926099,0.0509431650261724
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,39980,-0.00582440895460802,0.00298389711247,-0.0116728472950492,2.40293858331806e-05,0.0509624490370444
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZPR1,Zinc finger protein ZPR1,37541,0.0183631865620725,0.00941220735135468,-8.47398465826446e-05,0.0368111129707277,0.0510787313062027
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37959,-0.00553551161027189,0.00284560563275438,-0.0111128986504705,4.18754299266917e-05,0.0517615062190338
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLC,Galectin-10,40333,-0.0123152882110597,0.0063380576212528,-0.0247378811487152,0.000107304726595746,0.0520253753183803
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NLGN2,Neuroligin-2,37541,-0.00908664975668214,0.00467683689392008,-0.0182532500687655,7.99505554012099e-05,0.0520490522802094
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,40228,0.00943127592207476,0.00485991946357553,-9.41662265332797e-05,0.0189567180706828,0.0523217028497606
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37959,0.0213494456151425,0.0110053016949774,-0.000220945707013205,0.0429198369372981,0.0524097520038821
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACAN,Aggrecan core protein,40224,0.00529661015597562,0.00273361413188313,-6.12735425153102e-05,0.0106544938544665,0.0526916840802338
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37990,0.0136376142949681,0.00707961417507107,-0.000238429488171179,0.0275136580781074,0.054085130823662
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37541,0.0106485401731083,0.00553989745266345,-0.000209658834112055,0.0215067391803287,0.0546079707935458
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLMP,CXADR-like membrane protein,40489,0.00377457403415365,0.00196387923753503,-7.46292714150138e-05,0.00762377733972231,0.0546235743514173
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C9orf40,Uncharacterized protein C9orf40,37901,0.0152917669470669,0.00795648120228667,-0.000302936209414984,0.0308864701035488,0.0546361917396253
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40044,0.0222679629633985,0.011588564640593,-0.000445623732163791,0.0449815496589609,0.0546810843686884
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REXO2,"Oligoribonuclease, mitochondrial",37562,-0.00908460844518945,0.00474369200912917,-0.0183822447830826,0.000213027892703724,0.0555024579554587
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40471,0.00849245158432745,0.00444252945650849,-0.000214906150429191,0.0171998093190841,0.0559420985943768
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WNT9A,Protein Wnt-9a,40044,0.00527700978176141,0.00276591469611015,-0.000144183022614483,0.0106982025861373,0.0564261786364956
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LY96,Lymphocyte antigen 96,40228,0.00635174961992774,0.00334176173716399,-0.000198103384913679,0.0129016026247691,0.057357052890185
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COPE,Coatomer subunit epsilon,39961,0.00884189585339531,0.00465764614839925,-0.000287090597467222,0.0179708823042578,0.0576670312314053
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PFDN4,Prefoldin subunit 4,37482,0.00998521354327657,0.0052605306433894,-0.000325426517766653,0.0202958536043198,0.0576999718071914
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLK,STE20-like serine/threonine-protein kinase,37714,0.0142642524808934,0.00752137794851244,-0.000477648298191028,0.0290061532599777,0.0579163868274063
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCLRE1C,Protein artemis,37482,-0.00581069818236316,0.00307367516581839,-0.0118351015073672,0.000213705142640881,0.0587169721670589
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBP7,Retinoid-binding protein 7,37901,0.0106414136749017,0.00564047118743785,-0.000413909852476444,0.0216967372022799,0.0592332650291667
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUMF1,Formylglycine-generating enzyme,37598,0.0122496418067345,0.00649448389828529,-0.000479546633904654,0.0249788302473737,0.0592952947741908
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRTN,Neurturin,40044,0.00897450895326497,0.00477621994200447,-0.00038688213306378,0.0183359000395937,0.0602633691403337
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYPLA2,Acyl-protein thioesterase 2,37541,0.0196440813425517,0.0104741113268309,-0.000885176858036733,0.0401733395431402,0.060747713824096
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40536,0.00494821427319476,0.00264279219071255,-0.000231658420601842,0.0101280869669914,0.0611772524621332
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIF20B,Kinesin-like protein KIF20B,37541,0.0141579648500967,0.00756481164818298,-0.000669065980341985,0.0289849956805353,0.061290411734027
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40536,0.0126157046916776,0.00675637737570406,-0.000626794964702361,0.0258582043480575,0.0618877728320246
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37562,0.0160197642396364,0.00858400598324238,-0.000804887487518623,0.0328444159667915,0.0620309381578897
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,METAP1,Methionine aminopeptidase 1,39961,0.00549345179710056,0.00296021207516707,-0.000308563870226905,0.011295467464428,0.0635063149043085
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,37942,0.0100898846976109,0.0054542682372824,-0.000600481047462593,0.0207802504426844,0.0643489230697607
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37482,0.00474024496723361,0.00256380244703959,-0.000284807828963982,0.00976529776343121,0.0644931656160901
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,37987,0.00456103204447467,0.00247371629348851,-0.000287451890762804,0.00940951597971213,0.0652344941687416
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFB116,Beta-defensin 116,37541,-0.0141074475400261,0.00765978960735036,-0.0291206351704328,0.00090574009038062,0.0655337631717189
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NTF3,Neurotrophin-3,40341,0.0061964730054009,0.00336595816585982,-0.000400804999684339,0.0127937510104861,0.065651336746226
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGAP30,Rho GTPase-activating protein 30,37714,0.0066864286098412,0.00364757594189044,-0.000462820236264068,0.0138356774559465,0.0668077742416773
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INSL4,Early placenta insulin-like peptide,37900,-0.00958683229033815,0.00523202866019087,-0.0198416084643122,0.000667943883635946,0.0669235392297546
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCTPP1,dCTP pyrophosphatase 1,40359,0.00558074829246058,0.00305617557846533,-0.000409355841331464,0.0115708524262526,0.0678605362125446
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PEPD,Xaa-Pro dipeptidase,37987,0.00454843505967949,0.00249091306065622,-0.0003337545392067,0.00943062465856569,0.0678705998359451
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,40405,0.00892413266668074,0.00491132958056396,-0.000702073311224615,0.0185503386445861,0.0692281727725882
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSTP1,Glutathione S-transferase P,39871,-0.0122171635417925,0.00672765342172494,-0.0254033642483734,0.000969037164788364,0.0693956007566272
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHIT1,Chitotriosidase-1,40398,0.0259176918218094,0.0143749669226474,-0.00225724334657941,0.0540926269901982,0.0714111669237168
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPRING1,SREBP regulating gene protein,37482,0.0100500280190572,0.00557489834182164,-0.00087677273091318,0.0209768287690277,0.0714539636386843
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPM1B,Protein phosphatase 1B,37598,0.0110620630314112,0.0061389997137733,-0.000970376407584485,0.0230945024704069,0.0715789280808407
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZNF75D,Zinc finger protein 75D,37714,0.0103739422134653,0.0057587082375734,-0.000913125932178543,0.0216610103591092,0.071656948503582
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CBX2,Chromobox protein homolog 2,37562,-0.00710785518099134,0.00398073970305605,-0.0149101049989812,0.000694394636998513,0.0741934089042394
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDH12,Protocadherin-12,37959,0.00435403035059483,0.00247418231374892,-0.000495366984353063,0.00920342768554272,0.0784668033826367
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37942,0.00637263862187085,0.0036248535750843,-0.000732074385294385,0.0134773516290361,0.0787633301674042
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TTN,Titin,37562,-0.0111467735650447,0.00635337589310588,-0.0235993903155323,0.0013058431854428,0.0793742779877889
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMA1,Laminin subunit alpha-1,37562,-0.00950177881631568,0.00543364252840334,-0.0201517181719862,0.00114816053935487,0.080367307748876
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RSPO1,R-spondin-1,40228,0.00594002316544527,0.00341020608608183,-0.000743980763275107,0.0126240270941657,0.0815564585385027
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RYR1,Ryanodine receptor 1,37562,-0.00582442867136535,0.00334493078499811,-0.0123804930099616,0.000731635667230949,0.0816596645139716
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACTN4,Alpha-actinin-4,40044,0.00545648196320061,0.00313466273454206,-0.000687456996501835,0.0116004209229031,0.081757329103319
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AREG,Amphiregulin,40305,0.00828311792699371,0.00476532915323168,-0.00105692721334038,0.0176231630673278,0.0821941527724186
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BABAM1,BRISC and BRCA1-A complex member 1,37598,0.00489805462485033,0.00284806362919932,-0.000684150088380331,0.010480259338081,0.0854952257782611
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL3RA,Interleukin-3 receptor subunit alpha,40044,0.00525257105649774,0.00307330890007853,-0.000771114387656185,0.0112762565006517,0.0874536042251935
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNLZ,DNL-type zinc finger protein,37541,-0.015721535335725,0.00921205380439857,-0.0337771607923462,0.00233409012089619,0.0879152125873621
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCARB1,Scavenger receptor class B member 1,39961,0.00974229685831775,0.00571324734490922,-0.00145566793770432,0.0209402616543398,0.0881749536361878
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BEX3,Protein BEX3,37482,-0.00785635034822947,0.0046235081267912,-0.0169184262767402,0.00120572558028127,0.0893019001721151
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RRP15,RRP15-like protein,37541,-0.0149577935742167,0.00882728880257097,-0.0322592796272558,0.00234369247882238,0.0901951179229841
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDCL2,Phosducin-like protein 2,37482,0.00878649259694186,0.00522022336367027,-0.00144514519585187,0.0190181303897356,0.0923672831733012
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37541,0.00893239045255406,0.00531117960785852,-0.00147752157884863,0.0193423024839568,0.0926297091234193
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DOCK9,Dedicator of cytokinesis protein 9,37541,0.0194083921122123,0.0115690836581634,-0.00326701185778805,0.0420837960822127,0.0934474442220614
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,37541,-0.0115167763623709,0.00687142823856682,-0.0249847757099618,0.0019512229852201,0.0937545892802131
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGLYRP4,Peptidoglycan recognition protein 4,37562,0.0101935356172829,0.00609213758419125,-0.00174705404773193,0.0221341252822978,0.0943062642415027
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENDOU,Poly(U)-specific endoribonuclease,36973,0.00811418320665846,0.00485795942785471,-0.00140741727193678,0.0176357836852537,0.0948877215962724
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37959,-0.00380199876538732,0.00228370918949118,-0.00827806877679003,0.000674071246015395,0.0959688918682148
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SULT1A1,Sulfotransferase 1A1,40471,-0.0205533791716604,0.0123824239512665,-0.0448229301161428,0.00371617177282196,0.0969574979608451
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLSTN1,Calsyntenin-1,39961,0.00839513641572716,0.0050651098040303,-0.00153247880017223,0.0183227516316265,0.0974499450610641
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTN2,Contactin-2,40489,0.00715468747697868,0.00431865460434956,-0.00130987554754645,0.0156192505015038,0.0976009981868311
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACTA2,"Actin, aortic smooth muscle",40042,-0.00695705883677187,0.00420825886793694,-0.0152052462179283,0.00129112854438454,0.0983119799452782
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,37562,0.00622109114050099,0.00377981035741828,-0.00118733716003884,0.0136295194410408,0.0998136984936082
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,40332,-0.00514441196346883,0.00312980442126317,-0.0112788286291446,0.000990004702206969,0.100261122792021
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOX2,Transcription factor SOX-2,37937,0.00369670393486796,0.00225423359055577,-0.000721593902621358,0.00811500177235727,0.101050552233086
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40434,0.0116151221790858,0.00708415961858527,-0.00226983067334136,0.0255000750315129,0.101109980867934
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37900,0.0102845912673956,0.00628038534592367,-0.00202496401061477,0.022594146545406,0.10153413598977
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOH,Beta-2-glycoprotein 1,40332,0.00559268505495842,0.0034171665749519,-0.0011049614319473,0.0122903315418641,0.101724699287283
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICAM2,Intercellular adhesion molecule 2,40536,0.00489025450786992,0.00300100522482892,-0.000991715732794752,0.0107722247485346,0.103218586806567
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40359,-0.00492607762675894,0.00303717805255902,-0.0108789466097746,0.00102679135625674,0.104839041874182
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMEM25,Transmembrane protein 25,37959,-0.00683434196990231,0.00423355394941243,-0.0151321077107507,0.00146342377094605,0.10647979703592
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT17,"Keratin, type I cytoskeletal 17",37562,0.00597928851837401,0.00371004740550521,-0.00129240439641621,0.0132509814331642,0.107062746450182
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,37482,0.0128060373636153,0.00794699866243956,-0.00277008001476621,0.0283821547419969,0.107110107702151
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLXDC2,Plexin domain-containing protein 2,37942,-0.00415843629917772,0.00258075672703469,-0.0092167194841657,0.000899846885810265,0.107132428739737
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37598,-0.00456524708500429,0.0028459996228563,-0.0101434063458026,0.00101291217579405,0.10871765341475
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BSND,Barttin,37482,-0.00531356855123664,0.00331948190361773,-0.0118197530823274,0.00119261597985411,0.109462692823695
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GHRHR,Growth hormone-releasing hormone receptor,39961,0.00861767077998641,0.00539099368836685,-0.00194867684921262,0.0191840184091854,0.109945212779525
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEO1,Neogenin,37959,0.00328866487169984,0.00206081138339413,-0.00075052543975266,0.00732785518315235,0.110554456921895
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL36G,Interleukin-36 gamma,37551,0.0106464666291355,0.00667499176110813,-0.00243651722263644,0.0237294504809074,0.110741226263134
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37562,0.0069828827822909,0.00442137952116768,-0.00168302107919776,0.0156487866437796,0.114281115369521
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REST,RE1-silencing transcription factor,37482,-0.00545965002217222,0.00347033673021699,-0.0122615100133975,0.00134220996905309,0.115689038698067
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LY6D,Lymphocyte antigen 6D,40268,0.00566082713689768,0.00360001717730875,-0.00139520653062748,0.0127168608044228,0.115867508523952
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39961,0.0102329573430473,0.00652369415469882,-0.0025534832001624,0.023019397886257,0.116765480193303
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,37598,0.00338939846859678,0.00216546922675522,-0.000854921215843455,0.00763371815303701,0.117559438113385
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37541,-0.00479591997009687,0.00306409639708838,-0.0108015489083901,0.00120970896819635,0.117560480041796
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOX9,Transcription factor SOX-9,37572,0.00410762493440731,0.00262628312989965,-0.001039890000196,0.00925513986901062,0.117831124572225
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37562,-0.00941717588244225,0.00606111915946411,-0.0212969694349919,0.00246261767010741,0.120279539262517
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37541,-0.0085972653105604,0.00557864319300196,-0.0195314059688442,0.00233687534772344,0.123315826251697
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PALM3,Paralemmin-3,37562,0.0107757106695775,0.0070173964979127,-0.00297838646633139,0.0245298078054864,0.124667759192134
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTNAP4,Contactin-associated protein-like 4,37572,0.0150009927727759,0.00982626165212244,-0.00425848006538411,0.0342604656109358,0.126878997817449
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTSL5,ADAMTS-like protein 5,37990,-0.00571420335736939,0.00374313674664179,-0.0130507513807873,0.00162234466604852,0.126888468007023
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37598,0.00535902025370729,0.00351277948143274,-0.00152602752990088,0.0122440680373155,0.127138968865114
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TLR4,Toll-like receptor 4,37598,0.00419234500513694,0.00275091336125381,-0.00119944518292053,0.0095841351931944,0.127537029977449
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,40289,0.00401403693831326,0.00264403813445472,-0.001168277805218,0.00919635168184452,0.128997460744148
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,37482,-0.013995861351199,0.00923580180447234,-0.0320980328879648,0.0041063101855668,0.129697386671416
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFB118,Beta-defensin 118,37541,0.00854588710231286,0.00564257518487778,-0.00251356026004758,0.0196053344646733,0.129913923667295
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL36A,Interleukin-36 alpha,37598,-0.00866444255061296,0.00572342456899888,-0.0198823547058508,0.00255346960462484,0.130086320925447
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,40042,0.0116399198000775,0.00772351390630158,-0.00349816745627354,0.0267780070564286,0.13181152734165
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSTM4,Glutathione S-transferase Mu 4,37562,-0.0104285845759753,0.00693442773733329,-0.0240200629411485,0.00316289378919798,0.132634967481117
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHGA,Chromogranin-A,37998,-0.0131119721324853,0.00871913290493769,-0.0302014726261631,0.00397752836119263,0.13265204668175
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RELB,Transcription factor RelB,37598,0.00750480779108115,0.00499089347555692,-0.00227734342101042,0.0172869590031727,0.132682585774532
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP13,Collagenase 3,39961,-0.0047641295379039,0.00317649220719725,-0.0109900542640105,0.00146179518820272,0.1336844088731
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM171A2,Protein FAM171A2,37959,0.0233131732258777,0.0155454758631519,-0.00715595946590005,0.0537823059176554,0.133721786239706
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,37562,-0.00752936394516788,0.00505299588726869,-0.0174332358842145,0.00237450799387876,0.136227476013321
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRHR1,Corticotropin-releasing factor receptor 1,40042,0.00911076588021761,0.00612272312645222,-0.00288977144762875,0.021111303208064,0.136764491920666
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37541,0.00467704725781858,0.00315051395121682,-0.00149796008656639,0.0108520546022036,0.137691207442178
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37714,-0.0105746397265416,0.00713976369854018,-0.0245685765756804,0.00341929712259715,0.138606083829333
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37572,-0.00727955479264565,0.0049229679859543,-0.0169285720451161,0.00236946245982478,0.139246581423917
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37901,-0.0246505548943253,0.0167531321307911,-0.0574866938706758,0.00818558408202521,0.141206430617355
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37987,0.00668275775172636,0.00457106159916897,-0.00227652298264482,0.0156420384860975,0.143772478057631
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHH,Sonic hedgehog protein,37598,-0.00614510034983117,0.00420650637963604,-0.0143898528539178,0.00209965215425547,0.144078845748132
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DLL1,Delta-like protein 1,40411,0.00411396428767533,0.0028194260885077,-0.00141211084579977,0.00964003942115042,0.144543634373447
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,39961,0.00967454689501926,0.00667845113057393,-0.00341521732090564,0.0227643111109442,0.14746357223432
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37900,0.00632754270431725,0.00437277501846544,-0.00224309633187502,0.0148981817405095,0.147911441285058
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBQLN3,Ubiquilin-3,37562,-0.00631750977065149,0.00436830949505016,-0.0148793963809498,0.00224437683964682,0.148141131164095
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39961,0.00644666662440592,0.00447129691463308,-0.00231707532827492,0.0152104085770867,0.149382103809779
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37562,-0.00734578291320151,0.00510953565890367,-0.0173604728046527,0.00266890697824969,0.150553977560205
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC4C,C-type lectin domain family 4 member C,40341,0.00627089636113015,0.00439732964225667,-0.00234786973769292,0.0148896624599532,0.153868014766266
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXNDC15,Thioredoxin domain-containing protein 15,40411,0.0037263289347544,0.00261707160825703,-0.00140313141742938,0.00885578928693818,0.154508173847478
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OSTN,Osteocrin,37572,-0.00591836462859486,0.00416513171478929,-0.0140820227895819,0.00224529353239215,0.155360595540275
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37900,-0.011607668489245,0.00824042736195539,-0.0277589061186776,0.00454356914018755,0.158969327466533
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDSN,Corneodesmosin,40456,-0.00585604320923257,0.00415779613573832,-0.0140053236352797,0.00229323721681453,0.159017627272399
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPTP,Ceramide-1-phosphate transfer protein,37562,-0.00548354459315342,0.00390178012156226,-0.0131310336314154,0.00216394444510862,0.159927372323176
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPEP2,Dipeptidase 2,40305,-0.00385893242312888,0.00276123073282037,-0.0092709446594568,0.00155307981319903,0.162270583075282
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37572,-0.00569899113749248,0.00409027677608555,-0.0137159336186202,0.00231795134363521,0.163552065560923
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCUN1D1,DCN1-like protein 1,37541,-0.0100092280412774,0.00724103907238085,-0.0242016646231438,0.0041832085405891,0.166905746727284
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JCHAIN,Immunoglobulin J chain,40044,-0.00822992688428814,0.00595831606975504,-0.019908226381008,0.00344837261243174,0.167221754760398
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGLC2,Immunoglobulin lambda constant 2,37978,0.00323367128160848,0.00234438937969891,-0.00136133190260139,0.00782867446581835,0.167817849283475
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DUSP29,Dual specificity phosphatase 29,37572,-0.00887480798374706,0.00645094364905947,-0.0215186575359036,0.0037690415684095,0.168926263246776
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PKLR,Pyruvate kinase PKLR,40374,0.00877362151216671,0.00640621400168759,-0.00378255793114097,0.0213298009554744,0.170847164400739
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37677,-0.00872058655468605,0.00637311447654605,-0.0212118909287163,0.00377071781934421,0.171228965363707
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICAM3,Intercellular adhesion molecule 3,40536,-0.00331899700502172,0.00243065244283807,-0.00808307579298434,0.0014450817829409,0.172122660826094
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NXPH3,Neurexophilin-3,37598,0.00397725868449996,0.00293156234911759,-0.00176860351977051,0.00972312088877043,0.17489897652636
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RTKN2,Rhotekin-2,37562,-0.00691280557542031,0.0050997999889982,-0.0169084135538568,0.00308280240301615,0.175279993239595
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TOP1,DNA topoisomerase 1,37901,0.0139189296175771,0.0103133684709501,-0.00629527258548504,0.0341331318206393,0.177166806228088
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL24,Interleukin-24,40044,0.00642137166117268,0.00475999469688378,-0.00290821794471953,0.0157509612670649,0.177347189475004
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FZD10,Frizzled-10,37572,0.00793854148204298,0.00589561313221419,-0.00361686025709683,0.0194939432211828,0.178159202232676
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HIP1,Huntingtin-interacting protein 1,37562,0.00443185541690838,0.00329486884973854,-0.00202608752857917,0.0108897983623959,0.178623331817759
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37482,-0.00579159937795244,0.00432106605565188,-0.0142608888470301,0.00267769009112524,0.180165594681785
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MERTK,Tyrosine-protein kinase Mer,40516,-0.00337396926261024,0.00251914356024952,-0.00831149064069929,0.00156355211547881,0.1804816059417
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC11A,C-type lectin domain family 11 member A,40296,0.00617661192359597,0.00461804689475074,-0.00287475999011548,0.0152279838373074,0.181080503573726
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ESPL1,Separin,37482,-0.00742082448573599,0.00554883606267877,-0.0182965431685864,0.0034548941971144,0.181126553102874
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TLR2,Toll-like receptor 2,37714,0.00296145731224536,0.00222489696214819,-0.00139934073356509,0.00732225535805581,0.183194226693235
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA5,Annexin A5,39896,0.00391893377640795,0.00294669392383791,-0.00185658631431436,0.00969445386713026,0.183556824786932
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRNN,Cornulin,39857,0.00846623878122713,0.00640001186554913,-0.00407778447524917,0.0210102620377034,0.185905780722243
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB6A,Ras-related protein Rab-6A,40341,0.00607535724353542,0.0045989543117,-0.00293859320739657,0.0150893076944674,0.186510339825965
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PYDC1,Pyrin domain-containing protein 1,37628,-0.00545113626555948,0.00413045957631605,-0.0135468370351389,0.00264456450401999,0.186944482822948
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40332,0.0151065279909782,0.0114753637793658,-0.00738518501657883,0.0375982409985353,0.188048324251556
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTLA,B- and T-lymphocyte attenuator,37482,0.0112863440461845,0.00860016652798915,-0.00556998234867424,0.0281426704410432,0.189428498920642
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ISM2,Isthmin-2,37998,-0.00564785209271295,0.00430777878357666,-0.0140910985085232,0.00279539432309731,0.18985221742714
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,37562,-0.00642319688476647,0.00493902528405977,-0.0161036864415236,0.00325729267199068,0.193452897676836
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EVPL,Envoplakin,37714,-0.0043318216644175,0.00334049839085171,-0.0108791985104868,0.00221555518165184,0.194736650889367
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37482,0.00726249119916031,0.0056067985343223,-0.0037268339281114,0.018251816326432,0.195239396199419
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF12,Fibroblast growth factor 12,37598,0.00603425087508068,0.00466686335354308,-0.00311280129786375,0.0151813030480251,0.196034036329676
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHPK,Sedoheptulokinase,37714,-0.00535924217522524,0.00414903337844119,-0.01349134759697,0.0027728632465195,0.196488931697688
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GJA8,Gap junction alpha-8 protein,37482,0.00776034212703354,0.00602910825498667,-0.00405671005274033,0.0195773943068074,0.198066294289829
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSPAN15,Tetraspanin-15,37562,-0.00633485982014185,0.00494198478693578,-0.016021150002536,0.00335143036225227,0.199919598802868
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YY1,Transcriptional repressor protein YY1,37598,0.00344706701871144,0.00271835772649334,-0.00188091412521551,0.00877504816263839,0.204795524400641
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GID8,Glucose-induced degradation protein 8 homolog,37959,0.00414268863096073,0.00326962248100413,-0.00226577143180737,0.0105511486937288,0.205168720744633
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DENND2B,DENN domain-containing protein 2B,37562,-0.00643526822963555,0.00508047772479463,-0.016393004570233,0.00352246811096194,0.205297257225068
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX1,ATP-dependent RNA helicase DDX1,37901,0.00631197788827804,0.00499941503807183,-0.00348687558634275,0.0161108313628988,0.206775251860789
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA6C,Semaphorin-6C,37598,0.00324234682774542,0.00257616232628425,-0.00180693133177171,0.00829162498726255,0.208198751527759
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37628,0.00447652744666756,0.00356618997938929,-0.00251320491293544,0.0114662598062706,0.209403415285633
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP112,Centrosomal protein of 112 kDa,37562,0.00573306326137965,0.00456868516205721,-0.00322155965625248,0.0146876861790118,0.209551717752572
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37671,0.00465336709628583,0.00371202513880714,-0.00262220217577617,0.0119289363683478,0.210012307036487
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,37572,0.004276777271523,0.00342205419405697,-0.00243044894882865,0.0109840034918747,0.211406233756587
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FBN2,Fibrillin-2,37572,0.00732005568540599,0.00589691867785969,-0.00423790492319901,0.018878016294011,0.21450395384853
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,37572,0.00869850771405143,0.00703831262956937,-0.00509658503990454,0.0224936004680074,0.216525409821653
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37990,0.00392367021203832,0.00318537047782213,-0.00231965592449305,0.0101669963485697,0.218053308603592
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHP1,Calcineurin B homologous protein 1,37541,0.00869528259341177,0.00706956378817809,-0.00516106243141728,0.0225516276182408,0.218734088689227
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MORF4L2,Mortality factor 4-like protein 2,37482,-0.00432449279037646,0.0035243234915659,-0.0112321668338456,0.00258318125309271,0.219828991733406
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TP53BP1,TP53-binding protein 1,37598,0.0104998846520991,0.00860557173971946,-0.00636703595775102,0.0273668052619493,0.222438876212105
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAMT,Guanidinoacetate N-methyltransferase,37562,-0.00459641084179275,0.0037693119962442,-0.0119842623544314,0.00279144067084588,0.222703096922146
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37541,-0.00541397921279817,0.00444526004376883,-0.0141266888985851,0.00329873047298874,0.223275636809911
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40276,0.00704438457786295,0.00579552545815571,-0.00431484532012225,0.0184036144758481,0.224198621672704
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KDM3A,Lysine-specific demethylase 3A,37598,-0.0108441580648342,0.00896669371141381,-0.0284188777392053,0.00673056160953686,0.226537865618288
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39961,0.00938730809701422,0.00781004125594247,-0.00592037276463302,0.0246949889586615,0.229399813772861
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TAP1,Antigen peptide transporter 1,37714,-0.00715545470604279,0.0059690693096574,-0.0188548305529713,0.00454392114088573,0.230644447201597
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VNN2,Vascular non-inflammatory molecule 2,40305,0.005145363479815,0.00432296366696368,-0.00332764530743382,0.0136183722670638,0.23396997120708
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37562,-0.00433892658665331,0.00366270296609488,-0.0115178244001993,0.00283997122689264,0.236187537715921
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCGN,Secretagogin,40044,-0.00500375496778346,0.00423309539705174,-0.0133006219460049,0.00329311201043796,0.237201587219235
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,37562,-0.00411829671671716,0.00350303904230204,-0.0109842532396292,0.00274765980619483,0.239761951112597
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,37562,0.013596326108458,0.0115668428042769,-0.00907468578792478,0.0362673380048408,0.239833285460857
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTF,Ciliary neurotrophic factor,37541,-0.00384425844870813,0.00327981087402137,-0.01027268776179,0.00258417086437374,0.241179207187364
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RLN1,Prorelaxin H1,37959,-0.00933622643039773,0.00797615757823518,-0.0249694952837387,0.00629704242294323,0.24181370921769
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37598,-0.00519710713211664,0.00444228547094344,-0.0139039866551658,0.00350977239093252,0.242055414771191
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GKN1,Gastrokine-1,39602,0.00314529349397509,0.00269267607502848,-0.00213235161308073,0.00842293860103092,0.242788021624413
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TG,Thyroglobulin,37900,-0.0131785996203583,0.0113499250751356,-0.035424452767624,0.00906725352690735,0.245614621220835
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDAN1,Codanin-1,37942,0.00259189680785781,0.00224355409938036,-0.00180546922692769,0.00698926284264331,0.248002882056102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OTOA,Otoancorin,37541,-0.00610179734911586,0.00530723845724882,-0.0165039847253236,0.00430039002709182,0.250283391814835
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37998,-0.0152463282380996,0.013307176251645,-0.0413283936913238,0.0108357372151246,0.251930324456395
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40341,0.00939778478049559,0.00820707578244085,-0.00668808375308847,0.0254836533140797,0.252191932444139
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DIPK2B,Divergent protein kinase domain 2B,37671,0.00295077650956318,0.00258032797502686,-0.00210666632148947,0.00800821934061583,0.252824189392791
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NENF,Neudesin,37900,0.0119431458467111,0.0104640086391216,-0.00856631108596716,0.0324526027793894,0.253742654936532
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A16,Protein S100-A16,39934,0.0068188094075748,0.00599104420701638,-0.0049236372381773,0.0185612560533269,0.255068326308227
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB7,Integrin beta-7,40489,0.00494969750596764,0.00438452438069118,-0.00364397028018708,0.0135433652921224,0.258956143992554
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GH2,Growth hormone variant,39980,0.0183658784477312,0.016281105085474,-0.0135450875197978,0.0502768444152602,0.259316806790649
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPVL,Probable serine carboxypeptidase CPVL,40465,0.00439715760303788,0.00390455413192008,-0.00325576849552548,0.0120500837016012,0.260114144693736
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL22,Interleukin-22,37900,0.00706328042785236,0.00630476497518298,-0.00529405892350627,0.019420619779211,0.262602420036341
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMPD1,Sphingomyelin phosphodiesterase,40380,0.00511532537588633,0.00457821484526837,-0.00385797572083967,0.0140886264726123,0.263874906066772
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPR158,Probable G-protein coupled receptor 158,37959,0.00397081311253031,0.00356496527948092,-0.00301651883525229,0.0109581450603129,0.265366186884308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37998,-0.00268592365629777,0.00241323693462263,-0.00741586804815813,0.00204402073556259,0.265729790518069
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NME3,Nucleoside diphosphate kinase 3,40379,0.00256072414269082,0.00230703538526253,-0.00196106521242375,0.00708251349780538,0.267031686375286
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMEM132A,Transmembrane protein 132A,37628,0.00673449839464643,0.00608050026775169,-0.00518328213014688,0.0186522789194397,0.26807356001331
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRISP2,Cysteine-rich secretory protein 2,40489,-0.00653196062852082,0.0059020122136244,-0.0180999045672246,0.005035983310183,0.268425328310152
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD70,CD70 antigen,40341,-0.00438011473560128,0.00400493638445336,-0.0122297900491299,0.0034695605779273,0.274112377004039
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40374,0.00596127642893617,0.0054945135551857,-0.0048079701392278,0.0167305229971001,0.277959909877138
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37562,0.00625015008303821,0.00580585386538473,-0.00512932349311586,0.0176296236591923,0.28171208552672
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37184,0.00504599033719472,0.00472002440397372,-0.00420525749459377,0.0142972381689832,0.285062801699824
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBP1,Retinol-binding protein 1,37572,0.00710974126814602,0.00666850508113903,-0.00596052869088648,0.0201800112271785,0.286367693614837
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCUN1D2,DCN1-like protein 2,37482,0.00832406170449223,0.00783010077853733,-0.00702293582144094,0.0236710592304254,0.287763164397772
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,37942,0.00409035307186249,0.0038535340776023,-0.00346257372023802,0.011643279863963,0.288502168719421
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEZ6L,Seizure 6-like protein,40411,-0.00279674331072987,0.00264368592921831,-0.00797836773199775,0.00238488111053801,0.29011912287262
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNNI3,"Troponin I, cardiac muscle",40042,0.00862962268656127,0.0081643167641016,-0.00737243817107788,0.0246316835442004,0.290531326984302
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,40424,-0.00213634224782888,0.00202222184166354,-0.00609989705748942,0.00182721256183166,0.29078633289398
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL10,Interleukin-10,40044,0.00875107339536779,0.00829922404346856,-0.00751540572983058,0.0250175525205662,0.291695672661249
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASPN,Asporin,37990,0.00276556451708149,0.00263290414041642,-0.00239492759813468,0.00792605663229766,0.293559626635827
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TAGLN3,Transgelin-3,37482,-0.00618836165866844,0.00590531256265692,-0.017762774281476,0.00538605096413913,0.29468971401266
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VASN,Vasorin,40116,-0.00269582099617761,0.00264464807450551,-0.00787933122220841,0.00248768922985318,0.308052760509958
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBR1,T-box brain protein 1,37572,0.00481193156160466,0.00472180557810231,-0.00444280737147587,0.0140666704946852,0.308180367903441
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DUOX2,Dual oxidase 2,40042,0.00711423349652255,0.00699037969084976,-0.00658691069754299,0.0208153776905881,0.308827902158258
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCNE1,G1/S-specific cyclin-E1,37598,0.00921913581917545,0.00906761170915766,-0.00855338313077357,0.0269916547691245,0.309309891559981
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37714,0.00352851850026099,0.0034936729528087,-0.00331908048724406,0.0103761174877661,0.312526220518352
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37482,0.00491614331278598,0.00489667055717992,-0.00468133097928666,0.0145136176048586,0.315408471751903
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC44A4,Choline transporter-like protein 4,37572,-0.00679035927368544,0.00678161841392253,-0.0200823313649736,0.00650161281760272,0.316705621734807
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCIN,Adseverin,37541,0.00708743549857793,0.00711054216296103,-0.00684922714082569,0.0210240981379815,0.318904122061718
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1A,Interleukin-1 alpha,40044,0.00517771212791358,0.00519810538973126,-0.00501057443595969,0.0153659986917869,0.319228294008015
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STEAP4,Metalloreductase STEAP4,37541,-0.00723905892282408,0.00729504528938137,-0.0215373476900116,0.00705922984436341,0.321057147956757
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40333,0.00709625579613889,0.00715681544880337,-0.00693110248351571,0.0211236140757935,0.321437963415967
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MUC2,Mucin-2,37998,0.00867596788676848,0.00875927420510434,-0.00849220955523602,0.025844145328773,0.321952679939362
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRN1,Neuritin,37959,-0.00349767114685907,0.0035405506652448,-0.0104371504507389,0.00344180815702073,0.323224696597063
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,37572,-0.00758190335984057,0.00767952243864019,-0.0226337673395754,0.00746996061989421,0.323519486275386
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40400,0.00605125415209412,0.00616120673254087,-0.00602471104368599,0.0181272193478742,0.326038859573654
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37562,-0.00670636857844264,0.00683187247457601,-0.0200968386286116,0.00668410147172634,0.326300449922099
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38013,0.00178999760849365,0.00183408282381439,-0.00180480472618256,0.00538479994316985,0.329100037917833
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNL2,Interferon lambda-2,37541,0.00612014899293977,0.00627092632106242,-0.00617086659634257,0.0184111645822221,0.329104240595017
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MUCL3,Mucin-like protein 3,37482,-0.00424128981887311,0.00436318774165401,-0.012793137792515,0.00431055815476874,0.331037656292931
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPHS2,Podocin,37598,-0.00987064236709247,0.0101559697685426,-0.0297763431134359,0.010035058379251,0.331115470252332
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,40536,0.00275854335040388,0.00284069758844755,-0.00280922392295333,0.00832631062376108,0.331523266738576
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLHL41,Kelch-like protein 41,37959,0.00444242807116845,0.00458978865125722,-0.0045535576852957,0.0134384138276326,0.333114731177419
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGAX,Integrin alpha-X,37714,0.00514896582132271,0.00534758843519034,-0.00533230751165035,0.0156302391542958,0.335636577899624
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA8,Carbonic anhydrase-related protein,37598,-0.00259271967890384,0.00269289034420957,-0.00787078475355459,0.00268534539574691,0.335664705012125
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFBR1,TGF-beta receptor type-1,37598,0.00200553415350958,0.00208467325975671,-0.00208042543561356,0.00609149374263273,0.336048389078546
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,37482,-0.00596975974773177,0.00621164884737322,-0.0181445914885833,0.00620507199311974,0.336540440359397
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP15,Matrix metalloproteinase-15,37990,0.00461948987025472,0.00481761610006629,-0.00482303768587521,0.0140620174263846,0.337639029113089
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRR5,Proline-rich protein 5,37598,0.00447667559159061,0.00467026087927796,-0.00467703573179419,0.0136303869149754,0.337803440582317
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDNRB,Endothelin receptor type B,37598,0.00438832232425796,0.00458783807145875,-0.00460384029580119,0.0133804849443171,0.3388311968489
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,40044,0.00269657691883664,0.0028199938901599,-0.00283061110587675,0.00822376494355004,0.338968335413672
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJA1,DnaJ homolog subfamily A member 1,37482,-0.00434015140050176,0.00454787791502968,-0.0132539921139599,0.0045736893129564,0.339937104465683
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNMA2,Paraneoplastic antigen Ma2,37541,0.00400419798097485,0.00420688980336422,-0.00424130603361901,0.0122497019955687,0.341206319463498
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HLA_DRA,,40288,-0.00328980467708666,0.00347368663627246,-0.0100982304841807,0.00351862113000736,0.343620454744249
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFB104A_DEFB104B,Beta-defensin 104,37541,0.00519219487479907,0.00549073574990335,-0.00556964719501151,0.0159540369446096,0.344355682503928
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NXPE4,NXPE family member 4,37562,-0.00331857822504682,0.00352076594028255,-0.0102192794680006,0.00358212301790697,0.345916824454252
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LCN15,Lipocalin-15,37959,-0.00579467642649384,0.0061660929359775,-0.0178802185810097,0.00629086572802206,0.347355078927868
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EVI2B,Protein EVI2B,37482,0.00382525713757573,0.00407903376037194,-0.00416964903275327,0.0118201633079047,0.348372234587268
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STC2,Stanniocalcin-2,40309,0.00244076874413424,0.00261569679482649,-0.00268599697372569,0.00756753446199417,0.35077029711388
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,37572,0.00772718819761468,0.00838602550929008,-0.00870942180059388,0.0241637981958232,0.35683963430091
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,37572,-0.00624987903030149,0.00678472478371593,-0.0195479396063847,0.00704818154578174,0.356979069686452
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37457,-0.0045817071960376,0.00497445879735132,-0.0143316464388462,0.00516823204677098,0.35704330526452
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMIGO1,Amphoterin-induced protein 1,37572,0.00445167335910071,0.00483450376729896,-0.00502395402480525,0.0139273007430067,0.357165057379836
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37714,0.00616723140748861,0.00672347487157066,-0.00701077934078989,0.0193452421557671,0.359018663278398
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL13,Interleukin-13,40044,0.00423393338781408,0.00462903430304709,-0.00483897384615822,0.0133068406217864,0.360391001359712
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOS1,"Nitric oxide synthase, brain",39961,0.00438904541523915,0.00480542982982952,-0.00502959705122671,0.013807687881705,0.36107202623358
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37482,-0.00304947141830183,0.00334198099287279,-0.0095997541643325,0.00350081132772884,0.361536029160759
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLAMF1,Signaling lymphocytic activation molecule,40044,0.00523416415987627,0.00574033545850658,-0.00601689333879663,0.0164852216585492,0.361876524176953
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,37572,-0.00341733705918752,0.00375496706913208,-0.0107770725146864,0.00394239839631136,0.362794704660735
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAPT,Microtubule-associated protein tau,39961,0.00465458014204437,0.00512056368614464,-0.00538172468279914,0.0146908849668879,0.363365513694176
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,37714,0.0039539686040908,0.00435266317368441,-0.00457725121633064,0.0124851884245122,0.36368229471036
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DLGAP5,Disks large-associated protein 5,37959,-0.00470540472079168,0.00519518702641063,-0.0148879712925565,0.00547716185097315,0.365098198861626
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PITHD1,PITH domain-containing protein 1,37457,-0.00719201786587754,0.00794747348159397,-0.0227690658898017,0.00838503015804663,0.365511857489267
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39980,0.0109970835717123,0.0122067107381286,-0.0129280694750198,0.0349222366184443,0.367652942596928
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DBH,Dopamine beta-hydroxylase,37967,-0.00916831207738522,0.0101897373271937,-0.029140197238685,0.0108035730839145,0.368264328860146
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HEBP1,Heme-binding protein 1,40042,0.00471715746181813,0.00525328218579947,-0.00557927562234883,0.0150135905459851,0.369228841758694
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHGB,Secretogranin-1,40406,-0.00348092906545654,0.00388349670495413,-0.0110925826071666,0.00413072447625355,0.370085327022098
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF9,Fibroblast growth factor 9,37457,0.00351646497378163,0.00393021685840926,-0.00418676006870052,0.0112196900162638,0.370950438980939
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARG2,"Arginase-2, mitochondrial",37900,0.00380975806068104,0.00429746525200063,-0.0046132738332402,0.0122327899546023,0.375357098962969
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL21R,Interleukin-21 receptor,37598,0.00480339670128394,0.00542243577569491,-0.00582457741907809,0.015431370821646,0.375721327289635
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRG3,Proteoglycan 3,37998,-0.00428568996822069,0.00483874353062789,-0.0137696272882514,0.00519824735180997,0.375793279323661
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37714,0.00537940418319257,0.00610826384571633,-0.00659279295441143,0.0173516013207966,0.378508920092751
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSRP3,Cysteine and glycine-rich protein 3,37562,-0.0082307458035132,0.00935526119506367,-0.026567057745838,0.0101055661388116,0.378984543701474
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,37572,0.00306906968392156,0.00348951859695288,-0.00377038676610609,0.00990852613394921,0.379140427430263
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37541,0.00619408842999563,0.00707202622957483,-0.00766708297997104,0.0200552598399623,0.381123485563716
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHEK2,Serine/threonine-protein kinase Chk2,40042,-0.00282876986289418,0.00325256364408814,-0.00920379460530694,0.00354625487951858,0.384475197115455
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAP1A,Ras-related protein Rap-1A,37598,0.00577100684781351,0.00674882178822834,-0.00745668385711404,0.0189986975527411,0.392504045776804
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ABO,Histo-blood group ABO system transferase,37987,-0.0119059130654528,0.0139252094031095,-0.0391993234955474,0.0153874973646418,0.392571885751025
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD82,CD82 antigen,37714,-0.00346449798687942,0.00405395778889947,-0.0114102552531224,0.00448125927936354,0.392790023544927
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAGE2A,G antigen 2A,37482,0.00514266478116235,0.0060289853918146,-0.00667414658679427,0.016959476149119,0.393680479842664
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,37541,0.0041101271728616,0.00482465063934385,-0.00534618808025234,0.0135664424259755,0.394284343909849
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DSC2,Desmocollin-2,40177,-0.00275226616897568,0.00324666066200924,-0.00911572106651379,0.00361118872856242,0.396605627992395
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37562,-0.00207145579320528,0.0024836522800952,-0.00693941426219187,0.00279650267578132,0.40427580760795
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCND2,G1/S-specific cyclin-D2,37714,0.002948465175466,0.00355119930108999,-0.00401188545467037,0.00990881580560238,0.406399351311878
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HDAC8,Histone deacetylase 8,37598,0.00497978898385306,0.00605574751847235,-0.00688947615235275,0.0168490541200589,0.410907204346994
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCARE,Photoreceptor cilium actin regulator,37541,0.00685526932814389,0.00834230675185887,-0.00949565190549949,0.0232061905617873,0.411235613343934
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OFD1,Oral-facial-digital syndrome 1 protein,37714,0.00539274076030935,0.00657999509617522,-0.00750404962819409,0.0182895311488128,0.412478247622628
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LPO,Lactoperoxidase,39831,-0.00466451608333376,0.00570518443028792,-0.0158466775666981,0.00651764540003057,0.41360256944182
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37562,-0.00386590844582729,0.00476290988618505,-0.01320121182275,0.00546939493109541,0.416996065115405
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPA33,Cell surface A33 antigen,40305,-0.0106337831974895,0.0131148865656276,-0.0363389608661196,0.0150713944711405,0.417482494907035
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLXDC1,Plexin domain-containing protein 1,39980,0.00265381082995565,0.00327378846178438,-0.00376281455514174,0.00907043621505303,0.417594170609347
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40471,0.00213353654959551,0.00263247285748046,-0.0030261102510662,0.00729318335025721,0.417682953813224
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37482,0.00441990402757144,0.00546493816255543,-0.0062913747710372,0.0151311828261801,0.418659485975363
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37562,-0.00470895441284197,0.00588581621288455,-0.0162451541900957,0.00682724536441176,0.423695621075787
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TEX33,Testis-expressed protein 33,37714,-0.00305591738157548,0.00382258869041609,-0.010548191214791,0.00443635645164006,0.424051601435381
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDDM3B,Epididymal secretory protein E3-beta,37900,-0.0032859028438568,0.00412655307001904,-0.0113739468610941,0.00480214117338051,0.425881791475489
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRL5,Fc receptor-like protein 5,40332,-0.00426142699027659,0.00539089821495392,-0.0148275874915863,0.0063047335110331,0.429256078605164
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,37562,-0.00443753317024161,0.00561407817554722,-0.0154411263943142,0.00656606005383093,0.429291259940947
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD34,Hematopoietic progenitor cell antigen CD34,40408,-0.00184399583822941,0.0023359904116269,-0.00642253704501813,0.00273454536855931,0.429898737979939
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCN3B,Sodium channel subunit beta-3,37541,0.00348461211388251,0.00444560513493369,-0.00522877395058753,0.0121979981783525,0.433152277437845
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,37714,0.00487392088171653,0.00624235670630351,-0.00736109826263835,0.0171089400260714,0.434944552288414
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,37598,0.00705984872696448,0.00907997616859037,-0.0107369045634726,0.0248566020174016,0.43686696259893
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTR,Methionine synthase,37562,0.00490370395581462,0.00633506422957588,-0.00751302193415411,0.0173204298457833,0.438910749248503
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDH17,Protocadherin-17,40359,0.0025949519128023,0.00335823657259981,-0.00398719176949332,0.00917709559509792,0.43970393385395
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,37998,-0.00217154773013989,0.00285361074226815,-0.00776462478498546,0.00342152932470569,0.446680788558612
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINT3,Kunitz-type protease inhibitor 3,37901,0.00946329806519695,0.0124389746133611,-0.0149170921769908,0.0338436883073847,0.446803022512958
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPTXR,Neuronal pentraxin receptor,40359,0.00248066244169869,0.00327178974933776,-0.00393204546700332,0.0088933703504007,0.448344057370432
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGM2,Phosphoglucomutase-2,37572,0.00438136942353299,0.00580619274397607,-0.00699876835466011,0.0157615072017261,0.45050087465292
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,37883,0.00306744295650549,0.00406842407490221,-0.00490666823030283,0.0110415541433138,0.450884400614459
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FRMD7,FERM domain-containing protein 7,37572,0.00242591980803067,0.00322113893068473,-0.0038875124961114,0.00873935211217274,0.451388399925318
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HLA_A,,37959,0.00237117504837852,0.00315999353165153,-0.00382241227365848,0.00856476237041552,0.453042925565879
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK12,Kallikrein-12,39980,-0.010332229820192,0.0138115628732796,-0.03740289305182,0.0167384334114359,0.454419921233518
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37564,0.00276080639746471,0.00369555045152552,-0.0044824724875253,0.0100040852824547,0.455039355077181
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,37998,-0.00199481821468851,0.00268230728985137,-0.00725214050279719,0.00326250407342017,0.457073982764521
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC51B,Organic solute transporter subunit beta,37562,-0.00571688302981767,0.00770337408813268,-0.0208154962425577,0.00938173018292238,0.458023599028435
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MORC3,MORC family CW-type zinc finger protein 3,37942,0.00202629321148212,0.00273062034949422,-0.00332572267352655,0.00737830909649079,0.458061889589218
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPTN,Neuroplastin,39980,0.00604055166823494,0.00814991816869441,-0.00993328794240611,0.022014391278876,0.458595864789276
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLB1,"Phospholipase B1, membrane-associated",37942,-0.00433828212835999,0.00586095365375292,-0.0158257512897157,0.00714918703299574,0.459191091208007
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PEAR1,Platelet endothelial aggregation receptor 1,40536,0.00160098163125901,0.00217424532620616,-0.00266053920810506,0.00586250247062308,0.461535155860327
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL20,Interleukin-20,40044,0.00362068126721412,0.00492296356144563,-0.00602832731321931,0.0132696898476476,0.462065695263987
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMC3,Structural maintenance of chromosomes protein 3,37482,0.00390230368010679,0.00540321299793439,-0.00668799379584462,0.0144926011560582,0.470172737153935
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37628,-0.00283884571051649,0.00393594283769225,-0.0105532936723933,0.00487560225136032,0.470761175301701
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WIF1,Wnt inhibitory factor 1,40489,-0.00236892297504531,0.00329698305368807,-0.00883100976027392,0.00409316381018329,0.472451916068091
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DHODH,Dihydroorotate dehydrogenase,37562,0.00336218006399994,0.00467979670086335,-0.00581022146969223,0.0125345815976921,0.47249528816271
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,37541,-0.00492026478460736,0.00687693500473507,-0.0183990573938881,0.00855852782467338,0.474329269661028
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMMR,Hyaluronan mediated motility receptor,37460,-0.0032980959530202,0.00471558445377837,-0.0125406414824258,0.00594444957638542,0.484312449191081
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,H2AP,Huntingtin-interacting protein M,37482,-0.00352192834920175,0.00504454379187756,-0.0134092341812818,0.00636537748287827,0.485085921514096
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRND,Prion-like protein doppel,37942,-0.00358869820067324,0.00518718484176952,-0.0137555804905415,0.00657818408919501,0.48905017580145
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPRR1B,Cornifin-B,37714,0.00569290037605555,0.00825081480678272,-0.0104786966452386,0.0218644973973497,0.490218596108292
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA4C,Semaphorin-4C,40305,-0.00184898462125428,0.00272692408695948,-0.00719375583169486,0.00349578658918629,0.497751342180197
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",37482,-0.00322701517574269,0.00479368196680697,-0.0126226318306843,0.00616860147919896,0.50084414540903
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC2L,C-type lectin domain family 2 member L,37572,0.00321345099961812,0.00480357925200436,-0.00620156433431043,0.0126284663335467,0.503526307654139
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC1A,C-type lectin domain family 1 member A,40042,-0.00212779688460096,0.00318509267335758,-0.00837057852438183,0.0041149847551799,0.504112423196561
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37562,0.00305321037706279,0.00459394602492514,-0.00595092383179047,0.0120573445859161,0.506307774480034
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,37572,0.00275304833935951,0.00415131893374991,-0.0053835367707903,0.0108896334495093,0.507230532272093
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAP18,Histone deacetylase complex subunit SAP18,37714,0.00479398936767146,0.0072308997525657,-0.00937857414735731,0.0189665528827002,0.507350683082104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37541,0.00368767352411892,0.00560842104572844,-0.00730483172550882,0.0146801787737467,0.510855367650731
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA11,Serpin A11,40536,-0.00250546480798713,0.00386830479615981,-0.0100873422084604,0.00507641259248609,0.517194304197594
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSH1,Chorionic somatomammotropin hormone 1,37987,0.0021809887911066,0.0033746421083741,-0.00443330974130663,0.00879528732351983,0.518104181703637
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK15,Kallikrein-15,37880,0.00318271102319495,0.00495120399576584,-0.0065216488085061,0.012887070854896,0.520354753943062
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB6B,Ras-related protein Rab-6B,39961,0.00301845906197967,0.00470120902568191,-0.00619591062835687,0.0122328287523162,0.520843606305622
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASQ2,Calsequestrin-2,37562,-0.00310913382538887,0.00485456430526599,-0.0126240798637102,0.00640581221293248,0.521887514764754
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGBL2,Cytosolic carboxypeptidase 2,37541,0.00559787341778998,0.00881789144315688,-0.0116851938107975,0.0228809406463775,0.525549548454177
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,37541,-0.00353395544603288,0.00559087041732126,-0.0144920614639825,0.00742415057191678,0.527336519108407
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPHA2,Glycoprotein hormone alpha-2,37901,0.00299005736770603,0.00473292143167687,-0.00628646863838065,0.0122665833737927,0.52755625844118
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXK,Tyrosine-protein kinase TXK,37714,0.00463519608574894,0.00734607920898883,-0.00976311916386916,0.019033511335367,0.52806741009162
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17C,Interleukin-17C,40044,-0.00425034979545447,0.00676996116029852,-0.0175194736696396,0.00901877407873062,0.530127885132558
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT14,"Keratin, type I cytoskeletal 14",39530,0.00171379282082267,0.00275484654195141,-0.0036857064014021,0.00711329204304744,0.53388485640097
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRRT3,Proline-rich transmembrane protein 3,37628,0.002249960802348,0.00363683275569014,-0.00487823139880467,0.00937815300350067,0.536151450627958
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALMS1,Alstrom syndrome protein 1,37714,0.00267877461264791,0.00436293908106804,-0.00587258598624543,0.0112301352115413,0.539236458367642
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",37959,0.00250813991586845,0.00408710801741604,-0.00550259179826699,0.0105188716300039,0.53944304914146
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB5,Integrin beta-5,40411,-0.0021609081842355,0.00356761055628755,-0.0091534248745591,0.00483160850608811,0.544721393221328
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPSG1,Tryptase gamma,37598,-0.00159962698520599,0.00264246912021978,-0.00677886646083676,0.00357961249042477,0.544954828176977
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TLR1,Toll-like receptor 1,37598,0.0015249736893199,0.00253349821339238,-0.00344068280892917,0.00649063018756896,0.54723502684542
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,37598,0.00341120990225072,0.0056703924085342,-0.00770275921847632,0.0145251790229777,0.547462329765927
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37482,-0.00499025147976301,0.00833233518686187,-0.0213216284460123,0.0113411254864863,0.549248707552816
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CBLN1,Cerebellin-1,37541,-0.00568440366139384,0.0095048980211963,-0.0243140037829386,0.0129451964601509,0.549816960723846
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF20,Fibroblast growth factor 20,37598,-0.00256094269774045,0.00432838018891232,-0.0110445678680086,0.00592268247252769,0.554086406885774
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UGDH,UDP-glucose 6-dehydrogenase,37562,0.00554501050941717,0.00940851365514429,-0.0128956762546656,0.0239856972735,0.55562932448145
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39980,0.00687614536331557,0.011685285135416,-0.0160270135020999,0.029779304228731,0.556242328277151
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCDC50,Coiled-coil domain-containing protein 50,37959,0.00443716232475655,0.00758071026091335,-0.0104210297866336,0.0192953544361467,0.558340485770329
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF6,Fibroblast growth factor 6,37598,-0.00242149411926276,0.00416472505091015,-0.0105843552190467,0.00574136698052114,0.560960970379876
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OMP,Olfactory marker protein,37541,0.00284961595378039,0.00490511387203672,-0.00676440723541159,0.0124636391429724,0.561285522249737
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RUVBL1,RuvB-like 1,39980,0.00601944046978708,0.0103631238870048,-0.0142922823487423,0.0263311632883165,0.561348684868115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39708,-0.00208104695859916,0.00359756779121879,-0.00913227982938799,0.00497018591218968,0.562962529572499
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SELL,L-selectin,38013,0.00128671004159846,0.00223588074026589,-0.00309561620932269,0.00566903629251961,0.564974630701098
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,40422,0.00153972640451404,0.0026798602097061,-0.00371279960650992,0.00679225241553801,0.565600557583786
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPESP1,Sperm equatorial segment protein 1,37990,0.00152942378836233,0.0026646549342346,-0.00369329988273749,0.00675214745946216,0.565999721333078
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF2RB,Cytokine receptor common subunit beta,37598,-0.00244113417073561,0.00428652219311228,-0.0108427176692357,0.00596044932776445,0.569032966713103
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MFAP3,Microfibril-associated glycoprotein 3,40042,0.00272207184380718,0.00480084768443184,-0.00668758961767922,0.0121317333052936,0.570723589286508
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCNA,Proliferating cell nuclear antigen,37482,0.00342976314806537,0.00605291422887677,-0.0084339487405331,0.0152934750366638,0.570975307772913
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPT1,Palmitoyl-protein thioesterase 1,37572,0.00428042302982594,0.00755711996707838,-0.0105315321056477,0.0190923781652996,0.571125262558686
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC123,Cell division cycle protein 123 homolog,37482,0.003448127844862,0.00620609923536064,-0.00871582665644484,0.0156120823461688,0.578491764974743
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANKRA2,Ankyrin repeat family A protein 2,37482,0.00303399215114138,0.00546481692662142,-0.0076770490250366,0.0137450333273194,0.578776686517158
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MORF4L1,Mortality factor 4-like protein 1,37714,-0.00219334393665278,0.00395685890439857,-0.00994878738927399,0.00556209951596842,0.579373032194051
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL4A4,Collagen alpha-4(IV) chain,37688,-0.00278775015278117,0.00508170979688485,-0.0127479013546755,0.00717240104911314,0.583299483034797
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37541,-0.0017974926117169,0.00328092373967665,-0.00822810314148313,0.00463311791804933,0.583796179008045
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DOC2B,Double C2-like domain-containing protein beta,37572,0.00190813120197128,0.00348633310571576,-0.00492508168523161,0.00874134408917417,0.584169916377633
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40042,-0.00168215563492658,0.00309123157988314,-0.00774096953149753,0.00437665826164437,0.586332243809867
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,37482,0.00745310522445249,0.0137000350606659,-0.0193989634944526,0.0343051739433576,0.586436408057206
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,40044,0.00196284765426169,0.00362096522942848,-0.00513424419541813,0.00905993950394151,0.587772127402757
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CGN,Cingulin,37572,0.00218904687551053,0.00406260659530545,-0.00577366205128817,0.0101517558023092,0.590014566580406
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HK2,Hexokinase-2,40042,-0.00141896495131106,0.00266750375062436,-0.0066472723025348,0.00380934239991268,0.594771755003461
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACHE,Acetylcholinesterase,37671,-0.00164071629726817,0.00308543388284371,-0.00768816670764184,0.00440673411310551,0.594899824359366
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37959,0.00167119382270817,0.0031743448680606,-0.00455052211869062,0.00789290976410695,0.598571105710096
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZNF174,Zinc finger protein 174,37598,-0.00197113728729748,0.00375849058658777,-0.00933777883700952,0.00539550426241455,0.5999750041127
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MFAP3L,Microfibrillar-associated protein 3-like,37572,0.00339896221652791,0.00649948277205318,-0.00934002401669631,0.0161379484497521,0.601011701454957
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL4R,Interleukin-4 receptor subunit alpha,40341,0.00182580318789403,0.00349590651642854,-0.00502617358430592,0.00867777996009397,0.601490413182153
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,37541,0.00371558983893556,0.00714944785938624,-0.0102973279654615,0.0177285076433326,0.603279351049815
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40411,0.00172342468962059,0.00334392976146447,-0.00483067764284976,0.00827752702209094,0.606288341086301
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HDAC9,Histone deacetylase 9,37541,-0.00315335127562425,0.00614159892018552,-0.0151908851591879,0.00888418260793937,0.607651243855227
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERCC1,DNA excision repair protein ERCC-1,37482,0.00166765467126325,0.00325174425128096,-0.00470576406124744,0.00804107340377394,0.608065454520078
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,37500,0.00171125974174297,0.0033402846189309,-0.0048356981113616,0.00825821759484754,0.608443047297075
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEB,Nebulin,37562,0.00180500124213573,0.0035252698107147,-0.00510452758686508,0.00871453007113655,0.608647107350182
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFRC,Transferrin receptor protein 1,40391,-0.00194615479002931,0.00380843925281685,-0.00941069572555034,0.00551838614549172,0.609350351443963
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZNF830,Zinc finger protein 830,37900,-0.00397247606804678,0.00780960253450472,-0.019279297035676,0.0113343448995825,0.610994991339798
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37541,0.00296953475945928,0.00584290456630951,-0.00848255819050736,0.0144216277094259,0.611301174609348
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40471,0.00231744739506336,0.0045676505969571,-0.00663514777497255,0.0112700425650993,0.611908587749441
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC25A,M-phase inducer phosphatase 1,37482,-0.00197839190122146,0.00396537346556305,-0.00975052389372505,0.00579374009128212,0.617846338802931
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THBS2,Thrombospondin-2,40332,0.00170435780153222,0.00344831764631975,-0.0050543447852545,0.00846306038831894,0.621130979742996
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSCA,Prostate stem cell antigen,37901,0.0123376067482457,0.0251169013072693,-0.0368915198140021,0.0615667333104936,0.623287810306702
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL31,Interleukin-31,37598,-0.00275013822008338,0.00563505334799697,-0.0137948427821574,0.00829456634199068,0.625528795507389
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANK2,Ankyrin-2,37562,0.00348419620543881,0.0071877302492934,-0.0106037550831762,0.0175721474940539,0.627867323443938
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOS,Proto-oncogene c-Fos,37457,0.00164629770073522,0.00339949433384276,-0.00501671119359659,0.00830930659506703,0.628197288326441
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,37562,-0.00153005610852402,0.00317534967850758,-0.00775374147839889,0.00469362926135084,0.629917448557977
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCP11,T-complex protein 11 homolog,37714,-0.00282474269356401,0.00588447346858383,-0.0143583106919883,0.00870882530486029,0.631211695050851
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PMCH,Pro-MCH,37562,-0.00394638399567771,0.0082255828708372,-0.0200685264225186,0.0121757584311632,0.631399287742327
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17F,Interleukin-17F,40044,0.00365794887652555,0.00767655077771629,-0.0113880906477984,0.0187039884008495,0.633718164353888
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENOPH1,Enolase-phosphatase E1,37900,0.0026360315120089,0.00554163166406217,-0.00822556654955295,0.0134976295735707,0.634311620156741
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAND5,DAN domain family member 5,37598,-0.00248657254744231,0.00527116606106922,-0.012818058027138,0.00784491293225337,0.637126621243452
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,37541,-0.0013625031628454,0.00290380086113647,-0.00705395285067288,0.00432894652498209,0.638924705116656
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHD,SH2 domain-containing adapter protein D,37531,0.00394658009740266,0.0085000027725819,-0.0127134253368579,0.0206065855316632,0.642438124064863
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,40489,-0.0015819072008649,0.00341637852223342,-0.0082780091044424,0.00511419470271259,0.643344645606643
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37901,-0.00134040160976101,0.00290998202506924,-0.00704396637889673,0.0043631631593747,0.64507730476528
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PXDNL,Peroxidasin-like protein,37900,0.00257635351259583,0.00566364215056886,-0.00852438510251915,0.0136770921277108,0.649193264403805
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPP10,Inactive dipeptidyl peptidase 10,40341,0.00147294285825254,0.0032797491811373,-0.00495536553677656,0.00790125125328165,0.65336399589832
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL12,Stromal cell-derived factor 1,40044,0.00175897419815714,0.00391767870258926,-0.0059196760589178,0.00943762445523209,0.653449596453485
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,37482,-0.00217086046824124,0.00488151044130805,-0.011738620933205,0.00739689999672254,0.656536141835316
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,40319,0.00102981620458453,0.00236366609140868,-0.00360296933457649,0.00566260174374554,0.663070497597502
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP4,Caspase-4,37714,0.00717064987918879,0.0165380985307012,-0.0252440232409856,0.0395853229993632,0.664597828964005
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAPN3,Calpain-3,37900,0.00153413213522323,0.0035891406259067,-0.0055005834915539,0.00856884776200036,0.669067777988712
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDIA2,Protein disulfide-isomerase A2,37482,-0.0017001271144285,0.00402582141638755,-0.00959073709054809,0.00619048286169109,0.672808905434681
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAYN,Layilin,40192,0.00139704072885723,0.0033094282119017,-0.00508943856647011,0.00788352002418457,0.672928884620993
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MLLT1,Protein ENL,37482,0.00292416512519396,0.00693557493122523,-0.0106695617400075,0.0165178919903954,0.6733106215483
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNPO1,Transportin-1,37714,-0.00144677045015793,0.00343492403815392,-0.00817922156493961,0.00528568066462376,0.673620026857029
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THY1,Thy-1 membrane glycoprotein,40471,0.00113406594554114,0.00269756080768034,-0.00415315323751232,0.0064212851285946,0.674195825377033
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPLX2,Complexin-2,37482,-0.00124696742729844,0.00299994760832955,-0.00712686473962436,0.00463292988502748,0.677663414537897
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYBPC1,"Myosin-binding protein C, slow-type",37990,-0.00250713202337456,0.00611303565145642,-0.0144886819002291,0.00947441785348003,0.681717951266552
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBM25,RNA-binding protein 25,37482,-0.001827594299532,0.00448526072437837,-0.0106187053193136,0.00696351672024961,0.683671955006439
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HCG22,Protein PBMUCL2,37562,-0.00206429019374826,0.00517092621457124,-0.0121993055743079,0.00807072518681136,0.689744302813592
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UPK3BL1,Uroplakin-3b-like protein 1,37692,0.0021372338863015,0.0053954939923977,-0.00843793433879799,0.012712402111401,0.692026879257317
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UPK3A,Uroplakin-3a,37541,0.0019169353139882,0.00484855076504084,-0.00758622418549185,0.0114200948134683,0.692581798546589
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37541,0.00186901066314396,0.00478986367244586,-0.00751912213484994,0.0112571434611379,0.69639410689195
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TEX101,Testis-expressed protein 101,37572,0.00147562844513447,0.00380223527595557,-0.00597675269573845,0.00892800958600739,0.697952039105776
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HRAS,GTPase Hras,37697,-0.00369313445809676,0.00953063699334872,-0.0223731829650603,0.0149869140488667,0.698391331129602
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37900,-0.00289498871217158,0.00751979591269061,-0.0176337887010452,0.011843811276702,0.700256579581014
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PODXL2,Podocalyxin-like protein 2,40411,-0.0010037238334717,0.00262828456365034,-0.00615516157822637,0.00414771391128297,0.702545716774058
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GUCY2C,Heat-stable enterotoxin receptor,37714,-0.00312091678103045,0.00821871511485485,-0.019229598406146,0.012987764844085,0.704149752892126
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHA10,Ephrin type-A receptor 10,39961,0.00238146065109979,0.00629873303273285,-0.00996405609305659,0.0147269773952562,0.705372133407612
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NECTIN4,Nectin-4,40411,0.00110928994653505,0.00294357141974405,-0.00466011003616329,0.00687868992923339,0.706288814372561
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LMOD2,Leiomodin-2,37541,0.00236100263894888,0.00629608320522666,-0.00997932044329538,0.0147013257211931,0.707669916361701
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37562,-0.00194893429774358,0.00523491639324638,-0.0122093704285065,0.00831150183301933,0.709679082389987
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A3,Protein S100-A3,37900,0.00162937477632627,0.00443976934032315,-0.0070725731307071,0.0103313226833597,0.713628248621631
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EXOSC10,Exosome component 10,37562,0.00221812099778272,0.00608178619827642,-0.00970217995083906,0.0141384219464045,0.715329755352564
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTNL10,Butyrophilin-like protein 10,37482,0.00146368092060854,0.00405187506030397,-0.00647799419758725,0.00940535603880432,0.717929298389297
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOLR3,Folate receptor gamma,40355,-0.00637119847543494,0.0177526738266758,-0.0411664391757195,0.0284240422248496,0.719684616072311
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37572,-0.00142626541662594,0.00399931831800735,-0.00926492931992034,0.00641239848666847,0.721376698905003
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HTR1A,5-hydroxytryptamine receptor 1A,37541,-0.00278480357313712,0.00783536061289823,-0.0181421103744177,0.0125725032281434,0.722284547204662
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYBPC2,"Myosin-binding protein C, fast-type",37628,-0.00281076803099603,0.00799076133361519,-0.0184726602448818,0.0128511241828897,0.72502971990915
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HBZ,Hemoglobin subunit zeta,37990,0.00355921264363909,0.0101382346000929,-0.016311727172543,0.0234301524598212,0.725542582612135
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,37541,0.00193786526073576,0.00553399937505608,-0.00890877351437416,0.0127845040358457,0.726213404913249
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NLGN1,Neuroligin-1,37572,-0.00236167830327312,0.00674659647265004,-0.0155850073896672,0.010861650783121,0.726303210380727
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRD2,Bromodomain-containing protein 2,37541,-0.00117098490995377,0.00334515617297419,-0.00772749100898319,0.00538552118907565,0.72630389178325
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39980,-0.00258006175079645,0.00740344411760064,-0.0170908122212937,0.0119306887197008,0.727473345624161
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,37541,0.00224838781140728,0.00645230457526654,-0.0103981291561151,0.0148949047789297,0.727498286674872
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPT1,Translationally-controlled tumor protein,40044,0.00223066624145259,0.00641840548803452,-0.0103494085150951,0.0148107409980003,0.728188773072455
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PALLD,Palladin,37598,-0.001388220151445,0.00401944546437002,-0.00926633326161023,0.00648989295872024,0.729817214694792
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGR,Progesterone receptor,37598,-0.00345678979742709,0.0100249206525243,-0.0231056342763748,0.0161920546815206,0.730235463293019
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRYBB2,Beta-crystallin B2,37942,-0.00228837135975922,0.00664258202680216,-0.0153078321322915,0.010731089412773,0.730475456618489
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IKZF2,Zinc finger protein Helios,39980,0.00306527228503923,0.00903698093930275,-0.0146472103559942,0.0207777549260726,0.734469628522219
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,37990,-0.000966820886538642,0.00285039147190239,-0.00655358817146733,0.00461994639839005,0.734472760823556
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TET2,Methylcytosine dioxygenase TET2,37697,0.00330750561750887,0.00975126801577101,-0.0158049796934023,0.0224199909284201,0.734474063745025
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB1,Integrin beta-1,40333,-0.000710265741176702,0.00210809308628867,-0.0048421281903025,0.0034215967079491,0.736179150443273
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD164L2,CD164 sialomucin-like 2 protein,37572,0.00115532121556881,0.00356596846274895,-0.00583397697141913,0.00814461940255675,0.745954358977378
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP350,Centrosome-associated protein 350,37482,0.00115699100070562,0.00362827982344891,-0.00595443745325425,0.0082684194546655,0.749821549960527
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMA1,Proteasome subunit alpha type-1,39980,-0.0013721197993112,0.0044913202172981,-0.0101751074252155,0.00743086782659308,0.759985824318897
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40365,-0.00142746951664178,0.0047649010993533,-0.0107666756713742,0.00791173663809068,0.764501382953487
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CYTH3,Cytohesin-3,37482,0.00213840263797177,0.0071415569127071,-0.0118590489109341,0.0161358541868777,0.764616082882278
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DIPK1C,Divergent protein kinase domain 1C,37572,-0.00124324153180728,0.00415439825419861,-0.00938586211003655,0.00689937904642199,0.764747089956843
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37572,0.00224703343202919,0.00759062760309662,-0.0126305966700402,0.0171246635340986,0.767213874048762
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37598,-0.000801344822380378,0.00272756036305336,-0.00614736313396496,0.00454467348920421,0.76891885073804
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37572,0.00162208417115196,0.0055213770353464,-0.00919981481812699,0.0124439831604309,0.768928724595908
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37714,0.00143415015811345,0.00489498882929978,-0.00816002794731412,0.011028328263541,0.769539472736892
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSP90B1,Endoplasmin,39878,-0.00197544471547526,0.0067657294002401,-0.0152362743399459,0.0112853849089953,0.770307306078056
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37714,-0.00175663099402972,0.00617692818312022,-0.0138634102329453,0.0103501482448859,0.776119138898931
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FZD8,Frizzled-8,37541,0.0012330137844108,0.00434751205491724,-0.007288109843227,0.00975413741204859,0.776710957088713
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF3,Fibroblast growth factor 3,37598,0.000824858580265468,0.00295010071657382,-0.00495733882421921,0.00660705598475015,0.779786095811977
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINB5,Serpin B5,40042,-0.00130773107882057,0.00470540828977456,-0.0105303313267787,0.00791486916913758,0.781076802453086
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ESR1,Estrogen receptor,37598,0.00156516417634752,0.00563613172415726,-0.00948165400300071,0.0126119823556957,0.781245611418273
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37598,0.0012962198366174,0.00469826728978888,-0.0079123840513688,0.0105048237246036,0.782634459783113
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIPR,Gastric inhibitory polypeptide receptor,37598,0.00130177992857021,0.00473693397456698,-0.00798261066158106,0.0105861705187215,0.783462786257231
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL20RB,Interleukin-20 receptor subunit beta,37598,0.00112959374501052,0.00413138087593837,-0.00696791277182868,0.00922710026184973,0.784536241130596
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REG1A,Lithostathine-1-alpha,40274,0.00127657292789377,0.0046993146935118,-0.00793408387138936,0.0104872297271769,0.785894024845992
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REN,Renin,40359,-0.00179272843981443,0.00687187629179935,-0.0152616059717412,0.0116761490921123,0.794189171675623
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40422,-0.00103227691417316,0.00399542735510041,-0.00886331453016996,0.00679876070182365,0.796128878614712
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPBGL,Trophoblast glycoprotein-like,37572,0.00103257689127723,0.00404210878211531,-0.00688995632166877,0.00895511010422323,0.798375701486245
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPT2,Angiopoietin-2,40489,0.000952784733996861,0.00372998340462676,-0.0063579827390716,0.00826355220706532,0.798387016593736
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANPEP,Aminopeptidase N,40370,0.000695236087546625,0.00272350443345776,-0.00464283260203058,0.00603330477712383,0.798515850711696
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37482,-0.00149649034582259,0.00586915890344454,-0.0130000417965739,0.0100070611049287,0.798746227829709
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,37714,-0.00197015339531773,0.00798249172741155,-0.0176158371810444,0.0136755303904089,0.80505961353699
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB2,Integrin beta-2,40221,0.000681838876228091,0.00276340546922801,-0.0047344358434588,0.00609811359591499,0.805113721035826
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL9,Interleukin-9,37714,0.00136480852557908,0.00556597886807024,-0.00954451005583858,0.0122741271069967,0.806301126702155
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,37598,-0.00129346209936702,0.00531618576157616,-0.0117131861920563,0.00912626199332226,0.807771831483164
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC39A14,Zinc transporter ZIP14,39961,-0.000775514894910426,0.00321881804748529,-0.00708439826798159,0.00553336847816074,0.809611336036164
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37959,0.000991858737874891,0.0041195630486603,-0.00708248483749931,0.00906620231324909,0.809738627739151
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37482,0.0014819423714293,0.00616560807937118,-0.0106026494641382,0.0135665342069968,0.810057881047058
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL3A1,Collagen alpha-1(III) chain,37998,0.000533567345686842,0.00223241667940545,-0.00384196934594785,0.00490910403732153,0.81110233521845
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL9A1,Collagen alpha-1(IX) chain,40341,0.00107780454194472,0.00454257932051,-0.00782565092625488,0.00998126001014433,0.812452656461378
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,37562,0.00110861032879186,0.00470823823660308,-0.00811953661495018,0.0103367572725339,0.813853989417622
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMCN2,Hemicentin-2,37648,0.00127216808763559,0.00552407698452388,-0.00955502280203121,0.0120993589773024,0.817866005938327
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",37959,0.00082135320954809,0.0035674695424906,-0.00617088709373349,0.00781359351282968,0.817913336896152
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL4,Interleukin-4,40044,0.00199209582524382,0.00866985485520867,-0.0150008196909652,0.0189850113414528,0.818271425452543
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZP3,Zona pellucida sperm-binding protein 3,37628,-0.00582988845597407,0.0254140670028317,-0.0556414597815243,0.0439816828695761,0.818564609351757
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSV,Cathepsin L2,40444,-0.000914727025672462,0.00408838217520073,-0.00892795608906589,0.00709850203772097,0.822963924278857
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCLN,Nicalin,40044,-0.00114914127631228,0.00515431829072241,-0.0112516051261282,0.00895332257350365,0.823579453655459
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,37714,-0.00116105370875034,0.0052660340522107,-0.0114824804510833,0.00916037303358263,0.825500959430875
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TP73,Tumor protein p73,37572,0.000741680621901937,0.00338457574674227,-0.00589208784171291,0.00737544908551678,0.826547924152282
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYL6B,Myosin light chain 6B,37572,0.00188007207559512,0.00895539585584262,-0.0156725038018564,0.0194326479530467,0.833719830350811
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KHDC3L,KH domain-containing protein 3,37482,-0.00134217936648259,0.00660396054893344,-0.0142859420423921,0.0116015833094269,0.838951756530476
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD177,CD177 antigen,40316,0.00244270569545707,0.0123094421288137,-0.0216838008770178,0.0265692122679319,0.842702095957351
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPGN,Epigen,37900,-0.000946133613758186,0.00478325772570834,-0.0103213187561465,0.00842905152863017,0.84320367938935
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAGEA3,Melanoma-associated antigen 3,37714,0.00160364450798035,0.00818513082777371,-0.0144392119144561,0.0176465009304168,0.844674476817428
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUSD4,Sushi domain-containing protein 4,37900,-0.000835516796320377,0.00431152091234923,-0.00928609778452486,0.00761506419188411,0.846345576451851
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENPEP,Glutamyl aminopeptidase,37562,-0.000844039001119713,0.00448987149441349,-0.00964418713017016,0.00795610912793073,0.850889484578641
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37562,0.00121954629929208,0.00650491967324066,-0.0115300962602596,0.0139691888588438,0.851286727561482
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLAU,Urokinase-type plasminogen activator,40332,-0.000526915494473725,0.00282885286942244,-0.00607146711854171,0.00501763612959426,0.852239549965471
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INSL3,Insulin-like 3,37942,-0.0010582283129442,0.00576656270884924,-0.0123606912222887,0.0102442345964003,0.854399761752524
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMY2B,Alpha-amylase 2B,39311,-0.000849490809048502,0.00465677561081338,-0.00997677100624272,0.00827778938814571,0.855255316299444
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,37687,-0.00083674972864004,0.00489758768137068,-0.0104360215841266,0.00876252212684649,0.864344826399686
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTNAP2,Contactin-associated protein-like 2,40341,-0.000638210160763966,0.00386691404637916,-0.00821736169166712,0.00694094137013918,0.868911612574451
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHC1,SHC-transforming protein 1,37482,0.00182008032541285,0.011306234913695,-0.0203401401054294,0.0239803007562551,0.872111465405134
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCDC2C,Doublecortin domain-containing protein 2C,37482,0.000980725233548858,0.00614679843342452,-0.0110669996959632,0.0130284501630609,0.873237587318465
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRP2BP,LRP2-binding protein,37572,0.00133676915580074,0.00840856687183836,-0.0151440219130024,0.0178175602246039,0.873689402292929
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REG3A,Regenerating islet-derived protein 3-alpha,40536,0.000909204310528417,0.00586956019666275,-0.0105951336749306,0.0124135422959874,0.876900829927692
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF7,Fibroblast growth factor 7,37482,0.0011771571296251,0.00784509991969633,-0.0141992387129797,0.0165535529722299,0.880727501329766
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH4,Cadherin-4,37541,0.00071225693054094,0.00479625874158693,-0.00868841020296943,0.0101129240640513,0.881948415735049
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,37598,0.000718523241551201,0.00488745676000711,-0.00886089200806274,0.0102979384911651,0.883123438636993
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40042,0.000462784556898949,0.00317269466482234,-0.00575569698615284,0.00668126609995074,0.884029984754931
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KCNIP4,Kv channel-interacting protein 4,39961,0.00071897101293854,0.00494747585564008,-0.00897808166411602,0.0104160236899931,0.884459503254229
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFAP2A,Transcription factor AP-2-alpha,37541,-0.000842453739358724,0.00587351886025167,-0.012354550705452,0.0106696432267346,0.885950792012879
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37482,-0.000775789095195654,0.00543519704173107,-0.0114287752969886,0.00987719710659724,0.886502226259991
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA6,Corticosteroid-binding globulin,38013,0.000245325897633712,0.00172437230683729,-0.00313444382376738,0.00362509561903481,0.886869107634881
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UNC5D,Netrin receptor UNC5D,37598,0.000361767879337129,0.00258788205316605,-0.00471048094486832,0.00543401670354258,0.888825660245995
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRTAC1,Cartilage acidic protein 1,40536,-0.000386527913007986,0.00282000592148502,-0.00591373951911863,0.00514068369310265,0.890980067380088
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,37959,0.000620094090001598,0.00456683254807447,-0.00833089770422437,0.00957108588422756,0.891995569671117
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEPTIN3,Neuronal-specific septin-3,37959,-0.000947167155293449,0.00712497422457601,-0.0149121166354624,0.0130177823248755,0.89424580040132
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RANGAP1,Ran GTPase-activating protein 1,39980,-0.000622845481262813,0.00480449787399273,-0.0100396613142886,0.00879397035176293,0.896854518715968
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,37541,-0.000500195410856581,0.00389125235891897,-0.00812705003433777,0.00712665921262461,0.897720807266393
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMPRSS11B,Transmembrane protease serine 11B,37541,-0.000963922225208242,0.00760937017201233,-0.0158782877623524,0.0139504433119359,0.89919903229782
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,37714,-0.000791054801963156,0.0065068590404762,-0.0135444985212965,0.0119623889173702,0.903239474417538
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37562,0.000755564384135214,0.00638655474336601,-0.0117620829128622,0.0132732116811326,0.905827432973719
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGLON5,IgLON family member 5,37482,-0.00106711082830881,0.00911938963340438,-0.0189411145097814,0.0168068928531638,0.906849496712487
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FH,"Fumarate hydratase, mitochondrial",37541,0.000966298980956689,0.008286818579013,-0.0152758654339088,0.0172084633958222,0.907173477607417
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMY2A,Pancreatic alpha-amylase,39695,0.000513358559633832,0.00454728707803153,-0.00839932411330796,0.00942604123257562,0.91011657986199
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL2,Interleukin-2,40044,-0.000338250237342216,0.00302336394148589,-0.00626404356265455,0.00558754308797012,0.910920970583168
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AXL,Tyrosine-protein kinase receptor UFO,40403,0.000284608315989982,0.00264974239937388,-0.00490888678678282,0.00547810341876278,0.914465226628637
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",37562,-0.000413519118656474,0.00398600779242292,-0.00822609439180539,0.00739905615449244,0.917375144938221
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PROK1,Prokineticin-1,40341,0.00066022747123646,0.00663452370465731,-0.0123434389898919,0.0136638939323648,0.920731490427272
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL3,Interleukin-3,37482,-0.00055486219134125,0.00582828479226396,-0.0119783003841786,0.0108685760014961,0.924156142126494
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MB,Myoglobin,40536,0.000438469600743609,0.00473136633890299,-0.00883500842350626,0.00971194762499348,0.926164554154386
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,39961,0.000565154005327866,0.00632294164389455,-0.0118278116167055,0.0129581196273612,0.928779880031757
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,40536,-0.00023599740645501,0.00278919365344422,-0.00570281696720568,0.00523082215429566,0.932571438181578
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASE10,Inactive ribonuclease-like protein 10,37628,-0.000367109952863835,0.0047262446225383,-0.0096305494130389,0.00889632950731123,0.938087945393307
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL18RAP,Interleukin-18 receptor accessory protein,40128,-0.00127026724886809,0.0168472091337721,-0.0342907971510614,0.0317502626533252,0.939898003157091
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,37541,0.000344775075264296,0.00488996511796148,-0.00923955655594021,0.0099291067064688,0.943791482300418
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPB41L5,Band 4.1-like protein 5,37572,0.000415322911680103,0.00616507671270598,-0.0116682274452236,0.0124988732685838,0.946290541823622
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFNB2,Ephrin-B2,37572,0.000375657252334303,0.005604702739276,-0.0106095601166467,0.0113608746213153,0.946562530765253
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC1A4,Neutral amino acid transporter A,37572,0.000332773394457575,0.00508489770425878,-0.00963362610588962,0.0102991728948048,0.947821904370064
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WFDC12,WAP four-disulfide core domain protein 12,40465,0.000388448131173458,0.00615205061349073,-0.0116695710712684,0.0124464673336153,0.949654819641287
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SKIV2L,Helicase SKI2W,37562,-0.000234779137619998,0.00392901843290714,-0.007935655266118,0.007466096990878,0.952351547115651
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLINT1,Clathrin interactor 1,37482,-0.000265506383652012,0.00444604426256335,-0.00897975313827617,0.00844874037097215,0.952381596832362
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39980,0.000194558396038969,0.00343867477369174,-0.00654524416039685,0.00693436095247479,0.954880916914769
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL2RB,Interleukin-2 receptor subunit beta,40044,0.000209989195725806,0.00374678042767842,-0.00713370044252389,0.00755367883397551,0.95530648825235
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ART5,Ecto-ADP-ribosyltransferase 5,37541,0.000335251442503459,0.00616439515304902,-0.0117469630574726,0.0124174659424795,0.956629154497421
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPSD1,Tryptase delta,37959,-0.00020059171911755,0.00369275019347415,-0.00743838209832687,0.00703719866009177,0.956680688960928
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFL4,Insulin growth factor-like family member 4,37598,0.000387664956497007,0.00762071098686077,-0.0145489285777501,0.0153242584907441,0.959429947875391
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAG,Myelin-associated glycoprotein,37572,-0.000220389709224636,0.00451184237999649,-0.00906360077401775,0.00862282135556848,0.961042014928466
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PFDN6,Prefoldin subunit 6,37572,0.000310954659050045,0.0064012540455835,-0.0122355032702936,0.0128574125883937,0.961257021884746
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MORN4,MORN repeat-containing protein 4,37482,0.000355842536264698,0.00763774355424536,-0.0146141348300562,0.0153258199025856,0.962840709528751
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSPAN7,Tetraspanin-7,37541,0.000405581074845989,0.00887196312728029,-0.0169834666546234,0.0177946288043154,0.963538170076154
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRC1,Protein regulator of cytokinesis 1,37900,0.000192101263674481,0.00451039518227908,-0.00864827329359251,0.00903247582094148,0.96602837501501
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOS2,"Nitric oxide synthase, inducible",37562,-0.000143309615414424,0.00380313081372339,-0.00759744601031227,0.00731082677948342,0.969941793057465
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAD2,Glutamate decarboxylase 2,37598,0.000163552261976961,0.00458667424981476,-0.00882632926765997,0.00915343379161389,0.97155549198262
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,37562,9.38515123605887e-05,0.00314463921632168,-0.0060696413516299,0.00625734437635108,0.976191186368226
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIRREL1,Kin of IRRE-like protein 1,37541,-0.00014268545274176,0.00597865837531121,-0.0118608558683517,0.0115754849628682,0.980960019602487
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,37541,0.000162699908304838,0.00731816140943263,-0.0141808964541831,0.0145062962707928,0.982262953195701
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,37714,7.13340763744563e-05,0.00398725926477857,-0.00774369408259154,0.00788636223534045,0.98572647393182
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYL4,Myosin light chain 4,37628,-8.61551655791473e-05,0.00508872166666647,-0.0100600496322454,0.00988773930108714,0.986492228790478
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRX,Cone-rod homeobox protein,40042,0.000152211971228322,0.0103619212253528,-0.0201571536304633,0.0204615775729199,0.988280043451821
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,37942,-2.98968283287701e-05,0.00299663492248331,-0.00590330127639606,0.00584350761973852,0.992039944622695
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,37598,-2.23004226562062e-05,0.00407299963986467,-0.00800537971679096,0.00796077887147855,0.995631540085182
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK3,Prostate-specific antigen,37998,-2.95937331460589e-05,0.00552707128890823,-0.0108626534594062,0.0108034659931141,0.995727966415981
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,37598,1.90983068403291e-05,0.00397264733387926,-0.00776729046756302,0.00780548708124368,0.996164296903537
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,37482,-1.25300406107657e-05,0.00477473215029478,-0.00937100505518854,0.00934594497396701,0.997906202412255
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL5,Interleukin-5,40044,-1.48246994653376e-05,0.0140768276048,-0.0276054068048734,0.0275757574059427,0.999159739160409
